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ABSTRACT  
 
Idiopathic Parkinson’s disease is a neurodegenerative condition that presents with a 
myriad of motor and non-motor symptoms. The complex and heterogeneous character 
of Parkinson’s disease suggests that it is a multisystem disorder with widespread 
pathology affecting different anatomical structures. In addition to localized dysfunction, 
changes in connections between brain regions and networks may contribute to 
Parkinson’s symptomology. This thesis explores this hypothesis in two prevalent 
symptoms of Parkinson’s disease: freezing of gait and visual hallucinations.  
 
Freezing of gait is an involuntarily paroxysmal breakdown of an individual’s footstep 
pattern whilst walking. Freezing of gait can be triggered by environmental factors or 
additional cognitive load. Furthermore, freezing behaviour can also be observed in non-
gait tasks, such as during speech or handwriting. These observations suggest that freezing 
cannot solely be attributed to a motor dysfunction. This thesis provides support for the 
notion that freezing of gait results from ineffective communication between distinct brain 
regions. Specifically, this thesis showed that freezing of gait is associated with deficits in 
executive functioning, mood and sleep disturbances as well as with the non-tremor 
dominant motor phenotype, confirming its multi-system nature.   
To investigate the underlying mechanisms of this multi-system symptom, the structural 
network topology in patients with freezing of gait was assessed. Importantly, the brain 
displays a modular structure and changes in the diversity of inter-modular connections 
(between-module connectivity) and the connections of a node within its own module 
(within-module connectivity) can inform about the integration and segregation of 
specialized communities. This thesis showed that patients with freezing of gait 
showed reduced between-module connectivity in subcortical and frontoparietal 
nodes. Several of these nodes were found within the brain’s ‘rich club’, a group of 
highly interconnected nodes that form the structural backbone of the connectome 
and, therefore, play an important role in global information integration between 
different modules in the brain. Freezing of gait could thus arise due to ineffective 
	 2 
communication between major cortical and subcortical integration centres. 
Furthermore, changes in within-module scores were observed across different 
sensory processing modalities. This may reflect a compensatory strategy and could 
indicate that compared to non-freezers, freezers rely more heavily on exogenous 
stimuli to guide their actions, perhaps due to a loss of automaticity.  
 
Visual hallucinations represent another common, yet poorly understood symptom of 
Parkinson’s disease. The pathophysiology of visual hallucinations is likely multi-faceted 
with changes across attentional and perceptual brain networks. First, we investigated 
attentional processing capability in patients with visual hallucinations using a 
computerized flanker task. With increasing task demands, Parkinson’s disease patients 
with visual hallucinations showed lower accuracy rates than patients without this 
symptom, yet the reaction times were similar between groups for correct trials. These 
findings suggest that hallucinators have specific impairments in sustained attention and 
conflict monitoring. Furthermore, the episodic nature suggests that visual hallucinations 
may arise during periods of ineffective integration of information. 
 
To investigate whether the severity of hallucinatory behaviour was associated with ability 
to successfully integrate information, changes in structural network topology were 
assessed. Severity of hallucinatory behaviour was associated with reduced connectivity 
across a structural bilateral sub-network. Nodes within this network showed higher 
between- and within-module scores compared to nodes outside this network. This may 
indicate that the system requires to reroute information across less efficient pathways, 
affecting the sensory integration process. Furthermore, severity of hallucinations was 
associated with changes in between-module scores across top-down visual processing 
centres and attentional networks. Thus, impaired integration across visual processing sites 
may result in the inefficient transfer of information that gives rise to visual hallucinations 
in Parkinson’s disease.  
 
The findings presented in this thesis suggest that freezing of gait and visual hallucinations 
may be the result of alterations in the brain’s information processing capability as 
indicated by reduced interactions between brain networks. By investigating the inherent 
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complexity of the brain’s interacting subsystems and their connections, we can advance 
our understanding of neurodegenerative disorders and ultimately, aid the developments of 
new and improved treatment strategies. 
 
		
	
	
CHAPTER	1	
INTRODUCTION	
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Chapter 1: Introduction 
1.1 Introduction to Parkinson’s disease 
Parkinson’s disease was first described in the Western medical literature in 175 AD as 
shaking palsy (van Swieten, 1742). However, it was not until 1817 that James Parkinson 
wrote a detailed essay that established this disorder as a medical condition (Parkinson, 
1817). Parkinson’s disease has traditionally been viewed as a movement disorder, with 
cardinal motor symptoms such as rest tremor, bradykinesia and muscular rigidity. Only 
recently, Parkinson’s disease has been reclassified as a far more complex disorder, 
affecting non-motor aspects including, but not limited to, cognition, speech, mood and 
sleep (Postuma et al., 2015). To date, Parkinson’s disease is amongst the most prevalent 
neurodegenerative disorders, yet is still poorly understood.  
Age is the greatest risk factor for Parkinson’s disease and with ageing population, the 
number of cases worldwide are expected to increase from an estimated 4.1 million in 
2005, to between 8.7 and 9.3 million by 2030 (Dorsey et al., 2007). Parkinson’s disease 
has a detrimental impact on quality of life and independence, especially with advancing 
disease (Schrag et al., 2000). Despite decades of research into this debilitating disorder 
there is no cure and whilst symptomatic treatments have been developed, many features 
are poorly managed or even untreated due to a lack of understanding of the underlying 
mechanisms.  
 
1.1.1 Basal ganglia dysfunction  
The main neuropathological hallmarks of Parkinson’s disease are Lewy bodies and Lewy 
neuritis (Lewy, 1912; Ohama & Ikuta, 1976). Lewy pathology, discovered in 1912 by the 
neurologist Dr Friedrich Lewy, consist of abnormal deposits of protein, with alpha-
synuclein as their main component, that disrupt the brain’s functioning. It is not known 
whether these inclusions directly disrupt neuronal functioning or represent some form of 
compensatory effort, but their presence is associated with cell death and thus dysfunction. 
The substantia nigra pars compacta (SNpc) is considered to be particularly vulnerable to 
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Lewy pathology. The subsequent loss of dopaminergic neurons in SNpc result in 
depletion of dopaminergic input to the striatum. The onset of the cardinal symptoms of 
Parkinson’s disease correlates with depletion in the dorsal striatum, specifically in the 
putamen. The striatum projects gamma-aminobutyric acid (GABAergic) efferents to the 
output nuclei of the basal ganglia, the ventrolateral internal pallidal segment (GPi) and 
the caudolateral substantia nigra pars reticulata (SNpr), either directly or indirectly via 
the intrinsic nuclei of the basal ganglia. The GPi/SNpr consist of inhibitory GABAergic 
neurons with a high rate of discharge that tonically fire to inhibit the brainstem nuclei. 
Thus, inhibitory projections to the GPi and SNpr, via the direct pathway, are associated 
with facilitating behaviour. Conversely, the indirect pathway inhibits the external part of 
the globus pallidus (GPe), which in turn results in disinhibition of the subthalamic 
nucleus (STN). The STN subsequently sends excitatory glutamatergic projections to 
GPi/SNpr neurons, thus activation of this pathway is associated with stopping or halting 
movement. A simplified description of the basal ganglia and its projections is illustrated 
in Figure 1.  
 
Figure 1. Simplified representation of the basal ganglia-thalamocortical circuit in a) healthy individuals 
and b) Parkinson’s disease patients. GPe = globus pallidus externus; GPi = globus pallidus internus; SNc 
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= substantia nigra pars compacta; SNr = substantia nigra pars reticulate; STN = subthalamic nucleus; 
PPN = pedunculopontine nucleus; SC = spinal cord; GABA = gamma-aminobutyric acid; BG  = basal 
ganglia. Thickness of lines and dashed lines represent increased and decreased activity. 
 
The basal ganglia are components of parallel basal ganglia–thalamocortical circuitry that 
display a spatial topological organization and are functionally subdivided into a motor, 
oculomotor, limbic and associative areas, following a dorsal-ventral gradient (Middleton 
et al., 2000). However, the input to the striatum from these segregated loops overlap and 
the striatum receives convergent input from multiple, often related, cortical areas. This 
enables the striatal nuclei to integrate information from different cortical areas and 
modalities (Bell et al., 2016; Chudler et al., 1995; Nagy et al., 2006). Evidently, basal 
ganglia dysfunction has major implications in patients with Parkinson’s disease. 
Dopamine depletion disrupts the balance of the direct and indirect routes and leads to a 
reduced ability of the basal ganglia to control the thalamic output to the cortex. 
Dysfunction within these subcortical nuclei has been associated with motor disturbances 
such as bradykinesia, impaired locomotion and postural muscle tone (Berardelli et al., 
200; Takakusaki et al., 2003), as well as deficits in executive functioning, working 
memory, motivation and learning capacity (Aarts et al., 2011; Frank, 2005; Middleton et 
al., 2000; Moustafa et al., 2008).   
 
1.1.2 Lewy pathology 
Other regions outside the SNpc are also affected by Lewy bodies, and according to the 
Braak hypothesis, Lewy bodies and Lewy neurites evolve according to a topographical 
sequence along major fibre pathways, starting with pre-symptomatic Lewy pathology in 
the dorsal motor nucleus of the vagal nerve and frequently in the anterior olfactory 
nucleus (Braak et al., 2003).  This involvement may explain prodromal features such as 
the dysregulation of parasympathetic functions such as constipation and the loss of smell, 
which are commonly seen prior to the clinical diagnosis of Parkinson’s disease (Goldman 
& Postuma, 2014). In Braak Stage 2, the Lewy pathology spreads in a caudal to rostral 
direction via the brainstem, affecting the serotonergic raphe nuclei, gigantocellular 
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reticular nucleus, and the noradrenergic coeruleus–subcoeruleus complex. These nuclei 
are involved in mood, somatic motor functioning and sleep mechanisms respectively; 
functions that can become deregulated before the cardinal motor symptoms of 
Parkinson’s disease appear. Indeed, only in Braak Stage 3, when Parkinson’s disease 
pathology reaches the SNpc, the pedunculopontine nucleus, the magnocellular nuclei of 
the basal forebrain and the amygdala, is it possible to make a diagnosis of Parkinson’s 
disease by current criteria (Postuma et al., 2015). In Braak Stage 4, Lewy pathology 
progresses to the hypothalamus, thalamus, and the anteromedial temporal mesocortex. 
Finally, in Braak Stage 5 and 6, the higher order association areas, including the insula 
and cingulate are affected.  
Whilst the stages described by Braak and colleagues generally appear to be confirmed 
when a clinical diagnosis of Parkinson’s disease has been made, it remains difficult to 
predict the course of the disease and the manifestations of the different symptoms in an 
individual. Indeed, not all patients will experience the same set of symptoms and even the 
chronological order of the manifestation of symptoms differs from one patient to another 
(Lewis et al., 2005). Additionally, neurofibrillary tangles, senile plaques, microvascular 
disease and argyrophilic inclusions also contribute to Parkinsonian pathology and their 
anatomical distribution varies between cases (Dickson et al., 2009; Halliday et al., 2014). 
Finally, axonopathy and synaptic dysfunction may impair white matter integrity in 
Parkinson’s disease (O’Malley, 2010). This complex and diverse milieu of 
neuropathological factors renders it challenging to provide a generalized model 
explaining the mechanisms underlying Parkinson’s disease and may cause the great 
clinical diversity seen in patients, which makes diagnosis and treatment strategies 
difficult. Finally, Parkinson’s heterogeneous manifestation raises the question of whether 
this neurodegenerative disorder is currently adequately characterized, or better serves as 
an umbrella term for different types of the condition (Fereshtehnejad et al., 2017).  
Studies using magnetic resonance imaging (MRI) combined with sensitive and specific 
behavioural tests have refined our understanding of Parkinson’s disease’s highly complex 
and heterogeneous pathophysiology. Such insights are crucial for facilitating accurate and 
timely diagnosis as well as to establish a robust brain-behaviour relationship to inform 
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pattern and progression of disease pathology. However, the clinical diversity of 
Parkinson’s disease has led to discrepancies in MRI studies investigating the underlying 
mechanisms of the disorder. This is specifically apparent in studies investigating 
structural brain changes. Gross macroscopic atrophy is not a key pathological process in 
Parkinson’s disease until the last clinical stages and changes in grey and white matter are 
likely to be subtler and symptom related. Indeed, when comparing Parkinson’s disease 
patients with healthy controls, studies investigating white matter using diffusion tensor 
imaging (DTI) have reported relatively robust subcortical findings but cortical changes 
varied, with results not always found to be replicable. This will become evident from the 
brief review provided on the current findings of white matter changes in section 1.3 of the 
Introduction. First, an overview of DTI theory is provided.  
 
1.2 White matter and diffusion tensor imaging  
Over half of the human brain consists of white matter: myelinated axons that connect 
neurons from different brain regions into functional circuits (Fields, 2010). Myelin 
affects the impulse conduction speed through axons, ensuring the temporal coincidence 
of firing from multiple, spatially differently located presynaptic neurons with regards to 
their joint postsynaptic firing (Fields, 2010). The summation of the conducted signals in 
the postsynaptic neuron creates a larger voltage response, which then can reach a critical 
threshold for the recipient neuron to fire. The conduction velocity of axons is therefore 
crucial for effective information processing (Fields, 2008) and any changes to the tract 
integrity can impair or suppress the transport of neurotransmitters through axons (Braak 
et al., 1999). There is some evidence that axonal degeneration is one of the earliest 
features of Parkinson’s disease. Specifically, it has been suggested that the loss of striatal 
axonal projections and terminals outweigh SN neuronal loss, and is responsible for 
progressive clinical deterioration (Burke et al., 2013; Rektor et al., 2018). This 
proposition needs further verification, but it warrants the exploration of white matter 
integrity in Parkinson’s disease.      
One MRI technique that can detect changes in white matter axons is DTI. DTI indirectly 
infers white matter integrity by measuring the three-dimensional motion of water 
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molecules (Le Bihan et al., 2001). In the absence of boundaries, water molecule 
displacement obeys a Gaussian distribution, described by Einstein’s diffusion equation 
(Einstein, 1956). Diffusion in biological tissues however, deviates from this law as 
cellular structures and membranes hinder the motion of water molecules. These structures 
cause water molecules to take more tortuous paths, thereby decreasing their mean 
displacement (Alexander et al., 2007). In fibrous tissues such as homogenous white 
matter axons, water moves relatively freely in the direction parallel to the axons. 
Conversely, water molecules are hindered in the direction perpendicular of the fibre 
orientation. The diffusion tensor can be described as a 3 x 3 covariance matrix that 
describes the covariance of the three-dimensional diffusion displacement (normalised by 
the diffusion time).  
! = !!! !!" !!" !!" !!! !!" !!" !!" !!!  
The diagonal elements in the diffusion matrix (Dii) represent the water displacement over 
the x, y and z axis (the eigenvalues λ1, λ2 and λ3) and the elements off the diagonal 
represent the covariance (the eigenvectors ε1, ε2 and ε3). The tensor can be visualised as 
an ellipsoid with the eigenvalues and eigenvectors describing its principal diffusion 
direction and apparent diffusivities (see Figure 2).  
The size of the eigenvalue is sensitive to change in local tissue integrity, due to axonal 
injury or demyelination (Le Bihan et al., 2001). Changes in white matter integrity lead to 
less convoluted paths, thereby increasing the mean or apparent displacement (MD) of the 
water molecules. Fractional anisotropy (FA) is the most commonly reported measure and 
characterizes the orientation distribution of the random movement of water molecules 
along the principal axis (Conturo et al., 1999). FA values close to 1 indicate anisotropic 
movement whilst values close to 0 indicate isotropic movement. Axial diffusivity (Da = 
λ1) is considered to be more specific to fibre degeneration whereas radial diffusivity (Dr 
= (λ2 + λ3)/2)) reflects changes in myelin (Le Bihan et al., 2001). 
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Figure 2. Schematic representation of diffusion displacement. The direction of greatest diffusivity (λ1) is 
assumed to be parallel to the local direction of white matter. 
Since the orientation of the diffusion tensor is thought to be aligned with the axon, white 
matter tracts can be reconstructed, in-vivo and non-invasively with a technique called 
tractography. Starting at the seed point, a tract can be reconstructed by following its 
principal direction, and moving forward in that direction until the tract is terminated, re-
evaluating its direction along the way (e.g. in each voxel). This approach is called 
deterministic tractography (Mori et al., 1999). Probabilistic tractography estimates the 
‘most likely’ fibre direction in each voxel, accounting for uncertainty (Parker et al., 
2003). 
Furthermore, whole brain white matter can be assessed using voxel-based analysis 
(originally developed for assessing changes in grey matter) or the more sophisticated 
technique Tract-Based Spatial Statistics (TBSS) (Smith et al., 2006). These techniques 
are fully automated and do not require a priori tracts or regions of interest. TBSS 
estimates a group mean FA skeleton that represents the centres of the fibre bundles that 
are common across subjects included in the investigation. The FA data of each subject is 
projected on the group mean skeleton, after which voxel-wise statistics can be carried out 
(Smith et al., 2006).  
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1.3 Diffusion tensor imaging in Parkinson’s disease 
Patients in the early stages of the disease already show changes in diffusivity, as observed 
by decreased FA values in both the olfactory region and the SN (Rolheiser et al., 2011; 
Vaillancourt et al., 2009). A recent meta-analysis including a heterogeneous group of 
1087 Parkinson’s disease patients and 769 healthy controls confirmed these changes and 
reported both lower FA and higher MD values in the SN (Atkinson-Clement et al., 2017). 
Importantly, both FA and MD measures within the SN were found to be good indicators 
for Parkinson’s disease identification as well as disease progression (Loane et al., 2016; 
Edward Ofori et al., 2015; Zhang et al., 2016). This meta-analysis also showed changes 
in the olfactory region, as well as other subcortical structures such as the putamen, 
pallidum and internal and external capsules with studies reporting either lower FA or 
higher MD values in patients compared to healthy controls. Surprisingly, the opposite 
pattern was found in the caudate nucleus and cortico-spinal tract in Parkinson’s disease 
patients compared to healthy controls, perhaps reflecting a reorganisation of the 
pathways. Increased FA or decreased MD could also reflect gliosis or glial scarring 
following axonal or neuronal insult (Budde et al., 2011). However, there is no apparent 
explanation of why this opposite pattern only affects the caudate nucleus.  
 
Parkinson’s disease patients in the early clinical stages also show increased axial 
diffusivity in the left superior and anterior corona radiata, internal and external capsule. 
Furthermore, elevations in radial and mean diffusivity and decreased white matter 
volume in the bilateral frontal and temporal areas are observed in patients without 
cognitive impairment relative to healthy control subjects (Martin et al., 2009; Rektor et 
al., 2018). However, a recent meta-analysis found that diffusivity changes in cortical 
areas were vastly heterogeneous: changes in diffusivity were not universal across groups 
but correlated to different symptoms (Atkinson-Clement et al., 2017). For example, a 
high variability was found in DTI measures of the corpus callosum but its white matter 
integrity was found to be associated with gait difficulties and impulse disorders 
(Atkinson-Clement et al., 2017). Furthermore, changes in diffusivity in the temporal 
cortex were only observed in patients with cognitive decline (Price et al., 2016).  
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Therefore, greater insights into Parkinson’s disease pathology might result from 
investigating the underlying mechanisms of isolated symptoms rather than grouping all 
Parkinson’s disease patients together. Chapter 2 of this thesis provides an in-depth 
review of the current findings on changes in diffusivity associated with specific motor, 
cognitive, associative and limbic symptoms.  
To get a better understanding of the heterogeneity in Parkinson’s disease, this thesis will 
particularly focus on two symptoms, namely freezing of gait and visual hallucinations. 
These seemingly disparate symptoms share several common features. Both freezing of 
gait and visual hallucinations are more often present in the advanced disease stages and 
are associated to the non-tremor dominant phenotype of Parkinson’s disease. Patients 
with this pyhenotype typically suffer from a range of cognitive and mood disturbances, 
on top of prominent motor symptoms such as gait disturbances and postural instability, 
rigidity and bradykinesia (Lewis et al., 2005) compared to patients in the tremor-
dominant group. Furthermore, previous work has suggested that both freezing and 
hallucinations are related to attentional network dysfunction (Shine, 2013b).  
 
The next sections will discuss the known associations of freezing of gait and visual 
hallucinations as well as the most putative hypotheses regarding their underlying 
neurobiology. However, investigations into the white matter changes underlying freezing 
of gait have been restricted and contradictory whilst studies evaluating visual 
hallucinations are lacking. It is possible that both of these symptoms could be the result 
of a broader network dysfunction that arises due to ineffective communication yet 
conventional DTI techniques might not be able to adequately capture the related changes. 
Therefore, Chapter 4 and 6 of this thesis will investigate whether these symptoms could 
be described as failure of effective communication across brain networks.   
 
1.4 Freezing of gait in Parkinson’s disease  
Freezing of gait is a common debilitating symptom described as a sudden inability to 
generate effective forward stepping, despite the intention to do so (Nutt et al., 2011), and 
is often described by patients as though their feet are ‘glued’ to the floor. Freezing of gait 
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has a major impact on a patient’s independence, risk of falls and quality of life (Gray et 
al., 2000; Walton et al., 2015; see Box 1). The freezing phenomenon is associated with 
impairments in executive functioning (Amboni et al., 2008; Muller et al., 2014; Naismith 
et al., 2010a), visuospatial processing (Ehgoetz Martens et al., 2014a; Matar et al., 2013) 
and anxiety (Ehgoetz Martens et al., 2014b; Lieberman, 2006). Environmental triggers, 
such as obstacles or doorways (Cowie et al., 2012), dual-tasking (de Souza Fortaleza et      
al., 2017; Spildooren et al., 2010) and stress (Giladi et al., 2006) can all trigger freezing 
of gait, whilst patients can sometimes use cueing strategies to alleviate this symptom 
(Rahman et al., 2008). Freezing is not restricted to the lower limbs but can also occur in 
the upper limbs (Nieuwboer et al., 2009) and speech (Ackermann et al., 1993), suggesting 
that the neural network underlying the phenomenon extends beyond the motor control of 
gait (Rahman et al., 2008). These observations have led to the proposal that freezing 
cannot be summarized by just a gait disturbance but might be the result of ineffective 
information processing across multiple circuits, leading to dysfunction in a common final 
pathway (Lewis & Barker, 2009; Lewis & Shine, 2016). In brief, it is proposed that due 
to an ineffective segregation of the motor, cognitive and limbic pathways, a variety of 
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stimuli and conditions can cause an overwhelming response when conflict arises. This 
overwhelming response leads to an increased firing of the STN, which is part of the 
inhibitory hyper-direct pathway of the basal ganglia. In turn, overactivity in the STN 
leads to paroxysmal activity in the GPi, subsequently inhibiting the activity of the basal 
ganglia output nuclei to the locomotor region in the brainstem, disrupting the effective 
motor plans (Lewis & Shine, 2016). Evidence for this hypothesis comes from a number 
of functional MRI studies that have shown alterations within frontal and parietal cortical, 
cerebellar and brainstem locomotor networks in Parkinson’s disease patients with 
freezing of gait. For example, during motor arrests provoked by a virtual reality 
paradigm, alterations in BOLD responses were observed within frontoparietal and insular 
cortices as well as sensorimotor regions, basal ganglia, thalamus and mesencephalic 
locomotor regions (Shine et al., 2013b). Furthermore, a functional decoupling between 
the bilateral cognitive control network and the basal ganglia during freezing behaviour 
was also evident (Shine, 2013a). Altered task-free (‘resting state’) functional connectivity 
has also been shown to be associated with the severity of freezing behaviour, specifically 
within the cognitive control network, visual networks and locomotor regions including 
Box 1: Evidence for the impact of freezing of gait on a patient’s quality of life 
Walton, C. C., Shine, J. M., Hall, J. M., O’Callaghan, C., Mowszowski, L., Gilat, M., 
Szeto, J. Y. Y., Naismith, S. L., Lewis, S. J. G. The major impact of freezing of gait 
on quality of life in Parkinson's disease. Journal of Neurology, 2015. 	
This study performed a regression analysis including factors that are known to impact 
a patient’s well-being. The model included cognition, motor severity, sleep and mood 
disturbances and freezing of gait. After controlling for disease duration and current 
dopaminergic treatment, the significant predictors to a patient’s quality of life were 
self-reported sleep-wake and mood disturbances and freezing of gait. Importantly, 
freezing of gait accounted for the highest amount of unique variance to a patient’s 
quality of life. We hypothesized that this finding is due to a loss of independence and 
fear of injury.  	
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the supplementary motor cortex, mesencephalic and cerebellar motor regions (Fling et al., 
2014; Tessitore et al., 2012). Together, these results confirm the involvement of both 
higher order cortical and locomotor regions in the manifestation of freezing of gait.  
 
Other models of freezing exist that have aimed to describe freezing behaviour in 
Parkinson’s disease.  Plotnik and colleagues (2012) hypothesized that freezing of gait 
results from poor control of one or more gait disturbances associated with freezing: 
deterioration in bilateral coordination, gait symmetry and rhythmicity, dynamic postural 
control and/or step scaling (Plotnik et al., 2012). When the overall gait performance can 
no longer be maintained above a certain threshold, a freezing episode takes place. 
Additionally, freezing of gait is often accompanied by a trembling of the knee and it was 
found that anticipatory postural adjustments coexist with knee trembling during 
automatically triggered stepping responses to platform perturbations. This observation 
gave rise to the suggestion that freezing results from a decoupling between pre-planned 
motor programs, such as anticipatory postural adjustment during step initiation and the 
release of an inherent stepping movement (Jacobs et al., 2009). The mechanisms in both 
models indicate involvement of the pedunculopontine nucleus (PPN), a collection of 
cholinergic and glutamatergic neurons located in the brainstem that is involved in 
voluntary limb movements, the planning of movement, posture as well as attention and 
arousal (Garcia-Rill et al., 2015; Tsang et al., 2010). Furthermore, the PPN provides 
sensory feedback to the cerebral cortex (Li et al., 2015).  These models are supported by 
research into deep brain stimulation of the PPN, which can sometimes improve postural 
instability and gait disorders (Wang et al., 2016). However, these models do not account 
for the symptoms that often accompany freezing, such as executive dysfunction and 
anxiety (Hall et al., 2014). In contrast, Vandenbossche et al. (2013) suggest that the 
interplay between decreased gait automaticity and impairments in cognitive control play 
a key role in the occurrence of freezing of gait. Parkinson’s disease patients suffer from 
motor automaticity as a result of subcortical impairments and therefore rely more heavily 
on attentional resources. During challenging or ambiguous task requirements, freezing 
episodes can occur as a result of a breakdown in stepping motion. This hypothesis also 
incorporates the amelioration of freezing by using cueing strategies. Visual or auditory 
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cues force patients to utilize attentional control to maintain a stepping motion, 
presumably by circumventing the impaired subcortical structures (Bella et al., 2017; Ghai 
et al., 2018; Nieuwboer, 2008).  
 
Evidently, more research into the associations and underlying mechanisms of this 
prevalent symptom is highly necessary. Chapter 3 of this thesis aimed to explore the 
epidemiology of freezing, as well as associated symptoms in different clinical stages of 
Parkinson’s disease. Subsequently, Chapter 4 assessed changes in the structural network 
topology of patients with freezing of gait, to explore whether this symptom can be 
described as a result of a more general network dysfunction due to ineffective 
information processing.  
 
1.5 Visual hallucinations in Parkinson’s disease 
Similar to freezing of gait, hallucinations are more common in advanced Parkinson’s 
disease. Visual hallucinations are the most frequently observed, with a reported 
prevalence of up to 80% in the later clinical stages (Hely et al., 2008; Amar et al., 2014). 
In addition, visual hallucinations are more often associated with dementia, sleep disorders 
and depression (Sanchez-Ramos et al., 1996). Visual hallucinations range from relatively 
benign misperceptions, such as a shadow in the peripheral visual field to well-formed 
(often more frightening) hallucinations with a loss of insight, such as seeing people or 
animals.  
 
Visual symptoms are often reported in Parkinson’s disease, with 78% of patients 
subjectively reporting visual complaints, including double vision whilst reading and 
misjudging objections and distances (Weil et al., 2016). Visual hallucinations more often 
occur in dim-light environments. Furthermore, it is well known that decreased contrast 
sensitivity and colour vision, as well as impaired visual acuity are common features in 
Parkinson’s disease (Archibald et al., 2011; Weil et al., 2016).  Such visual complaints 
more prevalent in Parkinson’s disease patients with hallucinations than in patients 
without (Gallagher et al., 2011). In addition to end organ deficits that might be regarded 
as arising from the eyes, hallucinators have reduced glucose consumption in the occipital-
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temporal regions (Boecker et al., 2007) and reduced grey matter volume in higher visual 
processing areas of the brain, such as the superior parietal lobe compared to non-
hallucinators (Ramírez-Ruiz et al., 2007; Lenka et al., 2015).  Thus there are likely to be 
combined ‘peripheral and central’ contributions to the visual hallucinations observed in 
Parkinson’s disease. One of the earlier theories about the mechanisms underlying 
Parkinsonian hallucinations proposed that they arise from decreased visual input, which 
in turn leads to the ‘inappropriate release of stored images’ (ffytche et al., 1999). 
Interestingly, significant glucose hypometabolism in visual association areas have been 
shown in patients with dementia with Lewy bodies (Higuchi et al., 2000). Whilst the 
visual pathway appears to be intact in this patient group, the inferior longitudinal 
fasciculus, involved in visuospatial cognition, is degenerated in dementia with Lewy 
bodies (Ota et al., 2009). Whilst lack of sensory input adds to the occurrence of simple 
misperceptions, loss of visual stimuli due to eye disease or stroke does not always lead to 
hallucinations. Indeed, some patients without any visual dysfunction also experience 
hallucinations, suggesting that these deficits alone are not sufficient to explain their 
occurrence (Muller et al., 2014). Neuropathological studies in dementia with Lewy 
bodies have shown aggregated Lewy bodies in the inferior temporal cortex, including the 
amygdala and parahippocampus, which have been linked with visual hallucinations 
(Harding et al., 2002). The inferior temporal cortex integrates predictive information 
from the orbitofrontal cortex with high spatial frequency information from the visual 
areas (Trapp and Bar, 2015). 
 
Models in Parkinson’s disease incorporate the interplay between perceptual and 
attentional impairments to the occurrence of misperceptions and hallucinations. For 
example, The Perception and Attention Deficit Model proposed that a hallucination might 
intrude due to a combination of impaired attention and visual perception (Collerton et al., 
2005). Proto-objects are subconscious object representations competing for further 
processing and reaching conscious awareness. When an incorrect visual proto-object is 
bound to the attentional focus of a scene, due to both impaired attentional binding and 
poor sensory activation of the proto-object, a visual hallucination can intrude within a 
relatively intact scene representation. Object perception relies primarily on the visual 
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ventral stream, whilst attentional object recognition is processed in the lateral prefrontal 
cortex (Collerton et al., 2005). Cholinergic pathology might disrupt communication 
between these areas, resulting in inadequate integration of sensory information and 
perceptual expectations. While this proposition is promising for recurrent visual 
hallucinations, certain aspects need further exploration, including the manifestation of 
unfamiliar images, and physiological details of proto-objects. Shine and colleagues 
(2011) proposed that a breakdown in communication between exogenous and 
endogenous attentional network give rise to visual hallucinations. Specifically, in the 
presence of an ambiguous percept, an inability to recruit the dorsal attentional network, a 
network responsible for focusing on externally driven percepts, leads to an over-reliance 
on attentional networks that are less equipped to interpret visual stimuli, such as the 
salience ventral attentional network and the default mode network, involved in the 
retrieval and manipulation of episodic memory and semantic knowledge (Raichle et al., 
2001). This hypothesis has gained support from task-free functional neuroimaging studies 
showing reduced coherence between the dorsal and ventral attentional network in 
individuals prone to hallucinate (Shine et al., 2014). Hallucinators also showed reduced 
grey matter volume within anterior insula, a node involved in shifting attention to the 
dorsal attentional network when an ambiguous percept is presented. Furthermore, a 
functional connectivity analysis showed increased coupling between the default mode 
network and the visual networks during misperceptions (Shine et al., 2015).  
 
Despite these advances, the exact mechanisms underlying this phenomenon are still 
poorly understood. Their episodic and involuntary nature provide challenges for 
investigating this symptom in real time, as it is difficult to elucidate misperceptions or 
hallucinations in a clinical setting. This thesis will first investigate the attentional 
processes in patients with visual hallucinations using an objective computerized task, 
followed by an investigation of structural connectome changes associated with 
hallucinatory behaviour. To date, few studies have investigated the contribution of white 
matter alterations to this symptom, and assessing the network topology can shine a new 
light on the interplay between the major attentional networks that possibly underlie 
adequate perceptual processing.  
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1.6 Parkinson’s disease as a disconnection disorder 
Considering their episodic nature and myriad of associations, it is anticipated that both 
freezing of gait and visual hallucinations are the result of a multisystem communication 
failure (Caligiore et al., 2016).  By re-framing our understanding of these two symptoms 
as impairments of a more general impairment in effective information transfer, we could 
improve not only our conceptual understanding of freezing of gait and visual 
hallucinations, but perhaps of Parkinson’s disease in general, and ultimately improve 
currently available treatments. 
To explore the role of connectivity in Parkinson’s disease, a newly emerging toolbox of 
analytical techniques is required. Graph theory offers a tool to explore the inherent 
complexity of the brain’s interacting subsystems and their connections. White matter 
axons in the human brain together form the structural connectome and provide the 
foundation for distributed patterns of brain activity. Brain regions strongly influence one 
another through their interconnections as part of a larger network, and this organizational 
structure plays a crucial role in healthy brain functioning (Bassett et al., 2009; van den 
Heuvel et al., 2009). Many biological networks, including the brain, display a modular 
structure in which communities of densely interconnected nodes are only sparsely 
connected with nodes of other sub-networks (Sporns et al., 2004). This structure 
promotes specialized processing and minimizes ‘wiring costs’ (Bullmore et al., 2012). 
High degree nodes or ‘connector hubs’ mediate communication between the relatively 
segregated modules and thus play a significant role in integrating information. Connector 
hubs have a higher number of connections with other nodes than one would expect by 
chance and damage to these key nodes significantly changes the balance in community 
structure (Guimerà, & Amaral, 2005).  
Recently, complex network analysis using graph metrics have led to new insights in 
neuropsychiatric and neurodegenerative disorders such as Alzheimer’s disease (Phillips 
et al., 2015; Vecchio et al., 2015), schizophrenia (van den Heuvel et al., 2013; van den 
Heuvel et al., 2010; Zalesky et al., 2011), multiple sclerosis (Li et al., 2013; Shu et al., 
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2011) and epilepsy (Bonilha et al., 2012; Liu et al., 2014; Otte et al., 2012). Notably, a 
meta-analysis of grey matter lesions across 26 neurological disorders showed that on 
average, connections central to the brain's infrastructure were disproportionally affected 
(Crossley et al., 2014). This finding was replicated in a recent meta-analysis on macro-
scale white matter pathways, showing that brain hubs were involved in the pathology of 
twelve neurological and psychiatric disorders (de Lange, 2018). Connections critical for 
integration and global network communication were particularly affected across 
disorders. The basal ganglia are part of a fundamental circuit that supports large-scale 
network integration. Given their known substantial involvement in Parkinson’s disease, 
this condition could also be described as a disconnection disorder. Additionally, recent 
work has shown an important role for the noradrenergic locus coeruleus in network 
integration (Shine et al., 2018). The locus coeruleus is a small brainstem structure that 
has been documented to show significant cell death already in the early stages of 
Parkinson’s disease (Gesi et al., 2000).  
 
However, to date, relatively few studies have investigated the structural network topology 
in Parkinson’s disease. These studies observed an unaffected modular structure, but a 
reduced white matter connectivity in frontoparietal-striatal nodes in Parkinson’s disease 
patients compared to healthy controls (Tinaz et al., 2017). Nodes within these superior 
frontal and parietal regions, as well as in the anterior and posterior cingulate cortices and 
insula are identified as connector hubs, and it is possible that the selective damage to 
these regions cause a range of symptoms in Parkinson’s disease. Furthermore, reduced 
global and local efficiency was observed when exploring changes in network topology 
(Li et al., 2017; Wen et al., 2017), whilst whole brain analysis using TBSS yielded 
negative results in the same individuals (Wen et al., 2017). These findings provide 
evidence for the notion that rather than a focalised lesion, Parkinson’s disease patients 
show a reorganisation of white matter network architecture. Indeed, the multitude of 
potentially altered individual connections, especially in a heterogeneous population, 
imposes significant methodological and statistical restrains. Utilizing a broader network 
dysfunction model could circumvent these constraints and may also benefit the 
neuromechanically explanation of Parkinson’s symptomatology. 
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Whilst previous research on network changes in Parkinson’s disease have mainly focused 
on the burden of the disorder in general, this thesis will focus on two different symptoms, 
namely freezing of gait and visual hallucinations. First, Parkinson’s disease is a 
heterogeneous disorder and focusing on symptoms separately may give distinctive 
insights into their pathophysiology. Freezing of gait and visual hallucinations are likely 
part of the same clinical phenotype. Furthermore, as mentioned above, both symptoms 
are of episodic nature and can be triggered by physiological and environmental factors. 
Therefore both freezing and hallucinations may result from a diffuse, network-level 
dysfunction (Lewis & Shine, 2016). 
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1.7 Aims of the thesis 
 
Aim 1:  Conduct an extensive literature review to explore the contribution of changes in 
diffusivity to Parkinson’s disease.  
The first aim of this thesis was to conduct a thorough review of all relevant 
literature to provide an overview of the current understanding of white matter 
alterations to different symptoms of Parkinson’s disease. Chapter 2 discusses 
empirical studies to date using DTI to investigate different motor symptoms such 
as bradykinesia, tremor and freezing of gait, cognition, including attention, 
executive function, mild cognitive impairment and dementia, mood and sleep 
disturbances.  
Aim 2: To investigate whether freezing of gait could be a result to ineffective 
communication between brain networks (Chapter 3 and Chapter 4). 
The pathophysiology of freezing of gait is still poorly understood, but previous 
work has shown an association between freezing behaviour and executive 
dysfunction. In order to expand our knowledge of this symptom, Chapter 3 aimed 
to investigate the prevalence of freezing of gait across the clinical motor stages. 
Furthermore, Chapter 3 provides an in-depth comparison of the clinical 
phenotype of patients with and without freezing of gait. It was hypothesized that 
freezing of gait is a multifaceted symptom rather than a sole gait disturbance. As 
such, we expected to show impairments on variables related to frontostriatal 
dysfunctions, rather than on variables related to brainstem pathology in 
Parkinson’s disease patients with freezing of gait.  
 
Furthermore, the contribution of white matter lesions to freezing of gait is poorly 
understood. In Chapter 4 of this thesis, I aimed to investigate the topological 
properties of the white matter connectome of Parkinson’s disease patients with 
and without freezing of gait. It was hypothesized that Parkinson’s disease patients 
exhibit changes in structural network topology, especially in frontoparietal and 
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subcortical networks. Key information processing may be affected in freezers, 
which can hamper effective communication between brain networks.  
Aim 3: To investigate whether visual hallucinations in Parkinson’s disease arise due to a 
reweighting of attentional and perceptual brain networks (Chapter 5 and Chapter 
6). 
Previous work has associated visual hallucinations with attentional dysfunction. 
Chapter 5 aimed to further explore attentional processing deficits in Parkinson’s 
disease patients with visual hallucinations using an objective attentional network 
test that can entangle different attentional processes. It was hypothesized that a 
disruption within and between attentional networks, as previously been shown in 
Parkinson’s disease patients with visual hallucinations, would lead to a deficit in 
the overall performance of the task. 
 
Finally, Chapter 6 aimed to investigate changes in structural network topology 
associated with severity of hallucinatory behaviour in Parkinson’s disease patient. 
Specifically, Chapter 6 of this thesis tested the hypothesis that visual 
hallucinations arise due to a reweighting of the perceptual processing system. 
Changes in connectivity could indicate inefficient integration of different 
perceptual sites, which would underlie inadequate interpretation of visual stimuli.  
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Chapter 2: Diffusion alterations associated with Parkinson’s disease 
symptomatology: A review of the literature 
 
Abstract 
Parkinson’s disease (PD) is a heterogeneous neurological disorder with a variety of motor 
and non-motor symptoms. The underlying mechanisms of these symptoms are not fully 
understood. An increased interest in structural connectivity analyses using diffusion 
tensor imaging (DTI) in PD has led to an expansion of our understanding of the impact of 
abnormalities in diffusivity on phenotype. This review outlines the contribution of these 
abnormalities to symptoms of PD including bradykinesia, tremor and non-tremor 
phenotypes, freezing of gait, cognitive impairment, mood, sleep disturbances, visual 
hallucinations and olfactory dysfunction.  Studies have shown that impairments in 
cognitive functioning are related to diffusion abnormalities in frontal and parietal regions, 
as well as in the corpus callosum and major fibres connecting midbrain and subcortical 
structures with the neocortex. However, the impact of diffusion alterations on motor, 
mood and other symptoms of PD are less well understood. The findings presented here 
highlight the challenges faced and the potential areas of future research avenues where 
DTI may be beneficial. Larger cohort studies and standardized imaging protocols are 
required to investigate current promising preliminary findings. 
Key words: Parkinson’s disease; white matter tracts; diffusion tensor imaging; 
heterogeneity  
Abbreviations: PD = Parkinson’s disease; DTI = diffusion tensor imaging; FA = 
fractional anisotropy; MD = mean diffusivity; TBSS = tract-based spatial statistics; ROI 
= region of interest; SN = substantia nigra; SLF = superior longitudinal fasciculus; IF-OF 
= inferior fronto-occipital fasciculus; PPN = pedunculopontine nucleus; PIGD = postural 
instability and gait disorder; FOG = freezing of gait; MCI = mild cognitive impairment; 
VH = visual hallucinations; RBD = REM sleep behaviour disorder. 
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Introduction  
Parkinson’s disease (PD) is classified as a movement disorder with its cardinal motor 
symptoms of bradykinesia, muscle rigidity and resting tremor predominantly arising from 
nigrostriatal dopaminergic denervation. However, it has become evident that PD is a 
multisystem disorder extending beyond the loss of dopamine (Langston, 2006). Indeed, 
PD can be better characterised as a heterogeneous disorder with a wide variety of both 
motor and non-motor symptoms, including cognitive impairments, sleep-wake 
disturbances, mood disorders, autonomic dysfunction and visual hallucinations 
(Chaudhuri et al., 2006). The complexity of this disorder is emphasised by its clinical 
diversity with symptoms differing greatly across patients (Lewis et al., 2005). This 
degree of heterogeneity has hampered the understanding of the neural underpinnings of 
each symptom, leaving many symptoms poorly managed or even unable to be treated. In 
an attempt to mitigate these issues, magnetic resonance imaging (MRI) techniques have 
been used to investigate tissue alteration and abnormalities that may be present in order to 
provide a more thorough understanding of the neural basis underlying symptomology in 
PD (Goveas et al., 2015; Weingarten et al., 2015).  
One such structural imaging technique, diffusion tensor imaging (DTI) is a non-invasive 
imaging approach that analyses the diffusivity in brain tissues. It is sensitive to the flow 
of water molecules, and as water predominantly diffuses along axons, DTI can be used to 
infer white matter tracts throughout the brain (Le Bihan, 1985; Merboldt et al., 1985). 
The organisation of axons and their properties (i.e. axonal ordering, diameter, density, 
myelination, microstructural complexity and white matter integrity changes) are the main 
contributors that influence the flow of water molecules along neural pathways. Water 
molecules move much faster along parallel white matter fibres compared to perpendicular 
fibres. Fractional anisotropy (FA) is a measure that reflects the degree of diffusivity in 
the different directions and can inform understanding of the microstructural organization 
of the tensors; an organized multidimensional array of numerical values, expressing a 
relationship between vectors (Basser et al., 1996). A decrease in FA values may arise 
from demyelination, axonal loss or changes in the size of axons. Mean diffusivity (MD) 
represents the overall movement of water molecules within the brain. Structurally intact 
white matter has high FA and low MD, whereas structurally compromised white matter 
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has low FA and high MD. Additionally, DTI provides an estimate of diffusivity along 
(axial diffusivity; AxD) and perpendicular (radial diffusivity; RxD) to the main fibre 
direction. RxD increases in response to demyelination (Song et al., 2005), whereas a 
decrease in AxD is indicative of axonal damage (Song et al., 2003). Grey matter 
abnormalities can also be detected with DTI analyses. Anisotropy in grey matter is much 
lower as the cellular membranes are not positioned along a preferential direction 
(Pierpaoli et al., 1996). As such, MD, rather than FA, is an appropriate metric for cortical 
and subcortical grey matter, and can inform about the possible breakdown of barriers to 
diffusion, resulting in higher MD values. DTI can detect microscopic tissue abnormalities 
and might be able to detect these changes earlier than conventional structural MRI 
sequences.  DTI data can be analysed using: i) tract based spatial statistics (TBSS)(Smith 
et al., 2006) (white matter) and voxel-based analyses (VBA; white and grey matter), 
which entail a whole-brain unbiased hypothesis-free approach, and/or ii) a probabilistic 
tractography approach which estimates the most likely fibre orientation at each voxel 
tracing a single tract (in contrast with streamline or deterministic tractography). 
Probabilistic tractography is a valuable and informative technique for testing a priori 
hypotheses.  
Diffusion tensor MRI can detect alterations in white matter in the early stages of PD and 
has therefore proven useful as a biomarker in our understanding of PD (Vaillancourt et 
al., 2009). Lewy neurites, a pathological hallmark of PD, might affect axons and 
dendrites in the brain and can be present from the early stages of PD (Kanazawa et al., 
2012). Lewy neurites might not only appear before Lewy bodies but they could extend 
subsequently to develop Lewy bodies (Braak et al., 2003).  White matter damage could 
add to the PD pathophysiology by disrupting neuromodulator projection systems (Double 
et al., 1996). Indeed, white matter atrophy has been shown to have a greater influence on 
remote metabolism than grey matter alterations in Alzheimer’s disease (Villain et al., 
2010). Additionally, altered patterns of functional connectivity correlate with axonal 
injury (Palacios et al., 2013; Sharp et al., 2011).  
DTI analysis of white matter changes has been shown to successfully distinguish PD 
patients from healthy controls (Vaillancourt et al., 2009) and from Parkinsonian 
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syndromes (Cochrane et al., 2013). Several studies using an a priori region of interest 
(ROI) approach have confirmed the widespread nature of PD by reporting alterations in 
diffusivity in subcortical structures as well as an association between reduced FA in the 
substantia nigra (SN) pars compacta and increasing motor severity (Ofori et al., 2015; 
Vaillancourt et al., 2009; Zhan et al., 2012).  
Although these interesting results provide insight into PD pathology, it is important to 
investigate the clinical diversity of this disorder in order to determine better treatment 
options and predictions of progression. Therefore, the aim of this review is to provide an 
overview of studies that have investigated the association between alterations in 
diffusivity and PD motor symptoms, such as tremor, bradykinesia and freezing of gait 
(FOG) as well as non-motor symptoms, including cognitive impairment, mood 
disturbances, visual hallucinations (VH), REM sleep behaviour disorder (RBD) and 
autonomic dysfunction. With the accumulated knowledge regarding the neural 
underpinnings of such symptoms, a more complete understanding of the underlying 
heterogeneity in PD will potentially result in improved symptom management and 
highlight the challenges faced and the potential areas of future research avenues where 
DTI may be beneficial. 
 
Search Strategy  
A literature search was carried out in September – December 2015 using the search 
engines PubMed and Scopus using the criteria of English language and human studies 
with no time scale restrictions. The following key words were used in the literature 
searches: Parkinson's disease (MeSH); diffusion tensor imaging (MeSH), white matter; 
fractional anisotropy, mean diffusivity, tractography. In total, 243 articles were found and 
91 articles were selected based on titles and abstracts. Articles were excluded when they 
were unrelated to the topic (e.g. focusing on Parkinsonism). The results were further 
examined and articles were excluded if they used DTI to investigate anatomical 
differences between PD and healthy controls (without relation to a specific PD symptom 
(28)), anatomical studies of the progression of PD (6), to inform deep brain surgery (16), 
or the influence of medication (1). Seven articles were added after scanning the reference 
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lists of the selected articles. A total of 47 articles met the criteria and were included in 
this review. An overview of these results is provided in Table 1.  
 
 
 
Figure 1. Flowchart of search strategy 
 
Results 
Motor correlates  
Motor dysfunctions are typically the initial signs of PD that lead to diagnosis and the 
administration of medication. The severity and progression of these motor symptoms can 
be assessed by rating scales including the Unified Parkinson’s Disease Rating Scale 
(UPDRS)(Goetz et al., 2008), the Hoehn and Yahr clinical motor scale (H&Y) (Hoehn & 
Yahr, 1967) and scale Schwab and England (SE) scale (Schwab et al., 1968). Lenfeldt 
and colleagues investigated the progression of alterations in diffusivity with motor 
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deterioration (Lenfeldt et al., 2013). They reported that worsening scores on the H&Y 
and SE scale correlated with an increase in MD in the putamen, globus pallidus and 
thalamus, while this correlation was not observed for the UPDRS (Lenfeldt et al., 2013). 
However, these are measures of generalised motor functioning and more specific 
symptoms have also been explored and will be discussed below. Nevertheless, these 
results demonstrate that progression of diffusivity abnormalities are associated with 
worsening of motor symptoms in PD. 
 
To accommodate for the heterogeneity in the clinical symptoms, several motor subtypes 
have been proposed that generally focus on features of tremor and non-tremor (Jankovic 
et al., 1990; Lewis et al., 2005; Zetusky et al., 1985). A few studies have investigated 
white matter pathology between the tremor dominant and postural instability and gait 
difficulty (PIGD) subgroups. The tremor dominant phenotype is characterized by modest 
motor symptoms other than tremor and relatively spared cognitive function (Lewis et al., 
2005). In contrast, patients in the PIGD or non-tremor dominant phenotype more often 
experience executive dysfunction and mood disorders in addition to gait and balance 
difficulties (Lewis et al., 2005).  Differences in white matter integrity between these 
subtypes are reported to be already present in the early stages of PD (Tessa et al., 2008). 
For example, whole brain analyses have shown FA reductions in the bilateral superior 
longitudinal fasciculus (SLF) in patients within the dominant PIGD phenotype compared 
to tremor dominant patients (Gu et al., 2014). The SLF connects the parietal, temporal 
and occipital lobes with ipsilateral frontal cortices and abnormalities within this tract 
could impair communication between these circuits (Makris et al., 2005), which might 
contribute to why patients with the PIGD phenotype have a greater severity and variety of 
symptoms. This study identified the subgroups based on the PIGD/tremor ratio derived 
from UPDRS scores. However, the PIGD score did not differ between the groups, 
suggesting the categorisation into subgroups was primarily based on tremor severity (Gu 
et al., 2014). Additionally, a region of interest analysis on diffusivity differences between 
tremor dominant patients and patients who initially presented with predominant postural 
instability, frequent falls, freezing and walking difficulties demonstrated reduced FA in 
the corpus callosum tracts and increased MD values in the thalamus, putamen and corpus 
	 45 
callosum in PIGD (Chan et al., 2014).  Furthermore, higher MD values in the thalamus, 
corona radiata, centrum semiovale and the corpus callosum are shown in PIGD patients 
compared to control participants. These findings are in keeping with the notion that PIGD 
pathophysiology is widespread with greater involvement of the corticostriatal motor loop 
and frontal areas compared to those patients with tremor dominant pathology (Lewis et 
al., 2005). Future studies should also take non-motor symptoms into account when 
classifying subtypes, as they form an important aspect of identifying phenotypes in PD.  
 
Several studies have investigated the association between diffusivity changes and a 
specific motor symptom, such as bradykinesia. Based on the notion that dopamine 
depletion in the SNpc is implicated in slowness of movement, Ofori et al. (2015) 
analysed ROI free-water imaging, a method for diffusion MRI which separately models 
the contribution of extracellular free water and water that is in the vicinity of cellular 
tissue. The authors found that an increase in free water values in the posterior SN could 
predict the progression of bradykinesia over one year. Additionally, it has been shown 
that frontal areas also contribute to bradykinesia (Lee et al., 2014). Lee and colleagues 
(2014) investigated 12 de novo PD patients and found that bradykinesia negatively 
correlated with FA values in the long association fibres connecting the frontal lobes to the 
temporal, parietal, and occipital lobes (the SLF, the uncinate fasciculus and the inferior 
fronto-occipital fasciculus (IF-OF)). The authors hypothesized that these regions are 
unable to correct hypokinetic movements due to the dysfunction of the error detector 
centre postulated to be within the anterior cingulate cortex (Carter et al., 1998; Lee et al., 
2014).  
 
Diffusivity changes have further been associated with FOG, a sudden and transient gait 
disturbance described as the inability to move forward despite the intention to walk 
(Giladi et al., 1992). Studies investigating FOG focused predominantly on the brainstem 
locomotor regions and found white matter abnormalities in the corticopontine and (right) 
pontine-cerebellar tracts in freezers (Canu et al., 2015; Fling et al., 2013a; Schweder et 
al., 2010; Vercruysse et al., 2015; Youn et al., 2015). The pedunculopontine nucleus 
(PPN) is associated with gait regulation and posture (Fraix et al., 2013; Karachi et al., 
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2010) and has frequently been identified as a key hub in this debilitating symptom (Nutt 
et al., 2011).  In addition to locomotor areas, the involvement of frontal regions in FOG 
has become increasingly recognized (Shine et al., 2013a; Vercruysse et al., 2014). A 
recent study found white matter abnormalities in the subcortico-cortical tracts 
(Vercruysse et al., 2015). Whole brain analyses further demonstrated white matter 
alterations within the major cortico-cortical, several frontostriatal tracts (see Table 1) as 
well as in regions in the cerebellum in FOG patients compared to non-FOG patients 
(Canu et al., 2015; Vercruysse et al., 2015). These results are in agreement with the 
notion that complimentary yet competing frontostriatal pathways might induce FOG that 
process motor, cognitive and limbic information (Lewis & Barker, 2009). However, the 
authors note that the difference between freezers and non-freezers in the whole brain 
analyses was partly driven by increased FA values in non-freezers compared to controls, 
which may indicate a possible compensation mechanism.  
 
These results emphasize the involvement of the long association fibres and frontal areas 
in the manifestation of different motor symptoms, but also highlight the distinct neural 
abnormalities underlying these symptoms in PD.  However, more research is needed to 
address the inconsistencies in the findings using objective measures to measure motor 
performance.    
 
Cognitive correlates 
Cognitive impairment is one of the most common non-motor aspects of PD and manifests 
in many domains such as attention, executive, visuospatial functioning and memory and 
can progress to dementia (Svenningsson et al., 2012). White matter tracts are key to 
efficient cognitive processing and changes in anisotropy have consistently been 
associated with cognitive deficiencies.  
 
The relationship between white matter damage and executive functions in PD has been 
investigated in several studies where DTI combined with neuropsychological testing is 
valuable for identifying correlations. Executive dysfunction has been associated with 
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widespread diffusion abnormalities in the left parietal and frontal regions (Auning et al., 
2014; Duncan et al., 2016; Gallagher et al., 2013; Koshimori et al., 2015; Matsui et al., 
2007b; Melzer et al., 2013; Rae et al., 2012; Theilmann et al., 2013; Zheng et al., 2014), 
corpus callosum and major fibres connecting midbrain and subcortical structures with the 
neocortex, such as the posterior thalamic radiation, anterior corona radiate and the 
internal capsule, as well as regions within the striatum (Al Serafy et al., 2015; Koshimori 
et al., 2015; Melzer et al., 2013; Zheng et al., 2014). Attentional capacity and language 
have also been associated with changes in areas implicated in executive dysfunction, such 
as in the major cortical tracts and thalamic radiation. However, unique patterns of 
diffusivity have also be identified for these separate cognitive domains, such as changes 
in the cingulate gyrus are associated with attention dysfunction (Zheng et al., 2014) and 
Broca’s and Wernicke’s areas relating to speech impairment (Lee, 2011). Response 
inhibition, as measured by NoGo errors, was not found to be associated with any FA 
reductions (Ye et al., 2014). Short-term memory impairment correlates inversely with the 
MD values within the fornix, whereas long-term memory performance inversely 
correlates with MD in the right anterior corona radiate (Zheng et al., 2014). Evidently, the 
white matter abnormalities as well as diffusivity changes in grey matter in cognitively 
impaired PD patients are widespread in keeping with the heterogeneous nature of 
cognitive impairments in PD.  
 
Dementia in PD (PDD) is common in the advanced stages and estimated to affect 48-83% 
of PD patients with disease duration over 15-20 years (Hely et al., 2005; 2008). Mild 
cognitive impairment (MCI) is a transitional state between normal cognitive functioning 
and dementia and several studies have investigated diffusion abnormalities in MCI and 
PDD. Correlations between cognitive assessments (Montreal Cognitive Assessment) and 
decreased FA values in major cortico-cortical tracts and hippocampus have been reported 
in PD (Carlesimo et al., 2012; Chen et al., 2015). Furthermore, in patients with PD-MCI, 
widespread FA reductions are also reported in the major cortical tracts (see Table 1), as 
well as in the corpus callosum, anterior limb of internal capsule compared with healthy 
controls. Compared to cognitively intact patients, one study reported diffusion alterations 
in the corona radiata, corpus collosum, IF-OF and SLF in PD-MCI (Agosta et al., 2014). 
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However, Rossi and colleagues only found a tendency towards decreasing FA values in 
MCI (Rossi et al., 2014) but also noted that younger age at disease onset was associated 
with increased FA values in frontal and parietal lobes, as well as in the right temporal and 
occipital lobes and thalamus.  Compared to non-demented patients and healthy controls, 
PDD patients show significantly lower FA values in bilateral posterior cingulate bundles 
(Kamagata et al., 2012; Matsui et al., 2007b), bilateral anterior cingulate bundles 
(Kamagata et al., 2012), corpus callosum splenium (Deng et al., 2013) and left 
hippocampus (Chen et al., 2015). However, not all studies support these findings in 
patients with mild PDD (Wiltshire et al., 2010). Nevertheless, cognitive impairments in 
PD are generally shown to be associated with widespread white matter alterations, 
predominantly in the frontal and parietal regions, corpus callosum and the subcortico-
cortical pathways, as well as with diffusivity changes within the hippocampus.    
 
Mood disturbances 
Mood disturbances are common in PD and are more frequently observed in patients 
within the non-tremor dominant phenotype.  Recently, it has even been suggested that 
Parkinsonian phenotypes could be classified based on psychological well-being (Brown 
et al., 2011; Landau et al., 2016). Though often experienced concurrently, it is now 
understood that depression, anxiety and apathy are dissociable symptoms in PD (Brown 
et al., 2011; Levy et al., 1998). The aetiology of these mood disturbances remains 
unclear. In fact, to our knowledge, no studies have investigated anxiety using DTI and 
only one study examined diffusivity changes in apathy, reporting no significant 
abnormalities associated with this symptom (Carriere et al., 2014).  
 
Additionally, only few reports with a limited number of participants have explored the 
contribution of white matter abnormalities to depression in PD (Huang et al., 2014). 
Damaged long association fibres and alterations in the left anterior thalamic radiation and 
left forceps minor were reported in patients with depression. This indicates prominent 
involvement of the neocortex, additionally to the locus coeruleus, which is thought to 
play a key role in mood disorders (Chan-Palay et al., 1989). However, another study 
reported no significant FA findings when looking at the uncinate fasciculus (Surdhar et 
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al., 2012), though this study only included six depressed patients. Furthermore, Li and 
colleagues investigated the involvement of the thalamus in PD depression using whole 
brain analyses and found decreased FA values in the bilateral medial dorsal thalamus 
(van den Heuvel et al., 2010). Decreased FA in the thalamus may reflect a reduction in 
either incoming or projecting white matter tracts. The medial dorsal thalamus is believed 
to relay inputs from the amygdala and olfactory cortex to the frontal cortex and limbic 
system (Tham et al., 2009). The medial dorsal thalamus receives numerous dopaminergic 
projections (Garcia-Cabezas et al., 2009) and loss of dopamine is also found in the limbic 
system in depressed patients (Remy et al., 2005). Finally, decreased FA values in the 
anterior cingulate bundle have been reported (Matsui et al., 2007a). The anterior 
cingulate is related to motivation, initiation of movement and apathy (Remy et al., 2005). 
Moreover, emotion recognition, particularly identifying negative emotions might be 
impaired in PD (Dujardin et al., 2004). FA levels in the portion of the right IF-OF 
correlate positively to the ability to recognize sadness as a facial expression (Baggio et 
al., 2012). Despite these interesting results, it is evident that more studies are needed to 
elucidate the contribution of diffusion abnormalities to mood disturbances. 
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Table 1. An overview of the DTI literature in Parkinson’s disease      
 
Study n Mean age ± SD 
Field 
strength 
Tesla 
No. of 
direc-
tions 
b-
values  
s/mm2 
Analyses 
methods 
Symptom 
studied / 
contrast 
Regions 
studied FA reductions 
MD (AD and RD) 
increases 
Statis-
tical 
thres-
hold, 
cor-
rection 
Motor correlates 
 
Chan et al. 
2014 
46 PD (25 
PIGD; 21 
TD), 19 
HC 
PIGD: 72. ± 
4.8; TD: 
73.3 ± 6.2; 
HC: 71.5 ± 
5.0 
3 30 800 Tractography Subtype Whole brain analyses 
PIGD < TD: CC body 
PIGD < controls: CC 
genu, body  
 
PIGD > TD: Thal, PU, 
CC body, splenium and 
centrum semiovale; 
PIGD > controls: SN, 
Thal, corona radiata, 
centrum semiovale 
(CST), CC body, 
centrum semiovale; PD 
> controls: SN;  
P < 0.05; 
logistic 
regression 
Gu et al. 2014 
24 PD (12 
PIGD, 12 
TD)  
PIGD: 55.7 
± 8.1; TD: 
56.0 ± 8.4 
3 15 1000 VBA Subtype 
SLF, anterior 
corona radiata, 
genu of CC 
Bilateral SLF   
P < 0.05  
FWE (cluster 
size >10 
voxels)  
Tessa et al. 
2008 
27 PD (de 
novo; 11 
PIGD, 13 
TD, 3 
mixed), 
16 HC 
PIGD:  62.2 
± 8.3; TD:  
57.9 ± 10.4; 
Mixed: 69.3 
± 7.7; HC: 
59.4 ± 9.4 
 
1.5 6 1000 Histogram analyses Subtype  
Whole brain 
histograms FA 
and MD 
PD and PIGD < 
controls: increase of 
the 25th percentile of 
FA histograms.  
 
n.s.  
P < 0.01 
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Lee et al. 
2014 
12 PD (de 
novo)  60.3 ± 9.1 3 45 600 TBSS 
Bradykinesi
a 
Whole brain 
analyses 
Bilateral SLF, UF in 
the contralateral 
hemisphere, IF-OF in 
the ipsilateral 
hemisphere of the 
affected hand (no 
correlated area for 
less affected hand) 
Cingulum, posterior / 
retrolenticular limb of 
internal capsule, 
posterior Thal radiation 
and cingulum 
(hippocampus) in the 
contralateral 
hemisphere;  SLF, 
corona radiata, CST and 
the inferior CP in the 
ipsilateral hemisphere, 
stria terminalis, anterior 
limb of internal capsule, 
CP, CC body and CC 
splenium, middle CP, 
and pontine crossing 
tract in the bilateral 
hemisphere  
P < 0.05  
TFCE 
 
Ofori et al. 
2015 
25 PD; 19 
HC 
Baseline: 
PD: 65.3 ± 
9.1; HC: 
65.3 ± 10.1 
3 64 1000 
ROI (free 
water 
mapping) 
Bradykinesi
a, cognition 
(MoCA) (& 
progression)  
Anterior and 
posterior SN 
n.s. 
Free water: posterior 
SN correlated with 
progression of 
bradykinesia and 
MoCA 
n.s. 
P < 0.05  
FDR 
Canu et al. 
2014 
22 PD 
(+FOG); 
35 HC 
(28 PD-
FOG, 25 
PD; 30 
HC*) 
PD: 66.9 ± 
8.0; HC: 67.7 
± 7.6 
3  (1.5*) 35 (65*) 900 
TBSS and 
tractography FOG 
Whole brain 
analyses and 
PPN tract 
Primary motor, 
premotor, prefrontal. 
orbitofrontal and 
inferior parietal 
cortices, cingulum, 
bilateral SLF, bilateral 
CP, CC genu, anterior 
body and splenium, 
temporo-occipital 
tracts 
Primary motor, 
premotor, prefrontal. 
orbitofrontal and 
inferior parietal 
cortices, cingulum, 
bilateral SLF, left CP, 
left CST, Thal radiation, 
bilateral external 
capsule, cerebellum in 
right lobule VIII, 
bilateral lobule IX (also 
increased AD and RD 
in these areas; 
increased AD in left 
PPN tract)  
PD-FOG vs. PD*: AD 
in CC genu and body 
P < 0.05  
FWE, TFCE 
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and WM under right 
parietal cortex and 
bilateral PPN tract) 
Fling et al. 
2013 
26 PD (14 
PD-FOG; 
12 PD), 
15 HC 
PD-FOG: 
67.1± 5.4; 
PD: 65.5 ± 
7.0; HC: 
66.7 ± 7.6 
3 30 1000 Tractography FOG PPN 
PD-FOG vs. PD and 
HC: PUT, internal 
GPi, cingulate, Thal, 
precentral and 
postcentral gyrus, 
superior and middle 
frontal gyrus, SMA, 
pre-SMA and bilateral 
cerebellar locomotor 
regions PPN fibre 
tract in the right 
hemisphere 
 
P < 0.05  
Bonferroni  
Peterson et al. 
2014 
25 PD (13 
PD-FOG; 
12 PD) 
PD-FOG: 
66.2 ± 5.5; 
PD: 64.9 ± 
6.9 
3 30 1000 Tractography 
FOG, dual 
tasks, stride 
length, 
stride length 
variability 
PPN 
Greater quantity in 
PPN tract in the right 
hemisphere; 
Correlation in FOG: 
lateralized PPN 
connectivity and 
larger dual task 
interference, stride 
length during normal 
and dual task walking 
   
P < 0.05  
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Vercruysse et 
al. 2014 
26 PD (11 
FOG; 15 
PD), 15 
HC 
PD-FOG: 
68.6 ± 8.7; 
PD: 67.6 ± 
5.6; HC: 
68.1 ± 6.5 
3 20/40/75* 
700/100
0/2800* 
TBSS and 
tractography FOG 
Whole brain 
analyses and 
subcortical-
cortical 
connections 
Left (lobule VI) and 
right (Crus I, lobule 
VIIIb) hemisphere of 
the cerebellum, left 
temporal part of the 
SLF; connections 
between the left 
caudate nucleus and 
ACC and 
orbitofrontal cortex, 
between the left 
middle CP and PPN  
Right anterior part of 
the capsula interna and 
corona radiata, the 
superior frontal cortex, 
and a left-hemispheric 
cluster in cerebellum 
Crus II; connecting the 
caudate, PUT, GP, and 
STN to frontal (ACC, 
superior and 
orbitofrontal cortex), 
motor (pre-SMA, SMA) 
and sensory (S1 and S2) 
cortical regions 
predominantly in the 
left hemisphere  
P < 0.001 
(cluster 
forming 
threshold); P 
< 0.05 (cluster 
size 
threshold), 
FDR  
Youn et al. 
2015 
42 PD (19 
PD-FOG; 
23 PD), 
33 HC  
PD-FOG: 
71.1 ± 6.1; 
PD: 67.7 ± 
6.4; HC: 
69.6 ± 5.8 
3 45 600 VBA and ROI FOG 
Whole brain 
analyses and 
PPN and 
projection fibres 
(ROI) 
Bilateral PPN 
Basal ganglia, Thal and 
cerebellum (in PPN 
tract); bilateral PPN  
P < 0.05  
FDR  
Cognitive correlates  
 
Gallagher et 
al. 2013 
15 PD; 15 
HC 
PD: 62.7 ± 
10; HC: 
60.3 ± 6.5 
3 25 Not reported TBSS 
Executive 
function  
Whole brain 
analyses 
Anterior limb of 
internal capsule, 
anterior corona 
radiata, CC body, 
sagittal 
stratum (ILF and IF-
OF), UF, and deep 
cerebellar WM, right 
midbrain and in WM 
subjacent to several 
frontal. temporal. 
parietal. and occipital 
gyri 
"More extensive than 
FA changes and present 
in portions of most 
tracks." 
P < 0.05  
FWE, TFCE  
Matsui et al. 
2007a 
21 PD (6 
PD with 
low EF 
scores; 15 
high EF 
PD-Low-
EF: 71.5 ± 
5.83; PD-
High EF: 
68.9 ± 10.3 
1.5 6 1000 ROI 
Executive 
function 
(WCST) 
Parietal WM 
(posterior to the 
central sulcus 
on the most 
caudalslice), 
PD-Low EF < PD-
High EF: Left parietal 
WM  
P < 0.05 
Bonferroni 
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scores) temporal WM 
(posterolateral 
to the lateral 
fissure on the 
most caudal 
slice where the 
lateral fissure 
was present), 
occipital WM 
(within the optic 
radiations on the 
most caudal 
slice where the 
occipital horn of 
the lateral 
ventricle was 
imaged). 
Rae et al. 
2012 
14 PD; 15 
HC 
PD: 65 
(range: 51-
78); HC: 64 
(range: 50-
75) 
3 12; 30** 
250/500
/750/95
0/1200; 
600/120
0** 
TBSS and 
VBA 
Executive 
function 
 Whole brain 
analyses 
Forceps minor, CC, 
forceps major, 
anterior Thal 
radiation, UF, IF-OF, 
CST, SLF, ILF 
Forceps minor, CC, 
forceps major, anterior 
Thal radiation, UF, IF-
OF, CST, SLF, ILF, 
internal and external 
capsule  
P < 0.01 
FWE, TFCE  
Theilmann et 
al. 2013 
25 PD; 26 
HC 
PD: 68.0 ± 
8.9; HC: 
65.9 ± 8.4 
1.5 51 1000 TBSS and ROI 
Executive 
function 
ROI generated 
from the voxels 
that  
showed 
significant 
group 
differences  
CC, cingulum, 
anterior and superior 
corona radiata, 
anterior Thal 
radiation, forceps 
minor, forceps major, 
IF-OF, SLF, IFL  
CC, cingulum, anterior 
corona radiata, anterior 
Thal radiation, forceps 
minor, forceps major, 
IF-OF, SLF, IFL  
P < 0.05 
 
Melzer et al. 
2013 
109 PD 
(18 PDD; 
28 PD-
MCI; 63 
PD), 32 
HC 
PDD: 73.7 ± 
6.5; PD-
MCI: 71.0 ± 
7.3; PD: 
64.0 ± 9.2; 
HC: 70.1 ± 
9.0 
3 28 1000 TBSS Global Whole brain analyses n.s. 
Correlations: Bilateral 
CC genu and body, 
internal capsule anterior 
and posterior limb, 
external capsule, 
anterior and superior 
corona radiata, anterior 
Thal radiation, left CST, 
left cingulum, bilateral 
IF-OF, UF, ILF, right 
SLF 
P < 0.05  
TFCE  
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Executive 
function n.s. 
Correlations: bilateral 
CC genu and body, 
internal capsule anterior 
and posterior limb, 
external capsule, 
anterior, posterior and 
superior corona radiata, 
anterior Thal radiation, 
left cingulum, bilateral 
IF-OF and UF, right 
ILF and SLF 
Attention 
Correlations: CC 
body, external 
capsule, anterior and 
superior corona 
radiata, anterior Thal 
radiation, CST, IF-
OF, ILF, SLF (all 
right) 
Correlations: bilateral 
CC genu and body, 
internal capsule anterior 
and posterior limb, 
external capsule, 
anterior and superior 
corona radiata, right 
posterior corona radiata, 
bilateral anterior Thal 
radiation, CST, left 
cingulum, bilateral IF-
OF, SLF and UF, right 
ILF 
Memory n.s. 
Correlations: bilateral 
CC genu and left body, 
bilateral internal 
capsule anterior and 
posterior limb, external 
capsule, anterior and 
superior corona radiata, 
bilateral anterior Thal 
radiation, bilateral IF-
OF and UF, right ILF 
and right SLF 
Visuospatial n.s. n.s. 
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MCI, 
Dementia 
PD-MCI and PDD < 
HC: bilateral CC 
genu, body, splenium, 
medial lemniscus 
(PD-MCI: left; PDD: 
bilateral), inferior 
(PDD) and superior 
CP, internal capsule 
anterior and posterior 
limb, external 
capsule, anterior 
superior and posterior 
corona radiata, 
anterior Thal 
radiation, CST (all 
bilateral); cingulum 
(PD-MCI-bilateral. 
PDD: left), IF-OF, 
ILF, SLF, UF (all 
bilateral). 
PD-MCI < PD: 
bilateral CC genu, 
right CC body, 
bilateral internal 
capsule anterior limb, 
right external capsule. 
PD < PD: right 
superior corona 
radiata, right CST 
PD > HC: bilateral CC 
body, left splenium, 
bilateral superior corona 
radiata, left cingulum. 
PD-MCI and PDD > 
HC: bilateral CC genu, 
body, splenium, right 
superior CP (PDD), left 
(MCI) and right (PDD) 
CP, internal capsule 
anterior and posterior 
limb, external capsule, 
anterior superior and 
posterior corona radiata, 
anterior Thal radiation, 
CST cingulum, IF-OF, 
ILF, SLF (all bilateral) 
UF (left PD-MCI, 
bilateral PDD). 
PD-MCI > PD: bilateral 
external capsule and 
internal capsule anterior 
limb, left anterior and 
superior corona radiata, 
left IF-OF and SLF, 
bilateral UF and SLF 
PDD > PD: bilateral CC 
genu and right body, 
bilateral internal 
capsule anterior limb, 
right internal capsule 
superior limb and 
external capsule, 
bilateral anterior and 
superior corona radiata, 
left Thal radiation, right 
CST, bilateral IF-OF, 
left UF. 
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Zheng et al. 
2014  16 PD 62.2 ± 9.6 3 20** 1000 ROI 
Executive 
function 
ROI derived 
from significant 
correlations of 
FA and MD 
with cognitive 
domains  
  
  
  
  
Correlation: right 
anterior corona 
radiata, left anterior 
limb of internal 
capsule, genu, right 
posterior Thal 
radiation  
Correlations: bilateral 
anterior corona radiata, 
left anterior limb of 
internal capsule, genu, 
right posterior Thal 
radiation, left sagittal 
stratum, left SFO  
P < 0.01  
  
Attention 
Correlations: bilateral 
cingulate gyrus, right 
external capsule, 
bilateral posterior 
Thal radiation, left 
retrolenticular part of 
internal capsule, left 
sagittal stratum, 
bilateral SFO 
Correlations: left 
cingulate gyrus, left 
anterior corona radiata, 
bilateral superior corona 
radiata, left CST, left 
hippocampus, bilateral 
posterior corona radiata, 
bilateral posterior Thal 
radiation, left 
retrolenticular part of 
internal capsule, left 
sagittal stratum, 
splenium, bilateral SFO 
Linguistic 
performance 
Correlations: left 
anterior limb of 
internal capsule, right 
sagittal stratum 
Correlations: bilateral 
corona radiata, genu, 
bilateral sagittal 
stratum, left SFO 
Visuospatial  n.s.  n.s. 
Short term 
memory  n.s.  Fornix 
Long term 
memory n.s. Anterior corona radiata  
Al Serafy, 
2015 
40 PD (10 
PD-MCI; 
23 PD), 
20 HC 
PD (total): 
59.9 ± 7.5; 
HC: 56.4 ± 
5.1 
1.5 25 800 ROI 
Attention 
Caudate, PUT, 
GP, Thal, SN, 
PFC, 
hippocampus. 
Correlations: Thal, 
GP, caudate, PFC 
 
P < 0.05  
 
Working 
memory 
Correlations: Thal, 
GP, caudate, PFC 
Immediate 
and delayed 
recall  
Correlations: Thal, 
PUT, PFC, 
hippocampus 
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Alternating 
and action 
verbal 
fluency 
Correlations: Thal, 
GP, caudate, PFC 
Naming, 
visuopercep
tual. 
visouconstr
uctual 
n.s. 
MCI 
PD-MCI < PD: Thal, 
GP, PUT, caudate, 
PFC 
Auning et al. 
2014 
18 PD; 19 
HC  
PD: 66.7 ± 
5.1; HC: 
64.6 ± 6.5 
1.5 12 750 TBSS and ROI 
Cognitive 
performance 
Middle frontal 
gyrus (rostral 
division)  
 
n.s. 
RD: correlation 
executive function tests 
(composite score, trail 
making task part B and 
colour-word 
interference task) and 
rostral middle frontal 
cortex  
P < 0.05 
TFCE  
Ye et al. 2014 21 PD; 20 HC 
PD: 64.0 ± 
8.1; HC: 65.3 
± 5.7 
3 63 Not reported TBSS 
Response 
inhibition 
Whole brain 
analyses n.s.  
P < 0.05 
TFCE  
Chen et al. 
2015 
30 PD (19 
PD; 11 
PDD), 21 
HC 
PDD: 64.1 ± 
11.4; PD: 
59.5 ± 8.8; 
HC: 61.1 
± 8.3 
3 
Not 
report
ed 
Not 
reported ROI 
Cognitive 
performance 
(MoCA) 
Body and 
splenium of CC, 
fornix, SFO, 
cingulate gyrus, 
hippocampus, 
IF-OF, ILF, 
SLF, UF 
PD vs. HC: n.s.; PDD 
< PD: left 
hippocampus  
HC vs. PD: n.s.; PDD > 
PD: right SLF, right 
cingulate gyrus, left 
ILF, left SLF, bilateral 
UF; PDD > HC: 
splenium and body of 
CC, right SFO, left 
SLF, bilateral UF  
P < 0.05  
Bonferroni  
Duncan et al. 
2016 
125 PD 
(newly 
diagnosed
), 50 HC 
PD: 66.0 ± 
10.5; HC: 
65.8 ± 8.0 
3 64 1000 TBSS Cognitive performance 
Whole brain 
analyses n.s. 
Forceps minor, 
cingulum, SLF, ILF, IF-
OF, CST, CC and 
internal capsule 
 
P < 0.05  
FWE, TFCE  
Koshimori et 
al. 2015 
16 PD; 14 
HC 
PD: 70.5 ± 
5.6; HC: 3 60 1000 TBSS 
Cognitive 
performance 
Whole brain 
analyses n.s. 
Forceps minor and 
major, cingulum, 
P < 0.05  TFCE	
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67.13 ± 5.1  anterior thalamic 
radiation, superior 
corona radiata, external 
capsule, body of CC, 
UF, IF-OF, SLF and 
ILF. 
Carlesimo et 
al. 2012 
25 PD; 25 
HC 
PD: 65.0 ± 
8.4; HC: 
65.0 ± 8.9 
3 30 1000 ROI Declarative memory Hippocampus   
Right hippocampus in 
PD compared to HC; 
hippocampus correlated 
to memory performance 
P < 0.05  
FWE 
Agosto et al. 
2014 
43 PD (30 
PD-MCI, 
13 PD); 
33 HC 
PD-MCI:  
63.9 ± 
7.1; PD: 
66.6 ± 8.2; 
HC: 64.0 ± 
7.3 
 
1.5 12  1000 TBSS MCI Whole brain analyses 
PD-MCI vs. PD: 
bilateral anterior and 
superior corona 
radiata, CC genu and 
body anterior inferior 
IF-OF/uncinate, 
anterior SLF;  
PD-MCI vs. HC: 
bilateral anterior and 
superior corona 
radiata, CC body, 
anterior SLF  
n.s. 
P < 0.05  
FWE, TFCE 
Rossi et al. 
2014 
33 PD; 19 
HC  
PD: median: 
71 (range 42 
– 86; MCI 
and 
cognitively 
intact), HC: 
median: 73 
(range: 44-
87) 
3 20 1000 TBSS MCI Whole brain analyses 
n.s. 
(Correlation: older 
age at disease onset 
associated and 
bilateral frontal and 
parietal lobes, right 
temporal and occipital 
lobes and right 
thalamus) 
 
 
P < 0.05 
 
Deng et al. 
2012 
64 PD (10 
PDD; 30 
PD-MCI; 
24 PD), 
21 HC 
PDD: 69.0 ± 
9.7; PD-
MCI: 65.1 ± 
11.8; PD: 
62.1 ± 8.6; 
HC: 60.1 ± 
13.6 
3 16 1000 ROI MCI; Dementia 
Temporal WM 
(posterolateral 
to the lateral 
fissure on most 
caudal slice), 
frontal WM 
(anterior 
/posterior 
PD < HC: left 
occipital WM and the 
left anterior cingulate 
bundle; PD-MCI and 
PDD < HC: left 
frontal and right 
temporal WM, 
bilateral anterior 
  
P < 0.05  
Fisher least 
significant 
difference t-
test 
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cingulate 
bundle, CC 
genu and 
splenium, and 
SLF), parietal 
WM (in the 
region posterior 
to the central 
sulcus on the 
most caudal 
slice), occipital 
WM (within the 
optic radiations 
on the most 
caudal slice), 
CST at the 
levels of the red 
nucleus and 
internal capsule.  
cingulate bundles; 
PDD < all groups: left 
anterior cingulate 
bundle and CC 
splenium; PDD vs. 
PD: left occipital 
WM. Correlations 
cognitive status: left 
frontal. right 
temporal. left 
occipital WM, 
bilateral anterior 
cingulate bundles and 
CC splenium 
Hattori et al. 
2012 
85 PD (25 
PDD; 28 
PD-MCI; 
32 PD), 
40 HC 
PDD: 80.0 ± 
4.5; PD-
MCI: 76.3 ± 
6.4; PD: 
75.9 ± 2.0; 
HC: 76.9 ± 
4.9 
1.5 12 1000 TBSS MCI; Dementia 
Whole brain 
analyses 
PD vs. HC: n.s. PD-
MCI and PDD < HC: 
SLF, ILF, IF-OF, UF, 
cingulum, CC; PDD 
vs. PD: SLF, IFL, IF-
OF, UF, cingulum, 
CC 
 
P < 0.05 
TFCE 
Kamagata et 
al. 2012 
30 PD (15 
PDD; 15 
PD), 15 
HC 
PDD: 71.3 ± 
5.6; PD: 
69.8 ± 5.9; 
HC: 69.5 ± 
6.9 
3 32 1000 Tractography Dementia 
Anterior and 
posterior 
cingulate 
bundle, CST 
PD < HC: anterior 
cingulate bundle; 
PDD < HC: anterior 
and posterior 
cingulate bundle; 
PDD vs. PD: n.s. 
PD > HC: anterior 
cingulate bundle; PDD 
vs. HC: n.s.; PDD vs. 
PD: n.s. 
P < 0.05  
Scheffé 
correction, 
Bonferroni  
 
Kamagata et 
al. 2013 
40 PD 
patients 
(20 PDD, 
20 PD), 
20 HC 
PDD: 71.7 ± 
5.3; PD: 
71.6 ± 4.3; 
HC: 72.2 ± 
3.3 
3 32 1000 TBSS and tractography Dementia 
Whole brain 
analyses and 
significant 
clusters found in 
TBSS as ROIs 
(genu CC) 
PDD < PD: anterior 
part of the IF-OF 
(adjacent to the 
prefrontal area) and in 
part of the genu of 
CC; PDD < HC: SLF, 
ILF, IF-OF, UF, 
cingulum, anterior 
limb of internal 
PDD > PD: anterior part 
of the IF-OF (adjacent 
to the prefrontal area) 
and in part of the genu 
of CC; PDD > HC:  
SLF, ILF, IF-OF, UF, 
cingulum, anterior and 
posterior limb of 
internal capsule, SN (all 
P < 0.05 
Bonferroni 
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capsule, SN (all 
bilateral). 
Correlation all PD 
patients and MMSE in 
genu CC.  
bilateral).  Correlation 
all PD patients and 
MMSE in genu CC. 
Matsui et al. 
2007b 
37 PD (11 
PDD; 26 
PD) 
PDD: 75.0  
± 7.7; PD: 
70.0 ± 8.6 
1.5 6 1000 ROI Dementia 
Bilateral 
parietal. 
temporal. 
frontal. occipital 
WM, bilateral 
anterior and 
posterior 
cingulate bundle  
Bilateral posterior 
cingulate bundles   
P < 0.05 
Fisher’s 
PLSD 
Wiltshire et 
al. 2010 
35 PD (6 
PDD; 29 
PD), 15 
HC 
PDD: 71.4 ± 
4.2; PD: 
70.9 ± 4.6; 
HC: 70.7 ± 
4.0 
1.5 6 1000 Tractography Dementia, cognition CC, cingulum n.s. 
PDD vs. PD vs. HC: 
n.s.  
Correlation: MMSE and 
CC anterior and 
posterior 
P < 0.05  
Bonferroni  
Lee et al., 
2011 
11 PD; 11 
HC 
PD: 70.4 ± 
4.7; HC:  
67.0 ± 3.8 
3 32 Not reported  ROI 
Speech 
impairment  
Broca’s and 
Wernicke’s 
areas  
Broca’s and 
Wernicke’s areas  n.s. 
P < 0.05 
Mood disturbances 
 
Carriere et al. 
2014 
20 PD (10 
PD-
Apathy; 
10 PD), 
10 HC 
PD-Apathy: 
67.2 ± 8.4; 
PD: 60.7 ± 
11.1; HC: 
66.8 ± 6.8 
3 15 1000 TBSS Apathy Whole brain analyses n.s.  n.s. 
P < 0.05  
TFCE  
Huang et al. 
2014 
30 PD (15 
PD-
Depressio
n; 15 PD) 
PD-
Depression: 
54.5 ± 12.2; 
PD: 54.8 ± 
10.1 
3 31 1000 TBSS and ROI Depression 
Whole brain 
analyses and 
significant 
clusters found in 
TBSS as ROIs 
Left UF, left SLF, left 
anterior Thal 
radiation, left forceps 
minor, ILF; 
Correlation deep 
temporal cortex with 
depression rating 
scale 
n.s.  
P < 0.01 
cluster-based 
thresholding 
method 
(cluster size > 
100 voxels) 
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Li et al. 2010 
32 PD (14 
PD-
Depressio
n; 18 PD) 
PD-
Depression: 
65.3 ± 8.9; 
PD: 61.1 ± 
10.2 
3 20 1000 ROI Depression Thal  
PD-depressed < PD: 
Bilateral mediodorsal 
Thal; Correlation 
between bilateral 
mediodorsal Thal and 
depression rating 
scale 
n.s.  
P < 0.05 
Matsui et al. 
2007c 
28 PD (14 
PD-
Depressio
n; 14 PD)  
PD-
Depression: 
72.1 ± 9.9; 
PD: 69.3 ± 
8.1 
1.5 6 1000 ROI Depression 
Orbitofrontal. 
prefrontal. 
temporal. 
occipital. 
parietal WM, 
anterior and 
posterior 
cingulate 
bundles  
PD-depressed < PD: 
Bilateral anterior 
cingulate bundles 
 
P < 0.05  
Surdhar et al. 
2012 
12 PD (6 
PD-
Depressio
n; 6 PD), 
6 HC 
PD-
Depression: 
70.1 ± 2.9; 
PD: 68.6 ± 
2.0; HC: 
70.7 ± 2.4 
1.5 6 1000 Tractography Depression (mild) CC, UF n.s.  n.s.  
P < 0.05 
Bonferroni 
Baggio et al. 
2012 
43 PD; 23 
HC 
PD: 63.5 ± 
11.4; HC: 
61.0 ± 9.7 
3 30 1000 TBSS, ROI 
Facial 
emotion 
recognition 
IF-OF, SLF, 
ILF, UF, 
cingulum, 
forceps minor 
Sadness: IF-OF in 
right frontal lobe and 
left temporal lobe, 
forceps minor, CC 
body, left CC 
semiovale, IF-OF in 
left temporal lobe. 
 
P < 0.05 FWE  
Visual hallucinations   
Yao et al. 
2015 
27 PD (12 
PD-VH; 
15 PD), 
HC: 14  
PD-VH: 70 
(percentile: 
64, 72.75); 
PD: 66 
(percentile: 
62, 72); HC: 
63 
(percentile: 
62,68.75) 
3 16 1000 ROI  VH  Hippocampus Not reported  
PD-VH > PD: Right 
posterior hippocampal 
regions and left 
hippocampal body  
P < 0.05 FWE 
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Zhong et al. 
2013 
66 PD (18 
PD-
Psychosis; 
48 PD) 
PD-
Psychosis: 
56.3 ± 23.7; 
PD: 55.6 ± 
22.3 
3 15 1000 ROI Psychosis 
SN, GP, frontal 
and occipital 
lobe, cingulate 
gyrus, 
hippocampus 
Bilateral frontal and 
occipital lobe, 
cingulate gyrus and 
left hippocampus 
 
P < 0.05 
REM Sleep behaviour disorder   
Ford et al. 
2013 
124 PD 
patients 
(46 PD-
RBD; 78 
PD) 
PD-RBD: 
66.4 ± 9.9; 
PD: 65.8 ± 
10.9  
3 64 1000 TBSS RBD Whole brain analyses 
n.s. (before correcting 
for multiple 
comparisons: Right 
IF-OF, left ILF, left 
SLF, right CST)  
n.s. (before correcting 
for multiple 
comparisons: bilateral 
ILF)  
P < 0.05 
TFCE  
Lim et al. 
2016 
38 PD (24 
PD-RBD; 
14 PD), 
25 HC 
PD-RBD: 
69.8 ± 6.4; 
PD: 69.7 ± 
7.2; HC: 
68.5 ± 6.6 
3 15 800 
TBSS, ROI 
and 
tractography 
RBD 
Whole brain 
analyses and 
PPN and 
projection fibres 
PD and PD-RBD < 
HC: bilateral frontal 
areas 
n.s. 
P < 0.05  
TFCE 
Autonomic function and miscellaneous studies   
Ibarretxe-
Bilbao et al. 
2010 
24 PD (9 
PD-
anosmic; 
9 PD-
hyposmic; 
6 PD), 24 
HC 
PD-
anosmic: 
57.9 ± 7.9; 
PD-
hyposmic: 
58.0 ± 5.8; 
PD: 50.7 ± 
l1.3; HC: 
57.3 ± 8.9 
3 30 1000 TBSS and ROI 
Olfactory 
impairment 
Whole brain 
analyses and 
WM adjacent to 
the orbitofrontal 
cortex 
(superficial WM 
structures), 
medial temporal 
lobe WM 
including WM 
adjacent to the 
amygdala, 
piriform cortex, 
and entorhinal 
cortex (primary 
olfactory 
system), UF 
Hypnosmic and 
anosmic PD < PD and 
HC: WM adjacent to 
bilateral gyrus rectus; 
Anosmic vs. PD and 
HC: primary olfactory 
cortex (adjacent to 
entorhinal cortex).  
Correlation olfactory 
tests in PD: left 
primary olfactory 
cortex, right gyrus 
rectus  
 
P < 0.05 FWE 
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PD = Parkinson’s disease, HC = healthy controls, FA = fractional anisotropy, MD = mean diffusivity, AD = axial diffusivity, RD = radial diffusivity, TBSS = tract-based spatial statistics, VBA 
= voxel-based analyses; ROI = region of interest, WM = WM, UPDRS = Unified Parkinson’s Disease Rating Scale, H&Y = Hoehn and Yahr, SE = Schwab and England, PIGD = postural 
instability and gait disorder, TD = tremor dominant; FOG = freezing of gait, PD-MCI = Parkinson’s disease with mild cognitive impairment, PDD = Parkinson’s disease with dementia, AD = 
Alzheimer’s disease; WCST = Wisconsin Card Sorting Test; VH = visual hallucinations, RBD = REM sleep behaviour disorder, MoCA = Montreal Cognitive Assessment CC = corpus 
callosum, SN = substantia nigra, Thal = thalamus, PUT = putamen, GP = globus pallidus (GPi/e = globus pallidus internus/externus), SLF = superior longitudinal fasciculus, ILF = inferior 
longitudinal fasciculus, UF = uncinate fasciculus, IF-OF = inferior fronto-occipital fasciculus; CST = corticospinal tract, PPN = pedunculopontine nucleus, CP = cerebral peduncle, STN = 
subthalamic nucleus, ACC = anterior cingulate cortex, SMA = supplementary motor area, PFC: prefrontal cortex, n.s. = not significant, FWE: family-wise error, TFCE: threshold-free cluster 
enhancement, FDR: false discovery rate, PLSD: partial least-squares difference 
 
*Subsequent analyses 
**Different imaging protocols used 
***One subject underwent a 60-direction acquisition 
Rolheiser et 
al. 2011 
14 PD; 14 
HC 
PD: 56 ± 
4.8; HC:  
55.2 ± 6.2  
1.5 31 900 TBSS and ROI 
Olfactory 
impairment 
and early 
diagnosis 
PD 
Whole brain 
analyses and 
ROI: Anterior 
olfactory 
structures and 
SN 
SN, anterior olfactory 
structures RD: SN  
P < 0.05 
Bonferroni  
Skorpil et al. 
2012 
14 PD; 15 
HC 
PD: 64 
(range: 47-
73); HC: 60 
(range: 44-
72) 
1.5 32 900 ROI 
Olfactory 
impairment, 
Parkinsonia
n severity 
Olfactory bulb, 
SN, CC (two 
DTI sequences) 
Olfactory bulb (first 
series), SN  
Olfactory bulb (first 
series) 
P < 0.05 
Zhang et al. 
2009  
25 PD; 25 
HC  
PD: 58.4 ± 
9.8; HC: 
58.4 ± 9.3 
3 12 1000 VBA  Olfactory impairment 
Whole brain 
analyses 
Bilateral cerebellar 
hemisphere and right 
rectus gyrus;  
Correlation with 
olfactory tests: left 
medial cerebellum 
white matter 
Bilateral orbitofrontal 
cortices and bilateral 
inferior temporal gyri; 
bilateral parietal lobes 
and left precentral 
gyrus; Correlation with 
olfactory tests:  right 
cerebellum, white 
matter in the left 
inferior parietal lobule  
P < 0.05  
Monte Carlo 
simulations 
cluster size for 
P < 0.001  
Regression: P 
< 0.001 
uncorrected 
Bertrand et al. 
2012 
26 PD (13 
PD-MCI; 
13 PD), 7 
HC 
26 PD: 64.1 
± 8.6; HC: 
70.4 ± 9.9 
3 64 700 TBSS 
Colour 
discriminati
on 
Whole brain 
analyses n.s. 
Temporal and parietal 
portions of the right 
SLF. 
RD: right IF-OF, CC 
splenium to posterior 
region of the body, IFL  
P < 0.05 
Voxel-wise 
correction  
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Visual hallucinations and psychosis 
VH in PD exist along a perceptual spectrum from simple images without a recognizable 
form, to complex well-formed hallucinations, which comprise images of people, faces, 
animals or scenery (Santhouse et al., 2000). VH are more often present in the advanced 
stages of PD and previous studies have shown that patients in the non-tremor dominant 
phenotype have a higher risk of developing visual hallucinations (VH) (Emre et al., 
2007). Patients with VH show higher MD values in the posterior regions of the 
hippocampus compared to non-VH patients and healthy controls (Yao et al., 2014), a 
finding related to impaired visuospatial memory. Moreover, the hippocampus has been 
identified as a key hub in the default mode network (Buckner et al., 2008). This network 
supports introspection, mental imagery and the capacity to retrieve and manipulate 
episodic memories (Buckner et al., 2008) and has recently been proposed to play a key 
role in the occurrence of VH (Shine et al., 2014; Shine et al., 2011a). Reductions in FA 
values in the hippocampus are also found in PD patients with psychosis (Zhong et al., 
2013). Furthermore, FA reductions within the cingulate gyrus, another region of the 
default mode network, have also been reported in this patient group, along with FA 
abnormalities in the frontal and occipital lobe. The majority of these patients also 
reported VH, however, it has yet to be investigated whether or not these changes were 
driven by this symptom.  
 
REM sleep behaviour disorder  
RBD is a parasomnia associated with PD. Patients with RBD not only lose muscle atonia 
during REM sleep but also show dream enactments, which are more vivid and often 
comprise aggressive or frightening content (Boeve, 2010). Muscle atonia is regulated by 
nuclei in the brainstem (Boeve, 2010), however, dream alteration in RBD indicates the 
involvement of neocortical structures. Studies investigating idiopathic RBD identify 
diffusivity changes in the brainstem, midbrain, pons and SN compared to age-matched 
controls (Scherfler et al., 2011; Unger et al., 2010). Surprisingly, the two studies using 
DTI to investigate the presence of white matter abnormalities in PD-RBD patients, both 
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report changes in the bilateral frontal areas but only before correcting for multiple 
comparisons (Ford et al., 2013; Lim et al., 2016). 
 
Autonomic dysfunction and miscellaneous studies  
Our search yielded no studies using DTI analyses to investigate bladder dysfunction, 
constipation, blood pressure, fatigue or other autonomic dysfunctions.  
 
Loss of smell is common in PD and often predates the clinical motor symptoms. Studies 
using DTI analyses have identified reduced FA values in the olfactory region (Ibarretxe-
Bilbao et al., 2010; Rolheiser et al., 2011; Skorpil et al., 2012; Zhang et al., 2011). 
Additionally, a correlation between reduced FA values in bilateral cerebellar white matter 
was reported (Zhang et al., 2011).  The cerebellum modulates the diaphragm and 
intercostal muscles and it has been suggested that smell could be improved by extra sniffs 
created by these muscles.  
 
Colour discrimination deficiency, another common symptom that might precede PD, is 
associated with increased diffusivity in the long association fibres in the temporal and 
parietal regions as well as in the corpus callosum (Bertrand et al., 2012). However, the 
authors suggest that the measure they used to test this symptom might reflect cognitive 
impairment instead of colour discrimination deficits, as the long fasciculi such as the SLF 
and IF-OF project to the frontal lobe, which is associated with cognitive performance.   
 
Conclusions and future directions  
This review has outlined the contribution of diffusivity abnormalities to different 
symptoms of PD using DTI analyses. The increased interest in axonal analyses using DTI 
in PD in the last decade has led to an expansion of our understanding of the impact of 
white matter damage and changes in membrane permeability in grey matter in 
symptomology of PD. White matter alterations within the long association and inter-
hemispheric fibres have implications for many symptoms of PD due to their extensive 
coverage of multiple regions. For example, the SLF is a large bundle of bidirectional 
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fibres that integrate motor and decision-making centres with visual, auditory and sensory 
regions (Makris et al., 2005). Damage within the SFL contributes to bradykinesia, FOG, 
executive dysfunction and depression (see summary of results in Table 1). Moreover, 
disruptions within the corpus callosum disrupt the frontal inter-hemispheric connections 
and have a huge impact on complex integrated behaviour such as motor programs and 
gait (Bhadelia et al., 2009) as well as cognitive functioning (Wiltshire et al., 2010).  
 
Abnormalities within other brain tissues are more symptom specific, such as changes in 
diffusivity in the putamen and its projection fibres (motor symptoms) or forceps minor 
(executive function and depression) and hippocampus (dementia and hallucinations). 
Investigations into these specific alterations are relevant for the understanding the neural 
underpinnings of these PD features and possibly provide new opportunities for disease 
modifying therapies. It further provides insights into the heterogeneous character of PD 
and could aid in identifying and predicting different PD phenotypes. However, whilst the 
association between changes in structural connectivity and cognitive correlates in PD are 
well studied, further research is needed to obtain a better understanding of several motor 
symptoms. It has been suggested that an increase in axonal density in pathways of the 
cortico-basal-ganglia-thalamo-cortical loop might reflect a potential compensation 
mechanism (Mole et al., 2016; Zhan et al., 2012). Increased FA values have been found 
in these motor pathways and should be taken into account when investigating white 
matter in PD in future studies.  Importantly, this review also highlights the limited 
research investigating symptoms such as autonomic dysfunction, anxiety, VH and RBD.  
 
Limitations and considerations for future research 
Of the studies reported here, many are limited by a low number of subjects, resulting in 
low statistical power, which might explain the conflicting results. Future studies should 
also include a large control cohort, as it has been shown that differences between healthy 
participants and PD patients might rely on high FA values in the control group (Schwarz 
et al., 2013). Furthermore, studies correlating imaging variables and symptoms can be 
confounded by disease severity. Whilst it is clinically difficult to distinguish the two, 
general disease severity should be taken into account when assessing symptomology of 
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PD in the research setting.  Furthermore, studies on grey matter are relatively limited and 
replication of the current results is very important. All of the studies included in our 
review included patients with a clinical diagnosis of PD; however this does not rule out 
the potential for other underlying pathologies, for example progressive supranuclear 
palsy or multiple system atrophy. An important future direction will be to corroborate 
DTI investigations in PD with postmortem data. Unique insights into PD symptomology 
can further be gained by conducting multimodal studies, combining advanced DTI 
analyses of structural connectivity with functional MRI (task-related and resting state) as 
well as grey matter volumetric MRI and cortical thinning analyses. Such studies are 
required to unravel how white matter injuries are affected by grey matter atrophy as well 
as their influence on functional connectivity.  Finally, exciting approaches such as graph 
theory could provide a more systematic analyses white matter topology.  
 
Protocol considerations 
Currently, DTI protocols vary across centres and these differences might impact the 
results. Firstly, the number of diffusion encoding directions differs across studies. A 
minimum of six non-collinear diffusion-encoding directions are required to measure the 
full diffusion tensor. However, the use of more than six gradient directions (e.g. 30 or 60) 
improves the accuracy of fibre-tract orientations. The longer scanning time required with 
the use of a higher number of gradient directions influences the signal to noise ratio 
(Lebel et al., 2012). Larger voxel sizes can improve this image signal to noise ratio, 
although this will increase partial volume averaging of tissues, leading to an increased 
risk of errors in the fits to the diffusion tensor model.  Secondly, higher field strength 
(e.g. 3 Tesla vs. 1.5 Tesla) may improve image quality and diagnostic accuracy. Less 
scanning time is required for a similar image, which can improve signal to noise ration by 
25%. Diffusion weighted gradients (or b-values) may also impact research outcomes. The 
use of weighted gradients for the brain of less than 700 s/mm2 is discouraged, and b-
values of 1000 s/mm2 are most commonly used. Higher weighted gradients show 
increased contrast and expose lesions more accurately (Alexander et al., 2007). 
Evidently, these different protocol considerations are highly dependent on each other.  
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Undeniably, it should be highlighted that DTI only allows for indirect validation and the 
measurements are error-prone and can be difficult to interpret.  Furthermore, the motion 
of water molecules does not inform about the directionality of axons. However, it is the 
only non-invasive technique that allows for analysing in vivo structural connectivity of 
the brain and is valuable for addressing new scientific questions. Given that DTI analyses 
is able to identify microscopic changes in white and grey matter in the early stages of PD, 
this technique could be valuable in predicting the manifestation of certain symptoms of 
PD. Furthermore, the quality of DTI analyses has improved substantially over the last 
decade. Advances such as the use of increased field strengths and diffusion-encoding 
directions, as well as improved motion-correction techniques have led to better quality of 
FA and MD images.  
Overall, clinical manifestations of PD are related to diffusivity abnormalities within 
divergent axons to extended brain regions.  However, several conflicting results call for 
further research using DTI analyses to clarify these abnormalities in more detail.   DTI 
could be a valuable technique to identify early alterations, which may lead to early 
interventions to treat key features of PD.  
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Chapter 3: Freezing of gait and its associations in the early and advanced clinical motor 
stages of Parkinson’s disease: a cross-sectional study 
 
Abstract 
Background: Freezing of gait is a common disabling symptom of Parkinson’s disease (PD) 
with limited treatment options. The pathophysiological mechanisms of freezing behaviour are 
still contentious.  
Objective: To investigate the prevalence of freezing of gait and its associations with 
increasing disease severity to gain a better understanding of the underlying pathophysiology.   
Method: This exploratory study included 389 idiopathic PD patients, divided into four 
groups; early and advanced PD with freezing of gait, and early and advanced PD without 
freezing of gait. Motor, cognitive and affective symptoms, REM sleep behaviour disorder and 
autonomic function were assessed.  
Results: Regardless of disease stage, patients with freezing of gait had more severe motor 
symptoms and a predominant non-tremor phenotype. In the early stages, freezers had a 
selective impairment in executive function and had more marked REM sleep behaviour 
disorder. Autonomic disturbances were not associated with freezing of gait across early or 
advanced disease stages. 
Conclusions:  These findings support the notion that impairments across the frontostriatal 
pathways are intricately linked to the pathophysiology underlying freezing of gait across all 
stages of PD. Features of REM sleep behaviour disorder suggest a contribution to freezing 
from brainstem pathology but this does not extend to more general autonomic dysfunction.  
 
 
Key words: Parkinson’s disease, freezing of gait, disease stage, pathophysiology, executive 
function 
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Introduction 
Freezing of gait (FOG) is a common symptom in Parkinson’s disease (PD) that is defined as 
a sudden involuntary motor arrest during walking (Nutt et al., 2011). With limited treatment 
options (Walton et al., 2014), FOG has a substantial impact on independence, quality of life 
and nursing home placement (Gray et al., 2000; Walton et al., 2015). Previous work has 
reported that FOG is present in around 80% of patients in the more advanced stages of PD 
whilst only 10% of patients experience this symptom in the early stages (Giladi et al., 2001; 
Macht et al., 2007).  
 
A number of phenotypic features have been associated with the presence of FOG. In relation 
to motor features, FOG has been commonly associated with a non-tremor dominant subgroup 
rather than tremulous PD (Factor et al., 2011; Lewis et al., 2005). Patients with this 
phenotype typically experience a more rapid disease progression and have more severe motor 
impairments, such as increased muscle rigidity with a concomitant deterioration of gait and 
balance (Lewis et al., 2005; Perez-Lloret et al., 2014). In addition, non-tremor dominant 
patients typically manifest a selective pattern of executive dysfunction (Lewis et al., 2005) 
and a higher risk of dementia (Kehagia et al., 2013).  
 
One recent study has confirmed that these distinct phenotypic differences are present between 
patients with and without FOG in the early clinical stages of PD (Hall et al., 2014). 
Specifically, patients in this study had disease duration of less than five years and were 
Hoehn and Yahr stage 2 or less.  Those patients with FOG had a non-tremor motor phenotype 
with selective executive impairments but did not differ from non-freezers on measures of 
tremor and more general cognition. Moreover, in this sample of early clinical stage patients, 
no differences were found on measures of autonomic function, REM sleep behaviour disorder 
(RBD) or mood between freezers and non-freezers (Hall et al., 2014).	 	 This finding is in 
distinction from earlier reports with less stringently selected patients who had more varied 
disease stages and durations (Giladi et al., 2006; Lieberman, 2006; Maidan et al., 2010; 
Romenets et al., 2012).  
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The finding that FOG was not related to autonomic dysfunction, RBD or mood disorder in 
patients with early disease (Hall et al., 2014) suggests that the underlying pathophysiology of 
freezing at this stage may be more closely related to disturbances in frontostriatal rather than 
brainstem circuitry.  However, it must be acknowledged that good evidence exists implicating 
the mesencephalic locomotor region and pedunculopontine nuclei (PPN) of the brainstem in 
gait and freezing (Fling et al., 2013; Lam et al., 2014; Snijders et al., 2011).  Early 
involvement of the frontostriatal pathways in FOG, however, contradicts the commonly 
accepted Braak hypothesis of disease spread in PD emphasises early brainstem pathology 
(Braak et al., 2003). Although Braak’s model elegantly integrates motor and non-motor 
symptoms, it is unable to currently account for the appearance of non-motor functions that 
precede the motor symptoms (Diederich et al., 2012), suggesting that the pathological 
degradation of regions outside the brainstem might be responsible for the complex, non-
motor symptoms of PD. Little is known about whether patients who experience freezing in 
the more advanced stages of PD have the same clinical phenotype that has been characterized 
for those in the early clinical stages of disease. Furthermore, it is not clear whether non-
freezers in the more advanced stages of PD demonstrate a distinct clinical phenotype that 
might also inform the mechanisms underlying FOG. The aim of this exploratory cross-
sectional study was to determine how key phenotypic features, including motor symptoms, 
cognition, mood, RBD and dysautonomia might be related to the freezing phenomenon FOG 
in the advanced stages (H&Y ≥ 2.5) and if this demonstrates a similar pattern as in the early 
stages (H&Y 1-2). We hypothesized that patients with FOG show impairments on variables 
related to frontostriatal dysfunctions. Conversely, we expected no differences on variables 
related to brainstem pathology in both the early and advanced stages.  
 
Methods 
Subjects 
Data was prospectively collected from 389 patients between 2009 and 2013 at the 
Parkinson’s Disease Research Clinic at the Brain and Mind Research Institute, University of 
Sydney. Idiopathic PD was diagnosed based on the UKPDSBB criteria (Hughes et al., 1992) 
and confirmed by a trained Neurologist (SJGL). Exclusion criteria included the presence of 
other neurological diseases or other conditions that are linked to gait impairment or dementia 
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as rated by the Movement Disorder Society (MDS) Task Force criteria (Emre et al., 2007). 
Freezers were firstly identified as those who were observed to freeze during MDS-UPDRS 
assessments (question 3.11). Additionally, patients were included if they a positive score on 
FOG-Questionnaire item 3 (“Do you feel that your feet get glued to the floor while walking, 
making a turn or when trying to initiate walking (freezing)?”) (Giladi et al., 2000). This item 
is the most accessible tool and has previously been shown to be a reliable screening 
instrument (Shine et al., 2012) and was included to avoid false negative classification that is 
common when relying on clinically observed ON-state FOG only. Patients were divided into 
four different groups, on the basis of the presence of FOG and the severity of PD according to 
the modified Hoehn and Yahr (H&Y) motor clinical staging (Hoehn & Yahr, 1967) 
distinguished by postural instability. Patients in H&Y stages 1 and 2 were classified as early 
PD patients with FOG (E-FOG) and early PD patients without FOG (E-NF). Patients in H&Y 
stages 2.5-5 with FOG were classified as advanced patients with (A-FOG) and without FOG 
(A-NF). All patients were assessed on their regular medication and their dopamine dose 
equivalence (LEDD; mg/day)(Tomlinson et al., 2010) was recorded. Written informed 
consent for this study was obtained from each patient, and the University of Sydney Human 
Research and Ethics Committee approved the study. 
 
Data collection 
Age and time since diagnosis were recorded for each patient. The Movement Disorder 
Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) (Goetz et al., 2008) was 
obtained as well as the motor sub-score, excluding question 3.11 (“Freezing of gait”).  Using 
a previously described method (Lewis et al., 2005), the tremor score was derived from the 
average of questions 2.10 and 3.15–3.18 of the MDS-UPDRS and a global score for non-
tremor features was obtained by averaging questions 2.1, 2.9, 2.11, 2.12, 3.1–3.10, 3.12-3.14.  
  
All patients were assessed on the Mini Mental State Examination (MMSE)(Folstein et al., 
1975) to measure general cognitive function for descriptive purposes. More detailed 
neuropsychological testing included psychomotor speed (TMTA) and attentional set-shifting 
(TMTB) (Army Battery, 1944). To control for psychomotor speed in part B of the TMT, the 
time to complete part A was subtracted from the time to complete part B (TMTB-A)(Corrigan 
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et al., 1987). The Digit Span (DS) Forward and Backward sub-tests (total score) were used to 
assess attention and working memory and Logical Memory (LM) Retention score (Wechsler 
Memory Scale – III) assessed verbal memory (Wechsler, 1997). Verbal (letters F, A, S) and 
semantic fluency (Animals) was also assessed (Benton, 1983). 
 
The Hospital Anxiety and Depression Scale (HADS) was obtained to assess affective 
function (Snaith et al., 1983). HADS depression and anxiety scores were compared between 
the groups, as well as the percentage of patients who scored above the cut-off score of 8, 
which indicates clinically significant symptomatology (Snaith et al., 1983).  
 
The RBD Screening Questionnaire (RBDSQ) (Stiasny-Kolster et al., 2007) was used to 
investigate symptoms of RBD. The autonomic function score was derived from averaging 
questions 1.10, 1.11, 1.12, 1.13 and 2.2 of the MDS-UPDRS.  
 
Statistical analyses  
All data analyses were performed using IBM SPSS Version 22. Due to the differences in 
sample size and inequalities of variances, Kruskal Wallis tests were used to determine 
differences between the four groups. To investigate whether there are any phenotypical 
differences between the groups, E-FOG was compared to E-NF, and A-FOG was compared 
to A-NF.  In addition, to investigate how phenotypical changes progress, E-FOG was 
compared to A-FOG and E-NF was compared to A-NF. Significant results were followed up 
with pairwise comparisons with a Mann Whitney test to determine which groups were 
significantly different from each other. In view of the exploratory nature of the study, p-
values were reported before corrections for multiple comparisons were made due to the 
increased risk of false negatives (Rothman, 1990). However, Dunn’s Bonferroni approach 
was also implemented to control for multiple comparisons and significant p-values that 
survived this correction are marked with a + in Table 2. Furthermore, Jonckheere-Terpstra 
tests were used to calculate effect sizes. Gender differences and the presence of RBD, 
depression and anxiety were analysed using the Pearson’s Chi-Square test. Z-scores for TMT 
(Tombaugh et al., 1996) were calculated and scores for verbal fluency (Tombaugh et al., 
1999) and LM (Wechsler, 1997) were adjusted for age and years of education. Z-scores based 
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on normative data were not computed for DS Forward and Backward tests, as normalized 
data was not available for these scores individually. Furthermore, the raw scores of the TMT 
were used to measure TMTB-A. In keeping with previous studies, the cut off score for TMTA 
was set at 180s and at 300s for TMTB (Thompson et al., 1999). All analyses used an alpha of 
0.05 and were two-tailed. 
 
Results  
In total 148 patients were classified as non-freezers (38%) whereas 241 patients (62%) were 
classified as freezers. The percentages of freezers and non-freezers across all H&Y stages are 
presented in Figure 1. Sixty-nine patients were identified as E-FOG, the E-NF group 
consisted of 113 patients. The A-FOG consisted of 172 patients and the A-NF of 35 patients. 
 
Clinical characteristics  
The medians and 25th and 75th percentiles of demographic data are presented in Table 1. 
Table 2 demonstrates the statistical differences between the four groups. As expected, 
patients in the advanced stages were older than patients in the early stages. No differences in 
age or gender were observed between the FOG and NF patients. Both the freezer groups had 
a significantly longer time since diagnosis than their respective non-freezer groups. E-FOG 
patients had significantly higher LEDD scores compared to E-NF.  Interestingly, LEDD 
scores did not differ between the early and advanged stages. Only three E-FOG patients 
(5%) had a LEDD score of zero and four of the A-FOG patients (2%) was untreated or 
refused to take medication. Seven patients in the E-NF group (7%) and five patients in the 
A-NF group (15%) had a LEDD score of zero.  In the A-NF group, all unmedicated patients 
had discontinued medications due to side-effect of confusion.		
 	
Motor function 
As demonstrated in Table 1 and 2, both the A-FOG and A-NF groups displayed higher total 
MDS-UPDRS, motor MDS-UPDRS-III and non-tremor scores comparing to the E-FOG and 
E-NF group respectively. A significant increase in tremor score was observed in A-NF 
compared to E-NF group. Compared to E-NF, E-FOG had significantly higher scores on the 
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total MDS-UPDRS, and both FOG groups performed more poorly on the non-tremor 
measures compared to the NF groups. Despite higher scores for the NF groups, the tremor 
score was not significantly different between FOG and NF patients after controlling for 
multiple comparisons. 
 
 
 
Figure 1. The percentage of freezers and non-freezers identified with the Freezing of Gait 
Questionnaire Item 3 across different Hoehn and Yahr stages (measured in the ON-state) of 
the disease.	(Number of patient in each group presented in bars).	
 	
Cognition	
Compared to E-FOG patients, the A-FOG group had significantly worse scores on the 
MMSE and LM Retention. Compared to E-NF patients, A-NF patients scored significantly 
worse on the MMSE and TMTB-A. No other differences were observed between these groups. 
E-FOG patients scored more poorly than E-NF patients on the MMSE, TMTA, TMTB, TMTB-
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A, DS-Backward, phonemic and semantic verbal fluency, however, after controlling for the 
multivariate approach only the differences on TMTA, phonemic and semantic verbal fluency 
performance remained significant between the groups. In the advanced stages, compared to 
the A-NF group, the A-FOG group had significantly poorer scores on DS- Backward, but this 
difference did not survive after controlling for multiple comparisons. However, due to the 
small number of patients in the A-NF group, these results should be interpreted with caution.  
 
Mood 
Depression scores increased in both FOG and NF as the disease progressed. In contrast, 
anxiety was not related to disease stage (see Table 1 and 2). Freezers in both the early and 
advanced stages had higher anxiety and depression scores compared to non-freezers, however 
the difference did not reach significance when using a multivariate approach. Clinically 
significant anxiety was found in 25.0% in the E-FOG group and in 31.9% of the patients in 
the A-FOG group, compared to 9.9% and 17.1% in the E-NF and A-NF groups. In 6.3% of 
the E-NF patients and 22.9% of the A-NF patients, clinically significant depression 
symptoms were reported, whilst the prevalence of depression in the E-FOG and A-FOG 
groups were 17.9% and 39.2% respectively.  
 
 
Autonomic function and REM Sleep Behaviour Disorder 
Compared to early disease stage, both the A-FOG as well as the A-NF group had 
significantly higher autonomic scores, but no differences were found between freezers and 
non-freezers in both early and advanced disease. RBD was independent of disease stage in 
both groups. Both FOG groups had higher RBDSQ scores than than the NF patients, reaching 
significance in the early clinical disease stages.  
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Table 1. Characteristics of Parkinson’s disease patients with and without freezing of gait (FOG) in the early and advanced stages 
(median (25th percentile – 75th percentile)  
 
 FOG Non-FOG 
 Early Advanced Early Advanced 
 N Median N Median N Median N Median 
Clinical characteristics  
Age (y) 66 65.03 (59.61 – 71.77) 160 75.15 (68.47 – 80.91) 104 66.47 (61.49 – 72.32) 33 78.50 (68.64 – 84.51) 
Gender (% male) 69 65.2% 164 59.3% 113 66.4% 35 48.6% 
Time since diagnosis (y) 69 6.21 (3.50 – 9.44) 166 9.95 (4.24 – 16.62) 111 3.43 (1.70 – 6.28) 34 4.34 (1.72 – 7.05) 
LEDD (mg/day) 63 750.00 (450.00 – 1100.00) 166 675.00 (300.00 – 1045.00) 104 456.25 (300.00 – 774.25) 30 425.00 (300.00 – 785.00) 
Minute since last dose  65 120.00 (60.00 – 205.00) 166 120.00 (60.00 – 225.00) 100 120.00 (60.00 – 240.00) 30 115.00 (13.75 – 212.50) 
Motor functions 
H&Y 69 2.00 (2.00 – 2.00) 172 3.00 (2.63 – 4.00) 113 2.00 (1.00 – 2.00) 35 3.00 (2.50 – 3.00) 
MDS- UPDRS total 69 50.00 (37.00 – 67.00) 168 93.50 (62.25 – 117.00) 112 39.00 (27.25 – 50.75) 35 72.00 (56.00 – 89.00) 
MSD-UPRDS III 69 29.00 (18.50 – 40.00) 168 51.00 (40.00 – 64.00) 112 21.50 (13.00 – 28.75) 35 43.00 (30.00 – 54.00) 
Non-Tremor 69 1.15 (0.69 – 1.52) 169 2.04 (1.54 – 2.54) 112 0.85 (0.50 – 1.12) 35 1.42 (1.08 – 2.00) 
Tremor 69 0.27 (0.18 – 0.55) 169 0.45 (0.18 – 0.91) 112 0.36 (0.11 – 0.63) 35 0.64 (0.36 – 1.00) 
Ratio score 69 0.43 (0.21 – 0.74) 169 0.32 (0.18 – 0.69) 112 0.56 (0.29 – 1.01) 35 0.43 (0.27 – 0.89) 
MDS-UPDRSQ46- FOG 69 1.00 (0.00 -1.00) 169 1.00 (0.00 – 2.00) 113 0.00 (0.00 – 0.00) 35 0.00 (0.00 - 0.00) 
FOG-Q item 3 69 2.00 (1.00 – 3.00) 172 3.00 (2.00 – 4.00) 113 0.00 (0.00 – 0.00) 35 0.00 (0.00 – 0.00) 
Sleep and autonomic functions 
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LEDD = Levodopa Equivalent Daily Dose; MDS-UPDRS = Movement Disorder Society – Unified Parkinson’s Disease Rating Scale; MDS UPDRS iii = Motor part of the MDS-
UPDRS excluding question 46 about freezing of gait; FOG-Q = Freezing of Gait Questionnaire; RBDSQ sub-score = REM Sleep Behaviour Screening Questionnaire, question 3, 
6i, 6ii, 6iii; MMSE = Mini Mental State Examination; TMT = Trail Making Test; VF = Verbal Fluency; LM = Logical Memory, ASS = Age Scaled Score; HADS = Hospital 
Anxiety and Depression Scale. Anxiety Frequency = Percentage of patients with sum HADS Anxiety score  ≥ 8; Depression Frequency = Percentage of patients with sum HADS 
Depression score ≥ 8. 
  
RBDSQ 68 6.00 (3.25 – 9.00) 167 6.00 (3.00 – 9.00) 112 4.00 (2.00 – 7.00) 33 4.00 (2.00 – 6.50) 
Autonomic function 69 0.83 (0.58 – 1.17) 169 1.67 (1.00 – 2.33) 113 0.67 (0.33 - 1.17) 35 1.33 (1.00 – 1.83) 
Cognitive functions 
MMSE 62 28.00 (26.00 – 30.00) 142 26.00 (23.00 – 29.00) 99 29.00 (28.00 – 30.00) 31 28.00 (24.00 – 29.00) 
TMTA z-score 55 -0.10 (-1.11 – 0.49) 86 -0.90 (-2.45 – 0.33) 85 0.50 (-0.34 – 0.99) 15 -0.38 (-0.60 – 0.91) 
TMTB z-score 54 0.01 (1.15 – 0.43) 73 -0.64 (-2.61 – 0.27) 84 0.31 (-0.32 – 0.80) 15 -0.30 (-1.00 – 0.00) 
TMTB-A time  55 55.00 (453.00 – 96.00) 74 85.50 (41.50 – 164.00) 84 41.50 (29.25 – 66.00) 15 64.00 (55.00 – 103.00) 
Digit Span Forward 55 10.00 (9.00 – 12.00) 89 10 .00 (8.00 - 11.00) 89 11.00 (9.00 – 12.00) 17 10.00 (9.50 -12.50) 
Digit Span Backward 55 6.00 (5.00 – 7.00) 89 5.00 (4.00 – 7.00) 89 7.00 (6.00 – 8.00) 17 7.00 (6.00 – 7.50) 
VF Animals z-score 55 -0.50  (-1.14 – 0.67) 87 -0.56 (-1.72 – 0.37) 91 0.40 (-0.43 – 1.14) 16 -0.43 (-0.96 – 0.81) 
VF Letters z-score 55 -0.41 (-1.30 – 0.41) 88 -0.71 (-1.56 – 0.37) 92 0.08 (-0.42 – 0.83) 16 -0.25 (-0.77 – 0.89) 
LM Retention ASS  55 12.00 (9.00 – 15.00) 87 10.00 (7.00 – 12.00) 83 11.00 (9.00 – 14.00) 16 10.50 (7.50 – 13.00) 
Mood 
HADS Anxiety 68 4.00 (2.00 – 7.75) 160 5.00 (2.00 – 8.00) 111 3.00 (1.00 – 5.00) 35 3.00 (1.00 – 6.00) 
Anxiety Frequency 68 25.0% 160 31.9% 111 9.9% 35 17.1% 
HADS Depression 67 3.00 (2.00 – 6.00) 161 6.00 (3.00 – 9.00) 111 2.00 (1.00 – 4.00) 35 3.00 (2.00 – 7.00) 
Depression Frequency 67 17.9% 161 39.2 % 111 6.3% 35 22.9% 
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Table 2. Evaluation of clinical characteristics of Parkinson’s disease patients with and without freezing of gait (FOG) in the early and 
advanced stages, illustrating the statistical differences between the four groups (Standard Test Statistics, p-values and Jonckheere 
effect sizes) 
 
 FOG Non-FOG Early stages Advanced stages 
 Early vs Advanced stages Early vs Advanced stages FOG vs Non-FOG FOG vs Non-FOG 
 Std. Test 
Stat  
p-value r Std. Test 
Stat 
p-value r Std. Test 
Stat 
p-value r Std. Test 
Stat 
p-value r 
Clinical characteristics 
Age (y) -5.820 <.001+ -0.39 -5.022 <.001+ -0.43 0.279 1.000 0.02 1.025 1.000 0.07 
Gender (% male) Χ2(1) = 4.354; p = .226 
Time since diagnosis (y) -2.926 .003+ -0.19 -1.007 .314 -0.08 -3.549 <.001+ -0.26 -4.068 <.001+ -0.29 
LEDD (mg/day) 1.662 .097 0.11 .235 .814 0.02 -3.535 <.001+ -0.27 -1.885 .064 -0.13 
Time since last dose (min) H(3) 1.542; p = .673 
Motor functions 
H&Y -12.346 <.001+ -0.86 -8.469 <.001+ -0.65 -0.665 .506 -0.05 -1.223 .211 -0.12 
MDS-UPDRS total -7.749 <.001+ -0.54 -5.990 <.001+ -0.46 -3.117 .002+ -0.23 -2.288 .022 -0.22 
MDS-UPRDS III -7.948 <.001+ -0.55 -5.733 <.001+ -0.44 -2.502 .012 -0.19 -2.199 .028 -0.22 
Non-Tremor -7.966 <.001+ -0.56 -5.294 <.001+ -0.41 -2.745 .006+ -0.21 -2.870 .004+ -0.28 
Tremor -2.197 .028 -0.16 -3.791 <.001+ -0.29 0.166 .868 0.01 2.400 .016 0.24 
Ratio score 0.848 .396 0.06 0.849 .396 0.07 1.892 .059 0.14 0.185 1.000 0.13 
MDS-UPDRSQ46 - FOG -2.483 .013 -0.17 0.000 1.000 0.00 -6.079 <.001+ -0.45 -6.911 <.001+ -0.68 
FOG-Q item 3 -3.371 .001+ -0.24 0.000 1.000 0.00 -8.945 <.001+ -0.66 -9.839 <.001+ -0.96 
Sleep and autonomic functions 
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LEDD = Levodopa Equivalent Daily Dose; MDS-UPDRS = Movement Disorder Society – Unified Parkinson’s Disease Rating Scale; MDS UPDRS iii = Motor part of the MDS-
UPDRS excluding question 46 about freezing of gait; FOG-Q = Freezing of Gait Questionnaire; RBDSQ = REM Sleep Behaviour Screening Questionnaire; MMSE = Mini Mental 
State Examination; TMT = Trail Making Test; VF = Verbal Fluency; LM = Logical Memory, ASS = Age Scaled Score; HADS = Hospital Anxiety and Depression Scale. Anxiety 
Frequency = Percentage of patients with sum HADS Anxiety score  ≥ 8; Depression Frequency = Percentage of patients with sum HADS Depression score ≥ 8.  
+ p – values significant after adjustments for multiple comparisons 
 
RBDSQ 0.915 .360 0.06 0.531 .595 0.04 -2.845 .004+ -0.21 -2.157 .031 -0.21 
Autonomic functions -6.161 <.001+ -0.43 -4.658 <.001+ -0.36 -1.185 .236 -0.09 -0.863 .388 -0.08 
Cognitive functions 
MMSE 3.510 <.001+ 0.27 3.271 .001+ 0.26 2.474 .013 0.19 1.321 .187 0.14 
TMTA, z-score 1.954 .051 0.19 1.274 .203 0.14 2.790 .005+ 0.21 1.657 .098 0.20 
TMTB, z-score 1.747 .081 0.19 2.437 .015 0.29 2.467 .014 0.21 0.830 1.000 0.03 
TMTB-A, time -2.187 .029 -0.23 -2.921 .003+ -0.34 -2.263 .024 -0.19 0.130 .896 0.02 
DS Forward 1.431 .251 0.14 0.055 .955 0.01 1.906 .078 0.16 2.096 .067 0.25 
DS Backward 1.167 .380 0.12 0.007 .994 0.00 2.403 .023 0.20 2.295 .042 0.27 
VF Animals 1.660 .109 0.17 1.738 .083 0.19 2.789 .005
+ 0.24 1.036 .288 0.12 
VF Letters 1.118 .288 0.11 0.889 .378 0.10 2.986 .003
+ 0.25 1.665 .091 0.20 
LM Retention ASS 3.113 .007
+ 0.31 0.951 .339 0.10 -0.105 .758 -0.01 0.784 .572 0.09 
Mood             
HADS Anxiety -1.173 .241 -0.08 -0.402 .688 -0.03 -2.012 .044 -0.15 -2.153 .031 -0.21 
Anxiety Frequency Χ2(1) = 
1.078 
.299  Χ2(1) = 
1.353 
.245  Χ2(1) 
= 
7.277 
.007  Χ2(1) 
= 
3.013 
.083  
HADS Depression -3.998 < 001
+ -0.29 -2.968 .003
+ -0.23 -2.492 .013 -0.19 -2.095 .036 -0.21 
Depression Frequency Χ2(1) = 
11.740 
.001  Χ2(1) = 
7.907 
.005  Χ2(1) 
= 
5.901 
.015  Χ2(1) 
= 
4.282 
.039  
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Discussion  
This large-scale cross-sectional study investigated the association between different 
characteristics of PD and FOG relative to disease severity. Here, we provide an in-depth 
comparison of the clinical phenotype of patients with and without FOG, at early versus 
advanced clinical disease stages. In doing so, a number of critical novel findings have 
emerged, which inform possible mechanistic explanations of the emergence of FOG 
across disease stages.  Regardless of disease stage, patients with FOG performed worse 
on their motor assessment particularly in relation to non-tremor symptoms. However, 
freezers and non-freezers demonstrated similar tremor scores in both clinical stages, but 
an increase in tremor score between the clinical stages was only found in non-freezers. 
Although tremor and FOG share some characteristics such as an increased prevalence 
during mental stress and an episodic character, there are significant distinct mechanisms 
underlying each symptom (Lewis et al., 2005). Specifically, the cerebello-thalamo-
cortical circuit is likely to be involved in the incidence of tremor (Helmich et al., 2012) 
rather than arising from frontostriatal pathways. 
 
Previous studies have demonstrated a selective cognitive impairment in freezers that 
typically affects executive functions such as verbal fluency (Amboni et al., 2008), 
conflict resolution (Vandenbossche et al., 2012; Walton et al., 2014) and set-shifting 
(Shine et al., 2012). Indeed, the current study demonstrated that FOG patients scored 
worse on measures for phonemic and semantic verbal fluency in the early stages.  
Additionally, though non-significant after controlling for multiple comparisons, freezers 
performed more poorly on set shifting in the early stages of the disease and working 
memory in both the early and advanced stages. In contrast, memory retention 
performance, which is known to reflect temporal lobe function, did not differ between 
groups across disease stages, thus reinforcing the possible selectivity of frontostriatal 
impairment in FOG. Although current results do not show a clear division between FOG 
and NF patients, a difference between these patient groups is plausible and in accordance 
with recent work using functional neuroimaging techniques. Namely, it has been shown 
that there is a paroxysmal functional decoupling of activity between neural networks 
including the cognitive control network and the basal ganglia in patients with FOG 
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(Shine, 2013a). Such impaired information processing in the frontostriatal system might 
be influenced by a faulty selective gating mechanism across the basal ganglia, which 
would normally be responsible for the rapid updating of information (van Schouwenburg 
et al., 2010). However, it is important to note that not all freezers present with executive 
dysfunction, pointing out the likelihood of different causes of FOG (Ferraye et al., 2013). 
Indeed, FOG is not due to executive dysfunction per se, but rather to impairments in 
conflict processing independent of the processing system of which the conflict occurred. 
As such, motor, cognitive, affective or perceptual conflict may underlie freezing 
behaviour, given that dysfunctional activity within each of these circuits is processed via 
a final common neural pathway, i.e. the subthalamic nucleus (Lewis & Shine, 2016).  
 
The current study demonstrated that in contrast with depression, anxiety is not related to 
disease stage. Freezers showed a trend towards significantly higher average anxiety 
scores. This is in accordance with an elegant study recently published, showing 
differences on depression and anxiety scores between FOG and non-FOG patient. 
However, this difference disappeared when using a multivariate approach (Perez-Lloret et 
al., 2014). The exact etiology of mood disturbances remains unknown (Aarsland et al., 
2012). The interplay of emotion and FOG might have an underlying neurobiological basis 
in shared frontostriatal limbic circuitry, an interpretation consistent with a SPECT study 
that found that bilateral ventromedial prefrontal cortex showed decreased perfusion in 
freezers compared to non-freezers (Rahman et al., 2008). However, previous work has 
also highlighted involvement of the locus coeruleus (Gesi et al., 2000; Pontone et al., 
2009). Therefore, as the current results are inconclusive, the association between freezing 
and anxiety and depression needs further exploration, as well as its influence on other 
variables associated with FOG, such as executive functioning, methods of assessments 
and cut-off scores, and their underlying pathophysiology. A relationship between these 
phenomena has potentially significant implications for future treatment strategies, such as 
targeted cognitive-behavioural therapy that would be designed to manage anxiety 
(Proudfoot et al., 2004), a non-pharmacological approach that would be advantageous in 
a patient population often requiring polypharmacy (Walton et al., 2014). 
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Higher RBD scores found in this study are in contrast with our previous study that used 
more stringent inclusion criteria, pointing out a role of disease progression. However, 
only in the early stages the RBD scores remained significantly different between the FOG 
and Non-FOG groups when using a multivariate approach. RBD suggest brainstem 
pathology (Grinberg et al., 2010), yet associations with executive dysfunction and mild 
cognitive impairment have been frequently reported (Gagnon et al., 2012; Gagnon et al., 
2009). Finally, autonomic functions did not differ between FOG and NF regardless of 
disease stage. These findings suggest that the pathological processes within the brainstem 
underlying autonomic functions are not intrinsically associated with freezing behaviour 
(Brooks et al., 2010). 
 
Braak and colleagues have identified distinct stages in the progression of PD that spreads 
rostrally from several nuclei in the brainstem with little inter-individual variability (Braak 
et al., 2003).  Despite this pattern of progression, disease heterogeneity is well recognised 
in PD.  Specifically, in relation to FOG, the results of our study do not indicate that early 
or advanced brainstem pathology uniquely contributes to FOG. Indeed, a recent positron 
emission tomography study demonstrated that the effects of cholinergic degeneration 
associated with FOG were driven by neocortical degeneration but not by PPN-thalamic 
degeneration, which was more associated with postural reflex impairments (Bohnen et 
al., 2014). This finding would be aligned with our observations and suggests that 
pathology within the PPN by itself is unlikely to be the underlying cause of FOG in PD.  
 
Whilst the partial amelioration of FOG by dopaminergic agents presumably operating 
through frontostriatal networks is well documented (Nantel et al., 2014; Schaafsma et al., 
2003), there is evidence for a dopamine resistant form of freezing (Espay et al., 2012; 
Perez-Lloret et al., 2014).  Furthermore, cholinergic degeneration in PD has been 
associated with a non-tremor dominant phenotype (Bohnen et al., 2011) along with 
executive and attentional dysfunction (Voytko, 1996), depression and apathy (Bohnen et 
al., 2007). These observations highlight the complex interplay required between 
complementary networks and neurotransmitter systems that when compromised lead to 
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FOG via dysfunction across cortical and subcortical regions. Furthermore, the 
paroxysmal nature of FOG suggests that FOG does not result from structural lesions, but 
rather from bouts of decreased neuronal activity. Indeed, FOG is best conceptualized as a 
functional disorder with multiple possible pathological underpinnings across a range of 
different areas in the brain.  
 
Limitations and further directions 
Whilst the current study raises several important clinical issues in relation to FOG in PD, 
it does suffer with a number of limitations. Group sizes were not equal and the data was 
only attained at one time point.  Therefore, it was not possible to determine when FOG 
had initially presented in the different groups. As such, more accurate temporal 
relationships between neuropathology and phenotypic features could not be explored. All 
patients were assessed on their optimal ON state and no differences were observed for 
time since last dose. However, it is hard to elicit ON-state FOG in the clinical setting; 
Levodopa helps in reducing the frequency and duration of 'off'-related FOG (Schaafsma 
et al., 2007), and thus many patients report significant FOG at home (Aarsland et al., 
2012) (Schaafsma et al., 2003). Therefore, we have included a subjective questionnaire to 
identify freezers. Future studies will be necessary to assess the effect of dopaminergic 
medication, including potential wearing-off phenomena along with other neurotransmitter 
disturbances in PD patients with FOG. Furthermore, the inability to match subgroups on 
all demographic features may also have influenced our findings, but it should be 
acknowledged that it might not be possible to control for the effects of FOG, such as the 
use of higher dopaminergic therapy in an attempt to reduce freezing episodes. Both FOG 
groups had a significantly longer time since diagnosis. Therefore, future longitudinal 
studies observing the evolution of FOG within patients may offer important further 
insights to those offered here. In addition, the executive functioning scores should be 
interpreted with caution. Only 15-17 patients in the A-NF group performed these tests 
and not all differences remained significant after controlling for multiple comparisons. 
Finally, whilst we acknowledge that using solely behavioural tests in this study limits our 
speculation regarding the pathophysiology underlying FOG, our results are aligned with 
previous functional imaging data (Shine et al., 2011; 2013b). 
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Conclusions 
In conclusion, this study suggests that FOG is associated with non-tremor motor severity, 
selective executive dysfunction, mood disturbance and RBD but not more general 
autonomic dysfunction or tremor. In patients with more severe tremor, the frontostriatal 
pattern of neuropathology might be less affected in these patients compared to patients in 
the non-tremor phenotype. The current findings do not support the notion that distinctly 
different pathophysiological processes may underlie the freezing phenomenon across 
advancing disease stages, however the differences between the groups become less strict 
with progressing pathology. Future prospective clinicopathological studies may help 
better understand these associations and could provide insights into novel therapies. 
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Box 2a: Evidence for the association between freezing of gait and executive 
dysfunction  
Walton, C. C., Shine, J. M., Mowszowski, L., Gilat, M., Hall, J. M., O'Callaghan, C., 
Naismith, S. L., Lewis, S. J. G. Impaired cognitive control in Parkinson's disease 
patients with freezing of gait in response to cognitive load. Journal of Neural 
Transmission, 2015 
 
In this study, we further explored the association between freezing of gait and executive 
dysfunction and showed specific deficits in inhibition and cognitive control. Specifically, 
we explored self-monitoring ability of performance using the colour word interference 
test. During the inhibition task, patients showed more self corrected, but not uncorrected 
errors compared to non-freezers. However, when the switching element was introduced, 
freezers were unable to self-correct their errors. These results indicated that freezers fail 
to effectively monitor their performance with increasing cognitive load. Therefore, 
patients with freezing of gait may use additional cognitive resources to perform difficult 
tasks, impeding mechanisms to monitor errors.  
 
 
 
 	
Box 2b: Evidence for the association between freezing of gait and executive 
dysfunction  
Walton, C. C., O'Callaghan, C., Hall, J. M., Gilat, M., Mowszowski, L., Naismith, S. 
L., Burrell, J. R., Shine, J. M., Lewis, S. J. G. Antisaccade errors reveal cognitive 
control deficits in Parkinson's disease with freezing of gait. Journal of Neurology, 
2015  
 
In this study, we assessed antisaccade performance between groups and found no 
differences on the simple saccade task, whilst freezers performed more poorly on the anti-
saccade task compared to non-freezers, showing disruptions with inhibiting the reflexitve 
saccade. Furthermore, a reduction in grey matter density in the fronto-parietal regions and 
occipital cortex was related to the anti-saccade task performance, a finding that supports 
the involvement of cortical disruptions in freezing of gait.   	
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Box 3: Evidence for the association between freezing of gait and mood 
disturbances  
Ehgoetz Martens, K. A., Hall, J. M., Gilat, M., Georgiades, M. J., Walton, C. C.,  Lewis, S. 
J. G. Anxiety is associated with freezing of gait and attentional set-shifting in Parkinson’s 
disease: A new perspective for early intervention. Gait and Posture 2016 
 
Using a similar cohort of patients as presented in Chapter 3, this study further explored the 
association between anxiety and the freezing of gait. We showed that freezers reported 
significantly higher anxiety scores compared to non-freezers, and this effect remained 
significant even when controlled for age disease duration, severity, global cognitive 
andexecutive functioning and depression. Furthermore, both anxiety and depression were 
correlated to set-shifting and freezing of gait. Finally, anxiety and depression were 
significant predictors of freezing. In the presence of clinical anxiety, a patient was 3.4 times 
more likely to have freezing of gait. However, both anxiety and depression as well as 
executive dysfunction were not present in all freezers, therefore, these symptoms do not 
entirely explain freezing. It can be hypothesized that diffuse cortical and sub-cortical 
changes contribute to ineffective information processing, leading to functional disturbances, 
such as freezing of gait.  
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Chapter 4: Alterations in white matter network topology contribute to freezing of 
gait in Parkinson’s disease 
 
Abstract 
Freezing of gait (FOG) is a common symptom in advanced Parkinson’s disease (PD). 
Despite current advances, the neural mechanisms underpinning this disturbance remain 
poorly understood. To this end, we investigated the structural organization of the white 
matter connectome in PD freezers and non-freezers. We hypothesized that freezers would 
show an altered network architecture, which could hinder the effective information 
processing that characterizes the disorder.  Twenty-six freezers and twenty-four well-
matched non-freezers were included in this study. Using diffusion tensor imaging, we 
investigated the modularity and integration of the regional connectome by calculating the 
module degree z-score and the participation coefficient, respectively. Compared to non-
freezers, freezers demonstrated lower participation coefficients in the right caudate, 
thalamus and hippocampus, as well as within superior frontal and parietal cortical 
regions. Importantly, several of these nodes were found within the brain’s ‘rich club’. 
Furthermore, group differences in module degree z-scores within cortical frontal regions 
and in sensory processing areas were found. Together, our results suggest that changes in 
the structural network topology contribute to the manifestation of FOG in PD, 
specifically due to a lack of structural integration between key information processing 
hubs of the brain.  
 
Key Words: Parkinson’s disease; Freezing of Gait; Connectome; Diffusion imaging
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Introduction 
Freezing of gait (FOG) is a sudden and involuntary gait cessation that is common in 
idiopathic Parkinson’s disease (PD) (Nutt et al., 2011) and has a prominent impact on 
quality of life (Walton et al., 2015). Freezing behaviour can be provoked by a range of 
triggers, including turning, dual tasking and emotional stress (Plotnik et al., 2012). 
Treatment options are limited, and although dopaminergic medication can partially 
ameliorate freezing, patients are often forced to rely on behavioural strategies that 
temporarily enhance their gait pattern using goal directed strategies (Nutt et al., 2011). 
Furthermore, patients with freezing often experience executive dysfunction, mood 
disorders and perceptual problems (Ehgoetz Martens et al., 2014a, 2014b; Naismith et al., 
2010). These observations have led to the suggestion that FOG is not simply the result of 
dysfunctional locomotor output, but rather results from a diffuse, network-level 
dysfunction that ultimately manifests as a loss of top-down control over the brainstem 
structures that control gait (Lewis & Shine, 2016). 
 
A range of studies has been conducted to determine whether individuals with FOG 
demonstrate white matter abnormalities. For instance, widespread alterations in structural 
connections between cortical, subcortical and brainstem regions have been reported in 
studies using diffusion tensor imaging (DTI), a technique that infers the integrity of inter-
regional white matter. Compared to non-freezers, freezers have shown abnormalities in 
the corticopontine, pontine-cerebellar (Fling et al., 2013; Schweder et al., 2010; 
Vercruysse et al., 2015; Youn et al., 2015), major cortico-cortical and frontostriatal tracts 
(Pietracupa et al., 2018; Vercruysse et al., 2015). Conversely, differences were not 
observed in a study investigating the frontostriatal hyper-direct pathway (Fling et al., 
2014) or in a whole brain analysis between freezers and non-freezers (Canu et al., 2015). 
These divergent results suggest that structural lesions in freezers might be subtle and 
dispersed, and hence raise the question of whether FOG actually stems from a focal 
anatomical lesion at all (Lewis & Shine, 2016). Indeed, a key caveat of the majority of 
studies to date is that they have used diffusion imaging in an attempt to identify lesions 
within specific regions or tracts. As such, they offer insights that are relatively limited to 
	 113 
the field of interest and therefore miss more complex, distributed patterns that might exist 
in the data.  
 
Given the multi-dimensional nature of FOG, the primary objective of this study was to 
investigate the structural brain network architecture in patients with FOG and this 
debilitating phenomenon. Specifically, we investigated whether white matter changes that 
contribute to freezing might emerge as alterations in structural network topology. The 
brain displays a modular structure, in which discrete communities (‘modules’) with 
densely interconnected nodes are only sparsely connected with nodes of other 
communities (Shine et al., 2017; Sporns et al., 2016). These specialist modules allow for 
processing without unnecessary cross-talk (Bassett et al., 2015). Conversely, the 
integration of communities is crucial for incorporating complex information streams of 
different modalities, such as in cognitively challenging tasks (Figure 1b) (Bertolero et al., 
2015; Shine et al., 2017). 
 
Graph theory offers a robust mathematical framework for interrogating neural network 
topology, and can offer a detailed in vivo analysis of the brain at the level of circuits and 
modules (Sporns et al., 2004). Importantly, whole brain graph theoretical embraces the 
inherent complexity of interacting subsystems, rather than isolating a particular region 
within a circuit. Here, we used a combination of DTI and graph theoretical analyses to 
investigate the global and regional topology of the structural connectome in individuals 
with PD and FOG. Given the known impairments in multi-domain behaviour in patients 
with freezing, we predicted that freezers should exhibit impairments in inter-modular 
connectivity, especially in frontoparietal and subcortical networks (Lewis & Shine, 
2016).  
 
Materials and methods 
Fifty patients with mild to moderate idiopathic PD, recruited from the Parkinson’s 
Disease Research Clinic at the Brain and Mind Centre, University of Sydney were 
included in this study. Demographic and clinical details including age, gender, disease 
duration, levodopa equivalent daily dose and motor severity were obtained and are listed 
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in Table 1. Motor severity was measured by the Movement Disorder Society Unified 
Parkinson’s Disease Rating Scale (MDS-UPDRS) part III (Goetz et al., 2008) and Hoehn 
and Yahr (H&Y) scale (Hoehn & Yahr, 1967). Patients with an H&Y score of > 3 were 
excluded from the study. Cognitive screening was performed using the Mini Mental State 
Examination (Folstein et al., 1975) and patients with a score of ≤ 25 on this test were also 
excluded from the study. Finally, Logical Memory (Wechsler, 1997), the Trail Making 
Test Part B – A (TMTB-A) (Army Battery, 1944) and Digit Span Backward (DSB) 
(Wechsler, 1997) were used as measures of memory and executive functioning ability. 
Patients were identified as ‘freezers’ if they scored positively on the Freezing of Gait 
Questionnaire item 3 (Giladi et al., 2000; Shine et al., 2012) and as ‘non-freezers’ if they 
scored a 0 on this item.  
 
MRI Acquisition   
Neuroimaging was acquired on a 3-Tesla General Electric Discovery MR750 scanner 
(GE Medical Systems) using an eight-channel phased array head coil. 3D T1-weighted, 
anatomical images (voxel size 1 × 1 × 1 mm) were obtained for parcellation of cortical 
regions, using the following protocol: Repetition time 7.2 ms, echo time 2.7 ms, inversion 
time 450 ms, 196 transverse slices, 256 × 256 matrix; field of view 256 x 256 mm, flip 
angle 12°. Diffusion weighted images (DWI) were acquired in 61-gradient directions, 
using the following echoplanar imaging protocol: repetition time 7025 ms, echo time 80 
ms, 55 transverse slices, 2.5 mm slice thickness, 256 × 256 matrix; field of view 240 x 
240 mm. The effective diffusion weighting was b = 1000 s/mm2. Four volumes with no 
diffusion weighting (b = 0 s/mm2) were acquired at the beginning of each diffusion 
sequence and used for robust individual registration between T1-weighted anatomical and 
the diffusion weighted images.  
 
Image pre-processing  
Diffusion image pre-processing was performed using the FMRIB Software Library (FSL, 
http://fsl.fmrib.ox.ac.uk). Raw DWI were corrected for susceptibility, head motion and 
eddy current distortions using FSL’s tool eddy and skull stripped using BET. T1-weighted 
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images were segmented into white and grey matter (cortical and subcortical structures) 
and cerebrospinal fluid using FreeSurfer (version 5.3; http://surfer.nmr.mgh.harvard.edu). 
The cortical surface was further parcellated into 219 cortical regions using the Lausanne 
anatomical atlas (Cammoun et al., 2012) distributed as part of the Connectome Mapping 
Toolkit (Daducci et al., 2012) and validated for diffusion MRI analysis. Using 
FreeSurfer, fourteen subcortical structures were segmented including the left and right 
thalamus, caudate, putamen, pallidum, amygdala, hippocampus and nucleus accumbens 
area by an atlas based segmentation (Fischl et al., 2002).  This atlas was chosen because 
this scale has been shown to provide local interpretability whilst containing homogeneous 
clusters (Cammoun et al., 2012). T1-weighted images were registered in DWI space to 
the b0 volume. Fibre reconstruction was performed using robust tensor fitting. The main 
diffusion direction of each voxel was estimated after decomposition of the tensor into 
eigenvectors and eigenvalues, and fractional anisotropy values, a measure of magnitude 
of directionally of diffusion in white matter fibres, were computed. White matter 
pathways were constructed using deterministic fibre tracking approach. The deterministic 
approach was chosen to control for the number of false positives, which are unfavourable 
when investigating network topology (Zalesky et al., 2016). Using the fibre assignment 
by continuous tracking algorithm, streamlines were traced following the main diffusion 
direction starting from eight seeds evenly distributed in each white matter voxel and 
stopping when one of the following criteria was met: 1) fractional anisotropy < 0.1; 2) 
turn > 45 degrees; 3) the end of the brain mask was reached. Connectome maps were 
reconstructed using the Connectome Mapper (Daducci et al., 2012). By combining the 
parcellation map and the reconstructed fibres a connectivity matrix was created for each 
subject, using the average fractional anisotropy of voxels of the reconstructed 
streamlines. The pipeline is illustrated in Figure 1a. Finally, to account for spurious 
streamlines, values of tracts that were present in less than 50% of all participants were set 
to zero by applying a threshold on the individual connectivity matrices (de Reus et al., 
2013).  To verify the results were not skewed by the choice of threshold, the analysis was 
also performed using thresholds of 40% and 60%.  
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Figure 1a) Imaging processing flow. b) Representation of a brain network with a 
modular structure. Different graph metrics are highlighted.  
 
Graph Theoretical Analyses 
Graph metrics were calculated on the thresholded adjacency matrices using MATLAB 
scripts from the Brain Connectivity Toolbox (Rubinov et al., 2010). First, we confirmed 
that the group mean structural connectome demonstrated a ‘small-world’ architecture, by 
comparing the ratio of the mean clustering coefficient (the average intensity of triangles 
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around a node) to the shortest path length (a metric of information transmission) of the 
thresholded connectivity matrix. We next sought to identify significant differences in 
graph metrics between the two groups. To this end, network modularity was calculated 
using the Louvain modularity algorithm (Rubinov et al., 2010). This algorithm iteratively 
assigns nodes to different communities, until the maximum possible modularity statistic 
Q is reached. In this way, the network is subdivided into non-overlapping groups of 
highly connected nodes that minimizes between module edges.  	 	 ! = !!  !!" − !!" !!!!!!"       [1] 
 
Equation 1 – Louvain modularity algorithm, where v is the total weight of the network 
(sum of all positive connections), wij is the weighted connection between regions i and j, 
eij is the strength of a connection divided by the total weight of the network, and δMiMj is 
set to 1 when regions are in the same community and 0 otherwise.  
 
Due to the stochastic nature of the Louvain algorithm, the community assignment for 
each region was assessed 100 times on the group average connectome and a consensus 
partition was identified using a fine-tuning algorithm. To define an appropriate value for 
the resolution parameter (γ), we iterated the Louvain algorithm across a range of values 
(0.5 – 2.5 in steps of 0.1) for 100 iterations and then estimated the similarity of the 
resultant partitions using mutual information. A γ parameter of 1.0 provided the most 
robust estimates of topology across these iterations, and thus was used for the main 
experiment. 
 
To estimate the topology at the regional level, we calculated the module degree z-score 
(Wi; a measure of intra-module connectivity; see equation 2) and participation coefficient 
(Bi; a measure of inter-module connectivity; see equation 3) for each node. Positive Wi-
values reflect nodes with more connections to other members of the same community 
(compared to the average number of connections), and vice versa. In contrast, the Bi 
values ranges between 0 and 1, with a value of 0 indicating that all connections are within 
its community, whereas a value of 1 indicates uniformly distributed connections across 
modules (github.com/juliemaehall/topology).  
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   !! = !!!!!!!!!!        [2] 
 
Equation 2 – Module degree z-score Wi, where κi is the strength of the connections of 
region i to other regions in its module si, !!! is the average of κ over all the regions in si, 
and !!!!  is the standard deviation of κ in si  
 
 !! = 1− !!"!! !!!!!!       [3] 
 
Equation 3 - Participation coefficient Bi, where κis is the strength of the positive 
connections of region i to regions in module s, and κi is the sum of strengths of all 
positive connections of region i. The participation coefficient of a region is therefore 
close to 1 if its connections are uniformly distributed among all the modules and 0 if all 
of its links are within its own module. 
 
Rich Club Analysis 
We next identified the structural ‘rich club’ of the binarized group mean connectivity 
matrix of the entire sample. The ‘rich club’ of a network represents a set of high degree 
nodes (i.e. nodes with a large number of edges) that are more densely interconnected with 
other high degree nodes than would be expected by chance (van den Heuvel et al., 2011). 
To estimate these regions, the degree of each node i was determined by taking the sum of 
the number of connections node i shared with k other nodes in the network. Then a sub-
network (the ‘k core’) was obtained by removing all nodes that had connections ≤ k. For 
each value of k, the rich-club coefficient Φk was then computed as the ratio of the number 
of connections between the nodes in the k core network and the sum of possible 
connections that would be present if the network was completely connected (see equation 
4).  
 	 Φ! = !!!!!!!(!!!!!)				       [4] 
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Equation 4 – Rich club coefficient Φ! at a specific k level is the fraction of edges E that 
connect nodes of a specific level of k or higher out of the maximum number of edges that 
nodes may share. 
 
Since random networks also show an increasing function of Φk, we next normalized the 
rich club coefficient in reference to a null model. To this end, we created 5000 random 
networks with a preserved degree distribution, and then the average rich-club coefficient 
Φrand over the set of random networks was calculated for each level of k. We then divided 
Φk by Φrand, and to define the normalized rich club coefficient (ΦZ). Values of k with a ΦZ 
> 1 can thus be said to contain a stronger rich club architecture than expected under the 
conditions of the null model (van den Heuvel et al., 2011). The identity of rich club nodes 
for the highest value of k with ΦZ > 1 can be found by identifying nodes that were present 
within the k core network for that value of k. The 85th percentile of nodes was selected as 
part of the rich club.  
 
Statistical analyses  
Data analyses for demographic and clinical variables were performed using IBM SPSS 
Version 19. Independent t-tests and Mann-Whitney U-tests were performed, depending 
on the distribution of the data. Missing values for LEDD (n = 1; 2% of the sample), 
Logical Memory (n=1; 2% of the sample), TMTB-A (n = 2; 4% of the sample) and DBS (n 
= 1, 2% of the sample) were replaced using the Expectation Minimization algorithm. The 
results are presented in Table 1. To assess statistical significance for the global and 
regional level metrics, a non-parametric permutation testing approach was used (5000 
iterations) that effectively controls for multiple comparisons (Nichols et al., 2002). 
Additionally, permutation testing with 5000 iterations was applied following a 
Spearman’s correlation analysis between the significant Bi and Wi-values and TMTB-A 
and DSB scores. 
 
To determine whether there was overlap between the rich club and regions with altered 
topology in our two clinical groups, we compared the spatial overlap between the three 
variables. To analyse whether this overlap was statistically significant, a permutation test 
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was performed in which we randomly permuted the rich club identity of each region 
(5000 iterations) and used the overlap between the randomized vector and the 
significantly different Wi and Bi scores to populate two separate null distributions. We 
then compared the empirical overlap between rich club and topological outcome 
measures with the null distributions and rejected the null hypothesis of no overlap if the 
true overlap was less than the 97.5th percentile of null distribution (i.e. the top 2.5%).   
 
The difference scores between the groups on the Bi and Wi values were compared across 
the three different thresholds, and moderate to very strong correlations were found, 
confirming the robustness of the findings (see Supplementary Materials).  
 
Results  
Demographics 
Twenty-six patients were identified as freezers and twenty-four as non-freezers. There 
were no differences between the groups for age, disease duration, dopaminergic 
medication, disease severity as measured by the MDS-UPDRS part III and H&Y scale 
and the MMSE, Logical Memory, TMTB-A and DSB (see Table 1). 
 
Graph metrics 
A small-world organisation of the structural brain networks was confirmed in both patient 
groups (van den Heuvel et al., 2011). Table 2 and Figure 2a demonstrate the 23 nodes 
that had significantly lower Bi-values in freezers compared to non-freezers (nodes 
coloured in green in Figure 2a). Three of these more segregated nodes encompassed 
subcortical nuclei, including the right caudate, thalamus and hippocampus. In the left 
hemisphere, we found six nodes in the frontal cortex, six nodes in the parietal cortex and 
one node in the posterior cingulate gyrus. In the right hemisphere, six nodes in the frontal 
cortex and one node in the anterior cingulate gyrus showed significantly lower values in 
freezers compared to non-freezers. Conversely, the caudal middle frontal gyrus showed a 
significantly higher Bi-value in freezers. Nine nodes in distributed cortical nodes with a 
lower Wi-score were found (nodes coloured in green in Figure 2b) and six cortical nodes 
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with a higher z-score (nodes coloured in orange in Figure 2b) in PD freezers were found 
(see Table 3).  
 
Table 1. Demographic and clinical data of patients with and without freezing of gait  	
 Freezers Non-freezers p-value 
n 26 24 - 
Age, years, mean ± SD 64.2 ± 9.4 66.9 ± 5.3 0.220 
Disease duration, years, mean ± SD 5.2 ± 3.8 5.2 ± 3.0 0.970 
LEDD, mg, mean (range)* 656.7 (0 - 1548) 526.6 (0 - 1200) 0.431 
MDS-UPDRS III, mean ± SD 25.5 ± 13.0 23.3 ± 13.5 0.558 
H&Y, mean (range)* 2.0 (1 - 2.5) 1.8 (1 - 2.5) 0.131 
MMSE, mean (range) * 28.5 (26 - 30) 29.1 (26 - 30) 0.051 
Logical Memory I, mean ± SD 36.1 ± 10.0 39.8 ± 10.3 0.201 
Logical Memory II, mean ± SD 21.3 ± 7.8 22.5 ± 10.4 0.657 
TMTB-A, sec, mean (range) * 61.6 (17 - 216) 41.0 (-1 - 92) 0.063 
Digit Span Backward, mean ± SD 6.38 ± 1.8 7.57 ± 3.3 0.118 
* Mann-Whitney U test; LEDD = levodopa equivalence daily dose; MDS-UPDRS III = motor part of the Movement Disorder Society 
Unified Parkinson’s Disease Rating Scale; H&Y = Hoehn and Yahr motor scale; MMSE = Mini-Mental State Examination; TMTB-A = 
Trail Making Test part B - A 
 
 
Of the regions that showed significantly different Bi-values, two nodes in the superior 
parietal cortex negatively correlated with the TMTB-A scores ('lh-superior-parietal_2': r = 
-0.32, p < 0.05; 'lh-superior-parietal_4': r = -0.34, p < 0.05), whilst the right hippocampus 
and node ‘rh-superiorfrontal_4’ showed a positive correlation with the DSB (r = 0.35, p < 
0.01 and r = 0.27, p < 0.05 respectively). One node with a significantly different Wi-value 
showed a positive correlation (left 'superior-frontal': r  = 0.30, p < 0.05) with the TMTB-A. 
Finally, node ‘rh-superiorfrontal_8’ showed a negative correlation with the DSB (r = 
0.17, p < 0.05), whilst node ‘rh-rostralmiddlefrontal_4’ showed a negative correlation 
with this test performance (r = -0.27 p < 0.05). 
 
A rich-club network encompassing 35 nodes was identified. Of the 24 nodes that had a 
significantly different Bi-value between groups, six nodes were identified as part of the 
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rich-club, which was deemed significant (p < 0.05; see Table 2, Figure 3 and 
Supplementary materials). Of the 15 nodes with different Wi-values between groups,	two 
nodes were considered within the rich-club network but this overlap was not significant 
(p > 0.05).  
 
 
 
 
 
Figure 2a: Nodes with a significantly different Bi score in freezers compared to non-
freezers, b: nodes with a significantly different Wi score in freezers compared to non-
freezers. 
 
a	
b	
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Figure 3. Representation of the rich-club network. 
 
Discussion 
Here we used graph theoretical methods to assess the structural network topology of PD 
patients with FOG. This approach allowed us to investigate both integrative as well as 
specialized properties of individual nodes within the brain’s structural connectivity 
network in a data-driven manner, thus obviating any a priori assumptions about selected 
regions. In doing so, we demonstrated that freezers had a significantly lower participation 
coefficient in 23 of the 233 nodes, compared to non-freezers. Specifically, these more 
segregated nodes included the right subcortical caudate, thalamus and hippocampus, as 
well as nodes within bilateral frontal and parietal regions. Moreover, the six of these 
nodes were also part of the rich-club network that forms the backbone of the structural 
connectome by reducing path length (as opposed to multiple short-path connections) and 
hence permits faster and less noisy signal transmission (Bertolero et al., 2015; Bullmore 
et al., 2012; van den Heuvel et al., 2011).  
 
Therefore, in keeping with other biological models (Crossley et al., 2014; Robbins et al., 
2009), we hypothesize that the symptoms of FOG may in part arise due to a lack of 
structural integration between key information processing hubs of the brain including 
motor, cognitive and limbic structures.  
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Table 2. Nodes with significantly different participation coefficients between groups 
 
lh = left hemisphere; rh = right hemisphere 
 
 
 
 
 
Node Region  x y z Freezers Non-freezers Rich club 
Non-freezers > freezers        
 Subcortical       
R caudate Basal ganglia 15 10 11 0.690 ± 0.05 
 
0.731 ± 0.05 
  
✓ 
R hippocampus Hippocampus 28 -22 -13 0.613 ± 0.09 0.668 ± 0.08 ✓ 
R thalamus Thalamus 13 -17 7 0.699 ± 0.07 0.752 ± 0.05 ✓ 
 Frontal       
lh-lateralorbitofrontal_4 Orbitofrontal cortex -12 52 -19 0.562 ± 0.12 0.628 ± 0.10 - 
rh-lateralorbitofrontal_4 Orbitofrontal cortex 16 52 -18 0.525 ± 0.13 0.612 ± 0.10 ✓ 
lh-medialorbitofrontal_2  Orbitofrontal cortex -5 33 -20 0.596 ± 0.11 0.676 ± 0.07 - 
lh-superiorfrontal_5 Prefrontal cortex  -11 36 47 0.594 ± 0.10 0.653 ± 0.09 - 
lh-superiorfrontal_7 Premotor cortex  -8 14 52 0.579 ± 0.16 0.660 ± 0.08 - 
lh-superiorfrontal_8 Premotor cortex  -8 -2 63 0.524 ± 0.13 0.628 ± 0.10 - 
lh-superiorfrontal_9 Premotor cortex -17 -1 67 0.524 ± 0.10 0.608 ± 0.09 - 
rh-superiorfrontal_3 Prefrontal cortex 11 40 40 0.580 ± 0.16 0.670 ± 0.11 - 
rh-superiorfrontal_4 Prefrontal cortex 18 34 47 0.571 ± 0.17 0.674 ± 0.09 - 
rh-superiorfrontal_5 Premotor cortex 12 18 52 0.583 ± 0.14 0.679 ± 0.09 - 
rh-superiorfrontal_6 Premotor cortex 11 2 60 0.521 ± 0.15 0.611 ± 0.09 - 
rh-paracentral_2  Primary motor cortex 10 -16 59 0.199 ± 0.18 0.325 ± 0.18 - 
 Parietal       
lh-inferiorparietal_4 Somatosensory 
association cortex  
-36 -71 42 0.304 ± 0.16 0.423 ± 0.18 - 
lh-postcentral_2 Primary somatosensory 
cortex  
-26 -31 65 0.596 ± 0.11 0.676 ± 0.10 - 
lh-postcentral_3 Primary somatosensory 
cortex 
-40 -30 57 0.479 ± 0.15 0.565 ± 0.16 - 
lh-superiorparietal_2 Somatosensory 
association cortex  
-33 -43 55 0.239 ± 0.16 0.373 ± 0.17 - 
lh-superiorparietal_4 Somatosensory 
association cortex  
-20 -62 61 0.574 ± 0.14 0.681 ± 0.08 ✓ 
lh-superiorparietal_7 Visual association cortex -13 -87 34 0.548 ± 0.15 0.640 ± 0.10 ✓ 
 Cingulate       
lh-posteriorcingulate_1 Posterior cingulate gyrus  -4 -11 35 0.409 ± 0.16 0.512 ± 0.18 - 
rh-caudalanteriorcingulate_1 Anterior cingulate gyrus 9 36 5 0.497 ± 0.17 0.602 ± 0.18 - 
Non-freezers < freezers         
rh-caudalmiddlefrontal_1 Prefrontal cortex  36 2 47 0.333 ± 0.17 0.235 ± 0.16 - 
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Table 3. Nodes with significantly different module degree z-scores between groups 
lh = left hemisphere; rh = right hemisphere 
 	
 
A decreased ability to recruit alternative routes for parallel information processing 
(Achard et al., 2006) would lead to a lack of resilience when there are functional network 
challenges (such as cognitive dual-task performance) and also offer an explanation for the 
known characteristic set-shifting deficits in individuals with FOG (Naismith et al., 
2010b). The motor manifestation of FOG could thus arise due to a flow-on effect, 
Node  Region  x y z Freezers Non-freezers 
Non-freezers > freezers       
 Frontal      
lh-medialorbitofrontal_1 Orbitofrontal cortex -7 52 -
11 
-0.482 ± 0.70 0.189 ± 0.95 
lh-parstriangularis_1 Prefrontal cortex  -
43 
33 2 0.371 ± 0.74 0.847 ± 0.88 
rh-parsorbitalis_1 Prefrontal cortex 43 43 -
10 
0.324 ± 0.80 0.904 ± 0.66 
rh-superiorfrontal_8 Prefrontal cortex  22 10 58 -0.574 ± 0.49 -0.181 ± 0.51 
 Parietal      
lh-postcentral_5 Primary sensory cortex -
55 
-
15 
43 -0.686 ± 0.48 -0.367 ± 0.52 
rh-postcentral_5 Primary sensory cortex 28 -
32 
69 0.249 ± 0.72 0.826 ± 0.91 
 Occipital      
lh-lateraloccipital_5 Visual association cortex -
34 
-
83 
-
10 
-0.222 ± 0.80 0.534 ± 0.78 
 Cingulate       
lh-
rostralanteriorcingulate_1 
Anterior cingulate -7 37 2 0.566 ± 1.00 1.234 ± 0.83 
rh-
rostralanteriorcingulate_1 
Anterior cingulate 14 -
33 
52 0.713 ± 0.93 1.397 ± 0.50 
Non-freezers < freezers       
 Frontal      
lh-superiorfrontal_4 Prefrontal cortex  -8 32 37 -0.556 ± 0.87 -1.082 ± 0.57 
rh-rostralmiddlefrontal_4 Prefrontal cortex  34 52 10 -0.837 ± 0.54 -1.187 ± 0.55 
 Parietal      
lh-postcentral_7 Retrosubicular area -
52 
-
11 
19 -0.354 ± 0.75 -0.724 ± 0.52 
rh-superiorparietal_1 Somatosensory association cortex 33 -
43 
54 0.550 ± 0.85 0.095 ± 0.79 
rh-precuneus_1 Visual association cortex 23 -
65 
21 0.282 ± 0.76 -0.183 ± 0.71 
 Temporal      
lh-inferiortemporal_1 Inferior temporal gyrus -
41 
-3 -
38 
-0.100 ± 0.61 -0.518 ± 0.68 
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whereby inefficient network architecture would hamper the effective communication 
between major cortical and subcortical integration centres (Lewis & Shine, 2016).  
 
Nodes with high participating coefficients have previously been characterized as 
‘connector hubs’ (Guimera et al., 2005), as they tend to interconnect otherwise segregated 
communities. In the brain, nodes with high participation are thought to be crucial for 
incorporating complex information streams of different modalities. Affected participation 
scores, especially across these connector hubs, may cause disruptions extending across 
cognitive, motor and limbic domains (Bertolero et al., 2015). Nodes with high 
participation coefficients exhibit more activity when coordinated activity occurs across 
communities, such as during cognitive task performance (Shine et al., 2017). These hubs 
provide an integrative network function to an even greater extent than rich club nodes 
(Bertolero et al., 2017) and importantly, ten regions affected in freezers were amongst the 
nodes with the highest participation scores. Hence they likely play a crucial role in 
disrupted information processing in these patients.  
 
The caudate nucleus and thalamus have previously been implicated in the freezing 
pathophysiology with studies showing reduced grey matter volume (Herman et al., 2014) 
and hypo-activity within subcortical structures (Shine et al., 2013b). Importantly, the 
thalamic nuclei receive input from and project to diffuse areas in the cortex, basal ganglia 
and cerebellum play a role in modulating activity in the rest of the brain. Rather than 
simply being a relay station, the thalamic nuclei are a major hub for controlling the 
information flow across cortical and subcortical regions (Sherman, 2016). The caudate 
nucleus also receives inputs from various prefrontal regions (Jarbo et al., 2015) and plays 
a major part in task-switching behaviour, which can be understood in terms of activating 
different modules for specialised function. Despite not reaching significance, the left 
thalamus and caudate also showed a lower participation coefficient in freezers (p = 0.07 
and p = 0.08, respectively), hence there was no strong lateralisation effect observed. 
Thus, the lower participation scores of these nodes may contribute to the pathophysiology 
of FOG through either ineffective integration of motor, sensory and limbic activity during 
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gait or inefficient shifting between functionally distinct but complementary neural 
pathways (Lewis & Shine, 2016). 
 
Previous findings of neuromodulatory systems have demonstrated the existence of an 
inverted U-shaped curve on executive functioning (Robbins et al., 2009), and recent 
conceptual work has suggested that this relationship may also be present in network 
topology (Shine et al., 2017). Consistent with the well-established association between 
FOG and impaired executive function (Hall et al., 2015; Vandenbossche et al., 2012; 
Walton et al., 2015b), our findings showed less integrated nodes in the caudate, bilateral 
dorsolateral prefrontal (DLPFC) and anterior cingulate cortex. Moreover, participation 
coefficients of nodes within the DLPFC, superior parietal cortex and hippocampus were 
associated with a performance on tasks investigating set-shifting and working memory. 
Thus, is it possible that changes in integration scores in areas associated with cognitive 
performance affect effective information transfer across the network, and might explain 
these phenotypic changes.  
 
Lower participation coefficients were also found across frontoparietal structures, 
including the premotor, primary motor cortex and somatosensory association cortices, 
whilst a node with a higher participation coefficient was also found in the premotor 
cortex, perhaps reflecting a rerouting of pathways in this region. Automated movements 
are performed by activity in segregated modules (Bassett et al., 2015; Shine et al., 2017), 
and these movements are affected by PD pathology (Redgrave et al., 2010). As such, PD 
patients rely more on effective communication in superior frontoparietal regions since 
combining different sources of information between these regions is fundamental for 
successful completion of an accurate and context-appropriate movement (Wu et al., 
2005). When a region becomes too specialized or segregated, it loses its flexibility that is 
necessary to navigate through changing circumstances, which may underpin the 
difficulties freezers experience navigating complex environments.  
 
A number of fMRI studies using region of interest analyses comparing PD freezers to 
non-freezers, have shown alterations in similar regions as reported in the current study. 
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Specifically, a functional decoupling between the bilateral cognitive control network and 
the basal ganglia during freezing episodes has been reported during motor arrests 
provoked by a virtual reality paradigm (Shine, 2013a). Furthermore, using this paradigm, 
freezing episodes were associated with alterations in BOLD response within 
frontoparietal sensorimotor regions, basal ganglia, thalamus and in the mesencephalic 
locomotor region (Shine et al., 2013b). Altered resting state functional connectivity 
within the cognitive control network, visual networks and locomotor regions has further 
been shown to be associated with FOG severity (Fling et al., 2014; Tessitore et al., 2012). 
However, future research avenues should explore alterations in functional network 
topology associated with freezing of gait.  
 
The current study also compared within-module connectivity across groups. Segregation 
into isolated modules allows for specialized processing of an action and increases 
efficiency, flexibility and robustness to perturbation (Bullmore et al., 2012). Abnormal 
within-module scores can affect these characteristics by increasing effective metabolic 
costs (Bullmore et al., 2012). Compared to non-freezers, freezers showed lower module 
degree z-scores in nodes within the prefrontal cortex (pars orbitalis, pars triangularis, 
orbitofrontal and rostral anterior cingulate), primary sensory, primary motor and visual 
association cortex. Perhaps surprisingly, higher module degree z-scores were observed in 
patients with FOG in prefrontal cortices (DLPFC and dorsal anterior cingulate), and 
various sensory information-processing areas such as the somatosensory association, 
visual association and inferior temporal regions. Interestingly, higher module degree z-
scores are considered favourable for behaviours that require specific, unimodal function, 
such as certain sensory processing systems (Park et al., 2013). As such, freezers may 
need to rely more heavily on exogenous stimuli to gather information to guide their 
actions, perhaps due to a loss of automaticity (Vandenbossche et al., 2012). Indeed, 
previous studies have shown a proprioceptive deficit in PD patients with (Ehgoetz 
Martens et al., 2013) and without freezing (Wu et al., 2005) along with a greater 
dependence on visual information (Davidsdottir et al., 2005). Therefore, it could be 
speculated that a reweighting of sensory systems occurs in PD patients with freezing. 
Specifically, there may be an increased emphasis placed on discrete modality specific 
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pathways that process afferent information, however if the system is unable to effectively 
integrate this information, the dynamic evolution of the gait pattern may suffer. 
 
Limitations and future directions 
The current study has several limitations. Firstly, we grouped the participants based on a 
subjective question of the FOGQ. Currently, there is no gold standard to define FOG and 
whilst objective measures are preferable, FOG can be difficult to elicit in a clinical or 
experimental environment and might remain unnoticed (Nieuwboer et al., 1998). Another 
possible weakness of this study’s methodology is that the Louvain algorithm does not 
allow for overlapping modules, as a node is only assigned to one community. 
Furthermore, although DTI is an established method for measuring white matter integrity 
and has led to great insights in PD (de Oliveira et al., 2017; Hall et al., 2016), it suffers 
from inherent limitations. Specifically, diffusion imaging measures the motion of water 
molecules along a tract and thus only allows for indirect validation of streamlines. The 
deterministic diffusion tensor fitting approach used in this study requires sufficient 
directional information at each voxel and is incapable of resolving crossing or ‘kissing’ 
fibres. However, the deterministic diffusion tensor fitting approach used in this study 
requires sufficient directional information at each voxel and is incapable of resolving 
crossing or ‘kissing’ fibres. At an ambiguous directional point in a voxel, fractional 
anisotropy values might drop leading to a premature termination of the reconstruction of 
a tract. This could be especially problematic in structures with complex fibre architecture 
such as subcortical nuclei. Future research should use more sophisticated methods, such 
as constrained spherical deconvolution, that are better equipped to deal with complex 
fibre configurations. Finally, this study used single shell DTI data, without EPI distortion 
corrections, which could have impacted the registration accuracy between the DTI and T1 
images, creating suboptimal connectomes. Hence, these results should be interpreted with 
caution and replication studies using multi-shell sequences are necessary to fully 
understand the changes in network topology associated with FOG. Despite its discernible 
limitations, diffusion imaging is the only non-invasive in-vivo structural imaging 
technique and has successfully addressed important scientific matters. 
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Conclusion 
This is the first study to use graph theory to demonstrate subtle alterations in network 
topology in PD patients with FOG compared to those without this symptom. Specifically, 
we showed that freezers have lower participation scores in subcortical regions as well as 
higher order and integrative cortical cortices. We argue that this increase in segregation 
hinders efficient communication between major cortical and subcortical centres, resulting 
in ineffective integration of motor, sensory and limbic activity, as well as inefficient 
shifting between specialised modules that could disrupt gait in PD. Decreased intra-
module connectivity might reflect a less cost effective processing of information, whereas 
an increase in these scores in the sensory cortex of freezers, suggests a possible 
compensatory strategy.  
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Supplementary Materials  
 
 
Figure 1. Average degree of the rich club nodes  
*Nodes with significantly lower participation coefficient in freezers compared to non-freezers lh = left 
hemisphere; rh = right hemisphere 
 
 
Table 1. Pearson correlation coefficient (p-value) between different thresholds across 
difference scores between freezers and non-freezers 
 40% vs. 50% 50% vs. 60% 40% vs. 60% 
Participation coefficient  0.75 (<0.0001) 0.56 (<0.0001) 0.45 (<0.0001) 
Module degree z-score 0.90 (<0.0001) 0.61 (<0.0001) 0.64 (<0.0001) 	
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Chapter 5: Dysfunction in attentional processing in patients with Parkinson’s 
disease and visual hallucinations 	
Abstract  
Mechanistic insights into visual hallucinations (VH) in Parkinson’s disease (PD) have 
suggested a role for impaired attentional processes. The current study tested 25 PD 
patients with and 28 PD patients without VH on the Attentional Network Test. 
Hallucinators had significantly lower accuracy rates compared to non-hallucinators, but 
no differences were found in reaction times. This suggests that hallucinators show deficits 
in attentional processes and conflict monitoring. Our findings provide novel behavioural 
insights that dovetail with current neurobiological frameworks of VH.   
 
Key words: Parkinson’s disease, visual hallucinations, attentional network test, dorsal 
attentional network  
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Introduction 
One of the most disabling non-motor symptoms of Parkinson’s disease (PD) is the 
emergence of visual hallucinations (VH) (Hely et al., 2008). VH often appear recurrently 
without external stimuli (Goetz et al., 2010; Sanchez-Ramos et al., 1996) and exist along 
a perceptual spectrum; from simple images without a recognizable form, to complex 
hallucinations, which consist of well-formed images of faces, animals or scenery 
(Santhouse et al., 2000). Once established, VH not only become more frequent over time 
but many patients also report their VH as becoming more threatening (Goetz et al., 2001).  
 
At present, several competing hypotheses have been proposed regarding the development 
and neurobiology of VH (Muller et al., 2014). One proposal supported by recent 
empirical evidence is that VH arise from a breakdown between large-scale attentional 
networks across the brain (Shine et al., 2014). These comprise the dorsal attentional 
network (DAN), which is involved in goal-driven and sustained attention, the ventral 
attention network (VAN), which is responsible for the re-orienting of attention towards a 
salient stimulus, and the default mode network (DMN), a network that supports 
introspection, mental imagery and the capacity to retrieve and manipulate episodic 
memories (Buckner et al., 2008). In the Attentional Networks Hypothesis, VH can 
emerge due to a failure in recruiting the DAN during periods of conflict resolution, such 
that an ambiguous visual input is incorporated in the visual processing stream (Shine et 
al., 2011a). Interpreting incoming perceptual information then relies on the VAN and 
DMN. Importantly, increased activity in the DMN allows for augmented connectivity of 
the visual cortices (Shine et al., 2015), influencing ongoing activity within the visual 
stream. This increased coupling may predispose an individual to hallucinate. In the 
context of over-activation of the DMN, autobiographical information can be incorporated 
to resolve the ambiguous input, such that familiar people or objects might be 
hallucinated, and aberrant activation of the VAN can lead to an increased salience 
attached to the percept (Shine 2011a; Yao et al., 2014). Finally, the frontoparietal control 
network mediates activity between the three attentional networks (Petersen et al., 2012). 
 
Here, we further explore attentional processing deficits in PD patients with VH using the 
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Attentional Network Test (ANT) (Fan et al., 2002). This computerized task is a 
combination of a cued reaction time task (Posner, 1980) and a flanker task (Eriksen et al., 
1974). Successful performance of this task requires sustained attention and visual search, 
which are regulated by the DAN, and conflict resolution abilities, a task of the 
frontoparietal control network (Fan et al., 2002). Therefore, we hypothesized that a 
disruption within and between these attentional networks, as seen in PD VH, would lead 
to a deficit in the overall performance of the ANT, with a profound impairment on the 
conflict resolution task.  
 
Methods  
Participants 
Fifty-three non-demented PD patients were recruited from the Parkinson’s Disease 
Research Clinic at the Brain and Mind Centre, University of Sydney. All patients 
satisfied the UKPDS Brain Bank Criteria and informed consent was obtained from all 
individuals in the study. Permission was acquired from the local Ethics Committee. In 
keeping with previous work (Goldman et al., 2014), PD patients were classified as 
hallucinators (n=25) or non-hallucinators (n=28) according to their response on question 
2 of the MDS-UPDRS (Goetz et al, 2010): “Over the past week have you seen, heard, 
smelled or felt things that were not really there?  [If yes, examiner asks patient or 
caregiver to elaborate and probes for information]” (hallucinators ≥1 (slight to severe 
VH); non-hallucinators = 0 (no hallucinations or psychotic behaviour).  
 
Assessments  
Groups were matched on age, disease duration, Levodopa equivalent dose (LED), motor 
severity (Hoehn and Yahr clinical staging; H&Y (Hoehn & Yahr, 1967) and MDS-
UPDRS part III (Goetz et al., 2008), mood (Beck’s Depression Inventory (BDI-II)) (Beck 
et al., 1961) and general cognition (Mini Mental State Examination (MMSE) (Folstein et 
al., 1983). See Table 1 for demographics and clinical characteristics.  
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Table 1. Demographical data and clinical characteristics (Mean (SD)) 
  PD Non-VH PD-VH p-value 
N 28 25 n.a. 
Age (y) 66.65 (8.20) 69.28 (5.74) .187 
Duration (y)a,b 6.18 (3.37) 6.74 (5.22) .652 
H&Y 2.11 (0.39) 2.24 (0.60) .406 
MDS-UPDRS iiib,c 28.15 (11.95) 34.63 (15.26) .096 
LEDa 590.50 (259.79) 688.50 (395.63) .553 
MMSEa 28.58 (1.47) 28.72 (1.72) .596 
BDI-IIc 7.30 (6.38) 12.64 (11.64) .054 
PD Non-VH = Parkinson’s disease patients without visual hallucinations; PD-VH = Parkinson’s disease patients with 
visual hallucinations; H&Y = Hoehn and Yahr clinical motor staging; MDS-UPDRS iii = Part three of the Movement 
Disorder Society Unified Parkinson’s Disease Rating Scale; LED = Levodopa equivalent dose; MMSE = Mini Mental 
State Examination; BDI-II = Beck’s Depression Inventory (revised)  a PD Non-VH: n= 26; b PD-VH: n = 24; c PD 
Non-VH: n = 27; Note: The removal of RTs of patients with a response percentage < 70% did not affect these results.   
 
Attentional Network Test  
A shortened version of the ANT (Fan et al., 2002) was used to explore attentional 
processes. The task and its procedure are explained elsewhere in more detail (Fan et al., 
2002). Both accuracy and reaction time (RT) were recorded.  Each participant completed 
96 trials. Warning cues appeared before the presentation of the target. There were four 
types of warning cues: double (two asterisk at the top and bottom of the screen) centre 
(one asterisk in the centre of the screen), spatial (one asterisk in the position where the 
target would appear) or no asterisk. Congruent or incongruent flanker arrows or neutral 
lines surround the target arrow. In line with the original study of Fan and colleagues 
(2002), three attentional processes can be calculated using the following methods:  
Alerting = RT no cue - double cue condition; Orienting = RT centre cue – RT spatial cue 
condition; Executive network = RT incongruent – RT congruent condition 
 
Data processing and statistical analyses 
All data analyses were performed using IBM SPSS version 22. All analyses were two-
tailed using a significance level of 0.05. Due to the non-parametric nature of the task 
data, response percentage and accuracy were analysed using Mann Whitney U tests for 
different flanker and cue conditions for the groups. Corrections for multiple comparisons 
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were not implemented to keep the risk of a Type 2 error minimal (Perneger, 1998). 
However, effect sizes of the accuracy data were calculated to determine the strength of 
the outcomes (Table 2). RT of the ANT was analysed using 2 (group) x 4 (cue condition) 
x 3 (flanker type) mixed factorial ANOVAs. For the alerting, orienting and executive 
aspects of the task we performed three separate 2x2 repeated measures ANOVAs with 
group as between-subject factor, and cue type (alerting: no- and double-cue trials; 
orienting: centre- and spatial-cue trials) or target type (executive: incongruent and 
congruent flankers) as within-subject factors. The RT of erroneous responses were 
excluded from the analyses. Furthermore, patients with a response percentage of  < 70% 
(five hallucinators and one non-hallucinator) were excluded from further analyses as their 
RT were not considered reliable. 
 
Results 
ANT Accuracy  
Missed and erroneous responses were combined to calculate accuracy percentages. 
Overall, hallucinators had significantly lower accuracy compared to non-hallucinators (p 
= 0.016). As shown in Table 2, hallucinators had more erroneous responses on all 
incongruent flanker condition (p-values < 0.05) apart from the no cue condition (p = 
0.115), and in selected trials of the neutral flanker condition (no cue and spatial cue 
condition: p-values < 0.05) compared to non-hallucinators. No differences were found 
between the groups on the congruent flanker condition (p-values > 0.05; see table 2).  
 
ANT Reaction times (RT) 
Reaction times are shown in Table 2. No interaction effect was found for group x cue x 
flanker type (p = 0.566), cue x flanker type (p = 0.821), group x cue (p = 0.904) and 
group x flanker type (p = 0.284). Main effects for cue condition (p = 0.002) and flanker 
type (p < 0.001) were found. Overall, both groups were slower to respond to targets 
surrounded by incongruent flankers compared to neutral and congruent flankers, and 
when no, a centre or double cue was presented in comparison to a spatial cue. Finally, no 
main group differences were found (p = 0.145).  
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Attentional Processes 
As shown in Table 2, the 2x2 repeated measures showed no interaction effects (alerting: p 
= 0.719; orienting: p = 0.600; executive control: p = 0.815). A significant main effect 
was found for the orienting condition (p = 0.001), demonstrating that RT were lower for 
the spatial cue condition compared to the centre condition across all patients. 
Furthermore, a significant executive control effect was found (p < 0.001), demonstrating 
that RT were longer for the incongruent condition compared to the congruent flanker 
condition across all patients. No alerting effect was found (p = 0.649). Finally, no main 
group differences were found for the alerting (p = 0.139), orienting  (p = 0.115) or 
executive control processes (p = 0.146).  
 
Table 2. Accuracy percentages for each cue and flanker condition (Mean (SD)) and 
reaction times of the attentional networks (Mean (SD)) 
Flanker Cue PD-VH PD-Non VH U z r p-value 
Incongruent Total 73.00 (28.80) 88.84 (14.71) 218.50 -2.361 -0.32 .018 
 Spatial 71.50 (33.76) 89.29 (18.55) 241.00 -2.108 -0.29 .035 
 Double 72.50 (30.83) 89.73 (14.46) 228.50 -2.272 -0.31 .023 
 Centre 74.50 (30.93) 91.07 (12.66) 246.50 -1.976 -0.27 .048 
 None 73.50 (30.26) 87.95 (15.40) 265.50 -1.576 -0.22 .115 
Congruent Total 84.13 (27.06) 94.64 (10.31) 262.00 -1.651 -0.23 .099 
 Spatial 83.50 (26.45) 93.75 (13.82) 279.50 -1.471 -0.20 .141 
 Double 86.00 (28.71) 93.75 (13.39) 329.00 -0.483 -0.07 .629 
 Centre 83.50 (28.80) 93.75 (13.82) 295.00 -1.167 -0.16 .243 
 None 83.50 (28.12) 93.75 (12.03)  268.00 -1.667 -0.23 .095 
Neutral Total 86.25 (19.97) 94.31 (13.23) 199.50 -2.771 -0.38 .006 
 Spatial 88.00 (15.92) 95.54 (9.14) 247.00 -2.124 -0.29 .034 
 Double 89.00 (20.19) 95.09 (13.75) 273.00 -1.734 -0.24 .083 
 Centre 86.00 (25.60) 92.86 (14.20) 305.00 -0.954 -0.13 .340 
 None 82.00 (23.96) 95.54 (10.87) 205.00 -2.943 -0.40 .003 
   F (df, df error) η2 p-value 
Alerting RT Group 0.86 (60.82) 7.30 (60.82) 2.265 (1, 45) 0.048 .139 
 Cue   0.210 (1, 45) 0.005 .649 
 Group x cue   0.131 (1, 45) 0.003 .719 
Orienting RT Group 38.74 (61.80) 28.96 (63.29) 2.580 (1, 45) 0.054 .115 
 Cue   13.410 (1, 45) 0.230 .001 
 Group x cue   0.280 (1, 45) 0.006 .600 
Executive RT  Group 158.15 (115.04) 151.44 (80.77) 2.185 (1, 45) 0.046 .146 
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PD Non-VH = Parkinson’s disease patients without visual hallucinations; PD-VH = Parkinson’s disease 
patients with visual hallucinations; RT = reaction time; Executive = Executive control 
 
 
Discussion 
Here we explored attentional processing in PD patients with VH and identified a specific 
impairment in their accuracy levels. Whilst no differences in RT were observed, 
hallucinators had more missed and erroneous responses compared to non-hallucinators. 
This difference was most apparent in the incongruent task conditions, where the accuracy 
rate of hallucinators dropped to 73% reflecting greater impairments in attentional 
processing with increasing task demands.  Our findings are consistent with the 
hypothesised attentional network dysfunction thought to play a role in the emergence of 
hallucinations in PD. 
 
Sustained attention and visual search, both crucial for successful performance on the 
overall and incongruent task condition is regulated by the DAN. It is worth noting that 
clinically more VH occur in the context of cluttered or distracting environments. Conflict 
monitoring is regulated by the frontoparietal control regions (Petersen et al., 2012; Wang 
et al., 2010), and disruptions within this network could add to the deficiency in the 
incongruent task condition. Moreover, the frontoparietal control network mediates 
activity between the DAN and DMN (Buckner et al., 2008). Failure to recruit the DAN is 
in keeping with recently proposed hypothesis that VH patients increasingly rely on the 
VAN and DMN (Buckner et al., 2008; Shine et al., 2014).      
 
Similar RT scores for the alerting, orienting and executive control networks were found 
between the groups, suggesting that the incorrect responses were not mediated by 
increased response latencies in the hallucinators. This suggests that when coordination 
within and between each of the major attentional networks is effective, hallucinators are 
able to perform just as well on the attentional task as non-hallucinators. However, when a 
disruption of these attentional processes arise, VH patients fail to resolve conflicting 
 Cue   117.689 (1, 45) 0.723 <.001 
 Group x cue   0.055 (1, 45) 0.001 .815 
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information resulting in an erroneous response rather than a delayed response, which is in 
keeping with the episodic nature of VHs. 
 
In conclusion, we have demonstrated that hallucinators showed marked impairments in 
attentional processing, especially in more distracting conditions. Our results support the 
crucial role for deficits within attentional networks in the manifestation of VH in PD, 
which represents an important target for future pharmacological and behavioural 
treatment strategies. 
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Chapter 6: Changes in structural network topology correlate with severity of 
hallucinatory behaviour in Parkinson’s disease  
 
Abstract  
Inefficient integration between bottom-up visual input and higher-order visual processing 
regions is implicated in visual hallucinations in Parkinson’s disease (PD). Here, we 
investigated white matter contributions to this perceptual imbalance hypothesis. Twenty-
nine PD patients were assessed for hallucinatory behaviour. Hallucination severity was 
correlated to connectivity strength of the network using the Network Based Statistic 
approach. The results showed that hallucination severity was associated with reduced 
connectivity within a sub-network that included the majority of the diverse club. This 
network showed overall greater between-module scores compared to nodes not associated 
with hallucination severity. Reduced between-module connectivity in the lateral occipital 
cortex, insula and pars orbitalis, as well as decreased within-module connectivity in the 
prefrontal, somatosensory and primary visual cortices were associated with hallucination 
severity. Conversely, hallucination severity was associated with increased between- and 
within-module connectivity in the orbitofrontal and temporal cortex, as well as regions 
comprising the dorsal attentional and default mode network. These results suggest that 
hallucination severity is associated with marked alterations in structural network topology 
with changes in participation along the perceptual hierarchy. Therefore, impaired 
integration across the perceptual hierarchy may result in the inefficient transfer of 
information that gives rise to hallucinations in PD.  
 
Key words: Parkinson’s disease, visual hallucinations, diffusion tensor imaging, network 
topology, graph theory, connectomics 
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Introduction  
Visual hallucinations (VHs) in Parkinson’s disease (PD) exist on a spectrum ranging 
from simple misperceptions, to complex well-formed images (Barnes & David, 2001). 
With disease progression and loss of insight, VHs constitute a major source of distress for 
the patient (Goetz, 2009; Schrag, 2004) and comprise a high degree burden for caregivers 
(Aarsland et al., 2007). Risk factors of VHs include older age and disease duration, sleep 
and mood disturbances as well as cognitive decline (Barnes & David, 2001; Fénelon, 
Mahieux, Huon, & Ziégler, 2000; Lenka, Hegde, Arumugham, & Pal, 2017). 
Furthermore, previous work has shown that patients with VHs show disruptions in 
attentional processing (Hall et al., 2016), reduced performance on visuoperceptive tasks 
(Barnes, Boubert, Harris, Lee, & David, 2003; Gallagher et al., 2011; Ramirez-Ruiz, 
Junque, Marti, Valldeoriola, & Tolosa, 2006), decreased visual contrast sensitivity, 
colour discrimination (Diederich et al., 1998) and acuity (Matsui et al., 2006). Current 
models of VHs have therefore focused on the interaction of perceptual and attentional 
dysfunction (for review, see Muller, Shine, Halliday, & Lewis, 2014). Specifically, it has 
been proposed that failure to effectively integrate information from different processing 
sites across the perceptual hierarchy is likely to contribute to VHs and misperceptions in 
PD (Collerton, Perry & McKeith, 2005; Diederich, Goetz, & Stebbins, 2005; Muller et 
al., 2014; Shine, Halliday, Carlos, Naismith, & Lewis, 2012).  
 
Attention, prior experience and expectations strongly influence perception. Perceptual 
predictions, generated from a myriad of modalities across the brain, guide perceptual 
processes to facilitate the interpretation of noisy and ambiguous input (Bar, 2009; Engel, 
Fries, & Singer, 2001; Summerfield et al., 2006). The orbitofrontal cortex (OFC) process 
coarse information projected from the visual cortex and provides an “initial guess” of an 
object’s identity (Summerfield & Koechlin, 2008). Previous work in PD patients with 
VHs has shown that the accumulation of sensory evidence is slow and inefficient, which 
may result in an over-reliance on these top-down predictions (O’Callaghan et al., 2017). 
Importantly, top-down visual processing regions can modulate neural activity in early 
visual regions, with expected stimuli leading to reduced activity (Meyer & Olson, 2011). 
Additionally, activity within the default mode network (DMN), a network involved in 
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mediating endogenous perception, has shown to be increased during a misperception in 
this patient population (Shine et al., 2014). Therefore, VHs may arise when perceptual 
input is not properly integrated and internally generated images interfere with the 
perceptual process (Fletcher & Frith, 2008; Intaite, Noreika, Soliunas, & Falter, 2013; 
O’Callaghan et al., 2017; Powers, Kelley, & Corlett, 2016). 
 
While functional neuroimaging studies have made significant contributions to our 
understanding (Hepp, Foncke, Dubbelink, et al., 2017; RamírezRuiz et al., 2008; 
Shine, Halliday, et al., 2014; Shine, Muller, et al., 2015; Yao et al., 2014), less is known 
about the involvement of white matter changes in the manifestation of VHs in PD.  
Experiments using diffusion tensor imaging (DTI) have reported altered white matter 
integrity in the optic nerve and optic radiation (Lee et al., 2016) as well as ascending 
tracts from the cholinergic nucleus basalis of Meynert to parietal and occipital cortical 
regions (Hepp, Foncke, Berendse, et al., 2017). However, given the involvement of large-
scale brain networks in perception, unique insights into white matter changes associated 
with VHs can be gained by investigating whole brain network topology. Topological 
features of the human connectome allow us to describe the arrangement of connections 
within and between segregated sub-modules (Bullmore & Sporns, 2009). Specifically, 
nodes that integrate these specialist communities are crucial for incorporating information 
streams of different modalities, which is essential for processes such as perception 
(Bertolero, Yeo, & D’Esposito, 2015; Muller, O'Callaghan, Walton, Shine, & Lewis, 
2017). Therefore, investigating network topology can provide novel insights in changes 
across different perceptual hierarchies.  
 
The current study aimed to examine whether VHs are associated with changes in 
structural network topology. To identify hallucinatory behaviour in patients with PD, we 
assessed performance on a computerized task capable of inducing misperceptions (Shine 
et al., 2012), in combination with a validated questionnaire that evaluates hallucinatory 
behaviour in PD patients (Shine et al., 2015). We aimed to circumvent the sole reliance 
on self-reported symptom occurrence whilst controlling for the possibility of 
misclassifying hallucinators as non-hallucinators, when patients did not experience visual 
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hallucinations during their clinic visit or when ‘passage’ hallucinations go unreported. 
Additionally, by creating this composite score, we are able to assess visual hallucinatory 
severity, rather than classifying patients into artificial dichotomous patient groups. 
 
We hypothesized that the severity of hallucinatory behaviour would be associated with 
ineffective information processing as shown by reduced between-module scores in visual 
networks, reflecting reduced visual input to integration centres. Furthermore, increased 
between-module scores across top-down perceptual prediction areas and the DMN could 
indicate an over-reliance on regions involved in the generation of internal percepts 
(Shine, O'Callaghan, Halliday, & Lewis, 2014).  
 
Methods  
Twenty-nine patients with idiopathic PD were included in this study. Demographic 
information including age, disease duration and levodopa dose equivalent (LEDD) were 
obtained for all participants. All patients were assessed on the Hoehn & Yahr clinical 
stage (Hoehn & Yahr, 1998) and the motor aspect of the MDS-UPDRS (part III) (Goetz 
et al., 2008). Global cognition was assessed using the Mini-Mental State Examination 
(MMSE) (Folstein, Robins, & Helzer, 1983) and set-shifting performance was assessed 
using the Trail Making Test part B minus part A (TMTB-A) (Tombaugh, 2004). The study 
was approved by the ethics committee of the University of Sydney and was in accordance 
with the principles of the Helsinki Declaration. Written informed consent was obtained 
from all participants before participation. 
 
Bistable Percept Paradigm 
All patients performed the Bistable Percept Paradigm (BPP) (James M Shine et al., 
2012), a behavioural task capable of inducing misperceptions in susceptible patients. In 
this task, patients were presented with either single or bistable percepts (i.e. “hidden” 
images as shown in Figure 1) for a maximum of 30 sec in a randomised order. The 
participant had to decide whether the stimulus was a single or hidden image by a button 
press and describe to the examiner what they had seen. The recorded responses included 
the following: 1) correct single or correct hidden, 2) “missed”, recorded when the subject 
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perceived a single image when a bistable percept was presented and 3) “misperceptions”, 
recorded when a subject incorrectly identified a single image as a bistable image, i.e. 
incorrectly reported an image that was not presented on the screen.  
 
 
Figure 1. Example of single and hidden images of the BPP (Shine, Halliday, et al., 2012a) 
 
Psychosis and Hallucinations Questionnaire 
All patients completed the Psychosis and Hallucinations Questionnaire (PsycH-Q) 
(Shine, Mills, et al., 2015).  The PsycH-Q (part A) consists of three subscales including 
1) visual misperceptions, which includes questions about the presence of VHs, passage 
hallucinations and three frequently reported contents of VHs including people, animals 
and objects; 2) sensory misperceptions, including audition, touch, olfaction, and 
gustation, and; 3) disordered thought and psychotic behaviour. Participants rated the 
frequency of their symptoms on a 5-point Likert scale, ranging from 0 (“never 
experienced”) to 4 (“experienced daily”). The total score was calculated by summing the 
responses (Shine et al., 2015) (see Supplementary Materials). Part B of the PsycH-Q 
assesses symptoms related to VHs (i.e. attention and sleep) and was not included in this 
study.  
 
Composite score  
The percentage of misperceptions on the BPP (‘indirect’ measure of VH) and the total 
score on the PsycH-QA (‘direct’ measure of hallucinatory behaviour) were standardized 
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and then summed to create a composite score that reflected the severity of hallucinatory 
behaviour (hereafter referred to as the hallucination severity score (HSS)). The HSS was 
correlated with the demographic variables using parametric or non-parametric 
correlations depending on the distribution of the variables and was used as a correlate in 
the imaging analysis.  
 
MRI Acquisition  
All participants underwent magnetic resonance imaging (MRI) using a 3-Tesla General 
Electric Discovery MR750 scanner (GE Medical Systems) with an 8-channel phased 
array head coil. Diffusion weighted images (DWI) were obtained by using echo-planar 
imaging sequences with 61 different motion probing gradient directions (TR/TE: 7025/80 
ms, 55 transverse slices, slice thickness: 2.5 mm, matrix: 256 × 256, FOV: 240 x 240 
mm). The effective diffusion weighting was b = 1000 s/mm2 and four volumes with no 
diffusion weighting (b = 0 s/mm2) were obtained at the beginning of each diffusion 
sequence. 3D T1-weighted, anatomical images were obtained (TR/TE/TI: 7.2/2.7/450 ms, 
voxel size 1 × 1 × 1 mm, 196 transverse slices, 256 × 256 matrix, FOV: 256 x 256 mm, 
flip angle 12°). The 3D-T1 images were used for individual registration between T1 
weighted anatomical and the DWI images and cortical parcellation using FreeSurfer 
(version 5.3; http://surfer.nmr.mgh.harvard.edu).  
 
 
Diffusion tensor imaging pre-processing and deterministic fibre tracking  
DTI pre-processing was performed using the FMRIB Software Library (FSL, 
http://fsl.fmrib.ox.ac.uk). The pre-processing steps were as follows: i) DTI images were 
corrected for susceptibility, head motion and eddy current induced geometrical distortions 
using FSL’s tool eddy; ii) a binary brain mask was created using bet; iii) images were 
realigned using a rigid body registration to the b = 0 image; then iv) a tensor was fitted in 
each voxel (Chang, Jones, & Pierpaoli, 2005); followed by v) the computation of the 
fractional anisotropy (FA) level based on the eigenvalues for each voxel, in order to 
determine the preferred diffusion direction within a voxel. FA thus serves as a surrogate 
measure of white matter integrity, with lower levels of FA reflecting reduced white 
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matter integrity (Sun et al., 2003; van den Heuvel & Sporns, 2011; Verstraete et al., 
2010). The preferred diffusion direction information was then used to reconstruct the 
white matter tracts of the brain using a deterministic tracking approach based on the fibre 
assignment by continuous tracking (FACT) algorithm (Mori, Crain, Chacko, & van Zijl, 
1999). Deterministic tractography yields less false positive tracts compared to 
probabilistic methods (Bastiani, Shah, Goebel, & Roebroeck, 2012). False positives are 
detrimental in network modularity as they occur more prevalently between than within 
modules (Zalesky et al., 2016). A streamline was started from eight seeds within each 
voxel of the brain (grey and white matter) following the main diffusion direction of the 
voxel and stopped when: i) the FA value < 0.1; ii) the traced fibre made a turn >45°; or 
iii) when the tract left the brain mask. The images were acquired when reverse phase-
encoding direction approaches were not the standard procedure within acquisition 
protocols, which could have influenced the registration of diffusion and anatomical 
images. Therefore, anatomically constrained tractography was not applied (Smith, 
Tournier, Calamante, & Connelly, 2012). The atlas presented by Cammoun et al. (2012) 
was used, including 219 cortical regions and 14 subcortical regions.  The weighted brain 
network was calculated for each participant and consistency thresholding at 50% was 
applied (i.e. including the tracts found in 50% of the patients) (de Reus & van den 
Heuvel, 2013). The mean density of the thresholded group matrix was 8.7%. To verify 
the results were not skewed by the choice of threshold, we also applied the thresholding 
method that retained most consistent edges across subjects but controlling for their 
distance (i.e. the consistency of edges within "bins" based on their length to avoid 
preferential retention of short edges (Misic et al., 2015)). The mean density of the group 
matrix using this threshold was 13.2%. 
  
Network Based Statistic 
A Network Based Statistic (NBS) analysis was applied to investigate whether the HSS 
was associated with altered connectivity strength in an interconnected sub-network of the 
brain (Zalesky, Fornito, & Bullmore, 2010). NBS is a non-parametric method for 
connectome-wide analysis, which aims to detect specific pairs of brain regions showing a 
significant effect of interest, while controlling for family-wise-error (FWE) rate. 
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Importantly, no inferences of individual connections are made; instead the null-
hypothesis can only be rejected at the sub-network level. As such, NBS is similar to the 
cluster-based multiple-comparisons approaches used in standard functional MRI analysis. 
To identify changes in sub-networks associated with the HSS, the t-statistic was set at 1.7 
determined using the critical value of the t-distribution for our sample size (Field, 2009). 
Additionally, we verified the robustness of the results by controlling for disease severity 
using the MDS-UPDRS III (motor part) as covariate. Connections were deemed 
significant at FWE-corrected p-value < 0.05 (one-sided) using 5000 permutations.  
 
To investigate whether the sub-network involved particular functional networks, we 
investigated whether nodes in the sub-network that correlated with the HSS overlapped 
with previously defined resting state networks. To this end, seven canonical resting state 
networks from the Yeo et al. atlas (2011) were overlaid with the structural parcellation 
and the percentage of nodes from each network included within the structural sub-
network that inversely related to HSS was calculated for each resting state network. To 
analyse whether this overlap occurred significantly above chance, we randomly permuted 
the resting state network identity of each region (5000 iterations) and used the overlap 
between the randomized vector and the original node assignment to populate a null 
distribution. To test whether each individual resting state network overlapped with the 
significant sub-network, their overlap was compared with the null distributions. A resting 
state network was identified as targeted if the true overlap was more than the 97.5th 
percentile of null distribution (i.e. the top 2.5%). A network was considered not to be 
associated with the HSS if the overlap was less than the 2.5th percentile of the null 
distribution.   
 
Graph theoretical analysis 
The graph organizational measures were computed using the Brain Connectivity Toolbox 
(http://www.brain-connectivity-toolbox.net) (Rubinov & Sporns, 2010). The thresholded, 
weighted brain networks were then partitioned into modules, which are non-overlapping 
groups of highly connected nodes that are only sparsely connected with other modules, 
using the Louvain algorithm (Rubinov & Sporns, 2010). To account for the stochastic 
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nature of the Louvain algorithm, a consensus partition was identified by calculating the 
module assignment for each node 500 times. To define an appropriate value for the 
resolution parameter (γ), the Louvain algorithm was iterated 100 times across a range of 
values (0.5 – 2.0 in steps of 0.1) of the group mean connectivity matrix and then 
estimated the similarity of the resultant partitions using mutual information. The γ 
parameter of 1.9 provided the most robust estimates of topology across the iterations and 
was used to determine the optimal resolution of the network modularity.  
 
After the nodes were assigned to their modules, their intra- and inter-modular 
connectivity were calculated. Intra-modular connectivity was calculated using the module 
degree z-score Wi (see equation 1), in which a positive score reflects high within-module 
connections (compared to the node’s average number of connections), and negative z-
scores denote the opposite. Inter-modular connectivity was calculated using the 
participation coefficient Bi (see equation 2). Low Bi values indicate few between-module 
connections, whereas high Bi values indicate uniformly distributed connections across 
modules (github.com/juliemaehall/topology). High Wi and high Bi scores are not mutually 
exclusive (Guimerà & Nunes Amaral, 2005).  
 
    !! = !!!!!!!!!!         [1] 
Equation 1 – Module degree z-score Wi, where κi is the strength of the connections of region i to other regions in its 
module si, κ!!  is the average of κ over all the regions in si, and !!!!  is the standard deviation of κ in si  
 
  !! = 1− !!"!! !!!!!!        [2] 
Equation 2 - Participation coefficient Bi, where κis is the strength of the positive connections of region i to regions in 
module s, and κi is the sum of strengths of all positive connections of region i. The participation coefficient of a region 
is therefore close to 1 if its connections are uniformly distributed among all the modules and 0 if all of its links are 
within its own module. 
 
To test whether nodes within the sub-network identified using the NBS analysis differed 
from nodes not included in the sub-network, the average Wi and Bi of the sub-network 
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were contrasted against the average Wi and Bi of the nodes not included in the sub-
network using non-parametric permutation testing.  
 
To test whether the HSS correlated with the Wi and Bi nodes across the whole brain 
connectome, a Spearman’s rho correlation was performed followed by a non-linear 
permutation test using 5000 iterations to control for multiple comparisons (Nichols & 
Holmes, 2002), using an alpha of 0.05. This approach was repeated using the different 
threshold (Misic et al., 2015) and the outcome was correlated to the Wi and Bi using the 
original threshold.  Both the Wi and Bi scores calculated using the aforementioned 
threshold highly correlated with the Wi and Bi scores calculated with the consensus 
threshold (r = 0.92 and r = 0.94, respectively), indicating that the results were not biased 
by the chosen thresholding method.  
 
Diverse club analysis 
We identified the ‘diverse club’ of the network, which comprised of the top 20% of Bi 
nodes (Bertolero, Yeo, & D'Esposito, 2017). These nodes play an important role in 
network integration and changes to these nodes could affect between module 
communication (Bertolero et al., 2017). We normalized the diverse club coefficient in 
reference to a null model: a random vector with a preserved modular structure was 
created by randomizing the mean participation coefficient of each node for 5000 
iterations.  The diverse club was identified as those regions with a participation 
coefficient greater than the 95th percentile of the permuted distribution. We investigated 
whether the number of diverse club nodes was significantly higher within the sub-
network associated with the HSS, compared to nodes that were not included in the sub-
network identified using the NBS analysis.  
 
Results 
Demographics 
Table 1 presents the descriptive variables of the 29 patients. The mean percentage of 
misperceptions on the BPP was 18.48 (range: 0 – 49), and the mean score on the PsycH-
QA was 9.48 (range: 0 – 34 (max score = 52)), highlighting a diverse range of 
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hallucinatory behaviour in the patient cohort. The PsycH-QA and the BPP score showed a 
positive, significant correlation (r = 0.52, p = 0.004). Finally, to verify the severity score 
to the ‘gold standard’, we correlated the HSS in a large cohort of patients with PD and 
Lewy Body Dementia (n = 75) to the MDS-UPDRS item 2 and found a correlation of r = 
0.53 (p < 0.001).  However, given higher construct validity (Shine et al., 2015), we opted 
to include the PsycH-QA and the BPP scores in the composite score (HSS) for the 
remainder of our analysis. 
 
Table 1. Demographics and clinical variables  
Variable Mean (range) Correlation with HSS  
r (p-value) 
Age (y) 66.8.1 ± 8 (51 – 84) 0.18 (0.345) 
Duration (y) 5.8 ± 4 (1.2 – 16) -0.05 (0.785) 
LEDD 617.8 ± 392 (125 – 1548) -0.06 (0.767) 
H&Y 1.9 ± 0.5 (1 – 3) 0.01 (0.949) 
MDS-UPDRS III 30.0 ± 14 (7 – 55) 0.29 (0.125) 
MMSE 28.5 ± 2 (25 – 30) -0.06 (0.762) 
TMTB-A 78.9 ± 65 (-1 – 123) 0.33 (0.08) 
BPP % misperceptions  18.48 ± 17 (0 – 49) - 
PsycH-QA 9.48 ± 8 (0 – 34) - 
LEDD = Levodopa equivalence daily dose; MDS-UPDRS III = motor part of the Movement Disorder Society Unified Parkinson’s 
Disease Rating Scale; H & Y = Hoehn and Yahr; MMSE = Mini Mental State Examination; TMTB-A = Trail Making Test part B – 
part A; BPP = Bistable Percept Paradigm; PsycH-QA = Psychosis and Hallucinations Questionnaire, part A 
 
The HSS showed a positive correlation trending towards significance with the TMTB-A (r 
= 0.33, p = 0.08). No significant correlations were observed between the HSS and other 
demographic and clinical variables.  
 
The HSS correlated with decreased connectivity in a large sub-network 
As illustrated in Figure 2, the NBS analysis revealed a sub-network comprising 183 edges 
(8% of the edges in the thresholded connectivity matrix) and 127 nodes with reduced FA-
based connectivity strength correlated to the HSS (p < 0.05).  Using disease severity as a 
covariate, the NBS analysis revealed a similar sub-network comprising 177 edges and 
135 nodes that showed a correlation with the HSS that was trending towards significance 
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(p = 0.059). The effects presented with a fairly liberal threshold, suggesting the changes 
related to the HSS are subtle yet topological extended (Zalesky et al., 2010). The size of 
networks identified using a range of t-statistics are presented in the Supplementary 
Materials. No significant sub-network was identified in the opposite direction (positive 
correlation between the HSS and connectivity strength). 
 
Furthermore, the group average Bi score within the sub-network was 0.506, which was 
significantly higher (p < 0.05) than nodes outside this network, which show a group 
average of 0.310. The group average Wi score of the nodes within the network was higher 
than the group average Wi score of nodes outside the network (0.149 and -0.178, 
respectively), yet this difference did not remain significant when controlling for disease 
severity (p = 0.104). 
 
 
Figure 2. NBS analysis reveals a sub-network, comprising 183 edges with reduced connectivity strength 
correlated to increased HSS (p < 0.05). Figure visualized with BrainNet Viewer (Xia et al., 2013). 
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Figure 3: Overlap between the identified structural and functional resting-state networks. (A) The 
percentage of nodes included in the sub-network for each resting state network. DMN = default mode 
network; VAN = ventral attentional network; DAN = dorsal attentional network. (B) The functional resting 
state networks of the Yeo atlas (Yeo et al., 2011). 
 
The sub-network includes all sub-cortical nodes but did not target a specific cortical 
resting state network  
The sub-network that showed decreased connectivity strength correlated with the HSS 
included all 14 sub-cortical nodes (p < 0.05). As illustrated in Figure 3, the sub-network 
further included nodes across the cortex. However, none of the other the resting state 
networks were significantly correlated with the HSS (p > 0.05), yet the somatomotor 
network was relatively spared (p < 0.05).  
 
Nodes in the sub-network show high participation scores  
Eighteen nodes were included in the diverse club (see Supplementary Materials). 
Seventeen of the eighteen nodes (94%) of the diverse club were included in the 
aforementioned sub-network, which was deemed significantly above chance (p < 0.001). 
As illustrated in Figure 4, nodes with high participation coefficients were more often part 
of the sub-network. 
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The HSS correlated with Wi and Bi scores  
When investigating the whole structural connectome, the HSS positively correlated to 
regional Bi (i.e. higher participation scores were associated with higher severity values) 
for nodes in the left medial OFC, a node in the right anterior and left posterior cingulate, 
precuneus, and the caudal middle frontal gyrus. Furthermore, nodes in the right occipital, 
pars orbitalis and insula showed negative correlations between the HSS and participation 
coefficient (i.e. lower participation scores were associated with higher scores on the HSS; 
see Table 2 and Figure 5). However, when controlling for disease severity, the insula and 
medial OFC were only trending towards significance, whilst the lateral occipital cortex 
and anterior posterior cingulate did not remain significant. 
 
Increased HSS scores were further associated with increased module degree z-scores in 
the right thalamus, the bilateral lingual, left medial OFC, pars opercularis and 
supramarginal gyrus and superior temporal cortices. The right lateral occipital cortex also 
showed a positive correlation but this did not remain significant after controlling for 
disease severity. Decreased HSS were associated with increased module degree z-scores 
in the bilateral precuneus, the left parts triangularis, rostral middle frontal and superior 
parietal cortex. The right pericalcarine and precentral gyrus also a showed negative 
correlation with the HSS, yet this did not remain significant after controlling for disease 
severity (see Table 3 and Figure 5).  
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Figure 4. Nodes ranked according to the Bi scores. Blue: nodes included in the sub-network; grey: nodes 
not included in the sub-network correlated to the HSS.  
 
Table 2.  Spearman’s rho correlation between the participation coefficient and the HSS (p 
< 0.05; permutation test) 
Node X Y Z Rho Rho*  Sub-network 
Positively correlated       
Frontal       
ctx-lh-medialorbitofrontal_2 -5 33 -20 0.37 0.35#   
ctx-rh-caudalmiddlefrontal_2 40 15 39 0.43 0.53 - 
Parietal        
ctx-lh-precuneus_2 -10 -44 46 0.40 0.37    
Cingulate       
ctx-lh-posteriorcingulate_2 -8 -43 21 0.57 0.53    
ctx-rh-superiorfrontal_3 11 40 40 0.36 0.31^   
Negatively correlated       
Frontal       
ctx-rh-parsorbitalis_1 43 43 -10 -0.46 -0.46   
Occipital       
ctx-rh-lateraloccipital_5 47 -73 2 -0.39 -0.21^   
Insular       
ctx-rh-insula_1 36 -18 13 -0.40 -0.32#   
* Rho after controlling for disease severity; # p < 0.1; ^ p > 0.1. ctx-lh = left hemisphere; ctx-rh = right hemisphere 
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Table 3.  Spearman’s rho correlation between the module degree z-score and the HSS (p 
< 0.05; permutation test) 
Node X Y Z Rho Rho*  Sub-network 
Positively correlated       
Subcortical       
Right-Thalamus-Proper 13 -17 7 0.49 0.45   
Frontal       
ctx-lh-medialorbitofrontal_1 -7 52 -11 0.40 0.43 - 
ctx-lh-parsopercularis_2 -47 14 15 0.41 0.44 - 
Parietal       
ctx-lh-supramarginal_3 -55 -34 35 0.45 0.53 - 
Temporal       
ctx-rh-superiortemporal_4 46 -6 -11 0.57 0.47 - 
Occipital       
ctx-rh-lateraloccipital_3 27 -94 -6 0.39 0.34# - 
ctx-lh-lingual_2 -10 -70 0 0.42 0.50   
ctx-rh-lingual_1 14 -83 -7 0.41 0.37 - 
Negatively correlated       
Frontal       
ctx-lh-parstriangularis_1 -43 33 2 -0.50 -0.43   
ctx-lh-rostralmiddlefrontal_5 -31 56 2 -0.57 -0.50   
ctx-rh-precentral_6 22 -17 67 -0.39 -0.35#   
Parietal       
ctx-lh-precuneus_2 -10 -44 46 -0.46 -0.43   
ctx-lh-superiorparietal_6 -22 -76 29 -0.41 -0.47   
ctx-rh-precuneus_2 12 -54 26 -0.39 -0.43   
Occipital       
ctx-rh-pericalcarine_1 15 -75 12 -0.375 -0.24^   
* Rho after controlling for disease severity; # p < 0.1; ^ p > 0.1. ctx-lh = left hemisphere; ctx-rh = right hemisphere 
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Figure 5) Significant changes in between- and within-module scores associated with the HSS. (A) Nodes 
with a significant correlation between Bi scores and the HSS; (B) Nodes with a significant correlation 
between the Wi scores and HSS. Green indicates a positive correlation, red indicates a negative 
correlation. Figure visualized with BrainNet Viewer (Xia et al., 2013). 
 
Discussion  
The aim of this study was to determine whether changes in structural network topology 
were associated with hallucinatory behaviour in PD. We showed that severity of 
hallucinatory behaviour was negatively correlated with connectivity across a bilateral 
sub-network. Regions within this sub-network showed higher participation compared to 
regions outside this network. The loss of connectivity strength may force the system to 
adapt and reroute information across less efficient pathways, impeding the standard 
sensory integration process. Importantly, 94% of the nodes in the diverse club were 
included in this sub-network. This community of high participation nodes is thought to 
control the integration of relatively segregated regions (Bertolero et al., 2017). Indeed, 
the diverse connectivity pattern of these nodes makes them crucial for the functional 
coordination of brain regions during tasks, and activity in these nodes predicts changes in 
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the coupling of other regions (Bertolero et al., 2017). Severity of hallucinatory behaviour 
may thus be the result of impaired integration and segregation of brain networks or 
‘modules’, affecting effective information transfer. Finally, we showed regional changes 
in participation associated with hallucination severity (the HSS score), with a positive 
correlation between participation scores in the medial OFC, cingulate, precuneus and 
middle frontal gyrus and the HSS and negative correlation with participation scores in the 
lateral occipital cortex, pars orbitalis and insula. These findings suggest a reweighting of 
the regions along the perceptual hierarchy, which may give rise to hallucinations.  
 
Lower participation of the lateral occipital cortex may reflect reduced early visual 
processing, resulting in ineffective accumulation of visual information from the 
environment. Previous work using a Bayesian drift diffusion model has demonstrated that 
accumulation speed and quality of perceptual information are reduced in PD patients with 
VH (O’Callaghan et al., 2017). Furthermore, reduced quality or integration of visual 
stimuli may increase perceptual uncertainty, a suggestion that aligns with increased 
participation in the dorsal anterior cingulate cortex (Keri, Decety, Roland, & Gulyas, 
2004). Perceptual uncertainty may place excessive emphasis on top-down prediction 
centres, which subsequently could lead to a reduced activity in early visual regions 
(Meyer & Olson, 2011). However, the reduced participation score in the occipital and 
anterior cingulate cortex may not be specific to hallucinatory behaviour, as the negative 
correlations did not remain significant after controlling for disease severity. 
 
This emphasis on top-down visual processing centres is supported by the increased 
participation coefficient and module degree z-score in the medial OFC. The OFC has an 
integrative function across brain networks as evidenced by its high participation 
coefficient. Additionally, this region is thought to facilitates recognition during visual 
perception by integrating incoming sensory information with previous experiences and 
expectations (Panichello, Cheung, & Bar, 2012). During typical visual perception, the 
OFC is activated early in response to visual stimuli, receiving low spatial frequency 
signals from the visual cortex (Bar et al., 2006). Notably, only stimuli resembling known 
objects are shown to activate the OFC, which in turn generates a semantic association and 
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provides a predictive signal to the visual system (Chaumon, Kveraga, Barrett, & Bar, 
2014). Conversely, visual stimuli that carry no meaningful association do not activate the 
OFC in healthy individuals. Hence, it could be speculated that due to decreased quality of 
visual input, inappropriate recruitment of the OFC occurs, which may result in ascribing 
false associative information to visual stimuli.  
 
The manifestation of VHs has previously been recognized as a dysfunction between the 
attentional networks (Shine, Muller, et al., 2015). Specifically, patients with VHs are 
shown to be less able to recruit the dorsal attentional network (DAN), which enables the 
selection of appropriate sensory stimuli (Maurizio Corbetta, Patel, & Shulman, 2008). 
With reduced control of this network, ambiguous stimuli might instead be interpreted by 
the ventral attentional network (VAN) and the DMN, which are less well equipped for 
this task. Our results showed increased participation in the posterior cingulate cortex 
(PCC), a key hub of the DMN. PCC activity has been implicated in regulating the focus 
of attention, specifically, the shift from the external world into internal mentation 
(Weissman, Roberts, Visscher, & Woldorff, 2006). Furthermore, the PCC is involved in 
mind wandering and supports internally directed cognition (Leech & Sharp, 2013). A 
failure to suppress PCC activity may lead to the intrusion of internal thoughts into task 
performance (Sonuga-Barke & Castellanos, 2007). Moreover, a positive correlation was 
found between the HSS and the module degree z-score of the left pars opercularis, a node 
in the VAN, a network that is activated when expectations in perception are violated 
(Corbetta & Shulman, 2002; Shine, Halliday, et al., 2014). Conversely, a negative 
correlation between the HSS scores and module degree score and participation 
coefficients was found in other nodes of the VAN, namely the left pars triangularis, the 
right pars orbitalis and insula. The left pars triangularis supports resolving competition 
between simultaneously active representations (Badre & Wagner, 2007), whilst the insula 
plays an important role in dynamically shifting attention between the attentional control 
networks (Menon & Uddin, 2010). The anterior insula has previously been shown to be 
reduced in volume in PD patients with VH (Ibarretxe-Bilbao et al., 2010; Shine, Halliday, 
et al., 2014). Together, these results suggest that ineffective communication between 
attentional networks in the brain may predispose an individual to hallucinate. 
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Surprisingly, the participation coefficient of a node within the DAN (‘ctx-rh-
caudalmiddlefrontal_2’) showed a positive correlation with the HSS. This node was not 
part of the sub-network and it may be possible that this is a compensatory response to the 
loss of connectivity strength in the other DAN regions.  Notably, the connectivity matrix 
shows between module connections of this region with nodes in the somatomotor and the 
frontoparietal network, but not with the DMN or VAN.  
 
Finally, all nodes that showed negative correlations with the HSS were included in the 
sub-network. Decreased within-module scores were found across the prefrontal and the 
somatosensory association cortex, as well as in the primary visual cortex, whilst there 
was a positive correlation between the HSS and the bilateral secondary visual cortex, 
perhaps as a result of the decreased visual input from V1. Additionally, the supramarginal 
gyrus, a node that has been shown to be functionally active during spatial perception but 
also during visual imagery (Ganis, Thompson, & Kosslyn, 2004) showed an increased 
module degree z-score with increasing severity of VHs. Furthermore, a positive 
correlation with the HSS and the module degree score in the superior temporal cortex, a 
region involved in auditory processing was found. It could be speculated that increased 
visual uncertainty may stimulate other sensory processing areas. Conversely, previous 
work in schizophrenia has shown increased activation in the superior temporal cortex 
during a mis-match between expected and perceived auditory feedback (Fu et al., 2008). 
The HSS also included hallucinations of other sensory modalities and it could be 
speculated that a greater emphasize is being placed on predictions of auditory stimuli, as 
reflected as increased within-module connectivity in the superior temporal cortex. 
 
This study has several limitations worth noting. Firstly, the DWI data was acquired 
without EPI distortion correction. This may have affected the accuracy of registration 
between DWI and T1 images in the frontal and temporal cortices. Due to relatively low 
diffusion weighting used in the current MRI protocol, it was chosen to employ DTI rather 
than more sophisticated methods such as constrained spherical deconvolution, an 
algorithm that more adequately deals with multiple fibre directions within one voxel than 
DTI. Furthermore, after controlling for disease severity, the identified sub-network was 
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only trending towards significance. The correlation between the HSS and the 
participation coefficients of the lateral occipital and anterior cingulate did not remain 
significant, whilst the OFC and insula were only trending towards significance, and 
similar patterns were found for the module degree z-score: correlation with the HSS and 
nodes in the occipital and precentral regions did not remain significant. However, this 
may be expected given the close relationship between overall symptom severity and 
phenotypic symptom severity. Importantly, the correlation coefficients showed notable 
consistency across the analyses, suggesting the HSS was able to distinguish inter-
individual variability. Whilst the current study included PD patients with no self-reported 
hallucinations (n=6), no data from a healthy control group was acquired, which could 
have aided in disassociating the significant network measures and disease burden. The 
LEDD score was not associated with the HSS in the current study, and the relation 
between hallucinations and a LEDD-related side effect has been dismissed in previous 
work (Fénelon et al., 2000; Graham et al., 1997; Sanchez-Ramos et al., 1996; Shergill et 
al., 1998). Furthermore, hallucinations may occur in the absence of dopaminergic 
treatment in PD or Dementia with Lewy Bodies (Ala et al., 1997). Therefore, the current 
study chose not to include LEDD score as a covariate. Furthermore, the investigation was 
conducted in a relatively small group of PD patients and future studies should replicate 
our findings in a larger sample size. Finally, this study chose to include the PsycH-Q to 
assess hallucinations. This is an in-depth questionnaire with high construct validity, 
however, patients have to report their hallucinations themselves. Ideally, a trained 
neurologist or qualified researcher, who can probe the patients when in doubt, should 
assist with this process.  
   
Conclusions 
We cautiously conclude that hallucinatory behaviour in PD patients is associated with 
marked alterations in structural network topology. Severity of hallucinatory behaviour 
was associated with decreased connectivity in a large sub-network that included the 
majority of the diverse club. These changes may result in an inefficient rerouting of 
information across less efficient pathways, which may lead to impaired visual integration 
processes. Furthermore, nodes within the orbitofrontal cortex and temporal lobes showed 
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increased participation scores, whilst the visual association cortex, insula and middle 
frontal gyrus showed decreased scores associated with the HSS score. These findings 
suggest that impaired integration across different regions along the perceptual hierarchy 
may result in inefficient transfer of information. A failure to effectively switch between 
attentional networks and the intrusion of internal percepts could give rise to perceptual 
glitches, such as misperceptions and hallucinations. 
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Supplementary Table 1. Nodes of the diverse club 
 
Node Participation coefficient Inclusion sub-network 
'Left-Putamen' 0.814 ✓ 
'Right-Pallidum' 0.811 ✓ 
'Right-Putamen' 0.808 ✓ 
'Left-Pallidum' 0.807 ✓ 
'Right-Thalamus-Proper' 0.805 ✓ 
'Right-Caudate' 0.768 ✓ 
'ctx-rh-precuneus_4' 0.734 ✓ 
'ctx-lh-superiorparietal_5' 0.731 ✓ 
'ctx-lh-superiorparietal_4' 0.724 ✓ 
'ctx-rh-superiorfrontal_5' 0.721 ✓ 
'ctx-rh-isthmuscingulate_1' 0.716 ✓ 
'Left-Hippocampus' 0.713 ✓ 
'ctx-lh-insula_3' 0.705 ✓ 
'ctx-rh-rostralmiddlefrontal_5' 0.695 ✓ 
'ctx-lh-superiorfrontal_3' 0.664 ✓ 
'ctx-rh-superiorparietal_3' 0.658 ✓ 
'ctx-lh-lateraloccipital_1' 0.653 ✓ 
'ctx-rh-postcentral_5’ 0.612 - 
ctx-lh = left hemisphere; ctx-rh = right hemisphere		
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Supplementary figure 1. Mean connectivity matrix (thresholded)  
Connectivity matrix is deposited at github.com/juliemaehall 
 
 
 
 
 
 
Supplementary figure 2. Size of sub-networks correlated with the HSS for different t-statistics. 
Blue bars represent the number of edges; white bars represent the number of nodes. 
Asterisks (*) represent a significant correlation (p < 0.05). 
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7. General discussion 
The preceding Chapters in this thesis aimed to outline how new insights into the 
heterogeneous character could be gained by considering Parkinson’s disease as a 
‘disconnection disorder’. Specifically, this thesis has shown that two heretofore 
poorly understood symptoms of Parkinson’s disease, namely freezing of gait and 
visual hallucinations, could be recognized as a failure of effective communication 
within and between large-scale neuronal networks. The specific aims of this thesis 
were as follows: 1) to provide an overview of the current literature on white matter 
changes associated with different symptoms of Parkinson’s disease using DTI 
(Chapter 2), 2) To investigate whether freezing of gait could be result from 
ineffective communication between widespread brain networks (Chapter 3 and 
Chapter 4) and 3) to investigate whether visual hallucinations in Parkinson’s disease 
arise due to a reweighting of attentional and perceptual brain networks (Chapter 5 
and Chapter 6). The key findings of each chapter are summarized chiefly in their 
respective discussion sections. However, these points are briefly outlined again 
below in relation to how they meet the initial aims of the thesis.  
 
7.1 Summary of key findings  
7.1.1 To provide an overview of the current literature on white matter changes associated 
with different symptoms of Parkinson’s disease using DTI (Chapter 2) 
The first aim of this thesis was to provide an in depth overview of the current 
literature investigating diffusion alterations associated with specific symptoms of 
Parkinson’s disease. Chapter 2 demonstrated that distinct symptoms have unique 
neurobiological patterns and thus emphasised the importance of investigating 
homogeneous patient groups with Parkinson’s disease to avoid confounding results. 
This review further highlighted that changes in white matter associated with several 
symptoms, including visual hallucinations and freezing of gait, but also REM sleep 
behaviour disorders and mood disturbances, remain poorly understood, either due to 
a lack of research into these phenomena or because of conflicting results. One 
explanation for this variability can be found in the different MRI protocols used 
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across studies.  However, it is also possible that symptoms of Parkinson’s disease are 
not the result of a focalised lesion, but rather due to changes in network structure. 
These changes might go unexposed when using traditional methods such as TBSS or 
tractography. Instead, assessing whole brain connectivity using a data driven 
approach may reveal complex, distributed patterns in white matter tracts. Rather than 
trumpeting one region of a circuit as responsible for a specific function, this 
approach allows for the inherent complexity of interacting subsystems and their 
connections to be studied and therefore may provide unique insights into white 
matter pathology in Parkinson’s disease. 
 
The findings of the two symptoms central to this dissertation, freezing of gait and 
visual hallucinations, will be briefly discussed in the next section. 
 
Freezing of gait 
The review presented in Chapter 2 showed that studies investigating freezing of gait 
in Parkinson’s disease have focused predominantly on the brainstem locomotor 
regions and reported white matter abnormalities in the corticopontine and pontine-
cerebellar tracts. Cholinergic pedunculopontine nucleus projections regulate gait 
initiation, continuation and modulation in healthy adults (Grabli et al., 2012; 
Rochester et al., 2012). Furthermore, increasing evidence suggests that the 
pedunculopontine nucleus underlies an integrative function of distinct functional 
neuronal networks; hence disruptions in its ascending pathway could have 
implications beyond motor control (Snijders et al., 2016). Diffusivity changes were 
also found in major cortico-cortical and several frontostriatal tracts, highlighting the 
role of extensive cortical and subcortical changes. Finally, a recent study not 
included in the review chapter showed that diffusivity changes in long-range 
associative fibres that are involved in integration between left and right frontal lobes 
as well as intra-hemispheric connections between associative cortical areas (Sara 
Pietracupa et al., 2018). These findings are consistent with behavioural studies 
showing frontal impairment in patients with freezing (de Souza Fortaleza et al., 
2017; Hall et al., 2014; Naismith et al., 2010; Vastik et al., 2017; Walton et al., 
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2015), as well as functional connectivity abnormalities reported in the basal ganglia 
and frontal and parietal cortices (Mi et al., 2017; Shine et al., 2011b; Tessitore et al., 
2012). Deficits in complimentary yet competing pathways between motor, cognitive 
and limbic structures may contribute to freezing behaviour.  
 
Visual hallucinations 
At the time the search for this literature review was performed, only one study had 
been performed on diffusivity alterations underlying visual hallucinations. This study 
observed diffusivity changes in the hippocampus (Yao et al., 2014), a node that 
strongly projects to the default mode network (Lee & Xue, 2018). Since this review 
was published, two other studies have been performed that investigated white matter 
changes in Parkinson’s disease patients with visual hallucinations. Firstly, a study 
reported diffusivity changes in the optic nerve and optic radiation, which suggest that 
both pre- and postsynaptic fibres of the visual afferent neurons undergo degeneration 
in hallucinators (Lee et al., 2016). Secondly, changes in diffusivity were observed in 
tracts connecting the nucleus basalis of Meynert with parietal and occipital cortical 
regions and the authors suggested that this might be due to a loss of cholinergic 
innervation (Hepp et al., 2017). This hypothesis is supported by the tendency of 
anticholinergic drugs to induce visual hallucinations (Bullock et al., 2002; Burn et al., 
2006; Perry et al., 1995). Taken together, these studies demonstrate the likelihood of 
deficits in primary visual regions, as well as in regions associated with cognitive 
performance (Gratwicke et al., 2018; Squire et al., 1991) in patients with visual 
hallucinations.  
 
Studies investigating the white matter integrity associated with freezing and 
hallucinations have aided our understanding of these phenomena. Evidently, there are 
some discrepancies in the presented data. Studies have often targeted different 
regions of interest and used a differing array of methods (i.e. TBSS or tractography). 
Whilst tractography focuses on a specific tract rather than on the whole connectome, 
TBSS may not be sensitive enough to reveal subtle changes in connectivity strength. 
Graph theory allows for the measurement of global and regional changes in the 
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whole brain connectome without a predefined region of interest. By studying the 
structural connectome, subtle changes in the organisation of brain networks may 
become evident.  	
7.1.2. To investigate whether freezing of gait could be a result to ineffective 
communication between brain networks (Chapter 3 and Chapter 4) 
This thesis has made an important contribution to the understanding of the 
phenotypical associations across disease stages (Chapter 3), as well as to the 
neurobiological mechanisms (Chapter 4) of freezing of gait.  
 
Consistent with previous work (Naismith et al., 2010; Walton et al., 2015a; 2015b), 
results presented in Chapter 3 showed a significant association between executive 
dysfunction and freezing of gait, suggesting the involvement of frontostriatal 
networks (Shine et al., 2011b). This study extended previous work by mapping out a 
number of different phenotypical features in a large patient cohort across different 
disease stages. The results showed that freezing of gait was associated with the non-
tremor dominant motor phenotype. Furthermore, differences in mood and sleep 
disturbances were observed, with a higher prevalence of depression, anxiety and 
REM sleep behaviour disorder in freezers than in non-freezers. Depression scores 
increased with advancing disease stages in all patients, whilst anxiety and REM sleep 
behaviour disorder were not related to disease stage. These results support the 
hypothesis that a deficit in conflict processing, which can occur within and between 
motor, cognitive, affective or perceptual processing systems, may underlie freezing 
of gait results (Lewis & Barker, 2009; Lewis & Shine, 2016; Vandenbossche et al., 
2012). Finally, autonomic disturbances were not associated with freezing of gait 
across early or advanced disease stages, suggesting freezing behaviour does not 
simply arise as a result of a brainstem lesion, nor is it likely that one pathological 
lesion in a certain brain area will result in this transient and episodic symptom. 
Rather, we hypothesize that ineffective information processing across subcortical and 
cortical sites may underlie freezing of gait.  
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The results from Chapter 3 provided the theoretical foundation for the study 
presented in Chapter 4. Namely, I considered the organisation of the white matter 
connectome, allowing for assessing changes on the network level. Indeed, 
investigating changes in network topology can elucidate changes in nodes that are 
important in the integration and segregation of different networks (Sporns et al., 
2004). Changes in these scores could inform how effective the processing of 
information is within and across different brain networks (Bertolero et al., 2015). A 
group comparison between patients with and without freezing of gait showed low 
participation scores in several nodes across subcortical, superior frontal and superior 
parietal cortices. Moreover, a significant number of affected nodes were part of the 
‘rich-club’, a group of high degree nodes that are densely connected with each other 
and form the skeleton of the connectome. The rich-club plays a crucial role in global 
information integration between different modules in the brain (van den Heuvel et 
al., 2011). Moreover, the findings from Chapter 4 demonstrated that investigating 
network topology could be advantageous for understanding a symptom that is 
associated with pathological impairments at multiple levels across cortical and 
subcortical regions.   
 
The findings presented above are consistent with extensive evidence from functional 
MRI studies showing reduced activity within, and decoupling between cortico-
cortical and cortico-striatal networks (Shine, 2013a; 2013b; Tessitore et al., 2012). 
Whilst these results provide additional evidence for the hypothesis that freezing may 
arise from inefficient shifting between functionally distinct but complementary 
neural pathways (Lewis & Shine, 2016), the findings can also be interpreted as the 
interplay between decreased gait automaticity and impairments in cognitive control 
(Vandenbossche et al., 2012). The decreased participation scores in the basal ganglia 
could indicate impairment in automatic processing. In such circumstances, patients 
might need to rely on cortical control to operate an effective gait pattern. The study 
presented in Chapter 4 showed decreased participation scores in both frontal and 
parietal regions, which could indicate ineffective regulation of cognitive control 
necessary to compensate for the loss of automaticity. Alternative freezing of gait 
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models, such as the decoupling model (Jacobs et al., 2009) and the abnormal gait 
pattern generation hypothesis (Plotnik et al., 2005) were not directly investigated in 
Chapter 4. Indeed, the brain atlas used in Chapter 4 did not include the 
pedunculopontine nucleus as a region of interest. However, the findings in Chapter 3 
did not allude to specific brainstem lesions (as indicated by similar autonomic 
functioning across groups), and the current results argue that deficiencies across 
multiple cortical and subcortical domains contribute to the freezing phenomenon.  
 
7.1.3. To investigate whether visual hallucinations in Parkinson’s disease arise due to a 
reweighting of attentional and perceptual brain networks (Chapter 5 and Chapter 6) 
Visual hallucinations in Parkinson’s disease are common but the incomplete 
knowledge of its pathophysiology limits treatment strategies. Previous work has 
associated attentional dysfunction to hallucination proneness (Hepp et al., 2013; 
Meppelink et al., 2008). Attention encompasses several processes such as alerting 
and maintaining awareness, orienting, noticing and selecting stimuli for processing 
or executive control. One test that can dissociate different attentional processes is the 
Attentional Network Task (Fan et al., 2002). As such, to refine our understanding of 
attentional deficits, Chapter 5 explored attentional processes in patients with visual 
hallucinations using the Attentional Network Task. This study showed that 
hallucinators had more missed and erroneous responses, especially in incongruent 
trial conditions, compared to non-hallucinators. Hence, with increasing task 
demands, impairments in sustained attention and conflict processing arise. The 
reaction times between the groups on correct trials did not differ, suggesting a 
selective communication breakdown between attentional networks.  
 
However, not all patients with impaired attentional processes experience visual 
hallucinations. Indeed, several models that have tried to explain the underlying 
processes have suggested that hallucinations and misperceptions arise due to failure 
of effective coordinated activities within and between attentional networks (Shine et 
al., 2014; 2015). As such, when investigating the structural changes associated with 
hallucinatory behaviour, it may be beneficial to investigate the communication 
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between different perceptual processing sites. A system-level perspective can 
provide unique insights into between- and within-network communication, which 
was employed in Chapter 6 of this thesis. This study investigated changes in 
structural network topology associated with severity of hallucinatory behaviour, 
which was assessed using a composite score including both a behavioural test and a 
subscale of a questionnaire. This study found that the severity of hallucinatory 
behaviour was associated with an overall reduction in connectivity strength in a sub-
network, spanning both hemispheres. Importantly, nodes within this network on 
average showed higher between- and within-module scores compared to the 
unaffected network and the majority of diverse club nodes were included in this 
network. As such, this reduced connectivity associated with severity of 
hallucinations may have extensive implications for processing speed and efficiency 
across the connectome.  Furthermore, a number of connections between nodes of the 
diverse club (a network of nodes with high participation coefficients) also showed 
reduced connectivity strength. The diverse club is thought to organise network 
integration and segregation (Bertolero et al., 2015), thus changes between these 
nodes could have detrimental effects for network communication. On a regional 
level, the findings showed reduced participation in the right lateral occipital cortex, 
pars orbitalis and insula, whilst increased participation was observed the left medial 
orbitofrontal cortex, left posterior and right anterior cingulate, regions typically 
involved in generating perceptual predictions (Bar et al., 2006; Chaumon et al., 
2014), endogenous attention (Andrews-Hanna et al., 2010; Vincent et al., 2006) and 
error monitoring (Botvinick et al., 2004; 1999; Carter et al., 1998) respectively.  
 
These findings are in accordance with the hypothesis presented in Chapter 5 and the 
findings presented in Box 5 (O’Callaghan et al., 2017).  This structural pattern supports 
the assertion that visual misperceptions may arise due to increased reliance on areas 
involved in predictive processing, in combination with reduced visual input and less 
effective top-down control mechanisms that fail to recruit the appropriate networks 
(Shine et al., 2014). Interestingly, one node within the right dorsal attentional network 
(DAN) (‘ctx-rh-caudalmiddlefrontal_2’) was positively correlated with a higher 
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hallucination severity score. This finding was unexpected and contradictory to our 
hypothesis mentioned in Chapter 5 of this thesis, namely that a loss of connectivity 
between the DAN and other attentional networks. However, there were no connections 
between this node and nodes from the DAN or default mode network. As such, the higher 
between-module score may reflect a compensatory response to the loss of connectivity 
strength in other regions of the DAN.   
 
Finally, the current results also align with the Perception and Attention Deficit 
Model (Collerton et al., 2005), which proposes that a hallucination, or the intrusion 
of an incorrect proto-object, interfere with perception due to a combination of 
impaired attention and visual perception. This model does not specify where or how 
these unfitting proto-objects may arise. However, the results of Chapter 6 within this 
thesis, as well as previous findings (Shine et al., 2014) would suggest that the 
processes occurring in the default mode network represent a candidate mechanism 
for the generation of these internal perceptual intrusions.  
 
Finally, the Perception and Action Deficit Model as well as other previous work (Hepp et 
al., 2017; Bullock et al., 2002; Burn et al., 2006; Perry et al., 1995) have shown 
involvement of the cholinergic system in the occurrence of hallucinations in Parkinson’s 
disease. Acetylcholine modulates the orienting network (Posner, et al., 2008), but also 
influences the communication between attentional networks (Demeter & Sarter, 2012). 
Deficits in sustained attention may also indicate impairments in the cholinergic system 
(Turchi & Sarter, 2001). A follow-up unpublished analysis on the same dataset used in 
Chapter 5 investigated fluctuations in reaction times, but showed no differences 
between hallucinators and non-hallucinators on the coefficient of variation when 
investigating variability across all trials, nor when analysing congruent, incongruent 
and neutral trials separately. However, deficits in sustained attention may not be 
specific to patients with hallucincations. More research is needed to investigate this 
relationship.  
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7.1.4 Converging themes: similarities and differences between freezing of gait and visual 
hallucinations 
Albeit with differing specific manifestations, the current thesis has illustrated the 
pathophysiological overlap between seemingly disparate symptoms and suggests that 
freezing and hallucinations may occur due to a failure of effective information 
processing between large-scale neuronal networks.  	
Consistent with the presented results, previous work has shown that both freezing and 
hallucinations in Parkinson’s disease can be considered as an outcome of a 
communication breakdown between functional attentional networks (Shine, 2013a) and 
this may instigate the occurrence of transient, paroxysmal unwanted behaviours. Conflict 
in information processing can further explain the increasing occurrence of both of these 
symptoms under conditions where there is additional cognitive load. For example, 
freezing behaviour is exacerbated during dual-tasking or stress, whilst hallucinations are 
more likely to occur in cluttered environments with multiple competing stimuli that 
require processing.  
 
However, both hallucinations and freezing of gait also showed unique anatomical 
signatures.  Of the 29 patients included in the study presented in Chapter 6, sixteen 
patients scored positively on the Freezing of Gait Questionnaire item 3, indicating 
they have experienced freezing of gait. Specifically, thirteen patients self-reported 
both freezing of gait and hallucinations (a positive score on PsycH-QA), three 
patients reported freezing of gait but no hallucinations and thirteen patients reported 
hallucinations but no freezing of gait. This indicates that these symptoms are likely 
part of the same non-tremor dominant phenotype, yet occur often independently. In 
Chapter 4 of this thesis, patients with freezing showed predominantly lower 
participation scores, which is interpreted at an overall loss of effective information 
processing across subcortical, frontal and parietal sites, whilst hallucinatory 
behaviour (in Chapter 6) showed both decreased and increased scores across top-
down and bottom-up perceptual processing regions, reflecting a reweighting of the 
perceptual system. The most notable difference between the two symptoms was 
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found in the cingulate gyrus.  Freezing was associated with lower participation in the 
anterior and posterior cingulate, whilst hallucinations were associated with higher 
participation in these regions. Diffusivity changes as well as cortical thinning in 
freezing of gait in the cingulate gyrus have previously been reported (Pietracupa et 
al., 2018; Vastik et al., 2017). Conversely, previous work has not observed 
diffusivity changes in the cingulate tracts in PD hallucinators (Hepp et al., 2017), 
whilst functional imaging studies have shown increased activity within posterior 
cingulate (Yao et al., 2014). This region further showed increased functional activity 
in Dementia with Lewy Bodies, a Parkinsonian condition in which visual 
hallucinations are highly prevalent, compared to Alzheimer’s disease patients 
(Franciotti et al., 2013).  
 
These differences between freezing and hallucinatory behaviour highlight the 
importance of assessing well-matched groups when investigating different symptoms 
of Parkinson’s disease individually. Indeed, changes in network architecture 
associated with a specific symptom might skew the results when these issues are not 
taken into account. However, it needs to be acknowledged that patients present with 
co-morbid symptoms (Lewis et al., 2005). For example, both freezing of gait and 
visual hallucinations are both associated with the non-tremor dominant phenotype 
hence they commonly co-occur (Lewis et al., 2005) (see also Chapter 3). The 
refinement of our understanding of the different subtypes within Parkinson’s disease 
is therefore important in our ability to recognise the behavioural and 
pathophysiological interaction of symptoms.  
 
7.2 Limitations of the current work  
The work in this thesis does have some limitations. In the next section, the 
limitations and their implications will be discussed.  
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7.2.1 Self-reported symptoms   
An important limitation of the empirical work presented in this thesis is where the 
group allocation of patients is based on self-report questionnaire data. In Chapter 2 
and 3, freezing of gait was identified using the Freezing of Gait Questionnaire (FOG-
Q) (Giladi et al., 2000). Whilst previous work has shown that this is a reliable tool to 
identify freezers (Shine et al., 2012), ideally freezing of gait should be observed in 
the clinical setting, using objective gait assessments, such as a gait mat, 
accelerometry or Timed Up and Go tests (Galna et al., 2013). Objective assessments 
however, lend themselves to false-negative classification, since an affected 
individual might not freeze during their brief visit to the clinic, especially when 
taking their optimal dose of dopaminergic medication. As such, most research 
investigating freezing has used self-reported questionnaires (Iansek et al., 2016; 
Nieuwboer et al., 2013). Furthermore, Chapter 4 of this thesis identified patients 
with visual hallucinations using question 2 of the MDS-UPDRS. Hallucinations 
occur on a continuum and it is possible that patients with benign misperceptions 
might not yet recognize these more subtle events as being abnormal. On the other 
end of the spectrum, patients can also lose insight into their visual hallucinations. 
Both of these scenarios may cause discrepancies in responding to this item on the 
MDS-UPDRS. At the University of Sydney, Parkinson’s Disease Research Clinic, 
the MDS-UPDRS is obtained by a trained neurologist, who can probe the patient 
(and informant) if there is doubt. This approach may thus overcome some of the 
difficulties in capturing hallucinatory symptoms. 	
Whilst objective assessment of any symptom is desirable, this bears particular difficulties 
when assessing visual hallucinations, as they are not observable by anyone other than the 
affected individual. To circumvent this issue, the Bistable Percept Paradigm, an objective 
test that can elicit misperceptions in patients with Parkinson’s disease, was designed 
(Shine et al., 2012a). In Chapter 6, visual hallucinations were assessed using a detailed 
validated questionnaire about hallucinatory behaviour (Shine et al., 2015) and the 
Bistable Percept Paradigm (BPP). The BPP is a computerized task that aims to elucidate 
visual misperceptions, and can be compared to the Pareidolia test (Uchiyama et al., 
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2012), which is developed for patients with dementia with Lewy bodies. Whilst the 
Pareidoloa test has been shown to have a good inter-rater and test-retest reliability and 
exhibits high sensitivity to discriminate dementia with Lewy bodies from Alzheimer’s 
disease, it does not correlate with clinical visual hallucinations (Mamiya et al., 2016). A 
new simplified version of the Pareidolia test has shown to be a valid and reliable 
assessment of visual hallucinations in patients with dementia with Lewy bodies (Mamiya 
et al., 2016). Future work should compare the BPP and the adjusted Pareidolia test 
(Mamiya et al., 2016), which was not available at time of testing of the current work.   
The Psychosis and Hallucinations Questionnaire (PsycH-Q), includes items to probe 
a broad spectrum of hallucinatory symptoms and their frequency (Shine et al., 2015). 
This questionnaire is written in ‘non-scientific’ language and aimed to improve the 
sensitivity to changes in the frequency and severity of hallucinatory and psychotic 
symptoms in Parkinson’s disease. Using a combined score of objective and 
subjective assessments, we aimed to circumvent the sole reliance on self-reported 
symptom occurrence whilst controlling for the possibility of misclassifying 
hallucinators as non-hallucinators, when patients did not experience visual 
hallucinations during their clinic visit. Additionally, by creating this composite 
score, we are able to assess visual hallucinatory severity, rather than classifying 
patients into more artificial dichotomous patient groups.  	
Finally, whilst hallucinations in other modalities, including auditory, olfactory, tactile and 
gustatory systems, also exist in Parkinson’s disease, this thesis has mainly discussed 
hallucinations in the visual system. Importantly, the measurements used in Chapter 5 
(MDS-UPDRS item 2) and Chapter 6 (PsycH-Q) assess hallucinations in all sensory 
modalities. Hence, a firm conclusion about hallucinations in the visual domain cannot be 
made. However, sensory hallucinations other than visual hallucinations are rare in 
Parkinson’s disease, especially when unaccompanied by visual hallucinations or 
misperceptions (Inzelberg et al., 1998). Therefore, the majority of the hallucinations of 
our participants are likely of visual nature. Lastly, hallucinations in other sensory 
domains are poorly understood due to a dearth of studies in this area. However, the 
hypothesis proposed in Chapter 6 is not limited to visual hallucinations. In fact, previous 
	 200 
work has proposed that hallucinations in different sensory domains in mental illness are 
due to a bias towards top-down information (for review, see Powers et al., 2016).	  	
7.2.2 Cross-sectional studies 
The studies presented in this thesis used a cross-sectional study design. A cross-
sectional design limits the interpretation of a temporal relationship between two 
measures. For example, in the study presented in Chapter 3, I presented the 
prevalence of freezing across different disease stages. However, future work should 
carry out a longitudinal design to track disease progression in freezers compared to 
non-freezers to further elucidate temporal changes and their dependence on specific 
characteristics associated with this phenomenon.  	
7.2.3 Limitations of DTI  
Chapter 4 and 6 of this thesis used DTI analyses to investigate white matter changes 
in Parkinson’s disease patients. However, DTI suffers from a number of inherent 
limitations. Firstly, diffusion imaging measures the motion of water molecules along 
Box 4: Identifying risk factors for freezing of gait  
Ehgoetz Martens, K. A., Lukasik, E., Georgiades, M, J., Gilat, M., Hall, J.M., Walton, 
C. C., Lewis, S. J. G. Predicting the onset of freezing of gait: A Longitudinal study. 
Movement Disorders, 2017. 
 
This longitudinal study used a logistic regression model including demographic 
factors, motor, executive and mood disturbances, to identify risk factors for the 
development of freezing of gait. The model found that the Freezing of Gait 
Questionnaire (item 1 and 2) together with the Hospital Anxiety and Depression Scale 
could predict with > 70% accuracy if patients would transition into freezers at follow 
up (1 year). These results suggest that patients at risk for freezing could be identified, 
and allow for targeted interventions to delay or prevent the development of freezing 
behaviour in patients with Parkinson’s disease.  
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a tract from which no directionality can be differentiated. Additionally, this method 
only allows for an indirect validation of white matter tracts and therefore it is not 
possible to infer whether demyelination or axonal injury is the source of changes in 
anisotropy values. Secondly, DTI tractography approaches are incapable of resolving 
crossing or ‘kissing’ fibres (Lanyon, 2012). At an ambiguous directional point in a 
voxel, fractional anisotropy values fall below the cut-off threshold leading to a 
premature termination of the reconstructed tract. Therefore, connectomes constructed 
in these Chapters may potentially miss important axons. More sophisticated methods 
such as constrained spherical deconvolution (CSD) are capable of producing 
biologically expected ‘fan-shaped’ configuration of tracts (Tournier et al., 2004). So 
far, several studies investigating Parkinson’s disease have employed CSD. 
Specifically, a recent study compared a multi-shell, multi-tissue (MSMT) to single-
shell, single tissue (SSST) CSD approach to investigate structural network topology 
in Parkinson’s disease patients compared to healthy controls (Kamagata et al., 2018). 
Whilst the SSST technique was able to show differences in global strength and 
small-worldness, the MSMT CSD also revealed differences in efficiency and 
clustering between the groups, though it should be noted that the specificity was not 
investigated in this study. Nevertheless, these developments are promising to unravel 
white matter changes in Parkinson’s disease and other neurological disorders. 
Finally, our data was acquired when field maps or phase encodings in different 
directions were not readily available and as such, DTI scans were not corrected for 
inhomogeneities in field distortions. This can have implications for registration of 
images among individual diffusion weighted images that bias microstructural 
assessment. To address this issue, the b0 images were registered to the segmented T1 
using boundary-based registration (bbregister in FreeSurfer (Greve et al., 2009). 
Despite these approaches, it should be appreciated that the connectomes might have 
been suboptimal and the results should be validated, ideally implementing the 
aforementioned techniques such as MSMT CSD in future work.  	
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7.3 Future directions  
To ensure progress in understanding the nature of freezing and hallucinatory 
behaviour and how they relate to neural markers, candidate mechanisms need to be 
identified of how these symptoms might arise based on a growing understanding of 
the relevant systems. Whilst the work presented in this thesis has made a significant 
contribution to this understanding, more work is required to fully understand the 
pathophysiology of these symptoms. Recommendations for future research into these 
symptoms are discussed below. Furthermore, the use of graph theory can open up 
exciting avenues for further research in Parkinson’s disease, which are discussed in 
the next section.  
 
7.3.1 Assessing freezing of gait and visual hallucinations 
Objective testing  
To further our understanding of freezing behaviour, future research should explore 
novel, minimally invasive and time-consuming ways to identify this symptom, for 
example using body-worn technologies or a gait carpet, which is able to measure 
specific gait characteristics such as step length, and velocity, variability, and single 
and double stance time objectively (Mazilu et al., 2016). Unfortunately, these 
systems currently lack the ability to accurately detect freezing. Techniques for 
recording objective hallucinations (such as from ambulatory electroencephalographic 
recordings) are at a much less developed stage. The results presented in Chapter 6 
suggested that visual hallucinations might arise due to an over-reliance of top-down 
prediction centres. This assumption should further be tested in a clinical setting. An 
objective test that can identify shifts towards prior expectations has successfully been 
used to test patients with psychosis (Teufel et al., 2015).  In this test, participants 
were shown two-toned images that were meaningless without prior knowledge of 
their content, which was only provided in a number of cases.   
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Participants that rely more heavily on prior knowledge showed an advantage in 
discriminating the ambiguous images when prior knowledge about the image was 
available. Therefore, objective tasks capitalizing on subtle variation in perception can be 
applied in Parkinson’s disease patients with visual hallucinators to test the assumption of 
a shift towards prediction centres. Furthermore, computational explanations of changes 
along the perceptual processing sites can be tested in terms of Bayesian models of 
perception within a predictive coding framework, for example, using a drift diffusion 
model (O’Callaghan et al., 2017), in order to test the understanding of the reweighting 
occurring within the perceptual system.  
	
 
 
Box 5: Evidence for impaired sensory evidence accumulation in Parkinson’s disease 
patients with visual hallucinations  
O’Callaghan, C., Hall, J. M., Tomassini, A., Muller, A. J., Walpola, I. C., Moustafa, A. 
A., Shine, J. M., Lewis, S. J. G. Visual Hallucinations Are Characterized by Impaired 
Sensory Evidence Accumulation: Insights From Hierarchical Drift Diffusion Modeling in 
Parkinson's Disease. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 
2017 
 
Computational explanations of changes along the perceptual hierarchy can be tested in 
terms of Bayesian models of perception within a predictive coding framework.  Recent 
work has made an important contribution to perception research in Parkinson’s disease 
(O’Callaghan et al., 2017). This study fitted a hierarchical drift diffusion model to the 
ANT to identify the drift rates of the different task components. This study observed 
slower drift rates and wider decision boundaries in patients with visual hallucinations, 
suggesting reduced perceptual precision. The relative amount of evidence that bottom-up 
and top-down processes provide mediates the integration of information of each 
component. Perceptual information in this patient group might be less informative, and 
therefore down-weighted, which could result in an over-reliance on prior expectations.	
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Confirming lack of integration using transmagnetic stimulation  
Whilst increased severity of hallucinations (i.e. increased % misperceptions and/or 
increased frequency) is often accompanied by a lack of insight (Amar et al., 2014), 
this was not specifically tested in this thesis. However, Chapter 6 of this thesis 
showed that the severity of hallucinations was associated with reduced connectivity 
between a large-scale network and between several nodes of the diverse club. As 
such, it is possible that changes in the environmental awareness are associated with 
decreased network integration. Previous work has shown that transmagnetic 
stimulation (TMS) can induce an interaction between cortical areas, resulting in a 
more integrated state of these regions (Massimini et al., 2005). Thus, TMS may be 
capable of identifying a node’s integrative ability. As such, this quality of nodes may 
in future be testable using this an approach in patients with and without visual 
hallucinations or freezing of gait. 
 
7.3.4 Temporal course of pathophysiology 
Both freezing of gait and visual hallucinations are likely to be functional disorders, 
as evidenced by their transient and episodic nature. If these symptoms arose merely 
due to a structural lesion, then these phenomena would be more predictable. Hence, 
to fully understand the impact of the structural changes associated with freezing of 
gait and visual hallucination in Parkinson’s disease, future research should combine 
structural with functional with functional analysis, such as fMRI or 
electroencephalogram (EEG), to elucidate their interaction.  
 
Furthermore, longitudinal studies should investigate whether changes in white matter 
precede functional abnormalities and/or grey matter lesions.  Recent work in early 
Parkinson’s disease patients has shown that white matter alterations are present 
before grey matter degeneration and hereby challenged the traditional view that grey 
matter is initially affected (Rektor et al., 2018). Therefore, treatment strategies 
should focus on targeting any white matter abnormalities early in the course of 
disease. Previous research has shown that white matter health can be improved by a 
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combination of physical exercise and social engagement in healthy older adults 
(Burzynska et al., 2017). Importantly, this indicates that age-related changes in white 
matter integrity are at least partly reversible or modifiable. Such behavioural 
treatments could be beneficial for patients at risk of developing freezing or 
hallucinations (Burzynska et al., 2017), especially since these phenomena are not 
consistently responsive to dopaminergic treatment (Combs et al., 2017; Giladi, 
2008).  
	
Functional changes could occur before any cell death or demyelination has emerged. 
Functional activity is more intimately tied to synaptic firing, which is regulated by 
neurotransmitters and cellular events (Lodish, 2000). Furthermore, Lewy body 
pathology intrusion does not immediately result in atrophy of cortical brain structure 
(Sterling et al., 2016). Therefore, another important research avenue is to elucidate 
the effect of changes in the balance of different neurotransmitters on structural 
integrity and whether future disease modifying therapies that impact on disease 
progression could also reduce white matter disturbance.  
Box 6: Cognitive training in patients with freezing of gait  
Walton, C. C., Mowszowski, L. Gilat, M., Hall, J. M., O’Callaghan, C., Muller, A. J., 
Georgiades, M. J., Szeto, J. Y. Y., Ehgoetz Martens, K. A., Shine, J. M., Naismith, S. 
L., Lewis, S. J. G. Cognitive training for freezing of gait in Parkinson’s disease: a 
randomized controlled trial. NPJ Parkinson's Disease, 2018; 4(15). 
 
Our research group has recently completed a randomised controlled trial in which 
patients with freezing of gait underwent either a cognitive training program or an active 
sham program. The results were cautiously promising: patients in the training group 
reduced their time percent frozen (in the OFF state) significantly compared to the 
control group. Changes in functional MRI are currently being analysed, but 
unfortunately, diffusion weighted imaging was not included in this study, and future 
studies are necessary to assess if such a program could instigate changes in white matter 
in patients with a neurodegenerative disorder.   
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7.3.5 Network topology in Parkinson’s disease heterogeneity  
By reframing Parkinson’s disease as a ‘disconnection disorder’, this thesis has shown 
that unique insights in the pathophysiology of individual symptoms can be gained 
using graph theoretical methods. Graph theory can also be applied to elucidate the 
progression of neurodegenerative disorders and therefore will be able to verify or 
rearticulate current models.  
 
Parkinson’s disease pathology affects dissociated but dispersed brain networks, 
suggesting that the pathology transmits changes from the initial injury site to diffuse 
networks towards the later stages of the disease. Vulnerability of these secondary 
sites may be governed by the connectional structure of the brain, in which nodes with 
high participation coefficients are particularly vulnerable due to their greater 
susceptibility to oxidative stress, as a result of their myriad of connections and high 
metabolic demands (Buckner et al., 2009; Saxena et al., 2011). Indeed, previous 
work in other neurodegenerative disorders including Alzheimer’s disease, cortical 
basal syndrome, semantic and frontotemporal dementia, as well as schizophrenia, has 
shown that vulnerability of highly connected nodes could be predicted by the total 
functional connectional flow through the node in combination with the path length to 
the affected injury site (Crossley et al., 2014). Importantly, the anatomical location 
of the affected hub regions (“epicentres”) may be specific to an individual disorder. 
For example, in Alzheimer’s disease, the temporal lobe and the parietal regions were 
predominantly affected (Crossley et al., 2014; Park et al., 2017), whereas in 
schizophrenia, medial frontal and anterior cingulate regions were most affected 
(Brugger et al., 2017; Crossley et al., 2014; Rubinov et al., 2013). Parkinson’s 
disease could also be explained by this “transneuronal spread hypothesis” (Crossley 
et al., 2014), in which the striatal nuclei would serve as the epicentre and fulfil the 
criteria of high vulnerability: a short path length to a dominant injury site, the 
substantia nigra and high participation across different modules.  
 
Furthermore, the type of connections might dictate the vulnerability of a node to 
Lewy body pathology. Previous work has shown that long-range connections or 
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widely distributed axonal projections appear particularly vulnerable to amyloid 
(Wirths et al., 2006) whilst short-range or clustered dendritic and inter-neuronal 
connections are particularly vulnerable to certain tauopathies (McMillan et al., 
2008). Thus, specific pathogenic disfigurements direct how pathology disseminates 
across a network (Warren et al., 2013). Previous work has shown that Lewy body 
pathology appears to be transmitted retrogradely via axon terminals (Surmeier et al., 
2017). Whether or not Lewy body pathology prefers a certain configuration of 
connections remains to be investigated. Using graph theoretical models, the 
connectivity profile of each node could be determined and in combination with 
pathological studies, future studies could test whether nodes with high degree or high 
participation are more vulnerable to Lewy body intrusion, compared to nodes with 
lower connectivity strength. If so, investigations into network topology may not only 
predict the progression of Parkinson’s disease but could also allow insights to further 
explain the heterogeneity observed in this condition. Specifically, the site of 
pathology intrusion may inform how the pathology will spread. It could be 
hypothesized that patients in the non-tremor dominant phenotype, including 
symptoms such as freezing of gait and visual hallucinations, show a greater hub 
vulnerability in frontoparietal regions including connector hubs compared to patients 
in the tremor dominant phenotype (see Figure 1). Lesions of these rich club nodes 
lead to a more profound deterioration of network efficiency compared to changes 
peripheral nodes. In future, such a method combined with computational modelling 
may be implemented to test this hypothesis.  
  
Furthermore, longitudinal investigations into network topology changes are 
necessary to further understand the progression of Parkinson’s disease. Importantly, 
after neuronal injury to a node, the module or modules may reconfigure and therefore 
hyperconnectivity between other parts of the network can be observed (Hillary et al., 
2017). Longitudinal investigations into network architecture can thus provide 
information about insult as well as compensation strategies of the network over time.  
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Figure 1: A hypothetical overview of how pathology may spread if nodes with high 
connectivity strength display increased vulnerability, depicting two possible scenarios, 
representing different clinical phenotypes of Parkinson’s disease. Red: affected nodes; 
grey: non-affected nodes; dashed lines: affected edges; blue arrows: pathology intrusion 
 
 
Zooming in 
If changes in network integration and segregation underlie behavioural symptoms of 
Parkinson’s disease, an important next step is to identify which nodes play a crucial 
role in network configuration. As shown in this thesis, nodes belonging to the rich or 
diverse club are crucial for effective communication across networks. Specifically, 
cross-modular connections through rich clubs enhance network complexity (Zamora-
Lopez et al., 2016). Importantly, few candidate mechanisms have been proposed for 
the optimisation of integration and segregation. For example, disruptions in the 
coordinated projection of dopamine to the striatum likely result in a failure to timely 
activate and inhibit behaviours (Chakravarthy et al., 2018; Howard et al., 2017) and 
may be an obvious mechanism for changes in network topology in Parkinson’s 
disease. However, this dopamine-centric model cannot solely account for the 
multitude of non-motor symptoms observed in PD and other neuromodulatory 
systems of the brainstem are likely to be involved in the tuning of functional 
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connection strength and therefore the optimal global synchronisation. Indeed, Shine 
and colleagues (Shine et al., 2018) showed that nodes in the ascending arousal 
system, including the noradrenergic locus coeruleus, modulate neural gain. Neural 
gain controls the extent to which a particular region is excitable and thus susceptible 
to interacting with other regions within or between networks. Additionally, recent 
work in rodents has further highlighted the notion that integration does not depend 
on the largest network hubs, but can be coordinated by a set of low-degree nodes but 
highly influential nodes (Del Ferraro et al., 2018).  
 
It is possible that changes in nodes with a high collective influence underlie 
symptoms such as visual hallucinations and freezing of gait. As such, future studies 
should investigate whether local activity in nodes that previously have been 
implicated in the pathophysiology of these symptoms (e.g. the pedunculopontine 
nucleus and nucleus basalis of Meynert) influence global computation by calculating 
their intrinsic ignition (Deco et al., 2017). Identifying nodes with high collective 
influence could provide a new avenue for treatment strategies.  
 
7.4 Concluding remarks 
This thesis has made a notable contribution to the understanding of freezing of gait 
and visual hallucinations in Parkinson’s disease. The work has added to the known 
phenotypical associations of freezing of gait by comparing patients with and without 
this symptom across different disease stages. In addition, the relationship between 
visual hallucinations and attention were assessed through previously unexplored 
tasks. Importantly, to date most symptoms have been assessed using traditional DWI 
measures, which in some cases has led to conflicting results (as outlined in Chapter 
2). Paroxysmal symptoms of Parkinson’s disease, such as freezing of gait and visual 
hallucinations are not likely to be the result of a focalized disruption but rather stem 
from a network reconfiguration. Investigating the structural network topology 
associated with freezing and hallucinatory behaviour was able to elucidate this 
hypothesis. Disruptions in effective information processing that may underlie 
different symptoms of Parkinson’s disease, might be amplified by these affected hub 
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regions. Indeed, these connector hubs play a crucial role in selecting and inhibiting 
behaviours, and disruption in the integration within and between neurological 
networks can result in a multitude of symptoms across cognitive, motor and affective 
domains.  Finally, the future use of the approaches implemented in this thesis may 
provide critical information to our understanding of disease progression, 
heterogeneity and the targeting of future therapies to improve the lives of the 
millions of people affected by Parkinson’s disease.  
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Abstract Freezing of gait (FOG) is a disabling motor
symptom experienced by a large proportion of patients
with Parkinson’s disease (PD). While it is known that FOG
contributes to lower health-related quality of life (HRQoL),
previous studies have not accounted for other important
factors when measuring the specific impact of this symp-
tom. The aim of this study was to examine FOG and
HRQoL while controlling for other factors that are known
to impact patient well-being, including cognition, motor
severity, sleep disturbance and mood. Two hundred and
three patients with idiopathic PD (86 with FOG) were
included in the study. All patients were between Hoehn and
Yahr stages I–III. A forced entry multiple regression model
evaluating the relative contribution of all symptoms was
conducted, controlling for time since diagnosis and current
dopaminergic treatment. Entering all significantly corre-
lated variables into the regression model accounted for the
majority of variance exploring HRQoL. Self-reported
sleep–wake disturbances, depressive and anxious symp-
toms and FOG were individually significant predictors.
FOG accounted for the highest amount of unique variance.
While sleep–wake disturbance and mood have a significant
negative impact on HRQoL in PD, the emergence of FOG
represents the most substantial predictor among patients in
the earlier clinical stages of disease. This finding presum-
ably reflects the disabling loss of independence and fear of
injury associated with FOG and underlines the importance
of efforts to reduce this common symptom.
Keywords Parkinson’s disease ! Freezing of gait !
Quality of life ! Depression ! Anxiety ! Sleep
Introduction
Parkinson’s disease (PD) is a common neurodegenerative
disorder [1] in which the combination of both motor and
non-motor symptoms has a significant and negative impact
on patients’ quality of life. Health-related quality of life
(HRQoL) is the most typically used outcome measure
representing an assessment made by patients about the
detrimental impact of disease and its consequences on their
life. This is a crucial aspect of modern medicine given the
importance of applying biopsychosocial models to treat-
ment [2].
Many studies have now assessed HRQoL in PD, most
commonly using the Parkinson’s Disease Questionnaire
(PDQ-39) [3]. These studies have revealed that disease
severity, motor complications and dopaminergic treatment
all appear to contribute to HRQoL [4–6]. However, a
recent large-scale multicenter study showed that the com-
bined effect of non-motor symptoms was the most signif-
icant predictor of HRQoL, when compared to the motor
aspects of the disease [7]. More specifically, the study
identified mood disturbance and sleep problems/fatigue as
having the strongest negative impact on HRQoL. Indeed,
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this is a finding that replicates those shown previously in
the literature [8, 9]. Given the frequency with which non-
motor symptoms occur [10], understanding their significant
impact on individuals with PD is critical for effective
patient management.
While appreciating the significant impact of non-motor
aspects of PD is important, the same is true of freezing of
gait (FOG), which is a symptom also experienced by many
patients as their disease progresses. The phenomenon of
FOG presents as the sudden inability to generate effective
stepping and forward progression despite the intention to
do so [11]. The occurrence of FOG significantly increases a
patient’s likelihood of falling and subsequent nursing home
placement [12]. While research into this symptom is
growing in interest, treatment options for FOG are pres-
ently limited [13] representing the currently incomplete
understanding of the underlying pathophysiology [14].
Given the functional impact of FOG it is not surprising
that it has previously been linked to reduced HRQoL in PD
patients [15–17]. Moore and colleagues [17] have demon-
strated that FOG has a strong and significant impact on
HRQoL, irrespective of more general disease severity
measures. Similarly, Rahman and colleagues [16] have also
reported that FOG negatively impacts on HRQoL, although
this study used a non-validated questionnaire to identify
freezing and did not include this measure in their main
regression analyses. In a very recent study, Perez-Lloret
et al. [15] have also been able to correlate FOG with
HRQoL. They used logistic regression to show that this
relationship occurred irrespective of disease severity and
duration, in addition to motor complications.
Thus, previous studies exploring the impact of FOG on
HRQoL have not controlled well for variables outside of
disease and motor severity when assessing the impact of
this symptom, which represents a significant limitation in
interpreting the relative strength of these findings. Prob-
lems with depression [18], anxiety [19] and sleep [20] have
been related to FOG but are also large contributors to
HRQoL in PD more generally [7].
The aim of the current study was to assess whether
severity of self-reported FOG still independently predicted
HRQoL, after controlling for the contribution of other
factors within PD. The current study introduced new fac-
tors which have not previously been considered concur-
rently with FOG to determine the specific effects on
HRQoL. Based on previous findings in the field, we chose
to analyze key variables of generalized cognition, mood,
sleep disturbance and motor function [6–9]. It was
hypothesized that the combination of these measures would
account for a high proportion of variance in HRQoL scores.
However, our primary goal was to explore the unique
contribution of FOG to HRQoL while controlling for the
combined impact of these other key variables.
Methods
Sample
Data was collected from the baseline assessment of patients
at the ‘Parkinson’s Disease Research Clinic’ at the Brain
and Mind Research Institute, University of Sydney. Par-
ticipants included were assessed between December 2008
and November 2013. The diagnosis of idiopathic PD was
based on the UK Brain Bank clinical criteria [21] and was
confirmed by a neurologist (SJGL). Patients with an
MMSE of less than 24 were excluded due to possible
dementia and thus questionable validity of their self-report
questionnaires. Patients did not meet MDS criteria for PD
with dementia [22]. To explore the impact of FOG on
patients in the earlier clinical stages of disease where
paroxysmal limitation on mobility was more likely to be of
daily significance and impact, the sample was restricted to
those patients rated as Hoehn and Yahr (H and Y) stages I–
III [23]. This research was approved by the Human
Research Ethics Committee of The University of Sydney,
and written informed consent was obtained from all
participants.
A sample of 285 patients met criteria for inclusion in the
study. However, 78 were removed due to missing data for
questionnaire or clinical variables. During initial data
screening, four participants were further removed from the
analysis due to being strongly significant outliers. There-
fore, a sample of 203 patients was included in the study. Of
these, 86 reported a score of 1 or higher on ‘Question 3’ of
the Freezing of Gait Questionnaire (FOG-Q) [‘‘Do you feel
that your feet get glued to the floor while walking, making
a turn, or trying to initiate walking (freezing)?’’], which has
been shown to be a reliable screening tool to identify
freezers [24]. As such, 43 % of the sample was deemed to
experience FOG by subjective report. Patient characteris-
tics are shown in Table 1.
Measures
We assessed HRQoL using the scaled index of the PDQ-39
[3]. This questionnaire consists of 39 multiple choice items
covering eight dimensions of ‘mobility’, ‘activities of daily
living’, ‘emotional well-being’, ‘stigma’, ‘social support’,
‘cognitions’ ‘communication’ and ‘bodily discomfort’.
Scores are scaled between 0 and 100 with higher scores
suggesting poorer HRQoL. To assess FOG severity, we
used the FOG-Q [24]. The FOG-Q consists of six multiple
choice questions which assess a patient’s severity and
frequency of freezing. Scores range from 0 to 24, with
higher scores suggesting more severe FOG. Section III of
the Movement Disorder Society—Unified Parkinson’s
Disease Rating Scale (MDS-UPDRS) [25] was used to
J Neurol (2015) 262:108–115 109
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assess for motor severity. This assessment is conducted by
a clinician and contains 33 scores over 18 items. Scores
range from 0 to 132 with higher scores indicating worse
motor symptoms. Global cognitive functioning was asses-
sed using the Mini-Mental State Examination (MMSE)
[26]. The second edition of the Beck Depression Inventory
(BDI-II) [27] was used to measure depressive symptom
severity. This self-report questionnaire comprises 21 items
and yields a total score ranging from 0 to 63. Higher scores
suggest more severe depressive symptoms. Anxiety was
measured using the anxiety subscale of the Hospital Anx-
iety and Depression Scale (HADS-anxiety) [28]. The scale
consists of 7 questions, with scores ranging from 0 to 21.
Higher scores suggest worse symptoms of anxiety. The
SCOPA-Sleep (SCOPA-S) [29] was used to measure
nighttime and daytime disturbance. Scores range from 0 to
15 for nighttime sleep and 0–18 for daytime sleepiness,
with higher scores indicating poorer sleep quality. For
medically treated patients, dopamine dose equivalence
scores (DDE) were calculated (mg/day) [30]. Time since
diagnosis was calculated in months from date of diagnosis
to date of assessment.
Statistical analyses
Data analyses were conducted using the Statistical Package
for the Social Sciences (SPSS) version 21. All analyses
used an alpha of 0.05 and were two tailed. Pearson bivar-
iate correlations were employed to assess for relationships
between the predictor and the outcome variables for
regression. Significantly correlated predictor variables
were entered at once into a two-block multiple linear
regression model to assess their contribution to PDQ-39
scores. Statistical assumptions of normality and hetero-
scedasticity were not met in some variables included in the
model. For this reason, we performed more conservative
bootstrapping [31] with bias corrected and accelerated
confidence intervals for regression analyses. One thousand
bootstrap samples were implemented. The multicollinearity
assumption was met, assessed by correlations and collin-
earity statistics.
Results
Patients defined as freezers scored higher on the PDQ-39
(M = 29.57, SD = 15.29) than those defined as non-
freezers (M = 15.22, SD = 9.36). More specifically,
average PDQ-39 scores across responses to FOG-Q
Question 3 are illustrated in Fig. 1. This figure shows that
higher scores on this question show a linear relationship
with worsened PDQ-39 scores.
Table 1 Clinical characteristics of sample
Mean Standard deviation
Age (years) 66.77 8.9
Gender (n)
Male 139
Female 64
Time since diagnosis (months) 61.30 61.3
Hoehn and Yahr stage (n)
1 39
1.5 7
2 98
2.5 39
3 20
DDE (mg/day) 615.81 487.8
UPDRS III 27.60 15.1
MMSE 28.35 1.6
PDQ-39 21.21 14.0
SCOPA-S day 4.29 3.5
SCOPA-S night 4.67 4.2
BDI-II 9.77 7.0
HADS-anxiety 3.95 3.4
FOG-Q total 5.34 5.7
n = 203, DDE dopamine dose equivalence, MDS-UPDRS III
Movement Disorder Society Unified Parkinson’s Disease Rating
Scale (Motor subsection), MMSE Mini-Mental State Examination,
PDQ-39 39-item Parkinson’s Disease Questionnaire, SCOPA-
S Scales for Outcomes in Parkinson’s Disease (Sleep), BDI-II Beck
Depression Inventory 2nd Edition, HADS Hospital Anxiety and
Depression Scale (Anxiety scale), FOG-Q Freezing of Gait
Questionnaire
Fig. 1 Mean PDQ-39 scores for patients responding at differing
severity levels to Question 3 of the FOG-Q. Error bars represent 1
standard error
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Pearson bivariate correlations are displayed in Table 2
and show that PDQ-39 scores were significantly correlated
with our control variables of time since diagnosis and
DDE. Age and gender did not show significant correlations
with the PDQ-39 and were not included in the regression
model. All remaining predictor variables (i.e., MMSE,
MDS-UPDRS III, FOG-Q, BDI-II, HADS-anxiety, SCO-
PA-S day and SCOPA-S night) correlated significantly
with the PDQ-39. The strongest relationship was between
FOG-Q and PDQ-39 scores, and this correlation is illus-
trated in Fig. 2. Expanding on this, Table 3 also displays
correlations for measures of FOG with each of the eight
domains of the PDQ-39, showing that FOG significantly
correlated with all.
To control for time since diagnosis and dopaminergic
medication use, these variables were first force entered into
the model as a block. These variables alone significantly
predicted 17.8 % of the variance in PDQ-39 scores
(F2,202 = 21.651, p\ 0.0001). However, once the addi-
tional predictors were entered at the second stage, a DR2 of
54.4 % was found, suggesting a considerably stronger
model (72.2 % of total variance in HRQoL explained). At
this stage, however, time since diagnosis, DDE and MDS-
UPDRS III all became non-significant predictors, while the
Table 2 Pearson correlations between PDQ-39 and initial predictor variables
PDQ-
39
Time
since
diagnosis
DDE Age Gender MDS-
UPDRS
III
MMSE SCOPA-
S day
SCOPA-
S night
BDI-II HADS-
anxiety
FOG-Q
PDQ-39 – 0.374** 0.371** 0.093 0.092 0.313** -0.178* 0.522** 0.299** 0.615** 0.554** 0.628**
Time since
diagnosis
– 0.467** 0.111 -0.043 0.319** -0.221* 0.242** -0.001 0.147* 0.054 0.493*
DDE – 0.028 -0.066 0.160* -0.194** 0.351** 0.149* 0.144* 0.091 0.344**
Age – -0.054 0.342* -0.271** 0.141* 0.001 0.046 -0.155* 0.200**
Gender – -0.100 0.164* -0.010 0.131 0.146* 0.136 0.022
MDS-UPDRS
III
– -0.103 0.185** 0.013 0.195 0.037 0.419**
MMSE – -0.124 -0.028 -0.078 -0.041 -0.218**
SCOPA-S day – 0.356** 0.309** 0.226** 0.303**
SCOPA-S
night
– 0.209** 0.208** 0.050
BDI-II – 0.561** 0.293**
HADS-anxiety – 0.202**
FOG-Q –
* p B 0.05
** p B 0.01
Fig. 2 Scatterplot displaying individual FOG-Q and PDQ-39 scores
Table 3 Correlations between FOG measures and PDQ-39 subscales
FOG-Q total FOG-Q question 3
Mobility 0.801** 0.665**
Activities of daily living 0.560** 0.526**
Emotional well-being 0.352** 0.278**
Stigma 0.254** 0.210**
Social support 0.352** 0.303**
Cognitions 0.279** 0.250**
Communication 0.424** 0.441**
Bodily discomfort 0.369** 0.309**
* p B 0.05
** p B 0.01
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predictor variables of FOG-Q, BDI-II, HADS-anxiety and
both SCOPA-S scores were significant contributors to the
model. MMSE was not a significant predictor. This mod-
el’s overall predictive power was statistically significant
(F9,202 = 57.696, p\ 0.0001).
We next analyzed semi-partial correlations of the sig-
nificant contributors to account for the unique variance in
PDQ-scores that could be attributed to each of the signif-
icant predictors in the full model. While accounting for the
other variables in the model, FOG-Q scores uniquely
contributed 9.4 %. The contribution of BDI-II to the model
was 4.4 % and HADS-anxiety was 4.2 %. SCOPA-S day
scores contributed 3.2 % while night scores contributed
less than 1 %. Table 4 displays beta values along with
other relevant statistics from the regression models.
Motor phenotype analysis
As an additional analysis, we calculated motor phenotype
scores for ‘tremor’, ‘non-tremor’ and ‘rigidity’, as descri-
bed elsewhere [32, 33]. Tremor scores showed a weak
correlation with PDQ-39 (r = 0.145, p\ 0.05), non-tre-
mor showed a medium to strong correlation (r = 0.447,
p\ 0.01), while rigidity did not significantly correlate
(r = 0.120, p[ 0.05). Importantly, however, non-tremor
scores were strongly correlated with FOG-Q (r = 0.597,
p\ 0.01) and given this likely confound were not con-
sidered appropriate for inclusion in the regression model.
Discussion
The results of the current study have shown for the first
time that the independent contribution of FOG-Q scores
represents the strongest predictor of HRQoL in the earlier
clinical stages of PD, after accounting for the contribution
of other key variables (general cognition, sleep distur-
bance, mood problems and motor severity). The variance
that could be independently attributed to FOG was more
than double that of depression, anxiety and sleep distur-
bance scores. The contribution of general cognition, motor
severity, dopaminergic medication use and time since
diagnosis was minimal when considering these variables.
These findings consolidate the work of Moore et al. [17],
Rahman et al. [16] and Perez-Lloret et al. [15] who found
FOG to be related to HRQoL. However, the current results
significantly extend these findings by introducing addi-
tional clinical factors known to strongly contribute to
HRQoL, and illustrate that FOG still remains the most
significant predictor.
These results also confirm the hypothesis that measures
of self-reported FOG, mood and sleep disturbance all
contribute significantly to HRQoL in PD. This finding is
directly in agreement with previous studies highlighting the
importance of these factors in patient well-being [6–9, 15–
17]. The study also confirmed previous findings that non-
motor aspects of PD appear to have a more significant
impact on HRQoL than broad measures of motor severity
[7], with MDS-UPDRS III scores being a non-significant
contributor when included in the second stage of the
regression model.
While it might seem initially surprising that FOG can be
more disabling to HRQoL than sleep and mood distur-
bance, or motor severity, previously strong arguments have
been made for why this may be the case [17]. For example,
FOG is an episodic, paroxysmal phenomenon that can
occur in public or dangerous situations, which are stress
provoking (e.g., crossing roads or entering crowded spaces)
[34]. Thus, the disabling impact of a freezing episode can
occur at times which significantly impact patients’ sense of
safety, fear of falling and feeling of independence. Such
events can be embarrassing and frustrating and may lead to
patients feeling isolated and of burden to their carers and/or
family [35]. Thus, negative responses could be anticipated
in a HRQoL assessment and indeed the correlations in
Table 3 of domains such as ‘activities of daily living’,
‘social support’ and ‘emotional well-being’ support these
notions. In addition, our sample consisted of patients in the
Table 4 Linear model predictors of PDQ-39 scores showing boot-
strapped beta scores with the corresponding standard error, signifi-
cance values, and semi-partial correlations
Beta Std. error
of beta
Significance
value
Semi-partial
correlation
Model 1
Time since
diagnosis
0.052 0.017 0.003 0.203
DDE 0.008 0.002 0.002 0.234
Model 2
Time since
diagnosis
0.005 0.011 0.652 0.017
DDE 0.002 0.001 0.078 0.068
MDS-
UPDRS
III
0.020 0.040 0.622 0.019
MMSE -0.051 0.383 0.874 -0.006
SCOPA-S
night
0.283 0.148 0.044 0.077
SCOPA-S
day
0.842 0.179 0.001 0.178
BDI-II 0.527 0.098 0.001 0.210
HADS-
anxiety
1.041 0.211 0.001 0.206
FOG-Q 0.955 0.142 0.001 0.306
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earlier clinical stages of the disease. The loss of indepen-
dence may be one of the most significant challenges for
these patients to cope with, possibly contributing to chan-
ges for example in social engagement or early retirement.
Depression and anxiety were the next most important
predictors of HRQoL. Initial correlational analyses showed
that FOG was significantly correlated with these variables.
These relationships provide further support for the argu-
ment above that FOG may have its negative impact on
patient well-being by making patients feel isolated and of
burden to their nearest and dearest [17]. The impact of
sleep disturbance on HRQoL was less strong. Interestingly,
it was daytime sleep disturbance that showed the stronger
contribution, with night problems having a minimal impact
in the model. Our results suggest that duration of disease
and dopaminergic medication use do not strongly impact
on HRQoL relative to these other clinical measures.
Currently, treatment options for FOG are poor. Classi-
cally, pharmacological intervention and cueing therapies
have been employed; however, deep brain stimulation has
increasingly grown in appeal [36]. Unfortunately, the
effects of cueing and pharmacological options are often
short lived, while deep brain stimulation is invasive and
unfortunately often suitable for only a small number of
patients [13]. It has previously been suggested that com-
puterized cognitive training and virtual reality training may
be a beneficial option for the treatment of FOG and gait
disorders [13, 37]. However, the current results also pro-
vide strong support for the role of more rounded remedi-
ation techniques employing concurrent group-based
psychoeducation, for example [38]. Such interventions
have been proposed as important factors in possibly
improving quality of life and well-being [39]. Patients with
FOG could be presumed to benefit from these
interventions.
Limitations
It is important to consider the limitations to this study.
Primarily, we assessed freezing using self-report ques-
tionnaire, the most accessible and widely used research
tool, and the results are uncompromisingly strong in favor
of the contribution of the FOG-Q to HRQoL, suggesting a
very significant relationship. However, where resources
allow, correlating actual measures of freezing episodes
[e.g., 40] would be beneficial in future work. Secondly,
MMSE showed little impact on HRQoL, however, given
the role of cognitive impairment in FOG [e.g., 41, 42], a
more detailed cognitive assessment may have influenced
the model. Future studies could explore this impact more
precisely. Finally, we had a much higher proportion of
male participants, but this is typically reflective of the
disease [43].
Conclusions
The current results have shown that self-reported FOG
severity is a strong independent contributor to HRQoL in
individuals with PD. This is likely to stem from the daily
impact of FOG on mobility and independence, causing
stress and anxiety in addition to individuals perceiving
caregiver burden [35]. Follow-up studies to examine the
specific effect of FOG relative to these predictors in care-
giver QoL would be beneficial. These results highlight the
increasing need for a more solid understanding of patho-
physiological mechanisms underlying FOG leading to
better treatment options. Clinicians in the field of neurol-
ogy must show increased awareness to the impact of FOG
for optimal management of PD patients.
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Abstract Freezing of gait is a frequent and disabling
symptom experienced by many patients with Parkinson’s
disease. A number of executive deficits have been shown to
be associated with the phenomenon suggesting a common
underlying pathophysiology, which as of yet remains
unclear. Neuroimaging studies have also implicated the role
of the cognitive control network in patients with freezing. To
explore this concept, the current study examined error-
monitoring as a measure of cognitive control. Thirty-four
patients with and 38 without freezing of gait, who were
otherwise well matched on disease severity, completed a
colour-word interference task that allowed the specific
assessment of error monitoring during conflict. Whilst both
groups performed colour-naming and word-reading tasks
equally well, those patients with freezing showed a pattern
between conditionswhereby theywere better able tomonitor
performance and self-correct errors in the pure inhibition
task but not after a switching rule was introduced. The novel
results shown here provide insight into possible pathophys-
iological mechanisms involved in cognitive load and error
monitoring in patients with freezing of gait. These results
provide further evidence for the role of functional fronto-
striatal circuitry impairments in patients with freezing of gait
and have implications for future studies and possible thera-
peutic interventions.
Keywords Freezing of gait ! Parkinson’s disease !
Executive function ! Error monitoring ! Stroop task !
Cognitive control
Introduction
Freezing of gait (FOG) is a debilitating symptom experi-
enced by many patients with Parkinson’s disease (PD)
(Giladi et al. 2001). The complex phenomenon is clinically
defined as the sudden inability to generate effective step-
ping and forward progression despite the intention to do so
and is often described as feeling as though one’s feet are
glued to the ground (Nutt et al. 2011). The current treat-
ment options for FOG are limited (Walton et al. 2014), and
its occurrence leads to a significantly increased risk of falls
and reduced quality of life (Gray and Hildebrand 2000;
Moore et al. 2007) highlighting the importance of gaining
an increased understanding of its manifestation.
At present the pathophysiology underlying FOG is
poorly understood (Heremans et al. 2013b), although dys-
function of frontostriatal pathways is thought to be criti-
cally involved (Hall et al. 2014; Lewis and Barker 2009;
Shine et al. 2013d). One area of increasing interest in the
literature is the distinct pattern of neuropsychological
deficits demonstrated by PD patients with FOG, which may
inform our understanding of the underlying neural mech-
anisms of freezing. A range of specific executive impair-
ments are greater in patients with FOG than in those
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without. This has led many authors to suggest that partic-
ular cognitive functions may be intimately related to
freezing behaviour (For reviews see: Heremans et al.
2013a; Walton et al. 2014). General executive deficits have
been reported in patients with FOG (Amboni et al. 2010,
2008), more specifically in the domains of set-shifting
(Naismith et al. 2010; Shine et al. 2013e), conflict resolu-
tion and inhibitory control (Cohen et al. 2014; Matar et al.
2013; Vandenbossche et al. 2011, 2012) and implicit
learning (Vandenbossche et al. 2013b). These findings have
been further validated by recent functional neuroimaging
studies, which have implicated the dysfunctional role of a
putative cognitive control network (CCN) operating
through both fronto-parietal cortices and subcortical
structures including the subthalamic nucleus (STN) and
striatum (Shine et al. 2013a, b, c).
These neuroanatomical insights raise the possibility that
the executive deficits documented in FOG may be under-
pinned to an extent by impairments in cognitive control,
which refers to the ability to control goal directed behav-
iour by organizing and optimising appropriate information
processing to flexibly respond to changes in predicted
behavioural outcomes (Narayanan et al. 2013; Ridderink-
hof et al. 2004). Taking these findings together leads to an
intriguing proposition: given FOG has been hypothesised
to occur as a result of a decreased neural reserve for coping
with demands on the frontostriatal system (Lewis and
Barker 2009), it could be suggested that under highly
demanding cognitive situations, patients with FOG display
an inefficient recruitment of cognitive control.
Therefore, the aim of the current study was to further
explore impairments in cognitive control using increasingly
demanding conditions of a verbal Stroop task. By using a
verbal rather than computerized format, the stimulus used in
the task matches the form of response needed (i.e., word–
word rather than word-button) leading to more automatic
responding (Kornblum et al. 1990). This is important in
adequately differentiating between automatic versus effort-
ful processing (Vandenbossche et al. 2013a). Further, the
current Stroop task records both corrected and uncorrected
errors. Thus, different interpretations regarding cognitive
control can be recorded than in previous measures of Stroop
performance in FOG (Cohen et al. 2014; Vandenbossche
et al. 2012). An error that is corrected would imply cognitive
control has been enforced, albeit late. Conversely, uncor-
rected errors are suggestive of poor cognitive control.
In the current study, we sought to investigate novel
measures of error making and monitoring in PD patients
with and without FOG. We propose that if the CCN
underpins the pathophysiology of FOG, patients with FOG
should produce more uncorrected errors than patients
without FOG during the most demanding condition of the
task which requires set-shifting. Such a finding would
demonstrate inefficient recruitment of cognitive control
regions under high cognitive load, specifically occurring
under switching demands.
Experimental procedures
Participants
Participants were recruited from a larger cohort of patients
prospectively evaluated at the Parkinson’s Disease
Research Clinic at the Brain and Mind Research Institute,
University of Sydney. The diagnosis of idiopathic PD was
based on the UK brain bank clinical criteria (Hughes et al.
1992) and was confirmed by a neurologist (SJGL). The 109
patients originally included in this study were divided into
two groups based on their score on the FOG-Questionnaire
item 3 [FOGQ-3: ‘‘Do you feel that your feet get glued to
the floor while walking, making a turn, or trying to initiate
walking (freezing)?’’], which has been shown to be a
reliable screening tool to identify freezers (Giladi et al.
2000). Higher scores on FOGQ-3 indicate increased
freezing severity and patients who scored 2 or higher were
included in the FOG group, while those scoring 0 were
placed in the no-FOG group. Patients scoring 1 were not
included in the study to minimise the possibility of mis-
classification. Exclusion criteria included the presence of
other neurological diseases, other conditions that would
impair gait and a score of B24 on the mini mental state
examination (MMSE) (Folstein et al. 1975). All patients
were assessed on their regular medication. This research
was approved by the Human Research Ethics Committee of
The University of Sydney, and written informed consent
was obtained from all participants.
Clinical assessments
A series of demographic details were recorded, including
age, gender, and predicted premorbid intellectual func-
tioning (revised national adult reading test; NART-R)
(Nelson and Willison 1991). Clinical features including
disease duration, Hoehn & Yahr stage (H&Y) (Hoehn and
Yahr 1967), dopamine dose equivalence (DDE; mg/day)
(Tomlinson et al. 2010) and disease severity using the
Movement Disorder Society-Unified Parkinson’s Disease
Rating Scale (MDS-UPDRS) (Goetz et al. 2008), of which
the total score and section III (motor sub-score) were
assessed. Section ‘‘Demographic and clinical data’’ of the
MDS-UPDRS was also individually recorded to ensure
verbal responses to the task did not simply reflect problems
with speech output. Additionally, self-reported mood dis-
turbance using the beck depression inventory (BDI-II)
(Beck et al. 1996) and global cognitive functioning using
654 C. C. Walton et al.
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the MMSE (Folstein et al. 1975) were used to assess for
depression and dementia, respectively.
Inhibition and switching tasks
The task used in the current study was the Delis–Kaplan
executive function system (D-KEFS) colour-word interfer-
ence test (Delis et al. 2001). This task contains four condi-
tions: colour-naming (condition 1), word-reading
(condition 2), inhibition (condition 3) and inhibition/
switching (condition 4). In all conditions, the patient is
asked to read the colours or words aloud depending on the
rule given, as quickly as possible while minimising errors.
There are 50 words presented on the page in each condition.
Participants practice on ten word trials prior to the recorded
version to ensure they understand the rules. During the task,
participants are prompted if they make three consecutive
errors and reminded of the rules. This occurs only once
during each condition, however. Participants are told they
can correct any errors as they progress through the task.
In condition 1, participants must name aloud the colour
of red, green or blue squares on the page. In condition 2,
participants must read through a page containing the words
‘‘red’’, ‘‘green’’ and ‘‘blue’’ printed in black ink. In con-
dition 3, the same words in differing order are presented in
incongruent ink colour (e.g., the word ‘‘red’’ appears in
blue ink). The participant is asked to read aloud the colour
of the ink as quickly as possible without making mistakes.
This task, therefore, requires the participant to inhibit a
more automatic response (word reading). In condition 4,
the participant is presented with incongruent colour words
as in the previous condition but a selection of the colour
words are surrounded by a black rectangular outline. For
these selected words, the patient is asked to read the word
written and not to name the colour of the ink, thus requiring
them to set-shift in addition to maintaining inhibitory
control (condition 4 requires 37 switches).
Outcome measures include the total time taken to
complete each condition (raw and age scaled scores) (Delis
et al. 2001) as well as the number of uncorrected (UC),
self-corrected (SC) and total errors. In this study, contrast
scores between conditions were not calculated due to their
known unreliability for this test (Crawford et al. 2008).
Statistical analysis
This study employed a matched-groups sample to address
common critiques of other neuropsychological assessments
of FOG, which do not often account for disease severity
(Heremans et al. 2013a). Therefore, cases were removed
prior to task analysis where outliers for descriptive and
clinical variables led to significantly differing groups. This
was done in a stepwise fashion, removing patients with
particularly high or low MDS-UPDRS scores until there
was no significant group difference on this variable. Sub-
sequently, 34 patients with FOG and 38 without were
retained in the sample, matched on most key demographic
variables (see Table 1). Data analyses were conducted
using the Statistical Package for the Social Sciences (SPSS)
version 21. Due to the non-parametric nature of the task
data, Mann–Whitney U tests were conducted to assess for
differences between groups. Due to unequal variances for
error scores, the data were additionally analysed by cate-
gorising the data and using Pearson’s Chi Square test to
ensure the robustness and reliability of the results. For these
analyses, error scores were split into those who scored 0 or 1
error, and those who scored 2 or more errors (multiple
errors). Where the assumption of expected counts was
violated, Fisher’s exact test statistic was used (FET). Where
data met parametric assumptions for descriptive statistics,
t-tests were used. Wilcoxon signed ranks test was used to
assess within-groups differences across conditions. All
analyses used an alpha of 0.05 and were two-tailed. The
effect size for differences between groups using Mann–
Whitney U and Wilcoxon signed ranks tests was produced
using the following formula (r = Z/HN) while Crame´r’s V
was used for the Chi Square statistic. For both values, 0.10
represents a small, 0.30 a medium, and 0.50 a large effect.
One patient with FOG was unable to complete condition 4
despite sufficiently completing the prior three conditions,
and, therefore, a maximum time score was applied in
accordance with standard D-KEFS procedure and their error
scores were not included in the analysis of this condition.
Results
Demographic and clinical data
Table 1 displays the median, range, mean and standard
deviations for demographic and clinical data.
Colour-word interference test
For condition 1 and 2, there were no significant differences
between groups for any measure, suggesting no difference
between groups in simple reading or naming speed.
Table 2 displays the median, range, mean, standard devi-
ation and effect sizes for condition 3 and 4 representing the
critical trials in the study. For condition 3, there was no
significant difference between groups in completion time
for raw (U = 513.5, Z = -1.50, p = 0.135) or age-scaled
time scores (U = 502, Z = -1.63, p = 0.102). There was
also no significant difference between groups in UC errors
(U = 576, Z = -1.06, p = 0.288). However, there were
significant differences in SC errors (U = 473.5, Z = -2.04,
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p = 0.042) and total errors (U = 457, Z = -2.20,
p = 0.028), with patients with FOG producing more. In
condition 4, patients with FOG were significantly slower in
both raw (U = 474, Z = -1.94, p = 0.052) and age-
scaled time scores (U = 470, Z = -2.01, p = 0.045).
Patients with FOG also committed significantly more UC
errors than those without FOG (U = 434.5, Z = -2.39,
p = 0.017). However, groups did not differ significantly on
SC errors (U = 585.0, Z = -0.50, p = 0.614) or total
errors (U = 507, Z = -1.41, p = 0.158).
In order to confirm these results, a Chi Square test was
used to compare error rates between groups. Again, no
significant differences were found for any measures on
condition 1 and 2. In condition 3, the number of UC errors
was not significantly different between groups (FET (1),
p = 1.00), while patients with FOG produced significantly
more SC [v2 (1) = 5.46, p = 0.019] and total errors [v2
(1) = 6.55, p = 0.010]. In condition 4, participants with
FOG recorded significantly more UC errors [v2 (1) = 3.77,
p = 0.052], while SC [v2 (1) = 0.09, p = 0.761] and total
errors did not differ [v2 (1) = 0.96, p = 0.327] between
groups. Thus, all previous results were confirmed.
To further explore the pattern of error-making across
conditions, a within-group analysis using Wilcoxon signed
Table 1 Descriptive and clinical data for patients with and without FOG
FOG No FOG Significance
N 34 38 –
Gender (% male) 68 % 63 % 0.81a
Age (years) 66.44 ± 8.8 66.76 ± 8.1 0.87b
FOGQ-3 3 (2)/2.82 ± 0.8 – –
NART-R 106 (35)/107.88 ± 9.4 115 (55)/112.00 ± 10.5 0.06
MMSE 28 (5)/28.21 ± 1.5 29 (3)/29.05 ± 1.1 0.01
Disease duration (years) 6.54 ± 3.9 5.7 ± 3.6 0.37b
Hoehn & Yahr stage 2 (3)/2.18 ± 0.6 2 (1)/2.08 ± 0.2 0.40
DDE 650 (1820)/723.44 ± 452.9 575 (1508)/605.53 ± 310.4 0.42
MDS-UPDRS total 51.39 ± 20.4 44.79 ± 18.9 0.16b
MDS-UPDRS-III 22 (58)/28.06 ± 15.3 23.5 (68)/26.47 ± 13.0 0.95
MDS-UPDRS-speech 1 (2)/0.75 ± 0.7 1 (4)/0.86 ± 0.9 0.71
BDI-II 9 (30)/11.81 ± 7.4 7 (25)/8.63 ± 6.1 0.04
Scores represent median (range)/mean ± standard deviation
FOGQ-3 Freezing of gait questionnaire-question 3, NART-R revised national adult reading test, MMSE minimental state examination, DDE
dopamine dose equivalence, MDS-UPDRS movement disorder society-unified Parkinson’s disease rating scale: total, motor score (III), and part
3.1 (speech), BDI-II beck depression inventory
a Pearson’s Chi Square test used
b Independent samples t test used
Table 2 Descriptive data and
effect sizes for conditions 3 and
4
Scores represent median
(range)/mean ± standard
deviation
a Independent samples t test
used
ns p[ 0.05
* p B 0.05
** p B 0.01
Effect size
FOG No FOG Crame´r’s V r
Condition 3 (Inhibition)
Time 69 (130)/75.50 ± 27.9 61 (126)/68.11 ± 27.1 – 0.18
Age scaled score 9.53 ± 3.5 10.66 ± 3.6 – 0.07ns,a
Uncorrected errors 0 (12)/0.85 ± 2.3 0 (3)/0.37 ± 0.9 0.02ns 0.12ns
Self-corrected Errors 1 (13)/2.15 ± 2.9 1 (4)/0.92 ± 1.2 0.28* 0.24*
Total errors 2 (14)/3.00 ± 4.0 1 (6)/1.29 ± 1.6 0.30** 0.26*
Condition 4 (Switching)
Time 74.50 (142)/86.21 ± 33.3 64.5 (96)/74.66 ± 25.9 – 0.23*
Age scaled score 8.97 ± 4.0 10.42 ± 3.5 – 0.24*,a
Uncorrected errors 1 (11)/2.18 ± 3.0 0 (7)/0.87 ± 1.6 0.23* 0.28*
Self-corrected errors 1 (5)/1.42 ± 1.4 1 (8)/1.29 ± 1.5 0.04ns 0.06ns
Total errors 2 (14)/3.61 ± 3.9 2 (9)/2.16 ± 2.4 0.12ns 0.17ns
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ranks test was conducted. As shown in Fig. 1, there was a
medium to strong sized significant difference in UC errors
for patients with FOG between conditions 3 and 4 (Z =
-2.89, p = 0.004, r = 0.38). Conversely, UC errors for
patients without FOG (Z = -1.61, p = 0.108), and the SC
errors for those with (Z = -1.47, p = 0.143) and without
FOG (Z = -1.20, p = 0.230) between conditions were
not significant. Both patients with FOG (Z = -2.20,
p = 0.028) and those without FOG (Z = -2.15,
p = 0.031) showed significantly more total errors in
condition 4.
Discussion
This study presents the first investigation into self-moni-
toring of conflict-induced errors in FOG under differing
levels of cognitive load. The key finding was that the
introduction of switching demands to the task impaired
performance in patients with FOG, particularly in their UC
error making. More precisely, in condition 3, freezers
produced significantly more errors than non-freezers
(automatic responding), but also demonstrated the cogni-
tive control necessary to self-correct immediately after
responding. However, when the additional switching ele-
ment was introduced in condition 4, patients with FOG
displayed a large and significant increase in UC errors
while also being less likely to self-correct. These novel
results suggest that in the presence of intensified cognitive
load induced by switching, patients with FOG may no
longer be able to recruit appropriate monitoring mecha-
nisms to adjust response selection (Brown 2013; Lewis and
Barker 2009). This finding of a threshold-crossing is sim-
ilar to that of PD in general when compared to healthy
controls (Brown and Marsden 1988).
This finding is consistent with the understanding that
patients with FOG have deficits in both conflict interfer-
ence (Cohen et al. 2014; Matar et al. 2013; Vandenbossche
et al. 2011, 2012) and switching ability (Naismith et al.
2010; Shine et al. 2013e). However, the current results
extend this understanding by further exploring the precise
inability of patients with FOG to track and adapt their
responses under increased cognitive demand (combination
of conflict interference and switching). This raises impor-
tant questions regarding the underlying anatomical regions
associated with performance monitoring and how these
may be related to pathophysiological mechanisms under-
lying FOG.
Understanding the processes involved in error monitor-
ing is complex. For example, separating differing aspects
such as monitoring when aware and/or unaware of errors,
which may be self-made and/or external (incongruent
stimuli) in nature, in addition to the subsequent detection
and correction of these errors is extremely complex, and
not well understood (Orr and Hester 2012; Wessel 2012).
Generally, the process of detection and correction of errors
has been shown to involve the anterior cingulate, medial
frontal, posterior parietal, pre-supplementary motor area
(pSMA) and insular cortices (Garavan et al. 2003; Klein
et al. 2007; Narayanan et al. 2013; Orr and Hester 2012;
Ridderinkhof et al. 2004; Sharp et al. 2010). However, the
precise mechanism for how these areas interact in error
detection and correction remains unclear (Narayanan et al.
2013). These cortical regions are known to commonly co-
activate as part of a large-scale network (Niendam et al.
2012), and this network is thought to be involved in the
processing of response conflict and the effective switching
of attention during cognitively demanding tasks (Wager
et al. 2004). Additionally, sub-cortical circuitry has also
been associated with cognitive demands of inhibitory and
switching control, with the STN known to play key roles in
such processes (Aron and Poldrack 2006; Frank 2006),
including in PD patients (Alegre et al. 2013; Brittain et al.
2012; Obeso et al. 2014).
Interestingly, dysfunction within these regions is con-
sistent with findings from recent functional neuroimaging
experiments demonstrating impaired processing through
the pSMA, anterior insula, ventral striatum and STN during
cognitive processing in patients with FOG (Shine et al.
2013b). Furthermore, an additional study showed that
episodes of freezing were associated with increased activ-
ity within the fronto-parietal regions which are required to
Fig. 1 Mean error scores across conditions 3 and 4 for patients with
and without FOG. Error bars represent 1 SE. * p B 0.05, ** p B 0.01
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perform goal-directed behaviours (Shine et al. 2013a).
Expanding on these results, it has since been shown that in
FOG, there is a paroxysmal functional decoupling of
activity between multiple neural networks, including the
basal ganglia and CCN, and cross-talk between left and
right portions of the CCN (Shine et al. 2013c). Together,
these studies suggest that patients with FOG may require
activation of more cognitive resources to effectively per-
form challenging tasks, leaving less reserve available for
the ongoing monitoring of errors. This suggestion is similar
to that proposed of Pieruccini-Faria et al. (2014) who found
cognitive overload to impede on complex motor planning
in patients with FOG and that these deficits were associated
with executive dysfunction.
Alternatively, the inability to properly recruit appropri-
ate cortical regions during high cognitive load may be due
to the role of the STN. One hypothesis is that as cognitive
load increases in response to these executive tasks, it drives
an overwhelming increase in STN firing through the hyper-
direct pathway (Aron and Poldrack 2006), leading to
increased inhibition of basal ganglia output nuclei to the
thalamus. Although the hyper-direct pathway of the basal
ganglia was originally hypothesised as important for purely
motor cessation (Nambu et al. 2002), recent work has
implicated this network in stopping behaviour in executive
domains (Aron, Robbins and Poldrack 2014; Haynes and
Haber 2013). As such, overactivity in the executive regions
of this hyper-direct pathway may result in thalamo-cortical
inhibition, which would then mean that error-monitoring
hubs, including areas of medial and prefrontal cortex, are
unable to process information efficiently during periods of
high cognitive load (DeLong and Wichmann 2007). This
would be reflected in increased uncorrected errors, as
shown in the current study.
Conclusions and future directions
Further research employing behavioural and neuroimaging
techniques should be employed to help disentangle these
preliminary interpretations. In future studies, the role of
switching and inhibitory control along with the influence of
cognitive load could be manipulated using novel paradigms
to provide additional insight into these processes and how
they may relate to such functional networks. The current
findings may have implications for understanding the role
of performance monitoring during gait (Amboni et al.
2013; Cohen et al. 2014). For example, the current results
may well relate to the impaired ability of patients to
appropriately monitor and plan gait while dealing with
cognitive overload in overwhelming situations (Pieruccini-
Faria et al. 2014). Virtual reality studies may be employed
for this goal (Mirelman et al. 2013). Finally, the current
findings help advise on specific targets for cognitive
training in patients with FOG (Walton et al. 2014).
Overall, these novel findings demonstrate that in
patients with FOG, there is a specific deficit in monitoring
for self-made errors under high cognitive load. They raise
important questions regarding the underlying anatomical
regions associated with performance monitoring and the
pathophysiological mechanisms underlying FOG. Future
studies are needed to untangle this complex area of cog-
nitive control in patients with FOG.
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Brain activation underlying turning in Parkinson’s disease
patients with and without freezing of gait: a virtual reality
fMRI study
Moran Gilat1, James M Shine1,2, Courtney C Walton1, Claire O’Callaghan1,3, Julie M Hall1,4 and Simon JG Lewis1
BACKGROUND: Freezing of gait is a debilitating symptom affecting many patients with Parkinson’s disease (PD), causing severe
immobility and decreased quality of life. Turning is known to be the most common trigger for freezing and also causes the highest
rates of falls. However, the pathophysiological basis for these effects is not well understood.
METHODS: This study used a virtual reality paradigm in combination with functional magnetic resonance imaging to explore the
neural correlates underlying turning in 17 PD patients with freezing of gait (FOG) and 10 PD patients without FOG while off their
dopaminergic medication. Participants used foot pedals to navigate a virtual environment, which allowed for blood oxygen level-
dependent (BOLD) responses and footstep latencies to be compared between periods of straight “walking” and periods of turning
through 90°. BOLD data were then analyzed using a mixed effects analysis.
RESULTS: Within group similarities revealed that overall, PD patients with freezing relied heavily on cortical control to enable
effective stepping with increased visual cortex activation during turning. Between groups differences showed that when turning,
patients with freezing preferentially activated inferior frontal regions that have been implicated in the recruitment of a putative
stopping network. In addition, freezers failed to activate premotor and superior parietal cortices. Finally, increased task-based
functional connectivity was found in subcortical regions associated with gait and stopping within the freezers group during turning.
CONCLUSIONS: These findings suggest that an increased propensity towards stopping in combination with reduced sensorimotor
integration may underlie the neurobiology of freezing of gait during turning.
npj Parkinson's Disease (2015) 1, 15020; doi:10.1038/npjparkd.2015.20; published online 22 October 2015
INTRODUCTION
Turning is an integral yet complex task of daily mobility that
commonly precipitates falls in the elderly population.1 This effect
is greater in Parkinson’s disease (PD),2 significantly increasing the
risk of falls and related injuries, such as hip fractures1 leading to
nursing home placement.
One reason for the increased incidence of falls in PD is known to
be freezing of gait (FOG), which is described as a brief, episodic
absence or marked reduction of forward progression of the feet
despite the intention to walk.3 Importantly, turning is recognized
to be the most frequent trigger of this phenomenon.4 This
debilitating symptom impacts around half of PD patients, causing
regular falls and a decreased quality of life (for review see Nutt
et al.).3
Behavioral measures of turning difficulties and their association
with FOG have been widely studied. For instance, patients with
FOG turn more slowly, take more steps, are more variable in their
step times and implement a different turning strategy when
compared with PD patients without FOG and healthy controls.2,5
Turning difficulties in PD patients with FOG are only partly
improved by dopaminergic medication2 and any amelioration
achieved through cueing has only a short lasting carry over effect
after cue removal.6
Due to difficulties inherent in the neuroimaging of gait, the
pathophysiological mechanisms linking turning and freezing are
currently poorly understood, limiting our ability to develop
adequate therapeutic interventions. Recent insights have been
gained from the effects of deep brain stimulation in the
subthalamic nucleus (STN-DBS)7 and saccadic functioning8 in
Parkinson’s disease. The STN, with its striatal, cerebellar and hyper-
direct supplementary motor and other frontal cortex
connections,9–11 is thought to be involved in a common neural
pathway underlying FOG causing inhibition of the gait related
subcortical structures.12,13 As turning is a provocative trigger for
FOG, one might predict that abnormal STN activation by itself, or
indirectly through abnormal activation in its cerebellar, striatal and
frontal cortex connections is at least in part responsible for the
deficits in turning kinematics seen in PD patients with FOG.
Indeed, Lohnes and Earhart7 showed that STN-DBS in PD patients
shortened their turn duration, whereas it also improved saccadic
functions that are important for turning.7 STN-DBS has also been
shown to improve visuospatial attention14 and decrease interseg-
mental latencies (e.g., eye–head, eye–foot, and head–trunk), which
are both affected in PD patients, especially in those that
experience freezing.7,15 However, though these studies provide
valuable information regarding the STN’s role, little information
exists about other regions of the brain that are likely to be
involved in the functional impairments that cause turning
difficulties and FOG in PD patients.12
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It is therefore clear that novel paradigms are needed to improve
our understanding of the pathophysiology underlying turning
deficits in Parkinson’s disease, especially when exploring freezing
of gait. As such, the current study set out to investigate the effect
of turning during the performance of an interactive virtual reality
(VR) paradigm that has previously been used in combination with
functional magnetic resonance imaging (fMRI) to investigate the
pathophysiology underlying behavioral freezing episodes13 and
the effects of other known triggers of FOG, such as high cognitive
load.16,17 However, the current study will be the first to combine
an adjusted version of the VR with fMRI to explore the widespread
brain regions that underpin turning behavior in Parkinson’s
disease patients with and without freezing of gait. The current
VR paradigm allows for the investigation of complex sensorimotor
integration during turning, as it requires subjects to generate
effective lower limb motor output while updating changes in their
visual environment. We hypothesized that PD patients with FOG
would be slower and more variable in their step times during the
navigation of a turn in the VR18,19 and that turning would elicit
altered activation patterns in the STN7 and its hyperdirect frontal
cortex connections.9–11 In addition, we expected to find differ-
ences across the cortical, striatal and other subcortical regions that
have previously been identified in PD patients with FOG during
structural MRI,11,20 fMRI resting state,21 PET gait imagery tasks22
and during fMRI with a gait imagery tasks,23,24 upper limb motor
task,25 and VR performance.13,16,17
MATERIALS AND METHODS
Patient details and study protocol
A total of 27 levodopa-responsive patients with idiopathic PD were
recruited from the Parkinson’s Disease Research Clinic, Brain and Mind
Research Institute, the University of Sydney having satisfied UKPDS Brain
Bank clinical diagnostic criteria. Seventeen Parkinson’s disease patients
with freezing of gait (PD+FOG) were selected based on a previously
obtained positive score on the Freezing of Gait Questionnaire question 3
(FOG-Q3)26 (“do you feel that your feet get glued to the floor while
walking, making a turn or when trying to initiate walking (freezing)?”) and
10 non-freezing Parkinson’s disease− patients (PD−NF) were selected
based on a null score on this question. All patients underwent neurological
and neuropsychological assessment, completed a gait protocol and
performed an fMRI scanning session in their practically defined ‘off’ state,
having been withdrawn from dopaminergic medication overnight for
more than 12 h before testing. The patients in the current study were
measured “off” their dopaminergic medications to increase the likelihood
of eliciting freezing like behaviors in a standardized environment, to allow
us to better investigate dopamine dependent basal ganglia dysfunctions
and finally, to enable fair comparisons with previous fMRI studies.13,23,24
Ethical approval for this study was obtained from the University of Sydney
Human Research Ethics Committee and written informed consent was
obtained from each patient.
Neurological and cognitive assessment
All patients were assessed on the motor section of the Unified Parkinson’s
Disease Rating Scale (UPDRS-III) and Hoehn and Yahr Stage in their “off”
state. In addition, the Mini Mental State Examination, Montreal Cognitive
Assessment, and Hospital Anxiety and Depression Scale (HADS) were
obtained and their daily Dopamine Dose Equivalency was calculated.
Gait protocol
Each subject completed eight video recorded 5-m long timed up and go
tasks, during which each turn was performed inside a 50-cm2 taped box on
the ground. The timed up and go tasks incorporated 180 and 540° turns in
both directions, taking short steps around the outline of the box in both
directions and two vocal dual tasks (i.e., naming multiples of nine and
months of the year backwards) with 180° turns in both directions. The
videos were scored offline for periods of freezing as defined by a brief,
episodic absence or marked reduction of forward progression of the feet
despite the intention to walk.3 The timed up and go tasks clinically
confirmed FOG in all but one subjects in the PD+FOG group, whereas none
of the PD−NF patients experienced any freezing episode. The one subject
in the PD+FOG group was still included into the study based on a positive
score on the FOG-Q3 and UPDRS question 3.11 and because he was seen
by an experienced physician to have experienced freezing when arriving
into the clinic.
Virtual reality paradigm
Patients performed the VR while lying inside the fMRI scanner. The task
took ~ 6min to complete and was presented on a screen that could be
clearly viewed via a mirror mounted onto the head coil. The virtual
environment was a three-dimensional corridor presented in the
first-person. Forward progression through this corridor was accomplished
by alternately depressing left and right foot pedals at least 30° below
parallel in a “physiological” sequence (e.g., left–right). Out of sequence
steps (left–left or right–right) did not result in forward progression and
were disregarded from the analyses. Patients were instructed to tap the
pedals in a comfortable rhythm. The VR only contained turns and simple
“STOP” cues presented in the color red, followed by a simple “WALK” cues
presented in the color green (Figure 1), which were added to ensure that
the patients were still paying attention to the task. No other environmental
triggers (e.g., doorways) or complex cognitive cues were presented during
this experiment in distinction to our previous reports.13 The turns in the VR
were 90° and randomly presented in both directions (Figure 1). An average
of 23 turns were presented during the trial and patients had to take
between 3 and 6 steps to complete a turn, based on their stepping
latencies. The VR automatically presented the navigation of a turn as a
reaction to the physiological sequence of foot pedal depressions. We
chose to leave out an additional motor task to prevent dual tasking from
inducing any freezing.27 As such, no difference in behavioral motor
activation was required between periods of straight walking and periods of
turning, except for potential eye movements induced by the updating of
visual information as the turn was presented on the screen. Similar to
previous studies,2,24 no distinction was made between left and right turns
in order to increase the power of the analyses.
Behavioral measures
Footstep latencies were calculated by measuring the time between two
consecutive foot pedal depressions. The mean and standard deviation
were then used to calculate the coefficient of variation for the three steps
that were taken during a turn and for three randomly selected steps that
were unrelated to any turn or “STOP” and “WALK” cues (hereafter defined
as “walking”). In addition, we calculated the longest footstep latency in
those three steps (defined as the maximum footstep latency). Any
maximum footstep latency that was greater than twice the modal footstep
latency was considered to be a behavioral freezing episode, as described in
more detail elsewhere.13,19 All behavioral freezing episodes were removed
Figure 1. Representation of the virtual reality task showing a turn, a
period of virtual reality walking and a WALK and STOP cue. WALK,
walking.
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from the current analyses to ensure that any results in this study were
owing to the effect of turning and were not being driven by the
occurrence of any freezing episodes.17
Neuroimaging
Event related analysis. The image acquisition and image preprocessing
steps are described elsewhere.17 Individual first-level spatial maps were
created in Statistical parametric mapping software (SPM8, Wellcome Trust
Centre for Neuroimaging, London, UK, http://www.fil.ion.ucl.ac.uk/spm/
software/) using a general linear model analysis within an epoch-related
design in a fixed-effects analysis. A design matrix was created for each
patient by entering two regressors for each trial, namely, a regressor that
modeled the specific onset times and associated temporal derivatives for
each turn and a regressor that similarly modeled periods of walking. The
walking epochs were randomly selected and scaled to the number of
turning epochs, both covering the total duration of the task to control for
possible effects of fatigue. All patients were instructed to minimize head
motion by only moving the ankles, while not raising the legs and
preventing hip rotation. In addition, a brief trial run was performed inside
the scanner before the start of the task. This allowed a researcher to adjust
the position of the patient’s feet and give additional instructions if
extensive head motion was detected. This, together with the placement of
cushions inside the head coil ensured optimal performance with the least
amount of head motion. After data collection, any trial with43-mm head
motion was excluded from the analyses and six motion and nuisance
regressors were added into the first level analysis per subject, controlling
for movement artifacts in the three directions of translation and axes of
rotation. Contrast images from the first-level analyses were then entered
into a second-level random-effects independent samples t-test design
analysis to determine the group differences on the contrast of interest
(turning4walking). This contrast was chosen as it minimizes the
differences between the two conditions, both requiring bi-pedaling motor
output while watching a screen, with the only difference being going
through a turn. It therefore controls for the variance associated with
bi-pedaling motor output and watching a screen, while allowing the
resultant brain activation pattern to be interpreted as the effects
associated with turning. HADS anxiety, HADS depression and Montreal
Cognitive Assessment scores were entered as covariates at the
second level. Whole brain voxel maps were displayed using XjView
(www.alivelearn.net/xjview) software (Po0.005). To decrease the risk of
type-II error, we used a large cluster size threshold (k420 voxels).28
Region of interest analysis. Spherical 8-mm regions of interest (ROI) were
drawn around the peak voxels from the second level T-map by using the
MarsBar toolbox in SPM8 (ref. 29). The peak voxel values and their
coordinates are presented in Table 2. Importantly, these values were not
used for any further statistical inference, but instead allowed us to further
explore the linear direction of blood oxygen level-dependent (BOLD)
response patterns found in the whole brain analysis, as described
elsewhere.17
In addition, previous studies have implicated key striatal and subcortical
regions in turning and behavioral freezing in patients with Parkinson’s
disease.7,11,23,24 As such, we subsequently explored the images from the
first-level analysis using predefined regions of interest, which were
analyzed independently from the whole brain analyses. Spherical ROI’s
were drawn around the following left and right striatal regions: caudate
nucleus, putamen and ventral striatum, and subcortical regions: mesence-
phalic locomotor regions (MLR), globus pallidus internus (GPi), STN and the
bilateral cerebellar locomotor region (CLR; see Supplementary Table 1 for
coordinates in Montreal Neurological Institute (MNI) space). MarsBar29 was
used to extract percent signal change values for each region and a
difference score was calculated between periods of turning and periods of
walking. Two-sided independent sampled t-tests were performed on the
group level and paired sampled t-tests were used within groups. Alpha
levels were set to 0.05.
Task-based functional connectivity. On the basis of current perceptions
that FOG is likely due to functional network deficits,12,16 we aimed to
explore the task based functional connectivity patterns30 associated with
turning in the VR. As such, the Marsbar toolbox was also used to extract
raw ROI data (beta weights; or β) of each ROI for each patient.
MATLAB (The MathWorks Inc., Natick, MA, USA) was used to calculate
the temporal derivative (TD= β (Tn)—β (Tn-1)) of the raw β weights for each
ROI. After scaling each time course by its variance, the temporal derivatives
of each ROI were multiplied by the temporal derivatives of the other ROI’s
for each time point, such that a positive score reflected ‘functional
coupling’ between a pair of ROIs. For each subject, we multiplied the
functional coupling score for each temporal derivative by the convolved
time points associated with either turning or walking periods in the virtual
reality task. We then calculated the non-zero average for each ROI pair for
both contrasts for each patient. Paired sampled t-tests were employed to
analyze the differences in these non-zero average scores between periods
of turning and periods of walking. Finally, the non-zero average scores
were organized into two 13-by-13 matrices for each subject, one for the
periods of turning and one for the periods of walking for each of the 13
ROI’s. These matrices were then compared statistically using the Network
Based Statistics Toolbox31 with a threshold value of 3.0, Po0.05 as well as
the False Detection Rate option (Po0.05) in the network-based statistics
software to control for multiple comparisons.
RESULTS
Patient demographics
The demographic statistics, results of the gait assessments and the
behavioral measures from the VR are presented in Table 1. The
groups were matched for key demographics such as age, disease
duration, dopamine dose equivalency, mini mental state examina-
tion scores, disease severity and motor severity (UPDRS-III) after
removing the gait and freezing items. Moreover, both groups
included more males (χ2(1) = 0.764, P= 0.382). As is commonly
reported, the PD+FOG group did have significantly lower Montreal
Cognitive Assessment scores and higher HADS anxiety and HADS
depression scores (Table 1).17 The current study therefore
controlled for the significant group differences in Montreal
Cognitive Assessment and HADS scores through the use of
covariate analyses. Additional non-parametric analyses revealed
that the groups were also matched for Hoehn and Yahr stages and
that only the PD+FOG group scored positively on the FOG-Q3
(Table 1). Finally, 53% of the PD+FOG group and 60% of the
PD−NF group (χ2(1) = 0.127, P= 0.722) had worse Parkinson’s
disease symptoms on the left side of the body as calculated by a
ratio of the sum of UPDRS-III items related to symptom severity on
the right side and left side of the body. Finally, no significant
differences were found between the groups on handedness
(χ2(1) = 1.27, P=0.260), foot tapping abilities and leg agility as
obtained by the UPDRS questions 3.7 and 3.8, respectively (Table 1).
In addition, toe tapping and leg agility scores did not correlate with
the behavioral measures of the VR task (results not shown).
Gait assessment
Turning indeed proved to be a provocative trigger for FOG, as 76%
of the patients in the PD+FOG group froze during the 540° turns
and 41% froze during the 180° turns. In addition, only 35% of the
patients froze when having to perform a cognitive dual task
during straight walking while 71% froze when dual tasking was
performed during the performance of a 180° turn (Table 1).
PD−NF patients did not experience any freezing. There was no
significant difference in the amount of freezing experienced by PD
+FOG patients between left and right turns (540°: t= 1.541,
P= 0.143 and 180°: t= 0.490, P= 0.631).
Virtual reality task
Turning during the VR provoked behavioral freezing episodes in
10 PD+FOG patients with an average of 13% of turns eliciting a
freeze in those patients, whereas none of the PD−NF patients
experienced a behavioral freeze during turning (U= 35,
Z=− 2.793, Po0.01). In addition, even when removing all
behavioral freezing episodes, PD+FOG still had significantly higher
scaled maximum footstep latencies when turning compared with
walking (t(16) = 2.17, P= 0.045), whereas PD−NF had similar
scaled maximum footstep latencies (t(9) = 0.693, P= 0.506). As
predicted PD+FOG also had higher step time variability compared
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with the non-freezer group as shown by an increased coefficient
of variation during both turning and walking (Table 1).19 Within
groups, the coefficient of variation was slightly higher but not
significantly different during turning compared with walking
(PD+FOG: t=0.815, P=0.427, PD−NF: t=0.437, P=0.672). It is
important to note that although PD+FOG patients had a slightly
higher cadence, no significant differences in modal footstep latencies
were found between the groups, which together with similar
UPDRS-III questions 3.7 (toe tapping) and 3.8 (leg agility) scores,
indicates that any group differences found during turning were
unlikely to be due to an overall difference in motor performance.
Neuroimaging results
Within-group similarities. Figure 2 shows the whole brain BOLD
response patterns for periods of walking and turning for each
group separately. The results of the within group turning4walk-
ing contrasts are presented in Figure 3. The PD+FOG group
required widespread activation across the motor and visual
cortices, cerebellum, and MLR region to achieve stepping in the
virtual reality task when compared with the selective cortical
recruitment in the PD−NF group. The PD+FOG group also
activated the cerebellum during turning, but this time with a
more caudal region of the medulla. PD−NF required less
activation across the motor, visual and cerebellar cortices, while
recruiting more medial frontal regions.
Between group differences. Comparing the groups for the
contrast of turning4walking revealed four brain areas with
significantly different BOLD responses (Figure 4). PD+FOG showed
decreased BOLD responses across the left supplementary motor
area (SMA) extending to the left premotor area and the left
superior parietal lobule with increased BOLD responses in both
the left and right inferior frontal gyrus when compared with
PD−NF. Peak voxel statistics and coordinates are presented in
Table 2. Although the left superior parietal lobule was significantly
different with the current statistical settings, the right superior
parietal lobule also appeared as to have decreased BOLD
activation during turning in PD+FOG compared with PD−NF
when lowering the cluster size threshold to 13 voxels (t=− 3.08,
P= 0.003).
Predefined ROI analysis. No significant group differences were
found for percent signal changes of striatal and subcortical ROI’s
when contrasting turning with walking in the VR. However, within
the PD+FOG group a significant increased percent signal change
in the left caudate nucleus (t16 = 2.75, P= 0.014) was found in the
difference score between turning and walking, whereas no
differences were found for PD−NF. The right caudate also
showed increased percent signal change for the PD+FOG group,
but this did not reach statistical significance (t16 = 1.72, P= 0.106).
Finally, a supplementary analysis using a predefined spherical ROI
of the pre-SMA (MNI: − 3; 6; 53)32 revealed reduced activation,
although not significantly different, in the PD+FOG group during
turning compared with walking in the VR (Average beta: − 0.664,
t= 1.55, P= 0.138).
Task-based functional connectivity. Four highly significant
functional connectivity scores survived network-based statistics
correction31 with stringent threshold settings (threshold = 3.0,
Table 1. Demographic statistics and behavioral results
PD+FOG (n= 17) PD−NF (n= 10)
Demographics Mean s.d. Mean s.d. T-value P-value
Age 67.4 6.2 64.8 4.1 1.15 0.262
Disease duration 116 63 92.4 28 1.09 0.285
DDE 776 321 785 296 0.07 0.945
UPDRS-III 37.2 12 30.1 11 1.53 0.139
MMSE 28.0 2.2 29.4 0.7 1.96 0.061
MOCA 25.6 3.2 28.3 2.3 2.36 0.027
HADS (Anxiety) 6.12 3.3 3.40 2.4 2.29 0.031
HADS (Depression) 5.59 2.6 1.40 1.7 4.53 o0.01
Median Range Median Range Z-value P-value
H&Ya 2.5 2.0–3.0 2.0 2.0–2.5 − 1.55 0.122
FOG-Q3a 3.10 2.0–4.0 0 0 − 4.14 o0.01
UPDRS 3.7a (Toe tap R)a 2.0 0–3.0 1.0 0–2.0 − 1.70 0.127
UPDRS 3.7b (Toe tap L)a 2.0 0–3.0 1.0 0–2.0 − 1.13 0.286
UPDRS 3.8a (Leg agility R)a 1.0 0–3.0 1.0 0–2.0 − 1.67 0.127
UPDRS 3.8b (Leg agility L)a 1.0 0–3.0 1.0 0–2.0 − 1.33 0.223
Virtual Reality task Mean s.d. Mean s.d. T-value P-value
Max SFSL turning 1.14 0.09 1.07 0.10 2.33 0.028
Max SFSL walking 1.12 0.09 1.06 0.02 2.34 0.027
CV turning 16.5 5.84 9.60 3.9 3.31 o0.01
CV walking 15.7 5.44 9.26 3.9 3.27 o0.01
Modal FSL 0.56 0.11 0.62 0.10 1.39 0.172
Abbreviations: PD+FOG, Parkinson’s disease patients with freezing of gait; PD−NF, Parkinson’s disease patients without freezing of gait.
Independent sample t-test results presented unless otherwise indicated.
Demographics: Disease duration given in months, DDE, daily dopamine dose equivalence; FOG-Q3, question 3 of the freezing of gait questionnaire;
HADS, hospital anxiety and depression scale; H&Y, Hoehn and Yahr; MMSE, Mini Mental State Examination; MOCA, Montreal Cognitive Assessment; UPDRS-III,
motor section of the unified Parkinson’s disease rating scale without Q10 (gait) and Q11 (freezing); UPDRS 3.7 and 3.8, Average scores on Q3.7a and Q3.7b and
3.8a and 3.8b of the UPDRS (Left and right toe tapping and leg agility, respectively). Virtual Reality task: CV, coefficient of variation; Max SFSL, maximum scaled
footstep latency as scaled to the modal FSL; Modal FSL, modal footstep latency. All analyses were two-tailed with an alpha of 0.05.
aMann–Whitney U-test used.
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P= 0.007) when comparing periods of turning with walking within
the PD+FOG group (Figure 5). Specifically, we observed increased
connectivity between the bilateral MLR (t= 5.16, Po0.001),
between the left GPi and both the right (t= 4.14, Po0.001) and
the left (t= 3.53, Po0.01) MLR and finally, between the right GPi
and the left STN (t= 3.32, Po0.01). At a lower statistical threshold
of 2.5 (P= 0.023), additional significant functional connectivity
scores were revealed between the right GPi and the right STN
(t= 2.83, P= 0.01) and between the bilateral CLR with both the left
(t= 2.86, Po0.01) and right MLR (t= 2.84, P= 0.01). The increased
functional connectivity score between the bilateral MLR remained
significant (Po0.05) when using the false detection rate option in
the network-based statistics software. No changes in functional
connectivity were found within the PD−NF group between
periods of turning and walking. In addition, no significant group
differences in functional connectivity were found that survived
network based statistic or false detection rate correction.
DISCUSSION
This is the first study to investigate brain activation patterns
underlying turning during a virtual reality task in Parkinson’s
disease patients with and without freezing of gait. Within group
results revealed that PD+FOG relied heavily on widespread cortical
control of their movements, whereas PD−NF achieved more
successful stepping with a selective motor network. Between
group results showed that during turning, patients with freezing
of gait displayed increased BOLD responses in bilateral inferior
frontal regions and decreased BOLD across the left premotor
cortex and left superior parietal cortex when compared with
PD−NF. In addition, PD+FOG showed increased percent signal
changes in the left caudate nucleus and displayed strong
functional connectivity between the GPi, STN, cerebellar and
mesencephalic locomotor regions during turning relative to
walking. Importantly, an additional analysis without the subject
in the PD+FOG group that did not freeze during the gait
assessment (n= 16) revealed the same brain activation patterns,
aiding towards the robustness of our findings.
Turning during walking is a difficult motor task to investigate
using current neuroimaging techniques. Most evidence regarding
the effects of turning in PD patients with FOG therefore comes
from indirect and spatially limited techniques, such as the effect of
STN-DBS, transcranial magnetic stimulation and the effects of
dopaminergic medication.2,7,33 Thus far only one study has used
fMRI to investigate the effects of turning in PD patients with FOG.
Peterson et al.24 used gait imagery of simple (forward) and
complex (backward or turning) movements in combination with
fMRI to report BOLD responses of five locomotor regions of
interest in PD patients with and without FOG.24 They found that
for PD patients without FOG, gait imagery of simple forward
walking compared with rest was associated with increased BOLD
responses in several locomotor regions, including the SMA.
However, patients with FOG actually showed decreased activation
in the globus pallidus and mesencephalic locomotor region with
trends towards decreased activation in the right SMA.24 However,
despite the large clinical impact turning has on freezing, no
significant differences were found in that study between imagined
forward walking and turning in PD patients with and without FOG.
In addition, none of the patients in that study reported freezing
during imagined gait.24 This indicates that the complexity
between the gait imagery tasks might be too subtle to induce
detectable changes in brain activation within a Parkinson’s disease
cohort.24 These methods may also have lacked key challenges in
sensorimotor integration associated with turning and freezing of
gait.34–36 As such, the current study set out to investigate turning-
related brain activation by using an interactive virtual reality task
that required patients to perform a lower limb motor task while
Figure 2. Within-group whole brain results for periods of walking (WALK) and turning (TURN) in the virtual reality task. A, anterior, L, left; P,
posterior, R, right; k420 and Po0.005.
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having to update a changing visual environment similar to
turning.
Within groups: walking
The within-group similarities during periods of walking revealed
that when off medication, PD+FOG patients required widespread
activation across their motor cortices, cerebellum and MLR region,
whereas PD−NF used focused activation patterns across the
motor cortex, frontal cortex, and cerebellum to perform the task.
The widespread cortical involvement seen in the PD+FOG group
might indicate that even during simple forward walking in the VR,
these patients are unable to rely on lower-order automatic
behaviors and therefore must employ a more cortically controlled
locomotor network.3,11,12,37 Indeed, we found that PD+FOG were
unable to keep a consistent rhythm between their steps, as
indicated by high step time variability scores, when compared
with PD−NF. This result is consistent with previous studies
looking at virtual reality task performance19 and over ground
walking18 and is at least in part indicative to a loss of automaticity
in locomotion, as stride time variability has been shown to
improve with dopaminergic medication while worsening during
dual tasking,18,38 indicating an ineffective basal ganglia
involvement.3,39 Our findings also support the notion that
although FOG is a paroxysmal phenomenon, patients with
freezing already have altered brain activation patterns during
effective walking.18 This could increase their susceptibility to
freeze when additional information from competing pathways
(e.g., sensorimotor, cognitive, and limbic) require concurrent
processing by the basal ganglia causing response conflict that
eventually presents itself as FOG.12
Within groups: turning
Within group similarities during periods of turning in the VR
revealed that PD+FOG relied more heavily on visual information
while decreasing the recruitment of medial motor and left parietal
cortices. This might indicate that the PD+FOG were over-reliant on
visual information, possibly as a learned response to poor
kinesthetic feedback.35,40–42 Turning in the VR might worsen this
effect by preventing the subjects from actually rotating their
bodies according to the visually presented turn, altering their
expected kinesthetic feedback as associated with turning over
ground.
Alternatively, the extra visuo-parietal activation seen in the PD
+FOG group could reflect saccadic abnormalities that could lead
to unsuccessful sensorimotor integration.8,43,44 Indeed, we also
Figure 4. Results of the whole brain second level group effect for turning4walking in the virtual reality task. (a) Screenshots from the whole
brain second level independent t-test for the turning4walking contrast showing PD+FOG4PD−NF results (P= Posterior, A=Anterior, k420,
Po0.005, uncorrected, see Table 2), while using MOCA and HADS scores as covariates and. (b) The average beta intensities of the peak voxel
8 mm spherical ROI’s for the turning 4walking contrast in the virtual reality task for both Parkinson’s disease patients with freezing of
gait (FOG) and without freezing of gait (NF). HADS, Hospital Anxiety and Depression Scale; MOCA, Montreal Cognitive Assessment;
PD+FOG, Parkinson’s disease patients with freezing of gait; PD−NF, Parkinson’s disease patients without freezing of gait; ROI, regions of
interest.
Figure 3. Within-group whole brain results for the contrast turn-
ing4walking in the virtual reality task. A, anterior, L, left; P, posterior,
R, right; k420 and Po0.005.
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observed an increased percent signal change during turning in
the caudate nucleus for the PD+FOG group, an area implicated in
saccadic functioning.45 Because of strong functional interactions
between the oculomotor system and basal ganglia circuitry,46 any
inappropriate visuomotor integration could cause response
conflict between predicted and actual motor outcomes, thus
potentially eliciting FOG.12 Indeed, the failure to recruit medial
motor and medial frontal regions in the PD+FOG group during
turning could indicate a difficulty with facilitating internally driven
motor actions when visual support falls away.47 This notion is
supported by the fact that externally driven motor actions, such as
achieved through visual cueing techniques can alleviate freezing
of gait,48 whereas turning is the most provocative trigger for
freezing of gait.27 Future studies are now needed to confirm
saccadic dysfunctions during turning in the VR and to determine
whether dopaminergic medication improves the basal ganglia
circuitry during turning and thus visuomotor integration.49
The neural correlates underlying behavioral freezing episodes in
a similar VR task are described in detail elsewhere.13,16,17 Such an
analysis was not performed in the current study owing to the
limited amount of behavioral freezing episodes recorded. The
small amount of freezing episodes can partly be explained by
the turns being 90°, with previous studies showing that sharper
turns are more likely to cause FOG.5,27 Future studies are therefore
encouraged to implement sharper turns in virtual reality tasks to
increase the likelihood of eliciting FOG, allowing for those
episodes to be modeled with sufficient power when using fMRI.
In addition, studies are encouraged to use ambulatory
electroencephalography systems to provide information about
cortical activation underlying other critical sensorimotor
challenges associated with turning (e.g., balance, changing step
lengths, and posture) that could not be modeled in the current
study. Finally, no objective measures were obtained during
the current gait tasks, which were solely implemented to ensure
accurate group allocations. Future studies using objective
kinematical measures during turning are therefore needed to test
whether the VR and neuroimaging findings presented here are
indeed related to the deficits seen during over ground turning.
Between groups: turning4walking
Between group differences showed that navigating a virtual turn
caused PD+FOG to recruit similar regions as those associated with
the putative “stopping network”10 that has also been implicated in
detecting salient stimuli and attentional processes.50 In addition,
strong functional connectivity patterns were found in the PD+FOG
group during turning between subcortical regions and the STN,
which has neural projections to the regions of this stopping
network.10 The stopping network is most commonly implicated
through stop-signal tasks, showing activation of the right inferior
frontal gyrus together with the pre-SMA, which is both func-
tionally and structurally connected with the inferior frontal
gyrus.10 This network implements inhibition through the STN,
which regulates its effects via the Substantia Nigra pars reticulata,
leading to thalamic inhibition when stopping is successful.10
Although little is known regarding the involvement of this stopping
network across a broader range of motor tasks, a generalizability
of the brain’s network for simple stop signal tasks has been shown
to exist in more ecologically valid scenarios.51 In addition, the
regions of this network have already been implicated in several
pathophysiological hypotheses of FOG.11,12,39,52 The recruitment
of this braking network could be an adaptive brain function that
arose during the gradual development of FOG as a result of fear of
falling53 and difficulties navigating challenging environments.35 If
so, this braking network might be over recruited during such
locomotor challenges, precipitating more FOG.
A recent pathophysiological model suggests that the main
output structures of the basal ganglia (i.e., GPi and Substantia
Nigra pars reticulata) provide tonic GABAergic inhibitory tone over
the brainstem structures that control gait (such as the MLR and
dorsal pendunculopontine nucleus) and the motor thalamus,
preventing any unwanted movements at rest.12 Importantly, this
tonic inhibition can be deactivated when an appropriate motor
plan from the motor cortex is processed by the basal ganglia,
relieving this inhibitory output.12 However, one can argue that
when patients with PD and FOG proactively recruit a cortically
controlled braking network as described above, additional
activation of the STN might overrule any inhibitory relief
accomplished through the basal ganglia system. Furthermore, in
patients with PD and FOG the motor plans presented might
already be inappropriate due to abnormal sensory integration,34
Figure 5. Representation of the task based functional connectivity
results. Figure shows the comparison between periods of turning
and periods of walking in the virtual reality task within the
Parkinson’s disease patients with freezing of gait group.
CLR, cerebellar locomotor region; GPi, globus pallidus
internus; MLR, mesencephalic locomotor region; STN, subthalamic
nucleus.
Table 2. Brain areas with significantly different BOLD responses in the second level using an independent t-test design for the contrast
turning4walking in the virtual reality task, showing the PD+FOG4PD−NF peak voxel statistics
Brain area x y z # voxels T-value Z-value P-value
L—SMA—Premotor − 21 − 7 64 59 − 4.17 3.54 o0.001
L—Parietal superior − 30 − 46 58 57 − 3.91 3.37 o0.001
L—Inferior frontal − 30 35 13 35 3.58 3.14 o0.002
R—Inferior frontal 36 20 25 20 4.04 3.46 o0.001
Abbreviations: BOLD, blood oxygen level-dependent; L—SMA, left supplementary motor area; PD+FOG, Parkinson’s disease patients with freezing of gait;
PD−NF, Parkinson’s disease patients without freezing of gait; R, right.
k420, Po0.005, uncorrected with coordinates in MNI space.
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especially during challenging situations,42 which together with a
dopamine depleted basal ganglia system decreases the likelihood
of successful cortico-basal relief of gait inhibition.
The current study also found increased BOLD responses in the
PD+FOG group across the inferior frontal gyrus bilaterally along
with increased functional connectivity among subcortical regions
associated with stopping (e.g., STN and GPi) and movement
(e.g., MLR and CLR). Importantly however, another key region of
the stopping network, namely the pre-SMA, was absent while the
left premotor area actually showed significant decreased activa-
tion patterns in PD+FOG. Indeed, a predefined ROI analysis of the
pre-SMA revealed reduced activation, although not significantly
different, in the PD+FOG group during turning compared walking
in the VR. The lack of significant group differences across the basal
ganglia, thalamic and subcortical regions associated with stopping
can potentially be explained by the removal of all behavioral
freezing episodes from the analyses. As such, our results are
aligned with previous studies that also showed reduced premotor
activation in PD patient with FOG during gait imagery23,24 and
behavioral freezing in the virtual reality task,13 along with
profound structural20,54 and similarly increased functional
connectivity impairments11 that have been reported in PD+FOG
between the (pre-) SMA, STN and the CLR and MLR.
Based on the current results it can be speculated that PD
patients with FOG have an inherent over activity across a stopping
network when turning and that during this time the pre-SMA fails
to provide necessary contextual input, rendering the striatum
unable to correctly update the ongoing motor plan.11,52 This
forces the GPi and STN to “shut down” activity in its’ efferent
targets through the synchronization of the MLR and CLR,12 which
in turn prevents the movement centers of the brain (such as the
motor cortex, thalamus, and cerebellum) from receiving sensory
information to adjust the gait cycle. To make matters worse, much
of the sensory information gathered will already be inadequate, as
PD+FOG have known proprioceptive, postural, saccadic and
sensorimotor integration deficits,34,41–43 which are all essential
elements for the successful execution of a turn. Indeed, reduced
BOLD responses were found in the current study in both the left
premotor cortex along with the left and right superior parietal
lobule, which are thought to be involved in the prediction of
somatosensory consequences of a motor plan and the integration
of sensorimotor information.23 The movements during a turn will
therefore no longer match their predictions, leading to increased
response conflict, which together with the prospective recruit-
ment of a braking network, explains why turning is so likely to
trigger FOG.
Conclusion
During the navigation of a turn in the virtual reality task,
Parkinson’s disease patients with freezing of gait show altered
BOLD responses across regions that implicate the prospective
recruitment of a stopping network, which may be manifested
pathologically as a freeze when sensorimotor processing becomes
more complex.
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Abstract Freezing of gait is a poorly understood symptom
of Parkinson’s disease (PD) that is commonly accompanied
by executive dysfunction. This study employed an antisac-
cade task to measure deficits in inhibitory control in patients
with freezing, and to determine if these are associated with a
specific pattern of grey matter loss using voxel-based mor-
phometry. PD patients with (n = 15) and without (n = 11)
freezing along with 10 age-matched controls were included.
A simple prosaccade task was administered, followed by a
second antisaccade task that required subjects to either look
towards or away from a peripheral target. Behavioral results
from the antisaccade task were entered as covariates in the
voxel-based morphometry analysis. Patient and control
groups performed equally well on the first task. However,
patients with freezing were significantly worse on the sec-
ond, which was driven by a specific impairment in sup-
pressing their responses toward the target on the antisaccade
trials. Impaired antisaccade performance was associated
with grey matter loss across bilateral visual and fronto-
parietal regions. These results suggest that patients with
freezing have a significant deficit of inhibitory control that is
associated with volume reductions in regions crucial for
orchestrating both complex motor behaviors and cognitive
control. These findings highlight the inter-relationship
between freezing of gait and cognition and confirm that
dysfunction along common neural pathways is likely to
mediate the widespread cognitive dysfunction that emerges
with this symptom.
Keywords Antisaccades ! Cognitive control !
Freezing of gait ! Parkinson’s disease
Introduction
Freezing of gait (FOG) is a debilitating motor symptom
experienced by a significant number of people with
Parkinson’s disease (PD), which manifests when a patient
becomes unable to progress forward while walking [1]. The
symptom is highly related to poorer quality of life [2],
highlighting the importance in understanding its complex
nature. A number of mechanisms for FOG have been
hypothesized; however, our understanding of the phe-
nomenon is still evolving. Therefore, further investigations
into underlying neural processes employing new and novel
experimental designs are warranted, in order to advance the
potential for clinical treatments and biomarkers.
There now stands a significant body of evidence to
suggest that FOG is fundamentally related to dysfunction
across fronto-parietal and striatal regions [3, 4], which has
been identified via convergent evidence from neuropsy-
chological testing and both structural and functional
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neuroimaging [5, 6]. Yet, the classical neuropsychological
tasks that have been used to establish the cognitive profile
associated with FOG tend to be highly multidimensional,
relying on diverse cognitive and behavioral domains (in-
cluding verbal and motor responses), which can complicate
their interpretation. In contrast, saccadometry is a novel,
objective tool that can be used to probe discrete aspects of
neural decision-making behavior, even in patients with
significant motor and speech impairments [7]. Thus, it can
provide highly informative data relating to the neural
underpinnings of cognitive processing.
This tool measures saccades, the eye movements made
when rapidly shifting focus across the external environ-
ment. A typical experiment involves presenting a target
stimulus to a participant, who must then either direct their
attention towards (prosaccades) or away (antisaccades)
from a second peripheral stimulus, depending on the
paradigm rule. As such, during the antisaccade task the
patient is required to: (1) suppress the automatic response
to look to the target; and (2) to produce an internal vol-
untary command to look away from the target (see Fig. 1).
Additionally, working memory is required to keep the
paradigm rules online.
Though clearly involving visuospatial processing, the
cognitive demands of the antisaccade task have been
described in terms of inhibitory control and are linked with
functioning in the basal ganglia and frontal regions such as
the supplementary and frontal eye fields and dorsolateral
prefrontal cortex (DLPFC). These regions are involved in
an oculomotor network in which the superior colliculus is
the final region responsible for saccade responses. Appro-
priate processing therefore requires frontal inhibition onto
this structure [8]. Thus, antisaccade impairments are typi-
cally inferred as representative of frontostriatal dysfunction
[9]. Accordingly, performance in this task has been shown
to be impaired in various conditions with known frontos-
triatal dysfunction, including fronto-temporal dementia [7],
schizophrenia [10], attention deficit hyperactivity disorder
[11], frontal lobe lesions [12] and, of relevance here, PD.
There have been significant variations to the way sac-
cadic behavior has been investigated in PD, leading to
contradictory findings in the literature [13, 14]. Typically, a
higher proportion of research has focused on reflexive,
visually guided or memory-guided saccades, rather than
antisaccades. Nonetheless, Rivaud-Pehoux and colleagues
[15] have shown that in tasks where prosaccades and
antisaccades are combined together, patients with PD show
significant errors in antisaccade production. This is similar
to recent work [16] which has shown that even in drug-
naı¨ve PD, patients show significantly more antisaccade
errors compared to controls. In another particularly inter-
esting study [17], the antisaccade task was broken down
into three variations to assess the components necessary for
successful completion. This study suggested that deficits in
working memory for paradigm rules could not explain
differences in antisaccade performance in PD compared to
controls. Rather, they discovered that patients with PD
showed a generalized slowing of voluntary saccade pro-
duction. Additionally, they found that patients showed
significant problems in inhibiting their responses in a
delayed version of the task, concluding this to be core to
the deficits observed. This is in line with a Go/NoGo ver-
sion of the task which highlighted impaired inhibition of a
partially prepared saccadic response in patients with PD
[18].
However, antisaccades are not consistently impaired in
all patients with PD [19], and therefore it is plausible that
the heterogeneity present in the disease may impact on
antisaccade performance across study samples. Given the
observed frontostriatal deficits in patients with FOG, and in
Fig. 1 Representation of the antisaccade task used in this study.
a The participant keeps their eyes focused on the central cue (showing
green and red lights overlapping). A change in the color of the central
cue will then require one of two responses, as follows: b (prosaccade),
the patient must direct their eyes towards the peripheral light (as the
central cue is green) while in c (antisaccade), the patient must look
away from the peripheral light when it appears (as the central cue is
red)
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particular their difficulty with inhibitory control [20, 21], it
could be anticipated these patients would have an impaired
ability to perform antisaccades accurately. However, the
specific investigation of inhibitory eye movements is yet to
be investigated in PD patients with FOG.
In the current study, we aimed to explore whether
antisaccade performance was impaired in patients with
FOG, compared to those without, in relation to simple
prosaccades. Given that numerous structural changes have
been related to FOG [22–26], we aimed to investigate
whether structural imaging could help define some of the
core processes underlying poor performance of antisac-
cades. Thus, we used voxel-based morphometry (VBM) to
determine the neuroanatomical basis of any saccadic
abnormalities discovered in the antisaccade task. Specifi-
cally, we hypothesized that patients with and without FOG
would show similar levels of performance on the first,
simple prosaccade task. However, we expected those with
FOG to show an impaired ability to perform quickly and
accurately in the antisaccade task, reflecting a diminished
ability to activate effective cognitive control. Finally, we
anticipated poor antisaccade performance to correlate with
atrophy in visual and fronto-parietal areas involved in
cognitive control.
Methods
Recruitment of sample
Patient data were collected from the Parkinson’s Disease
Research Clinic at the Brain and Mind Centre, University
of Sydney. All patients met UK Brain Bank clinical criteria
[27] and did not meet MDS criteria for PD with dementia
[28]. We defined patients with FOG as those who were
observed to freeze during Movement Disorders Society-
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
[29] assessments or alternatively, if they reported FOG on
Question 3 of the Freezing of Gait Questionnaire (FOG-Q)
[30] and to a clinician during part II of the MDS-UPDRS.
Ten healthy age- and education-matched controls were
recruited from a volunteer panel, having been screened for
cognitive impairment or history of psychiatric or neuro-
logical disorders. This research was approved by the
Human Research Ethics Committee of The University of
Sydney, and written informed consent was obtained from
all participants.
Sample selection
We actively matched our groups prior to experimental
analysis to account for the possible impact of disease
severity and dopaminergic treatment on saccade
performance [31, 32]. Owing to the typical nature of
comparison between patients with (FOG) and without FOG
(no-FOG), significant group differences were shown in key
clinical characteristics for this initial sample. We chose to
remove two patients from the no-FOG group who were not
undergoing medical treatment and one patient who had
only recently been diagnosed, thus significantly altering the
profile of the no-FOG group. The groups still strongly
differed on disease duration and Hoehn and Yahr (H&Y)
staging [33] and thus we removed patients in a stepwise
manner starting with those in the FOG group with the
highest disease duration until no statistical difference
remained (four removed). This method has been used
previously [20] and led to groups being statistically
equivalent on key clinical variables prior to carrying out
any experimental testing (i.e., p[ .05; see Table 1).
Procedure
A standardized saccadometry protocol was administered
using a saccadometer Advanced (Ober Consulting,
Poland), which is a head-mounted device containing lasers
that project the target stimuli 2 m in front of the participant
on to a blank white wall [34]. Two experimental proce-
dures were carried out, each consisting of 100 trials that
were preceded by 20 calibration trials.
The first experiment (‘‘STEP task’’) was a 10-degree
STEP task designed to evoke saccades directly toward the
visual stimulus (prosaccades). Each experimental trial
began with a central target (presented during a random
fore-period of 1–2 s), followed by a peripheral target
located 10" randomly presented to the left or right. In this
task, the peripheral target was presented at the time of the
central stimulus removal, thus typically generating fewer
early saccades in normal subjects [7]. The participant was
asked to direct their eyes to this peripheral target as soon as
it appeared. The data recorded from this experiment were
used to calculate median saccadic latency and a number of
parameters (l, r, and rE) as specified in the Linear
Approach to Threshold with Ergodic Rate (LATER) model
of saccadometry analysis developed by Carpenter and
colleagues [35]. In this model, the value of l represents the
mean rate of decision processes within the main distribu-
tion of responses (with larger values indicating faster
decision-making). Additionally, r is the standard deviation
of l and thus represents variability of this rate. Finally, rE
represents the incidence of early saccades. These measures
are typically used to report data in prosaccade trials.
The second experiment (Peripheral Conflict with
Overlap; ‘‘PCO Task’’) was a cued antisaccade task (see
Fig. 1). Each trial began with overlapping central cues (1
red and 1 green) presented vertically for 1.5–2.5 s. A
single red or green central cue was then presented with a
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simultaneous and randomly sequenced left or right
peripheral target (red). If the single central cue was green,
participants were instructed to look at the peripheral tar-
get, whereas if the single central cue was red, they were
instructed to look away from the peripheral target, i.e., in
the opposite direction. Each individual trial was followed
by a gap of 750 ms, following which both central cues
would reappear. In this study, the primary outcome
measure was the percentage of correct responses for
overall (all saccades) and specific (pro- vs antisaccades)
scores in the PCO task. We did not anticipate any influ-
ence of fatigue on performance, with each trial taking
approximately 5 min to complete (including calibration).
Additionally, there is a small gap between trials, making
any oculomotor fatigue unlikely.
Raw saccadometry data were analyzed using Laten-
cyMeter (Ober Consulting, Version 4.9). Invalid traces
were automatically eliminated by LatencyMeter based on
a statistical analysis of the position and velocity profile of
each individual trace. Data were then exported to Sac-
cadic Programming and Instrumentation Computer soft-
ware (http://www.cudos.ac.uk/spic.html), for estimation
of best-fit LATER parameters of l, r, and rE. For the
STEP task, percentages and latency scores were derived
from LatencyMeter. The saccadometry tool and software
used in the current study have been used extensively in
saccade research, including in neurodegenerative diseases
[7, 36].
Clinical assessments
A series of demographic details were recorded, including
age, gender, and education. Clinical features including
disease duration, Hoehn and Yahr stage (H&Y) [33],
dopamine dose equivalence (DDE; mg/day) [37] and dis-
ease severity using the Movement Disorder Society-Uni-
fied Parkinson’s Disease Rating Scale (MDS-UPDRS) [29]
of which section III (motor sub-score) was assessed.
Additionally, self-reported mood disturbance using the
Beck Depression Inventory (BDI-II) [38] and global cog-
nitive functioning using the Minimental State Examination
(MMSE) [39] and the Montreal Cognitive Assessment
(MOCA) [40] were employed. A score comprising part B
minus part A of the trail-making test (TMT B - A) was
calculated as a typical measure of executive functioning
[41]. Color discrimination was assessed using the Farns-
worth–Munsell 100-Hue Test [42] to ensure there were no
significant visual differences between groups.
Table 1 Clinical and
demographic characteristics of
the sample including those with
(FOG), without (no-FOG)
freezing, and control subjects
FOG No-FOG Control p value
N 15 11 10
Age (years) 68.00 (7.7) 65.73 (5.2) 63.90 (7.5) .36a
Gender (male/female) 11/4 9/2 5/5 .26d
MDS-UPDRS III 33.27 (16.3) 22.45 (9.6) N/A .06b
H&Y stage (N) N/A .05d
1 1 1
2 6 9
2.5 3 0
3 4 1
5 1 0
DDE 632.00 (1300.0) 550.00 (992.0) N/A .53c
Years since diagnosis 8.13 (4.2) 5.27 (2.9) N/A .06b
Education (years) 13.86 (2.6) 13.30 (3.6) 14.25 (2.8) .78a
MMSE 30.00 (3.0) 30.00 (6.0) Not collected .84c
MOCA 28.00 (1.6) 27.60 (2.6) Not collected .64b
BDI-II 9.00 (27) 7.00 (21) Not collected .32c
Color contrast 167.00 (73.0) 120.00 (70.6) Not collected .13b
TMT B-A 54.20 (27.7) 56.36 (47.3) 43.44 (26.0) .68a
FOG-Q total 10.20 (6.0) 3.00 (2.5) N/A .00b
Means and standard deviations displayed unless data is non-parametric (c), in which case median (range)
given
a ANOVA used
b Independent samples t test used
c Mann–Whitney U test used
d Chi-square test used
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Statistical analyses
Analyses of variance (ANOVA) or Kruskal–Wallis H tests
were conducted across the three groups for parametric and
non-parametric data, respectively. Independent samples
t tests or Mann–Whitney U tests were conducted to assess
for differences between the two PD groups for parametric
and non-parametric data, respectively. Chi-square test was
used for categorical variables. The majority of saccadom-
etry data was non-parametric, and as such was entered at
once for a Kruskal–Wallis H test. Significant differences
were followed by post hoc pairwise comparisons using a
Dunn’s Bonferroni approach to control for multiple
comparisons.
Imaging acquisition
A subset of 20 PD patients (12 freezers, 8 non-freezers)
underwent structural magnetic resonance imaging (MRI).
This subset did not differ from the remaining population in
antisaccade performance or any other clinical variables (all
p[ .05). Whole-brain T1 images were acquired using a
General Electric 3 T MRI (General Electric, Milwaukee,
USA) with standard quadrature head coil (8 channels). The
3D T1-weighted sequences were acquired as follows:
coronal orientation, matrix 256 9 256, 200 slices,
1 9 1 mm2 in-plane resolution, slice thickness 1 mm, TE/
TR = 2.6/5.8 ms.
Voxel-based morphometry (VBM) analysis
Voxel-based morphometry (VBM) was performed on the
three-dimensional T1-weighted scans, using the FSL-VBM
toolbox in the FMRIB software library package. Pre-pro-
cessing of the scans firstly involved extracting the brain
from all scans using the BET algorithm in FSL, using a
fractional intensity threshold of 0.22 [43]. A grey matter
template, specific to this study, was then built from can-
vassing the maximum equal amounts from both groups
(i.e., FOG and no-FOG). Template scans were then regis-
tered to the Montreal Neurological Institute Standard space
(MNI 152) using non-linear b-spline representation of the
registration warp field, resulting in a study-specific grey
matter template at 2 mm3 resolution in standard space.
Simultaneously, the brain-extracted scans were also pro-
cessed with the FMRIB’s automatic segmentation tool
(FAST v4.0) [44] to achieve tissue segmentation into
cerebrospinal fluid, grey matter and white matter. The
FAST algorithm also corrected for spatial intensity varia-
tions such as bias field or radio-frequency inhomogeneities
in the scans, resulting in partial volume maps of the scans.
In the next step, grey matter partial volume maps were non-
linearly registered to the study-specific template via non-
linear b-spline representation of the registration warp.
These maps were then modulated by dividing by the
Jacobian of the warp field, to correct for any contraction/
enlargement caused by the non-linear component of the
transformation [45]. After normalization and modulation,
smoothing the grey matter maps occurred using an iso-
tropic Gaussian kernel (standard deviation = 3 mm; full
width half maximum = 8 mm). Finally, a voxel-wise
general linear model (GLM) was applied and permutation-
based non-parametric testing was used to form clusters
with the Threshold-Free Cluster Enhancement method.
Percent correct scores from the antisaccade task were
entered as covariates in a GLM matrix and a positive
Fig. 2 Boxplots representing error rates between groups on the PCO task; **p\ .01, *p\ .05, ns not significant; a percentage of correct
prosaccades; b percentage of correct antisaccades
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t-contrast was tested with 5000 permutations and reported
at a significance level of p\ .001 uncorrected and at a
conservative cluster threshold of greater than 100 con-
tiguous voxels.
Results
Demographic statistics and descriptives are presented in
Table 1. Table 2 shows detailed results for saccadometry
performance. Of note, there were no significant differences
across the groups for any of the STEP task outcomes (all
p values [.05), suggesting intact performance on basic
saccadometry metrics for both patient groups relative to
controls. However, the PCO task revealed specific deficits
for patients with FOG, evidenced by significantly lower
percentage of correct saccades relative to controls
(p = .00) and the same trend relative to the no-FOG group
(p = .07). Importantly, when separating the performance
between prosaccade and antisaccade trials (Fig. 2), it was
clear that the FOG groups’ poor performance on the anti-
saccade trials was driving this result, with their accuracy
significantly below the control and no-FOG groups
(p = .01). In contrast, the three groups were equivalent in
their accuracy for prosaccade trials (p = .23). The FOG
group had slower latencies compared to controls for anti-
saccade trials they performed correctly (p = .01), but not
compared to those without FOG. Both patient groups had
slower latencies than controls in the incorrect trials but this
was not statistically significant.
Relationship between antisaccade performance
and voxel-based morphometry
Across the PD patients, poorer performance (i.e., percent-
age of incorrect antisaccades) on the PCO task was related
to atrophy in occipital regions, in addition to a fronto-
parietal network. Specifically, clusters where found in the
occipital cortex, bilateral posterior parietal lobe, supple-
mentary motor cortex, left posterior lateral temporal cortex,
right inferior frontal gyrus, anterior/paracingulate cortex
and left orbitofrontal cortex (see Fig. 3; Table 3).
Discussion
In the current study, we have shown that the ability to
correctly execute antisaccades is significantly compro-
mised in patients with FOG. This was despite PD patients
with and without FOG showing relatively equal
Table 2 Descriptives and non-parametric test statistics across groups for all saccadometry variables
Saccadometry
outcomes
Group Test statistics
FOG No-FOG Control Overall group
difference
FOG vs no-FOG FOG vs control
STEP parameters
l 4.77 (4.6) 3.96 (3.8) 5.15 (1.2) H = 3.97,
p = .14
N/A N/A
r 1.02 (1.6) 1.20 (1.3) 0.88 (1.3) H = 2.70,
p = .26
N/A N/A
rE 5.06 (11.7) 0.00 (6.4) 0.00 (5.8) H = 5.37,
p = .07
N/A N/A
STEP latency 209.64 (529.4) 252.50 (297.3) 194.40 (47.0) H = 11.42,
p = .13
N/A N/A
STEP % correct 98.00 (36.0) 99.00 (31.0) 100.00 (9.0) H = 3.64,
p = .16
N/A N/A
PCO % correct 62.00 (27.0) 66.00 (33.0) 73.00 (40.0) H = 11.42,
p = .00
H = -9.51,
z = -2.28, p = .07
H = -13.78,
z = -3.21, p = .00
PCO % prosaccades
correct
92.00 (43.2) 85.70 (37.9) 90.65 (20.0) H = 2.92,
p = .23
N/A N/A
PCO % antisaccades
correct
32.00 (62.3) 58.00 (55.9) 56.65 (69.3) H = 12.86,
p = .00
H = -13.25,
z = -3.17, p = .01
H = -12.18,
z = -2.83, p = .01
PCO correct
antisaccades latency
534.00 (757.0) 476.00 (541.0) 387.00 (241.0) H = 9.88,
p = .01
H = -5.28,
z = 1.26, p = .62
H = -13.52,
z = 3.14, p = .01
PCO incorrect
antisaccades latency
297.00 (323.0) 334.00 (336.0) 219.00 (101.0) H = 11.28,
p = .00
H = -5.13,
z = -1.23, p = .66
H = -10.08,
z = 2.35, p = .06
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performance in a simple STEP task along with neuropsy-
chological measures of cognitive functioning. Moreover,
reduced performance of antisaccades related to atrophy in
fronto-parietal regions and occipital cortex, which have
previously been implicated in the pathophysiology of FOG.
These results suggest that saccadometry may be a useful
behavioral marker for FOG, and provide further evidence
of widespread visual and cognitive control regions being
associated with its pathology.
Results on the first task showed no significant differ-
ences across patient and control groups in terms of early
saccades and decision-making processes. Additionally,
measures of saccade latency and accuracy were similar for
this task across the groups. This is an important consider-
ation relative to the PCO task and suggests that differences
between these groups are not simply due to basic decision-
making or visual dysfunction. Rather, the more complex
higher cognitive demands induced by the PCO task led to
the significant group differences. However, it should be
noted that though not statistically significant, the rE vari-
able was trending towards a difference. Median rates across
groups clearly suggest a higher incidence of early saccades
in patients with FOG compared to patients without, and
controls. Table 2 shows that the median rE was 0 for both
no-FOG and control groups, while patients with FOG
showed much higher responses (5.06). This may be rele-
vant, as an increased incidence of early saccades could
indicate reduced inhibitory control of reflexive saccades
[7], consistent with impaired performance on the PCO task.
The trending difference found here may have become more
apparent in a larger sample. Even so, this is an area that is
not well understood in terms of the neural mechanics [46].
It is thought that early saccades may be a result of ineffi-
cient inhibition of the frontal cortex onto the superior
colliculus, though further exploration is needed to ade-
quately define the neural and neuropsychological correlates
of this measure.
Patients with FOG performed significantly worse on the
PCO task in terms of the overall percentages of trials that
were correctly responded to. Moreover, the errors in this
Fig. 3 VBM results showing regions of grey matter loss that
correlated with lower performance (i.e., higher error percentage) on
the antisaccade task. a Right orbitofrontal cortex; b right inferior/
middle frontal gyri; c left posterior middle/superior temporal gyri;
d supplementary motor cortex/primary motor cortex/frontal eye
fields, anterior cingulate, occipital lobe. Results uncorrected at
p\ .001; t[ 3.8
Table 3 VBM results showing areas of significant grey matter intensity decrease across all PD patients that correlated with reduced performance
on the antisaccade task
Region Hemisphere
(L/R/B)
MNI coordinates for voxel of maximal intensity Number of
voxels
T value
X Y Z
Occipital pole B 10 -92 28 696 4.90
Middle/superior temporal gyri L -50 -40 -6 567 4.90
Occipital pole R 20 -90 18 304 3.89
Inferior/middle frontal gyri R 44 8 34 203 3.89
Supramarginal gyrus/superior parietal lobule L -50 -42 4 201 4.90
Supplementary motor cortex/primary motor
cortex/frontal eye fields
B -10 -8 62 165 4.90
Anterior/paracingulate cortex B 14 24 34 141 3.89
Lateral occipital cortex/superior parietal lobule R 36 -60 46 139 3.89
Orbitofrontal cortex L -20 26 -12 125 3.58
Lateral occipital cortex/superior parietal lobule L -22 -64 64 117 4.90
Superior parietal lobule/postcentral gyrus R 12 -46 68 102 3.89
Results are uncorrected at p\ .001 and at a cluster threshold of greater than 100 contiguous voxels
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task could be specifically attributed to the antisaccade tri-
als, rather than the prosaccades. Thus, the primary deficit
observed in patients with FOG was in inhibiting the
reflexive saccade, and the production of a voluntary anti-
saccade without error. These results are aligned with recent
behavioral findings, which show that patients with FOG
make significantly more errors during incongruent tasks
which require control of inhibitory processes compared to
patients without FOG [20, 21]. Overall, the behavioral
results presented here dovetail with prior literature to
confirm that patients with FOG have deficient cognitive
control.
Cognitive control has previously been implicated as
involving a fronto-parietal network which is needed for the
orchestration of complex executive functions. In particular,
inhibitory control—a crucial function needed to perform
antisaccades—has been shown to recruit these regions. A
large-scale meta-analysis incorporating neuroimaging
results from a wide array of inhibitory tasks (Antisaccade,
Flanker, Go/No go, Simon and Stroop tasks) in 1112 par-
ticipants showed that the middle, inferior and medial
regions of frontal cortex along with the superior and infe-
rior parietal cortex are most consistently implicated in this
process [47]. In particular, the right inferior frontal cortex
is thought to behave as a brake to suppress or pause
inappropriate responses, along with involvement of sub-
cortical regions [48].
To complement our behavioral findings, and to assess if
antisaccade performance in PD was associated with atro-
phy in the aforementioned regions, antisaccade perfor-
mance was correlated with VBM analysis. Antisaccade
deficits were related to grey matter loss along key regions
in the visual processing stream, including occipital, tem-
poral and parietal cortex. Broadly, these areas are critical in
visual perception and saccade production. We also found
evidence of frontal involvement in relation to poorer per-
formance. The critical contribution of these regions,
including but not limited to the frontal eye fields, superior
parietal cortex and supramarginal gyrus, is aligned with
previous explorations of antisaccade performance [9, 49,
50]. We also identify regions in the right inferior prefrontal
cortex that correlate with antisaccade performance, regions
previously implicated in various inhibitory tasks, including
antisaccades [47]. Although we did not identify correlates
in the DLPFC specifically, which has been previously
shown to be involved in antisaccades [50], it is likely that
successful performance of antisaccade tasks relies on
integration between these many regions.
Taken together, the results of the current study suggest
that antisaccade measures are sensitive to FOG highlight-
ing that the condition is specifically associated with deficits
in cognitive control which may interact with other net-
works in the brain, presumably visual and motor, to cause
freezing episodes [4]. Our imaging results suggest that grey
matter atrophy in key visual and cognitive processing
regions mediates performance on the task, highlighting that
these regions are likely to be critically involved in the
pathophysiology of FOG. As we have previously proposed,
it is plausible that a more paroxysmal functional deficit in
communication between cortical regions described above,
and subcortical nuclei involved in locomotion are respon-
sible for the phenomenon [51]. More specifically, such a
decoupling of these regions may lead to an overwhelming
inhibition of locomotor nuclei via the subthalamic nucleus
[3]. How structural changes such as those found in this
study may influence this functional instability [51, 52] is an
interesting avenue for further research.
It is important to recognize, however, that the impaired
performance of antisaccades is not likely to be unique to
patients with FOG, but rather appears to be more exten-
sively impaired in those patients that experience FOG.
Antisaccades have indeed been shown to be impaired in PD
compared to healthy controls, similarly to executive func-
tioning [13]. We also highlight that the current results were
found in a relatively small sample size and thus need
replication. An important future direction of study would
be to assess whether antisaccade performance can act as an
early neurophysiological marker for subsequent FOG
evolution. Interestingly, antisaccade performance is
already in use as a potential predictor of motor and non-
motor progression in PD [16]. This is particularly relevant
given the current sample did not show differences in
classical neuropsychological measures of global cognition
and executive function (e.g., MoCA and trail-making test
scores). Therefore, saccadometry may provide a novel and
objective technique for tapping into early deficits, which
cannot be detected in more general neuropsychological
tasks. Only more extensive longitudinal studies could
answer these questions.
These findings also point to rehabilitation strategies
which target the fronto-parietal executive networks of the
brain, that are likely involved in the pathogenesis of
freezing episodes. As previously argued [53], we suggest
techniques such as cognitive training which is known to be
effective on executive functions in PD [54], or non-inva-
sive magnetic/electrical stimulation [55] are worth further
exploration to this end. Finally, given the functional nature
of FOG [3, 4], antisaccade tasks could be employed while
patients undergo functional imaging [50], offering a novel
window into the way in which executive and visual net-
works are dysfunctional in PD patients with FOG.
The current results have shown that patients with FOG
show a significant inability to inhibit reflexive saccades
prior to initiating goal-directed voluntary saccades. This
finding is aligned with the literature, and supports
hypotheses of a cognitive control deficit in FOG. The VBM
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analysis was able to uncover anatomical abnormalities
which may be responsible for these deficits, and infer that
cognitive control and visual-motor networks are central to
the behavioral deficits observed. Further research to
explore these processes in real-time are needed, and may
help to uncover important and vitally needed treatments for
this disabling condition.
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A B S T R A C T
Previous research has shown that anxiety in Parkinson’s disease (PD) is associated with freezing of gait
(FOG), and may even contribute to the underlying mechanism. However, limited research has
investigated whether PD patients with FOG (PD + FOG) have higher anxiety levels when compared
directly to non-freezing PD patients (PD-NF) and moreover, how anxiety might contribute to FOG. The
current study evaluated whether: (i) PD + FOG have greater anxiety compared to PD-NF, and (ii) anxiety in
PD is related to attentional set-shifting, in order to better understand how anxiety might be contributing
to FOG. In addition, we explored whether anxiety levels differed between those PD patients with mild
FOG (PD + MildFOG) compared to PD-NF. Four hundred and sixty-one patients with PD (231 PD-NF, 180
PD + FOG, 50 PD + MildFOG) were assessed using the Freezing of Gait Questionnaire item 3 (FOG-Q3),
Hospital Anxiety and Depression Scale (HADS), Digit Span Test, Logical Memory Retention Test and Trail
Making Tests. Compared to PD-NF, PD + FOG had significantly greater anxiety (p < 0.001). PD + MildFOG,
however, demonstrated similar levels of anxiety as the PD + FOG. In all patients, the severity of anxiety
symptoms was significantly correlated to their degree of self-reported FOG on FOG-Q3 (p < 0.001) and
TMT B-A (p = 0.039). Similar results were found for depression. In conclusion, these results confirm the
key role played by anxiety in FOG and also suggest that anxiety might be a promising biomarker for FOG.
Future research should consider whether treating anxiety with pharmacological and/or cognitive
behavioural therapies at early stages of gait impairment in PD may alleviate troublesome FOG.
ã 2016 Elsevier B.V. All rights reserved.
1. Introduction
Anxiety disorders such as generalized anxiety disorder, panic
disorder and phobias have been argued to be one of the earliest
manifestations of Parkinson’s disease (PD) [1–3]. Patients with PD
and their caregivers rank anxiety and falls as the top two
symptoms that require better management in order to improve
quality of life [4,5]. One of the most common causes of falls in PD is
freezing of gait (FOG), which is characteristically described as a
transient cessation of gait, where patients report feeling as though
their feet become glued to the floor [6]. A relationship between
generalized symptoms of anxiety and severe gait impairments has
been noted [7–9], and mood disorders (such as generalized anxiety
or depression) have also been suggested to be more common in
those with PD who experience FOG [7,10]. Panic attacks are also
often associated with freezing episodes [11,12], and recent findings
have shown that walking in threatening situations which provoke
anxiety, also provoke more FOG episodes [9].
Although, the underlying pathophysiological mechanisms of
FOG are still unclear, recent research has proposed that anxiety
might contribute to the underlying mechanism of FOG [9,11,13], by
overloading the capacity of the basal ganglia to process competing
yet concurrent inputs (i.e. cognitive, sensorimotor, emotional)
[13,14]. Interconnections between the limbic and motor circuits
within the basal ganglia (nucleus accumbens) permit emotional
input to interfere with motor outputs (resulting in FOG) [9].
Attention and executive function deficits are also features of
basal ganglia pathology even in early PD. Attentional set-shifting
deficits, which reflect disturbance in the fronto-striatal pathway
[14–17], are often worse in PD + FOG compared to PD-NF [18–21].
These cognitive impairments are especially detrimental to those
who have severe gait impairments, since they rely on attention to
compensate for their movement impairment [22]. Given that
individuals with PD, especially PD + FOG, rely on attention to
* Corresponding author.
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compensate for their gait impairments (i.e. loss of automaticity),
anxiety might also contribute to FOG by consuming attentional
resources [23–25]. As a result, anxiety may interfere with executive
processes (e.g. attentional set-shifting) that are needed in order to
compensate for severe gait impairments [9,26,27]. Therefore,
anxiety might play a key role in the development of FOG, and as
such may be important to consider for early interventions and
future therapies to delay or prevent the onset of FOG.
The aim of the current study was to evaluate (i) whether
PD + FOG have greater levels of anxiety compared to PD-NF, (ii)
whether anxiety in PD is associated with attentional set-shifting
deficits, and (iii) whether anxiety might be a useful predictor of
those who develop FOG. In addition, we explored whether anxiety
levels differed between those patients with PD in the early stages
of gait impairment (PD + MildFOG) compared to PD-NF. We
hypothesized that both the PD + FOG and PD + MildFOG groups
will demonstrate higher clinical levels of anxiety compared to the
PD-NF group. We also expected that attentional set-shifting
deficits will be related to the severity of anxiety in PD. Finally, it
was expected that the severity of anxiety might predict those who
experience FOG. By addressing these questions, we hope to
extend previous research by examining the relationship between
FOG, anxiety and attentional set-shifting, in order to provide
insight as to the feasibility of using anxiety as a FOG biomarker
and as a potential target for early interventions and future FOG
therapies.
2. Methods
2.1. Subjects
The subjects included in this study were recruited from a
larger cohort of cases prospectively evaluated between 2008 and
2015 at the PD Research Clinic at the Brain and Mind Centre,
University of Sydney. All participants have a confirmed diagnosis
of idiopathic PD (based on the United Kingdom Brain Bank clinical
criteria) by a trained neurologist (SGJL), and all patients gave
written informed consent to the study, which was approved by
the University of Sydney Human Research and Ethics Committee.
Four hundred and sixty-one PD patients were included in this
study. Participants were divided into three groups (PD-NF,
PD + FOG, PD + MildFOG) based on their score on the FOG-
Questionnaire item 3 (FOG-Q3) (“Do you feel that your feet get
glued to the floor while walking, making a turn or when trying to
initiate walking (freezing)?”) [28]. This measure is a reliable
screening tool to identify ‘freezers’[29]. Two hundred and thirty-
one patients were classified as PD-NF (scored 0-“Not at all” on
FOG-Q3), 180 patients were classified as PD + FOG (scored
between 2 and 4: 2-“rarely, about once a week”; 3-“often, about
once a day”; 4-“always, whenever walking” on FOG-Q3), and 50
patients were classified as PD + MildFOG (scored of 1-“Very rarely,
about once a month” on FOG-Q3). Exclusion criteria included: the
presence of neurological diseases other than PD, psychiatric
disorders other than an affective disorder, and/or mini-mental
state examination (MMSE) score below 24 indicating dementia.
One hundred and twenty-nine patients (62 PD-NF; 54 PD + FOG;
13 PD + MildFOG) in this study were taking anti-depressants and/
or anxiolytic medications.
2.2. Data collection and analyses
To evaluate anxiety and depression separately, the Hospital
Anxiety and Depression Scale was administered. The ‘Anxiety’
subscale (HADS-A) and ‘Depression’ subscale (HADS-D) was
subtotalled and compared between groups. FOG-Q3 was selected
to reflect FOG severity rather than the total FOG-Q score, based on
findings by Shine and colleagues which demonstrated that item 3
from the FOG-Q was most strongly associated with actual
behavioural freezing events compared to the total score of the
FOG-Q [29]. To evaluate attentional and executive functions
participants also completed the Trail Making Test Parts A (TMT-
A) and B (TMT-B), as well as the Digit Span Test (backwards and
forwards). The primary measure of set-shifting ability was the
difference in time to complete Parts A and B of the Trail Making test
(TMT B-A). Whereas, attention and working memory was assessed
by the forward and backward Digit Span respectively (refer to
Table 1). In order to demonstrate a selective relationship between
anxiety and executive functions, a Logical Memory Test (LM%
retention) was also carried out. Since this test is not an executive
function, it was not expected to be related to anxiety or FOG and
thus acted as a control measure to assess whether the relationship
between anxiety, FOG and cognition is specific to executive
functioning. Finally, global cognitive functioning was examined
with MMSE. Participants were assessed on their regular dopami-
nergic medication.
An ANOVA was conducted across the three groups and
significant findings were further analysed using Tukey’s post
hoc tests. Due to the group differences in MMSE, UPDRS-III and
Disease duration at baseline, a covariate analysis was also
conducted.
Pearson’s correlations were performed to test associations
between neuropsychiatric, neurocognitive, and clinical variables
(reported in Table 2). Stepwise multiple regression analyses were
performed to examine the relative contribution of neuropsychiat-
ric, neurocognitive and disease related variables to FOG in PD.
In order to determine whether HADS anxiety score might be a
useful measure to predict FOG, we collapsed the PD + MildFOG and
PD + FOG into one PD + FOG group (N = 230), compared to the PD-
NF group (N = 231). Then patients were categorized as having
anxiety and/or depression if they scored 8 or above on the HADS-A
and/or HADS-D section. Using this criterion, the PD-NF group had
24 patients with anxiety and 207 without, as well as 23 patients
with depression, and 208 without (10 of the patients in the PD-NF
group had both anxiety and depression). In the PD + FOG group
there were 65 patients with anxiety and 165 without, and 66
patients with depression and 164 without 39 of the patients in the
PD + FOG group had both anxiety and depression. Odds ratio,
positive predictive values and negative predictive values were
reported.
3. Results
3.1. Group differences in anxiety
A significant main effect of group was found for anxiety (F
(2,458) = 17.97, p < 0.001). PD + FOG had significantly greater levels
of anxiety compared to PD-NF (p < 0.001). However, PD + MildFOG
was not significantly different from PD + FOG (p = 0.18) (see Fig. 1).
Notably, even when UPDRS-III, disease duration and MMSE were
entered as covariates, the group effect remained significant (F
(2,371) = 11.92, p < 0.001). This group effect also remained signifi-
cant when depression (HADS-D) was added as a covariate (F
(2,368) = 4.23, p = 0.015), and likewise when TMT B-A and
backwards Digit Span were added as covariates (F(2,257) = 3.03,
p = 0.05).
3.2. Group differences in executive functioning
A significant main effect of group was found for the time to
complete TMT-A (F(2,289) = 8.27, p < 0.001), TMT-B (F
(2,281) = 8.62, p < 0.001) and TMT B-A (F(2,281) = 7.22, p = 0.001).
PD + FOG (p = 0.001) and PD + MildFOG (p = 0.041) took
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significantly longer to complete TMT-A compared to PD-NF.
PD + FOG (p = 0.001) and PD + MildFOG (p = 0.021) also took
significantly longer to complete TMT-B compared to PD-NF.
However, only the PD + FOG group scored significantly higher on
the TMT B-A (p = 0.002) compared to PD-NF. The PD + MildFOG
group scored marginally higher on the TMT B-A compared to the
PD-NF (p = 0.058). It should be noted that only the group effect seen
in the TMT-A remained significant when UPDRS-III, Disease
duration and MMSE were entered as covariates (TMT-A: F
(2,273) = 3.08), p = 0.048, TMT-B: F(2,266) = 2.65, p = 0.073; TMT
B-A: F(2,266) = 1.49, p = 0.228). The group effect for TMT-A also
remained significant if HADS-A and HADS-D were added as
covariates (F(2,269) = 3.43, p = 0.037).
A significant main effect of group was also found for the
backwards Digit Span (F(2,288) = 6.07, p = 0.003). PD + FOG per-
formed significantly worse on the backwards digit span compared
to PD-NF (p = 0.011). PD + MildFOG also performed significantly
worse on the backwards digit span compared to PD-NF (p = 0.027).
The main effect of group did not remain significant when UPDRS-
III, Disease duration and MMSE (F(2,270) = 2.55, p = 0.08) were
entered as covariates.
3.3. Predictors of freezing of gait
Disease duration, UPDRS-III, MMSE, HADS-A, HADS-D, TMT-A,
TMT-B, TMT B-A, backwards Digit Span were entered into a
stepwise regression analysis to predict FOG-Q3 (Table 2). The best
predictors of FOG were disease duration, depression, motor
symptom severity, and anxiety, which accounted for approximate-
ly 28% of the variance (F(4,261) = 25.17, p < 0.001). The resultant
regression equation was:
Predicted FOG = !0.304 + 0.057(disease duration) + 0.061
(HADS-D) + 0.018(UPDRS-III)+ 0.057(HADS-A).
Table 2
Correlations between FOG, neuropsychological, neuropsychiatric and demographic
variables.
FOG-Q3 HADS-A HADS-D
FOG-Q3 0.276*** 0.316***
HADS-A 0.276*** 0.619***
HADS-D 0.316*** 0.619***
Age 0.092 !0.120* 0.084
UPDRS-III 0.379*** 0.123* 0.332***
Disease Duration 0.292*** 0.101* 0.187***
MMSE !0.154** !0.169** !0.229***
TMT-A 0.231*** 0.026 0.174**
TMT-B 0215*** 0.104 0.179**
TMT B-A 0.199** 0.117* 0.153*
Forward Digit Span !0.049 !0.006 !0.025
Backwards Digit Span !0.165** !0.024 !0.029
Logical Memory (% retention) !0.088 !0.012 !0.072
R values reported in the table.
* Denotes a significant relationship at the p < 0.05 level.
** Indicates a significant relationship at the p < 0.01 level.
*** Denotes a significant relationship at the p < 0.001 level.
Fig. 1. highlights the group differences between PD + FOG and PD-NF on their HADS
anxiety score. * Indicates significant difference (p < 0.05).
Table 1
Demographic data and outcome measures of patient groups.
PD-NF PD + Mild FOG PD + FOG P-value
Age
M 67.8 69.3 69.2 P = 0.303
SE 0.64 1.09 0.77
N 228 49 173
Gender
150M 34M 109M
81F 16F 71F
Disease Duration
M 3.8 6.3 8.7 P < 0.001
SE 0.56 0.87 0.6
N 218 47 164
Age of Onset
M 63.5 63.3 59.3 P = 0.008
SE 0.7 1.4 1.4
N 222 46 168
UPDRS-III
M 28.3 33.5 41.5 *P < 0.001
SE 1.1 2.5 1.3
N 217 46 168
MMSE
M 28.2 27.6 27.4 *P < 0.005
SE 0.16 0.24 0.30
N 203 41 148
FOG-Q3
M 0 1 3 *P < 0.001
SE 0 0 0.05
N 231 50 180
HADS-A
M 3.5 4.7 5.8 *P < 0.001
SE 0.22 0.55 0.31
N 231 50 180
HADS-D
M 3.6 4.2 6.2 *P < 0.001
SE 0.23 0.48 0.31
N 230 50 179
TMT-A (sec)
M 41.0 52.1 52.1 P = 0.072
SE 1.47 5.17 2.74
N 161 31 100
TMT-B (sec)
M 101.8 141.6 138.6 P = 0.093
SE 5.12 17.77 8.28
N 159 31 94
TMT B-A (sec)
M 61.2 89.5 89.8 P = 0.241
SE 4.3 13.9 7.0
N 159 31 94
Forward Digit Span
M 10.3 9.8 10.1 P = 0.801
SE 0.19 0.43 0.26
N 160 31 101
Backward Digit Span
M 6.8 5.7 6.0 P = 0.087
SE 0.18 0.35 0.18
N 160 31 100
LM% Retention
M 75.0 77.3 70.6 P = 0.353
SE 1.57 3.33 2.06
N 158 31 97
Note: Bolded p-values denote p-values from covariate analysis where Age, UPDRS-
III and MMSE were factored out of outcome measure analysis. M = mean,
SE = standard error, N = number of participants, UPDRS-III = Unified Parkinson’s
Disease Rating Score, motor subsection.
* Reflects significant findings.
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3.4. Using anxiety and depression to determine the odds of developing
FOG
Finally, a significant odds ratio of 3.40 [95% CI: 2.04–5.66] was
found (z = 4.69, p < 0.0001) when anxiety (HADS-A score 8 + ) was
used as the exposure variable and FOG as the outcome.
Additionally, the HADS anxiety score yielded a Positive Predictive
Value of 28.26% [95% CI: 22.26%–34.55%] for identifying patients
with FOG and a Negative Predictive Value of 89.61% [95% CI:
84.94%–93.23%] for identifying patients without FOG.
A similar odds ratio of 3.63 [95% CI: 2.17–6.1] was found (z = 4.9,
p < 0.0001) when depression (HADS-D score 8 + ) was used as the
exposure variable and FOG as the outcome. The HADS depression
score yielded a similar Positive Predictive Value of 28.7% [95% CI:
22.94%–35.01%] for identifying patients with FOG and a Negative
Predictive Value of 90.04% [95% CI: 85.44%–93.58%] for identifying
patients without FOG.
4. Discussion
We sought to determine whether anxiety might be a useful
predictor of FOG by evaluating whether PD + FOG had more severe
generalized symptoms of anxiety compared to PD-NF and its’
relation to executive function and attentional set-shifting deficits.
First, PD + FOG reported significantly worse anxiety symptoms
compared to the PD-NF group as we had predicted. It is noteworthy
that this group effect remained significant after accounting for
motor symptom severity, disease duration, global cognitive status,
depression, set-shifting ability and working memory performance.
Individuals in the Mild + FOG group demonstrated more anxiety
symptoms than PD-NF but less than PD + FOG. Both freezer groups
also demonstrated attention and executive function deficits.
Second, anxiety and depression was significantly correlated with
set-shifting ability and FOG. Third, anxiety and depression was a
significant predictor of FOG and provided a significant odds ratio as
well as promising positive and negative predictive values. To our
knowledge, this is the first study to provide evidence that anxiety
may be a useful predictor of FOG, and also the first to demonstrate a
relationship between anxiety and set-attentional shifting deficits
in PD.
Consistent with previous literature, the current study provides
additional evidence that anxiety and FOG are associated [7,10,11],
and supports the notion that anxiety may be an important
independent contributor to the underlying pathophysiology of
FOG [9]. Anxiety has been postulated to be a prodromal symptom
of PD [30], resulting from damage to the brainstem nuclei (e.g.
locus coeruleus), striatum and amygdala [31–36]. Furthermore,
FOG has been suggested to manifest in instances where the
dopamine-depleted striatum is unable to process the competing
yet concurrent inputs from the cognitive-, motor- and limbic-
loops [13,14]. Researchers have suggested that anxiety might
contribute to FOG by overloading the limbic input into the striatum
and thus interfere with competing information processing within
the BG [9]. If anxiety does indeed present prior to motor
symptoms, then one explanation for why anxiety might predict
FOG is that as the basal ganglia degenerates, attention becomes
necessary to compensate for movement impairments. However,
anxiety or emotional dysregulation may also progressively
generate more interference by demanding greater attentional
resources and disrupting one’s ability to employ compensatory
strategies as the disease advances. Research has demonstrated the
strength of the limbic response, such that threat-related process-
ing receives privileged access and priority to attentional processing
resources, since the amygdala can allocate these resources through
the ventral attentional network to prioritize threat-related
processing and disrupt other cognitive processes [23–25]. In
support of this notion, greater anxiety was associated with longer
time to switch attention between tasks in the current study.
Previous research has also shown that anxiety in PD can disrupt
sensory feedback processing during walking, and provoke FOG
episodes [9,37]. Considering that anxiety might play a key role not
only provoking FOG but developing the phenomenon, this presents
a new avenue for FOG prevention and therapy. For example,
treating anxiety with pharmacological and cognitive behavioural
therapies when PD patients first develop freezing might alter the
progression and impact of this symptom. Unfortunately, there have
been no studies to date that have reported treating FOG by
attempting to reduce anxiety either pharmacologically or non-
pharmacologically so further research is needed.
Based on this sample, the chance of someone having FOG was
3.4 times more likely if PD patients had clinical anxiety (HADS-A
score 8 + ) compared to those who did not. The HADS-A also
provided an excellent negative predictive value of 89.61% (i.e.
correctly identifying those patients who do not have FOG),
whereas it had a much more modest positive predictive value of
28.26% (i.e. correctly identifying just over a quarter of those
patients who do have FOG). Depression revealed a similar odds
ratio, positive and negative predictive values as anxiety scores. This
was not a surprising result considering the comorbidity of these
affective symptoms. Furthermore, both anxiety and depression
were significant predictors of FOG in addition to disease duration
and motor symptom severity. Taken together, these findings
suggest that both anxiety and depression are important factors to
consider when trying to predict individuals with PD who will
develop FOG in order to implement early interventions.
It is important to point out that the HADS-A (or HADS-D) only
predicted a quarter of individuals that had FOG. Therefore, these
affective symptoms do not fully explain FOG but rather might
contribute to FOG in some individuals. Indeed, given that FOG
remains a difficult phenomenon to study, due to the heterogeneity
and unpredictable episodes, it is possible that different subtypes of
PD + FOG exist and that anxiety/depression may represent one
significant modifiable factor.
As predicted, we observed deficits in attentional and executive
functions in both FOG groups. More specifically, set-shifting ability
and working memory was worse in PD + FOG and PD + MildFOG
compared to PD-NF. These findings are similar to previous reports
[18–21] which have been argued to reflect disturbance in
frontostriatal pathways [14–17]. Although both of these measures
were associated with FOG, only attentional set-shifting was related
to anxiety and depression. This result in addition to the null results
found for logical memory provide support for our hypothesis
suggesting that anxiety in PD is selectively related to attentional
set-shifting.
We would like to acknowledge some limitations within this
study. Although the reliability and convergent validity for HADS is
good, it has poor discriminant validity, and recently has not been
recommended to diagnose anxiety in PD [38,39]. Others have
argued that HADS-A has clinical and research utility for evaluating
generalized anxiety symptom severity[40]. One of the major
concerns is with the sensitivity rather than the specificity of HADS
in PD. Taking this into consideration, our findings are likely a
conservative representation of the relationship between anxiety/
depression and FOG. We would recommend that future research
should investigate this relationship between anxiety/depression
and FOG with more sensitive measures of anxiety and depression,
and evaluate whether these measures can identify at risk
individuals who might respond to targeted early interventional
therapy to reduce troublesome FOG.
It is also important to recognize that the relationship between
anxiety and FOG does not dissociate whether anxiety precedes
the onset of FOG. PD + MildFOG reported more severe anxiety
434 K.A.E. Martens et al. / Gait & Posture 49 (2016) 431–436
than PD-NF but less than PD + FOG, but the PD + MildFOG did not
statistically differ from either group. This could be interpreted as
indirectly supporting the notion that anxiety may precede FOG,
since those with less FOG had similar levels of anxiety as those
who experience FOG much more frequently. Alternatively, one
might suggest that the onset of FOG leads to heighted anxiety due
to the unpredictable nature and debilitating consequences of
these episodes (such as falling). Unfortunately, a fall history or
fear of falling report was not assessed in the current study. We
recommend that future research should consider implementing
these measures in order to determine whether anxiety might be a
promising biomarker of FOG. Furthermore, limited research has
investigated the influence of anxiety on cognition in PD. In order
to better understand the relationship between anxiety, FOG and
executive functions, more detailed neuropsychological investiga-
tion needs to be done in order to understand how anxiety might
be affecting cognition in individuals with PD prior to developing
FOG.
In conclusion, this study provides direct evidence that anxiety is
greater in PD patients who experience troublesome FOG compared
to those who do not, and may be a useful predictor of those who
might develop FOG. This study also suggests that anxiety is
associated with set-shifting deficits common to PD + FOG. Future
research should consider whether treating anxiety with pharma-
cological and/or cognitive behavioural therapies at early stages of
gait impairment in PD may alter the onset and progression of FOG.
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Research on the implications of anxiety in Parkinson’s disease (PD) has been neglected despite its prevalence in nearly 50% of
patients and its negative impact on quality of life. Previous reports have noted that neuropsychiatric symptoms impair cognitive
performance in PD patients; however, to date, no study has directly compared PD patients with and without anxiety to examine
the impact of anxiety on cognitive impairments in PD.This study compared cognitive performance across 50 PD participants with
and without anxiety (17 PDA+; 33 PDA−), who underwent neurological and neuropsychological assessment. Group performance
was compared across the following cognitive domains: simple attention/visuomotor processing speed, executive function (e.g., set-
shifting), working memory, language, and memory/new verbal learning. Results showed that PDA+ performed significantly worse
on the Digit Span forward and backward test and Part B of the Trail Making Task (TMT-B) compared to the PDA− group.There
were no group differences in verbal fluency, logical memory, or TMT-A performance. In conclusion, anxiety in PD has ameasurable
impact on working memory and attentional set-shifting.
1. Introduction
Anxiety affects quality of life in those living with Parkinson’s
disease (PD) more so than overall cognitive status, motor
deficits, apathy, and depression [1–3]. Although anxiety and
depression are often related and coexist in PD patients [4],
recent research suggests that anxiety rather than depression
is themost prominent and prevalent mood disorder in PD [5,
6]. Yet, our current understanding of anxiety and its impact
on cognition in PD, as well as its neural basis and best treat-
ment practices, remains meager and lags far behind that of
depression [7].
Overall, neuropsychiatric symptoms in PD have been
shown to be negatively associated with cognitive perfor-
mance. For example, higher depression scores have been
correlated with lower scores on the Mini-Mental State Exam
(MMSE) [8, 9] as well as tests of memory and executive func-
tions (e.g., attention) [10–14]. Likewise, apathy and anhedonia
in PD patients have been associated with executive dysfunc-
tion [10, 15–23]. However, few studies have specifically inves-
tigated the relationship between anxiety and cognition in PD.
One study showed a strong negative relationship between
anxiety (both state and trait) and overall cognitive perfor-
mance (measured by the total of the repeatable battery for
the assessment of neuropsychological status index) within
a sample of 27 PD patients [24]. Furthermore, trait anxiety
was negatively associated with each of the cognitive domains
assessed by the RBANS (i.e., immediatememory, visuospatial
construction, language, attention, and delayedmemory). Two
further studies have examined whether anxiety differentially
affects cognition in patients with left-sided dominant PD
(LPD) versus right-sided dominant PD (RPD); however,
their findings were inconsistent. The first study found that
working memory performance was worse in LPD patients
with anxiety compared to RPD patients with anxiety [25],
whereas the second study reported that, in LPD, apathy but
not anxiety was associated with performance on nonverbally
mediated executive functions and visuospatial tasks (e.g.,
TMT-B,WMS-III spatial span), while in RPD, anxiety but not
apathy significantly correlated with performance on verbally
mediated tasks (e.g., clock reading test and Boston naming
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Table 1: Demographic and clinical variables in PD participants.
Variable PDA−(푁 = 33) PDA+(푁 = 17) 푝 values
Demographic
Age (years) 68.3 (8.9) 64.9 (8.1) 푝 = 0.20
Gender (% male) 19/14 (57.6%) 9/8 (52.9%) 푝 = 0.75
Clinical
Disease duration
(years) 6.6 (4.2) 6.6 (5.6) 푝 = 0.66
UPDRS-III 31.9 (13.0) 31.2 (15.3) 푝 = 0.65
LPD/RPD ratio
(% LPD) 15/17 (45.5%) 6/11 (35.3%) 푝 = 0.38
H&Y stage,
median (range) 2.0 (1–4) 2.0 (1–5) 푝 = 0.43
LEDD, mg/day 674.0 (550.5) 710.2 (478.7) 푝 = 0.80
HADS-A 2.03 (1.6) 10.5 (1.9) ∗푝 < 0.001
HADS-D 3.2 (1.7) 4.1 (1.6) 푝 = 0.06
HADS-total 5.2 (2.7) 14.7 (2.9) ∗푝 < 0.001
Note: values reflect mean (SD). LEDD: levodopa equivalent daily dose. ∗
indicates significant group differences.
test) [15]. Furthermore, anxiety was significantly correlated
with neuropsychological measures of attention and executive
and visuospatial functions [15]. Taken together, it is evident
that there are limited and inconsistent findings describing the
relationship between anxiety and cognition in PD and more
specifically how anxiety might influence particular domains
of cognition such as attention and memory and executive
functioning. It is also striking that, to date, no study has
examined the influence of anxiety on cognition in PD by
directly comparing groups of PD patients with and without
anxiety while excluding depression. This was the primary
objective of the current study.
Given that research on healthy young adults suggests that
anxiety reduces processing capacity and impairs processing
efficiency, especially in the central executive and attentional
systems of working memory [26, 27], we hypothesized
that PD patients with anxiety would show impairments in
attentional set-shifting and working memory compared to
PD patients without anxiety. Furthermore, since previous
work, albeit limited, has focused on the influence of symptom
laterality on anxiety and cognition, we also explored this
relationship.
2. Methods
Seventeen PD patients with anxiety and thirty-three PD
patients without anxiety were included in this study (see
Table 1).The cross-sectional data from these participants was
taken from a patient database that has been compiled over the
past 8 years (since 2008) at the Parkinson’s Disease Research
Clinic at the Brain and Mind Centre, University of Sydney.
Inclusion criteria involved a diagnosis of idiopathic PD
according to theUnitedKingdomParkinson’sDisease Society
Brain Bank criteria [28] and were confirmed by a neurologist
(SJGL). Patients also had to have an adequate proficiency
in English and have completed a full neuropsychological
assessment. Ten patients in this study (5 PD with anxiety;
5 PD without anxiety) were taking psychotropic drugs (i.e.,
benzodiazepine or selective serotonin reuptake inhibitor).
Patients with an MMSE of less than 24 were excluded.
Patients were also excluded if they had other neurological
disorders, psychiatric disorders other than affective disorders
(such as anxiety), or if they reported a score greater than
six on the depression subscale of the Hospital Anxiety and
Depression Scale (HADS).Thus, all participants who scored
within a “depressed” (HADS-D > 6) range were excluded
from this study, in attempt to examine a refined sample of
PD patients with and without anxiety in order to determine
the independent effect of anxiety on cognition.This research
was approved by the Human Research Ethics Committee of
the University of Sydney, and written informed consent was
obtained from all participants.
Self-reported HADS was used to assess anxiety in PD
and has been previously shown to be a useful measure of
clinical anxiety in PD [29]. A cut-off score of>8on the anxiety
subscale of the HADS (HADS-A) was used to identify PD
cases with anxiety (PDA+), while a cut-off score of <6 on
the HADS-A was used to identify PD cases without anxiety
(PDA−).This criterionwasmore stringent thanusual (>7 cut-
off score) [30], in effort to create distinct patient groups.
All participants underwent a neurological assessment
conducted while on their medications. The neurological
evaluation rated participants according to Hoehn and Yahr
(H&Y) stages [31] and assessed their motor symptoms using
part III of the revised MDS Task Force Unified Parkinson’s
Disease Rating Scale (UPDRS) [32]. In a similar way, symp-
tom laterality was determined by taking a left/right ratio.This
was determined by calculating a total left and right score
from rigidity items 30–35, voluntary movement items 36–43,
and tremor items 50–57 from the MDS-UPDRS part III (see
Table 1).
Neuropsychological functioning was assessed using stan-
dardized tests and appropriate normative data. A detailed
description of the neuropsychological battery was reported
elsewhere [33]. Processing speed was assessed using the Trail
Making Test, Part A (TMT-A, z-score) [34]. Attentional set-
shifting was measured using the Trail Making Test, Part
B (TMT-B, z-score) [34]. Working memory was assessed
using the Digit Span forward and backward subtest of the
Wechsler Memory Scale-III (raw scores) [35]. Language was
assessed with semantic and phonemic verbal fluency via the
Controlled Oral Word Associated test (COWAT animals and
letters, z-score) [36]. The ability to retain learned verbal
memory was assessed using the Logical Memory subtest
from the Wechsler Memory Scale-III (LM-I z-score, LM-II
z-score, % LM retention z-score) [35].TheMini-Mental State
Examination (MMSE) was used to assess global cognition.
2.1. Statistical Analyses. The Shapiro-Wilk test was performed
to determine normal distribution.Demographic, clinical, and
neuropsychological variables were compared between the
two groups with the independent t-test or Mann–Whitney푈 test, depending on whether the variable met parametric
assumptions. Chi-square tests were used to examine gender
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Table 2: Neuropsychological performance.
PDA−
(푁 = 33) PDA+(푁 = 17) 푝 values
Global cognition
MMSE 28.2 (1.5) 27.5 (1.8) 푝 = 0.23
Attention/visuomotor
processing speed
TMT-A, 푧-score −0.15 (1.2) 0.66 (2.23) 푝 = 0.62
Executive function
TMT-B, 푧-score −0.02 (1.1) −0.85 (1.8) ∗푝 = 0.048
Working memory
Digit Span forward total 10.6 (2.3) 8.8 (3.2) ∗푝 = 0.031
Digit Span backward total 7.2 (2.8) 5.7 (1.5) ∗푝 = 0.012
Language
Semantic verbal fluency,푧-score −0.04 (1.0) −0.26 (1.1) 푝 = 0.49
Phonemic verbal fluency,푧-score −0.10 (1.1) −0.23 (1.2) 푝 = 0.70
Memory/new verbal
learning
LM-I immediate recall,푧-score −0.21 (1.1) −0.83 (1.1) 푝 = 0.059
LM-II, 푧-score 0.10 (1.1) −0.29 (1.1) 푝 = 0.20
% LM retention, 푧-score 0.40 (1.2) 0.14 (1.2) 푝 = 0.43
Note: values represent mean (SD). ∗ indicates significant differences at the푝 < 0.05 level.
and symptom laterality differences between groups. All anal-
yses employed an alpha level of 푝 < 0.05 and were two-
tailed. Spearman correlations were performed separately in
each group to examine associations between anxiety and/or
depression ratings and cognitive functions.
3. Results
3.1. Demographic and Clinical Characteristics. As expected,
the PDA+ group reported significant greater levels of anxiety
on the HADS-A (푈 = 0, 푝 < 0.001) and higher total score
on the HADS (푈 = 1, 푝 < 0.001) compared to the PDA−
group (Table 1). Groups were matched in age (푡(48) = 1.31,푝 = 0.20), disease duration (푈 = 259, 푝 = 0.66), UPDRS-
III score (푈 = 250.5, 푝 = 0.65), H&Y (푈 = 245, 푝 = 0.43),
LEDD (푈 = 159.5, 푝 = 0.80), and depression (HADS-D)
(푈 = 190.5, 푝 = 0.06). Additionally, all groups were matched
in the distribution of gender (휒2 = 0.098, 푝 = 0.75) and side-
affected (휒2 = 0.765, 푝 = 0.38).
3.2. Cognitive Functioning. There were no group differences
for TMT-A performance (푈 = 256, 푝 = 0.62) (Table 2); how-
ever, the PDA+ group had worse performance on the Trail
Making Test Part B (푡(46) = 2.03, 푝 = 0.048) compared to the
PDA− group (Figure 1).The PDA+ group also demonstrated
significantly worse performance on the Digit Span forward
subtest (푡(48) = 2.22, 푝 = 0.031) and backward subtest (푈 =190.5, 푝 = 0.016) compared to the PDA− group (Figures 2(a)
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Figure 1: PD patients with anxiety performed significantly worse on
Part B of the Trail Making Task compared to PD patients without
anxiety. ∗ denotes 푝 values < 0.05. Error bars represent standard
error.
and 2(b)). Neither semantic verbal fluency (푡(47) = 0.70, 푝 =0.49) nor phonemic verbal fluency (푡(47) = 0.39, 푝 = 0.70)
differed between groups. Logical Memory I immediate recall
test (푈 = 176, 푝 = 0.059) showed a trend that the PDA+
group had worse new verbal learning and immediate recall
abilities than the PDA− group. However, Logical Memory II
test performance (푈 = 219, 푝 = 0.204) and Logical Memory
% retention (푈 = 242.5, 푝 = 0.434) did not differ between
groups. There were also no differences between groups in
global cognition (MMSE) (푈 = 222.5, 푝 = 0.23).
3.3. Comparison within LPD and RPD Patients. Partici-
pants were split into LPD and RPD, and then further
group differences were examined between PDA+ and PDA−.
Importantly, the groups remained matched in age, disease
duration, UPDRS-III, DDE, H&Y stage, and depression
but remained significantly different on self-reported anxiety.
LPDA+ demonstrated worse performance on the Digit Span
forward test (푡(19) = 2.29, 푝 = 0.033) compared to LPDA−,
whereas RPDA+ demonstrated worse performance on the
Digit Span backward test (푈 = 36.5, 푝 = 0.006), LM-I
immediate recall (푈 = 37.5,푝 = 0.008), and LM-II (푈 = 45.0,푝 = 0.021) but not LM % retention (푈 = 75.5, 푝 = 0.39)
compared to RPDA−.
4. Discussion
This study is the first to directly compare cognition between
PDpatients with andwithout anxiety.The findings confirmed
our hypothesis that anxiety negatively influences attentional
set-shifting andworkingmemory in PD.More specifically, we
found that PD patients with anxiety were more impaired on
the Trail Making Test Part B which assessed attentional set-
shifting, on both Digit Span Tests which assessed working
memory and attention, and to a lesser extent on the Log-
ical Memory test which assessed memory and new verbal
learning compared to PD patients without anxiety. Taken
together, these findings suggest that anxiety in PD may
reduce processing capacity and impair processing efficiency,
especially in the central executive and attentional systems of
working memory in a similar way as seen in young healthy
adults [26, 27].
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Figure 2: PD patients with anxiety performed significantly worse on the Digit Span forward (a) and backward (b) test compared to PD
patients without anxiety. ∗ denotes 푝 values < 0.05. Error bars represent standard error of the means.
Although the neurobiology of anxiety in PD remains
unknown, many researchers have postulated that anxiety
disorders are related to neurochemical changes that occur
during the early, premotor stages of PD-related degeneration
[37, 38] such as nigrostriatal dopamine depletion, as well
as cell loss within serotonergic and noradrenergic brainstem
nuclei (i.e., raphe nuclei and locus coeruleus, resp., which
provide massive inputs to corticolimbic regions). Over time,
chronic dysregulation of adrenocortical and catecholamine
functions can lead to hippocampal damage as well as dys-
functional prefrontal neural circuitries [39, 40], which play
a key role in memory and attention [24]. Recent functional
neuroimaging work has suggested that enhanced hippocam-
pal activation during executive functioning and working
memory tasks may represent compensatory processes for
impaired frontostriatal functions in PD patients compared
to controls [41]. Therefore, chronic stress from anxiety, for
example, may disrupt compensatory processes in PD patients
and explain the cognitive impairments specifically inworking
memory and attention seen in PD patients with anxiety. It has
also been suggested that hyperactivation within the putamen
may reflect a compensatory striatal mechanism to maintain
normal working memory performance in PD patients; how-
ever, losing this compensatory activation has been shown
to contribute to poor working memory performance [42].
Anxiety in mild PD has been linked to reduced putamen
dopamine uptake which becomes more extensive as the
disease progresses [43].This further supports the notion that
anxiety may disrupt compensatory striatal mechanisms as
well, providing another possible explanation for the cognitive
impairments observed in PD patients with anxiety in this
study.
Noradrenergic and serotonergic systems should also be
considered when trying to explain the mechanisms by which
anxiety may influence cognition in PD. Although these neu-
rotransmitter systems are relatively understudied in PD cog-
nition, treating the noradrenergic and serotonergic systems
has shown beneficial effects on cognition in PD. Selective
serotonin reuptake inhibitor, Citalopram, was shown to
improve response inhibition deficits in PD [44], while nora-
drenaline reuptake blocker, atomoxetine, has been recently
reported to have promising effects on cognition in PD [45,
46].
Overall, very few neuroimaging studies have been con-
ducted in PD in order to understand the neural correlates
of PD anxiety and its underlying neural pathology. Future
research should focus on relating anatomical changes and
neurochemical changes to neural activation in order to gain
a clearer understanding on how these pathologies affect
anxiety in PD. To further understand how anxiety and
cognitive dysfunction are related, future research should
focus on using advanced structural and function imaging
techniques to explain both cognitive and neural breakdowns
that are associated with anxiety in PD patients. Research has
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indicated that those with amnestic mild cognitive impair-
ment who have more neuropsychiatric symptoms have a
greater risk of developing dementia compared to those with
fewer neuropsychiatric symptoms [10]. Future studies should
also examine whether treating neuropsychiatric symptoms
might impact the progression of cognitive decline and
improve cognitive impairments in PD patients.
4.1. Does Symptom Laterality Influence the Effect of Anxiety
on Cognition? Previous studies have used PD symptom
laterality as a window to infer asymmetrical dysfunction
of neural circuits. For example, LPD patients have greater
inferred right hemisphere pathology, whereas RPD patients
have greater inferred left hemisphere pathology [15]. Thus,
cognitive domains predominantly subserved by the left hemi-
sphere (e.g., verballymediated tasks of executive function and
verbal memory) might be hypothesized to be more affected
in RPD than LPD; however, this remains controversial [47].
It has also been suggested that since anxiety is a common
feature of left hemisphere involvement [48, 49], cognitive
domains subserved by the left hemisphere may also be more
strongly related to anxiety [15]. Results from this study
showed selective verbal memory deficits in RPD patients
with anxiety compared to RPD without anxiety, whereas
LPD patients with anxiety had greater attentional/working
memory deficits compared to LPDwithout anxiety. Although
these results align with previous research [15], interpretations
of thesefindings should bemadewith caution due to the small
sample size in the LPD comparison specifically.
4.2. Limitations, Considerations, and Future Directions. We
would like to acknowledge a few shortcomings of this study.
Recent work has suggested that the HADS questionnaire may
underestimate the burden of anxiety related symptomology
and therefore be a less sensitive measure of anxiety in PD
[30, 50]. In addition, our small sample size also limited the
statistical power for detecting significant findings. Based on
these limitations, our findings are likely conservative and
underrepresent the true impact anxiety has on cognition in
PD. Additionally, the current study employed a very brief
neuropsychological assessment including one or two tests
for each cognitive domain. Future studies are encouraged to
collect a more complex and comprehensive battery from a
larger sample of PDparticipants in order to better understand
the role anxiety plays on cognition in PD.
Another limitation of this study was the absence of
diagnostic interviews to characterize participants’ psychiatric
symptoms and specify the type of anxiety disorders included
in this study. Future studies should perform diagnostic
interviews with participants (e.g., using DSM-V criteria)
rather than relying on self-reported measures to group par-
ticipants, in order to better understand whether the type of
anxiety disorder (e.g., social anxiety, phobias, panic disorders,
and generalized anxiety) influences cognitive performance
differently in PD.
One advantage the HADS questionnaire provided over
other anxiety scales was that it assessed both anxiety and
depression simultaneously and allowed us to control for
coexisting depression. Although there was a trend that the
PDA+ group self-reported higher levels of depression than
the PDA− group, all participants included in the study scored<6 on the depression subscale of the HADS. Controlling for
depressionwhile assessing anxiety has been identified as a key
shortcoming in the majority of recent work [10]. Considering
many previous studies have investigated the influence of
depression on cognition in PD without accounting for the
presence of anxiety and the inconsistent findings reported
to date, we recommend that future research should try to
disentangle the influence of anxiety versus depression on
cognitive impairments in PD.
Considering the growing number of clinical trials for
treating depression, there are few if any for the treatment of
anxiety in PD. Anxiety is a key contributor to decreased qual-
ity of life in PD and greatly requires better treatment options.
Moreover, anxiety has been suggested to play a key role in
freezing of gait (FOG) [51], which is also related to atten-
tional set-shifting [52, 53]. Future research should examine
the link between anxiety, set-shifting, and FOG, in order
to determine whether treating anxiety might be a potential
therapy for improving FOG.
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Dear Editors,
In a recent case study by Janssen et al. [1], the authors
reported that Freezing of Gait (FOG) was alleviated in an
individual with Parkinson’s disease (PD) when climbing
stairs, an effect that was preserved when walking on a
painted 3D staircase illusion. This is an important obser-
vation, as the clinical management of FOG remains chal-
lenging [2] due in part to a lack of consensus regarding the
underlying mechanisms driving effective compensation
[1, 3, 4]. The authors provided three hypotheses as to why
3D visual cues helped to alleviate FOG: enhanced visual
feedback from 3D cues were thought to either: (1) force
individuals to lift their feet higher; (2) perform larger lat-
eral weight shifts; and/or (3) compensate for visuomotor
deficits [1]. Here, we refine these hypotheses by providing
evidence that the compensatory mechanisms involved
during staircase climbing in PD patients with FOG are not
solely visual [1, 3, 4].
In this study, we asked seven male PD patients with
clinically confirmed FOG and ‘off’ their regular
dopaminergic medication to perform two Timed up and Go
(TUG) tasks and to climb up and down a staircase twice,
first with their eyes open and then with their eyes closed
(Fig. 1). All trials were videotaped for post hoc analysis of
freezing episodes, which were defined as brief, episodic
absence or marked reduction of forward progression of the
feet despite the intention to walk [5]. We hypothesized that
if visual information is essential for achieving compensa-
tion, then patients would experience more FOG with the
eyes closed and any improvements observed during stair-
case climbing should disappear in the absence of visual
input. As expected [6], the patients experienced more FOG
when performing the TUG tasks with their eyes closed as
compared to eyes open (Z = -2.36, p\ 0.05) during over-
ground TUG trials, confirming the importance of visual
feedback during over-ground walking in PD patients with
FOG [6]. Interestingly however, a strong beneficial effect
was observed during staircase climbing, with no patient
experiencing FOG during either the eyes open or eyes
closed conditions. Our data thus indicates that the com-
pensatory effect of staircase climbing can persist in the
absence of visual input, suggesting that enhanced visual
feedback is not the sole mechanism involved in the
compensation.
Indeed, there are other fundamental differences between
staircase climbing and over-ground walking that could
explain this finding. For instance, staircase climbing could
be a more discrete motor task that is carried out in an open-
loop fashion (e.g. lifting feet to a predictable target of set
height) [7, 8]. Discrete movements only require the initi-
ation and execution of a motor plan (open loop motor
control) and are likely controlled through higher cortical
planning areas and preserved cortico-cerebellar circuitry
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[7, 9], without the need for online sensorimotor feedback in
the impaired basal ganglia [6, 10]. In contrast, rhythmic
and continuous over-ground walking requires attention in
Parkinson’s disease and is, therefore, under closed-loop
motor control and heavily dependent on vision, which PD
patients with FOG use to compensate for sensorimotor
impairments [6, 11, 12]. Removing vision, therefore,
increases the load on the impaired basal ganglia system
during overground walking, resulting in an increased risk
for FOG [13], which is bypassed during staircase climbing
since this can be carried out in a feed-forward manner. Our
results support this hypothesis, although future studies are
needed to confirm that staircase climbing is a less rhythmic
task for PD patients with FOG as compared to overground
walking. Furthermore, similar to cycling, the tactile cues
provided by each stair may also regulate the timing and
amplitude of each movement, further mitigating sensori-
motor processing in the basal ganglia [14]. Finally, the
patients in the current study first performed the tasks with
the eyes open and were thus able to obtain visuospatial
memory of the staircase, which could have allowed them to
plan their movements in advance in a feed-forward manner
during the eyes-closed condition. Visuospatial memory of
an upcoming task could, therefore, contribute to the com-
pensatory effect of staircase climbing and 3D visual cues
without the need for online visual feedback [1].
We conclude that although vision is undoubtedly
important for PD patients with FOG [1, 6], online visual
feedback merely reflects one aspect of what makes
staircase climbing (and its painted illusion) an effective
compensatory strategy for FOG in PD [1, 3, 4]. Future
studies investigating the precise mechanisms underlying
compensatory strategies for FOG in PD (including feed-
forward motor control and visuospatial memory) in a
standardized manner will, therefore, aid the development
of more effective treatments for this devastating symp-
tom [2].
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A B S T R A C T
Impairments in motor automaticity cause patients with Parkinson's disease to rely on attentional resources
during gait, resulting in greater motor variability and a higher risk of falls. Although dopaminergic circuitry is
known to play an important role in motor automaticity, little evidence exists on the neural mechanisms
underlying the breakdown of locomotor automaticity in Parkinson's disease. This impedes clinical management
and is in great part due to mobility restrictions that accompany the neuroimaging of gait. This study therefore
utilized a virtual reality gait paradigm in conjunction with functional MRI to investigate the role of
dopaminergic medication on lower limb motor automaticity in 23 patients with Parkinson's disease that were
measured both on and off dopaminergic medication. Participants either operated foot pedals to navigate a
corridor (‘walk’ condition) or watched the screen while a researcher operated the paradigm from outside the
scanner (‘watch’ condition), a setting that controlled for the non-motor aspects of the task. Step time variability
during walk was used as a surrogate measure for motor automaticity (where higher variability equates to
reduced automaticity), and patients demonstrated a predicted increase in step time variability during the
dopaminergic “off” state. During the “off” state, subjects showed an increased blood oxygen level-dependent
response in the bilateral orbitofrontal cortices (walk >watch). To estimate step time variability, a parametric
modulator was designed that allowed for the examination of brain regions associated with periods of decreased
automaticity. This analysis showed that patients on dopaminergic medication recruited the cerebellum during
periods of increasing variability, whereas patients off medication instead relied upon cortical regions implicated
in cognitive control. Finally, a task-based functional connectivity analysis was conducted to examine the manner
in which dopamine modulates large-scale network interactions during gait. A main effect of medication was
found for functional connectivity within an attentional motor network and a significant condition by medication
interaction for functional connectivity was found within the striatum. Furthermore, functional connectivity
within the striatum correlated strongly with increasing step time variability during walk in the off state
(r=0.616, p=0.002), but not in the on state (r=−0.233, p=0.284). Post-hoc analyses revealed that functional
connectivity in the dopamine depleted state within an orbitofrontal-striatal limbic circuit was correlated with
worse step time variability (r=0.653, p < 0.001). Overall, this study demonstrates that dopamine ameliorates
gait automaticity in Parkinson's disease by altering striatal, limbic and cerebellar processing, thereby informing
future therapeutic avenues for gait and falls prevention.
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Introduction
Impairments in motor automaticity are a hallmark feature of
Parkinson's disease that cause patients to increasingly demand cortical
resources in order to execute basic motor operations via attentional
processes (Bohnen and Jahn, 2013; Wu et al., 2015). A reduction in
motor automaticity is of particular concern during gait in Parkinson's
disease, as the cortical resources that would be used for compensation
are not optimized for the fast and parallel processing required during
locomotion (Clark, 2015). Furthermore, the excessive attentional
demand of walking in Parkinson's disease demands a high computa-
tional cost and interferes with gait control in conditions of high
workload (Schneider and Chein, 2003; Lewis and Barker, 2009;
Lewis and Shine, 2014; Clark, 2015; Wu et al., 2015). As a result,
patients with Parkinson's disease have a greater risk of adverse
mobility outcomes and falls, especially during more complex everyday
situations where a secondary task is performed in parallel with gait
(Schaafsma et al., 2003; Clark, 2015; Hausdorff et al., 2003a;
Vandenbossche et al., 2012; Lewis and Shine, 2014; Strouwen et al.,
2015; Wu et al., 2015). Despite the clinical importance of gait in
Parkinson's disease, the precise neural mechanisms underlying im-
pairments in locomotor automaticity remain poorly understood, thus
impeding targeted management (Wu et al., 2015).
Increased step time variability is a robust predictor for falls in
Parkinson's disease (Hausdorff et al., 1998) and has previously been
suggested as a surrogate measure for reduced locomotor automaticity
(Frenkel-Toledo et al., 2005; Yogev et al., 2005; Peterson and Horak,
2016). A recently proposed framework by Wu and colleagues (2015)
outlines several features that indicate whether a motor deficit is directly
linked to an underlying impairment in motor automaticity in
Parkinson's disease, namely: i) the motor skill is performed automa-
tically (and without behavioural interference) in healthy subjects; ii)
dual task performance results in significant deterioration in the motor
skill in patients with Parkinson's disease as compared to healthy
subjects; and iii) external cueing (or attention) significantly improves
the performance of this motor skill (Wu et al., 2015). If this theoretical
model is applied to the existing literature, it indeed becomes evident
that step time variability fits these criteria as an index of locomotor
automaticity: i) stride time variability is resistant to interference during
dual-task walking in healthy subjects (Yogev et al., 2005), suggesting
that regulation of stride time variability is an automated motor skill in
healthy subjects (Friedman et al., 1982; Yogev et al., 2005; Wu et al.,
2015); ii) in Parkinson's disease, walking while performing a cognitive
dual task exacerbates stride time variability (Hausdorff et al., 2003b;
Yogev et al., 2005; Plotnik et al., 2011) and patients experience higher
dual task cost during walking as compared to healthy subjects (Yogev
et al., 2005); iii) stride time variability in Parkinson's disease has been
shown to reduce in the presence of external auditory cues (Willems
et al., 2006; Hausdorff et al., 2007; Rochester et al., 2011). Therefore,
this evidence suggests that step time variability, the regulation of which
is an automated process in the healthy population, is impaired in
Parkinson's disease and reflective of reduced motor automaticity
(Yogev et al., 2005; Bohnen and Jahn, 2013; Lewis and Shine, 2014;
Wu et al., 2015; Peterson and Horak, 2016).
Motor automaticity is typically achieved through motor learning,
followed by the timely initiation and maintenance of automated motor
sequences, even during interference (Wu et al., 2015). During motor
learning, the posterior striatum (putamen) is thought to ‘chunk’ motor
action sequences under the influence of dopamine (Graybiel, 1998).
This process allows performance of well-learned motor patterns to be
executed as a single unit of activity rather than multiple serial
computations, enhancing neural efficiency and reducing motor varia-
bility (Schneider and Chein, 2003; Poldrack et al., 2005; Wymbs et al.,
2012; Wu et al., 2015). The initiation of an automatic sequence is
thought to involve a shift from the anterior associative fronto-striatal
circuit to the posterior sensorimotor striatum (Miyachi et al., 1997;
Lehéricy et al., 2005; Wymbs et al., 2012; Wu et al., 2015), which frees
up frontal attentional resources that can then be used to process
concurrent secondary demands (Carbon and Marié, 2003; Monchi
et al., 2007; Lewis and Shine, 2014; Wu et al., 2015). The most well
described circuits involved with maintaining an automated motor
sequence include the spinal cord, brainstem locomotor regions, poster-
ior striatum, primary cortical motor regions and cerebellum (Fig. 1)
(Poldrack et al., 2005; Bohnen and Jahn, 2013; Clark, 2015; Wu et al.,
2015). Doyon et al. (2002) further proposed that during motor
learning, a transfer of experience-dependent changes from the cere-
bellar cortex to the deep cerebellar dentate nucleus takes place, and
then with extended practice, from a cerebellar-cortical to a striatal-
cortical network (Doyon et al., 2002). Evidently, a well functioning
striatum is integral for effective locomotor automaticity (Wu et al.,
2015).
Ascending dopaminergic neurons in the midbrain provide rich
innervation to the entire striatum, thereby exerting neuromodulatory
control over information processing across the striatum and parallel
cortico-striatal loops that underpin the execution of coordinated
behaviours (Alexander et al., 1986; Kelly et al., 2009; Helmich et al.,
2010; Surmeier et al., 2010; Hacker et al., 2012; Sharman et al., 2013;
Bell et al., 2014). In Parkinson's disease, the pathological degeneration
of nigrostriatal dopaminergic neurons impacts on the communication
across the striatum and parallel cortico-striatal circuits (Alexander
et al., 1986; Kelly et al., 2009; Helmich et al., 2010; Surmeier et al.,
2010; Hacker et al., 2012; Sharman et al., 2013; Bell et al., 2014),
Fig. 1. Schematic representation of the locomotor automaticity processes in health and hypothesized neural mechanisms underlying automaticity impairments in Parkinson's disease
with and without dopaminergic replacement therapy. Left image – hypothesized posterior motor network underlying locomotor automaticity in health; Middle image – dopaminergic
pathology in posterior striatum in Parkinson's disease is thought to cause patients to utilize attention demanding cortical resources to operate gait; Right image – dopaminergic
replacement therapy is thought to normalize locomotor automaticity impairments in Parkinson's disease. NOTE: “Off”=Dopamine depleted state; “On”=On dopaminergic replacement
therapy.
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which likely impairs motor learning and automaticity (Fig. 1)
(Vandenbossche et al., 2012; Bohnen and Jahn, 2013; Lewis and
Shine, 2014; Hamacher et al., 2015; Wu et al., 2015; Peterson and
Horak, 2016). Indeed, the dopaminergic insult is most severe in the
posterior striatum (i.e. sensorimotor putamen) that is involved with
motor learning and automaticity (Brooks et al., 1990; Poldrack et al.,
2005; Wu et al., 2015). Furthermore, step time variability improves
with dopaminergic replacement therapies in Parkinson's disease (Fig. 1)
(Hausdorff et al., 2003a; Schaafsma et al., 2003; Bryant et al., 2016). The
dopamine depletion in the posterior putamen is also likely to impact on
the anterior-to-posterior striatal shift (Ashby et al., 2010; Everitt and
Robbins, 2016), thus placing additional load on the frontal attentional
resources that further prevents patients from effectively utilizing com-
pensatory locomotor control strategies when automaticity is reduced
(Lewis and Barker, 2009; Helmich et al., 2010; Vandenbossche et al.,
2012; Lewis and Shine, 2014; Wu et al., 2015). Finally, it has often been
suggested that Parkinson's patients utilize the cortico-cerebellar path-
ways involved during early motor learning in order to maintain motor
functions following the cortico-striatal impairments (Hanakawa et al.,
1999; Wu and Hallett, 2013; Peterson and Horak, 2016). However, to
date little evidence exists describing the neural mechanisms underlying
deficits in locomotor automaticity and the role of compensatory
strategies in Parkinson's disease due in great part to the mobility
restrictions that accompany the neuroimaging of gait per se (Shine
et al., 2013a; Wu et al., 2015). As such, we currently lack a precise
understanding of how dopaminergic pathology impairs motor automa-
ticity during gait (Vandenbossche et al., 2012; Bohnen and Jahn, 2013;
Lewis and Shine, 2014; Hamacher et al., 2015; Wu et al., 2015; Peterson
and Horak, 2016). Furthermore, the role of dopaminergic medication in
regulating locomotor automaticity in Parkinson's disease remains poorly
understood. Finally, understanding compensatory mechanisms for over-
coming locomotor automaticity impairments in Parkinson's disease
remains an important unresolved clinical question (Nonnekes et al.,
2015; Wu et al., 2015; Peterson and Horak, 2016).
In this study we set out to investigate the neural mechanisms of
dopamine on repetitive lower limb movements in Parkinson's disease.
Twenty-three patients with Parkinson's disease performed a virtual
reality gait paradigm in conjunction with functional MRI both on and
off their dopaminergic medication. The virtual reality task required
patients to either operate foot pedals to navigate a virtual corridor
(walk condition) or to watch the screen while a researcher operated the
paradigm from outside the scanner (watch condition). We hypothe-
sized that in the off medication state, patients with Parkinson's disease
would show increased variability in their step times as compared to the
medicated state, indicative of reduced motor automaticity (Hausdorff
et al., 2003b; Yogev et al., 2005; Gilat et al., 2013). We further
hypothesized that this increase in variability would be associated with
increased Blood Oxygenation Level Dependent (BOLD) in frontal and
parietal cortical regions that are associated with the attentional control
of movements (Ouchi et al., 2001; Bohnen and Jahn, 2013; Wu et al.,
2011; 2015; Peterson and Horak, 2016). In addition, a recent resting
state functional MRI study showed that the strength of connectivity
across the striatum was significantly reduced in Parkinson patients off
their dopaminergic medication, which even at rest impacted on large-
scale sensorimotor network dynamics (Bell et al., 2014). As such, we
hypothesized that dopamine denervation would also have the strongest
effect on the connectivity across the striatum during the virtual gait
task (Bell et al., 2014), as shown by a significant condition (watch,
walk) by medication (off, on) interaction effect. Furthermore, we
hypothesized that dopamine depleted connectivity changes across the
striatum would correlate with increasing step time variability
(Hausdorff et al., 2003a; Schaafsma et al., 2003 Bryant et al., 2016)
and impact on the connectivity across large-scale motor automaticity
and attentional motor control networks involved with gait in
Parkinson's disease (Kelly et al., 2009; Helmich et al., 2010; Hacker
et al., 2012; Bohnen and Jahn, 2013; Bell et al., 2014; Wu et al., 2015).
Materials and methods
Study protocol
Twenty-three patients with Parkinson's disease that satisfied the
United Kingdom Parkinson's Disease Society Brain Bank clinical
diagnostic criteria were recruited for this study from the Parkinson's
Disease Research Clinic, Brain and Mind Centre, The University of
Sydney. None of the patients were diagnosed with dementia according
to the Movement Disorders Society guidelines (Goetz et al., 2008) or
major depression according to Diagnostic and Statistical Manual of
Mental Disorders-IV guidelines of the American Psychiatric
Association (Diagnostic and Statistical Manual of Mental Disorders
(4th ed., text rev.)). None of the participants had any additional
neurological comorbidities including no history of stroke or significant
head injury. In addition, high-resolution T1-weighted images of each
subject passed visual inspection by an experienced radiologist for
absence of any pathological white or grey matter lesions. All patients
received dopamine-replacement therapy as part of their daily clinical
management. Specifically, twelve patients were on levodopa mono-
therapy; two patients were on dopamine agonist monotherapy; four
patients were on levodopa plus a dopamine agonist; two patients were
on levodopa plus a monoamine oxidase inhibitor; three patients were
on levodopa plus a dopamine agonist plus a monoamine oxidase
inhibitor. Patients were tested on two separate occasions, once whilst
on their usual medications and once in the practically defined off state,
having been withdrawn from their dopaminergic medication overnight
for more than 12 h before testing. The order of testing (ON/OFF) was
randomized and counterbalanced between subjects with a minimum
interval of three weeks between trials (mean: 7.4±5 weeks).
In addition to PD participants, we also acquired imaging data in an
independent group of twelve healthy age matched control participants
(see Materials and methods: Regions of interest) that were scanned on
a single occasion. The acquisition of healthy control data enabled data-
driven functional localization of regions involved in lower limb motor
control during the virtual gait paradigm in an independent and
matched cohort. Ethical approval for this study was obtained from
the University of Sydney Human Research Ethics Committee and
written informed consent was obtained from each subject in accor-
dance with the Declaration of Helsinki.
Cognitive and neurological assessment
All subjects were assessed on the Mini Mental State Examination.
In addition, the motor section of the Movement Disorders Society
Unified Parkinson's Disease Rating Scale (UPDRS-III) and the Hoehn
and Yahr Stages (HY), both on and off medications were obtained from
patients with Parkinson disease. Motor symptom severity was assessed
per body side by calculating a sum score of the UPDRS-III items for the
left and right body side separately (items 3.3–3.8 and 3.15–3.17). The
body side with the highest sum score on these UPDRS-III items was
defined as being most affected. Furthermore, item 3 of the Freezing of
Gait Questionnaire (FOG-Q3) “Do you feel that your feet get glued to
the floor while walking, making a turn or when trying to initiate
walking (freezing)?” was obtained from each subject. Finally, dopa-
mine dose equivalency scores were recorded. Cognitive and neurologi-
cal measures were compared between medication states using a paired-
samples t-test or non-parametric Wilcoxon Signed Rank Sum test
(alpha=0.05).
Virtual reality task
The virtual reality task was performed while subjects lay supine
inside the MRI scanner. The duration of the task was 10 min. The task
stimuli were presented on a screen that could be clearly viewed via a
mirror mounted onto the head coil. The virtual environment consisted
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of a straight corridor presented in the first person that contained no
additional environmentally salient or cognitive triggers, which have
previously been utilised to trigger freezing behaviour (motor arrest)
(Fig. 2A) (Shine et al., 2013a; Gilat et al., 2013; 2015). Indeed very
little behavioural freezing (less than 0.05% of the total paradigm) was
observed in the current experiment. Progression through this corridor
was accomplished by alternately depressing left and right foot pedals at
least 30° below parallel in a physiological sequence (e.g. left-right-left-
…). Out of sequence steps (left-left or right-right) did not result in
forward progression and were disregarded from behavioural analyses.
Subjects were instructed to tap the pedals in a comfortable rhythm as
per previous work (Shine et al., 2013a; Gilat et al., 2013; 2015). The
paradigm was made up of alternating blocks that instructed the
participants to perform either of two rules. Walk blocks were initiated
with the word “WALK” being presented on screen instructing the
participants to start operating the pedals. In addition, participants
performed a control watch block. Watch blocks were initiated with the
word “WATCH” being presented on screen instructing participants to
refrain from operating the pedals and watch the screen while a
researcher operated the task from outside the MRI scanner in a similar
rhythm as the participants. Subjects were therefore presented with the
same visual input and baseline cognitive and limbic processes as during
walk, without the need for any motor activation of the legs. Each block
lasted for approximately one minute depending on the subject's latency
and was ended when the word “STOP” was presented on screen in the
colour red. Six seconds after participants had stopped accordingly, the
alternative of the previous instruction (either “WALK” or “WATCH”)
was presented. Each participant completed 4–5 alternating blocks of
both conditions with the first condition always being a walk block to
allow the researcher to ensure that the patient had understood the
instructions.
Behavioural measures
Footstep latency was calculated during walk by measuring the time
between two consecutive foot pedal depressions. The first five steps
following a “WALK” cue and any step following a “STOP” cue were
excluded from the analyses to remove the effects of motor initiation
and cessation (Georgiades et al., 2016). The mean and standard
deviation were then used to calculate the coefficient of variation, which
is a measure of step time variability (Hausdorff et al., 2003a; Gilat
et al., 2013). A coefficient of variation in footstep latencies was also
calculated for each foot separately. A repeated measures ANOVA was
then used to investigate the interaction between medication (off, on)
and symptom side (most affected, least affected) on the coefficient of
variation for each leg separately. In addition, the coefficient of variation
was compared between the most- and least affected side using a paired-
sampled t-test for both medication states. These analyses were
performed to assess whether any increase in variability may be
confounded by asymmetry in symptom severity. No behavioural
measures were obtained during watch blocks, however all participants
responded adequately to the “WALK” cue that followed a watch block (
< 2 s initiation times), indicating that they were likely to be paying
close attention to the task.
Neuroimaging
Image acquisition
A General Electric 3T MRI was used to obtain T2*-weighted echo
planar functional images in sequential order with repetition time (TR)
=3 s, echo time=32ms, flip angle=90°, 32 axial slices covering the
whole brain, field of view=220 mm, interslice gap=0.4 mm and raw
voxel size=3.9 mm×3.9 mm×4 mm thick. High-resolution 3D T1-
weighted anatomical images with voxel size=0.4×0.4×0.9 mm were
obtained for co-registration with functional scans.
Image pre-processing
Image processing and analyses were performed using Statistical
Parametric Mapping Software (SPM12, Wellcome Trust Centre for
Neuroimaging, London, UK). Functional images were pre-processed
using the standard pre-processing pipeline provided with SPM12.
Functional scans were: (i) manually realigned along the anterior-
posterior commissure; (ii) slice-time corrected to the median (17th)
slice in each scan; (iii) realigned to create a mean realigned image and
measures of 6 degrees of rigid head movements were created for later
use in the correction of minor head movements; (iv) unwarped to deal
with residual movement related variance induced by the susceptibility-
by-movement interaction effects; (v) spatially normalized using the T1-
weighted image to improve segmentation accuracy; (vi) co-registered
and estimated; and (vii) smoothed using an 8-mm full-width at half
Fig. 2. Whole Brain analysis for walk >watch. A=visual representation of the virtual
reality task; B=BOLD responses within the Parkinson's disease group (n=23) between
medication states (off > on) on the condition of interest (walk>watch); p < 0.005, k > 20,
TFCE corrected; C=Average beta values associated with the significant clusters as per
figure B. NOTE: OFC=Orbitofrontal cortex; PD=Parkinson's disease; OFF=Dopamine
depleted state; ON=On dopaminergic replacement therapy.
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maximum isotropic Gaussian kernel. Spatial normalization was then
manually checked for quality assurance.
Head motion correction
Multiple precautions were taken to ensure head motion was fully
accounted for: (i) all subjects were instructed to minimize head motion
by only moving the ankles, while not raising the legs and restrict hip
rotation; (ii) cushions were placed inside the head coil to ensure
optimal performance with the least amount of head motion; (iii)
following data collection, trials with > 3 mm or 3° of scan-to-scan
movement were considered a-priori exclusion criterion; (iv) six motion
and nuisance regressors were added into the first level analysis per
subject, controlling for minor movement artefacts in the three direc-
tions of translation and axes of rotation; (v) each trial was analysed
using ArtRepair (Mazaika et al., 2007) and trials with a large amount of
global drift or scan-to-scan head movement > 1.5 mm were corrected
using the interpolation method; and finally, (vi) mean frame-wise
displacement was calculated per trial and compared across sessions,
showing no significant differences between the on and off states
(Parkinson patients off versus on: Z=−0.304, p=0.761) or between
groups (Parkinson patients off versus controls: U=124, Z=−0.487,
p=0.644; Parkinson patients on versus controls: U=126, Z=−0.417,
p=0.694).
Event related whole brain analysis
Individual first-level spatial maps were created in SPM12 using a
general linear model analysis within an epoch-related design in a fixed-
effects analysis. A design matrix was created for each subject by
entering two regressors for each trial: a regressor that modelled the
specific onset times and associated temporal derivatives of walk blocks
and a regressor that similarly modelled the watch blocks. Contrast
images from the first-level analyses were then entered into a second-
level random-effects dependent samples t-test design to test the effects
of dopaminergic medication within the Parkinson's disease group on
the condition of interest (walk >watch), whereas a one-sample t-test
design was used for the healthy control group. To further investigate
imaging-behaviour associations, 8mm ROIs were created around the
peak voxel for each significant second-level cluster found when
contrasting walk >watch between medication states in Parkinson's
disease.
In addition, a whole brain parametric modulation analysis was used
to investigate which brain regions were involved in the modulation of
step time variability. First, a normalized footstep variability value per
TR was calculated for the walk blocks for each subject. The normalized
footstep variability was calculated as an absolute Z-score of footstep
latencies, which were then de-meaned and averaged per TR. This
parametric modulator vector was then entered into a general linear
model together with the six head motion regressors and time deriva-
tives of the hemodynamic response function in the first level analysis of
SPM12. Contrast images from this analysis were then entered into a
second-level random-effects analysis: dependent samples t-test to
investigate differences between dopaminergic states in the
Parkinson's disease group; and one-sample t-test analysis for the
healthy control group. Regions with a negative relationship to the
parametric modulator were associated with maintaining low step time
variability, whereas an increased BOLD response indicates that those
regions were involved during period of increasing step time variability,
and hence, worsened automaticity.
The whole brain voxel maps for both analyses were displayed using
xjView (www.alivelearn.net/xjview) software (p < 0.005, k > 20)
(Lieberman and Cunningham, 2009) and a threshold-free cluster
enhancement (TFCE) for multiple corrections was performed on each
second level contrast (Smith and Nichols, 2009). To explore the
direction of pattern in the BOLD responses found in this study,
significant clusters (See Supplementary Table 3 for MNI coordinates)
from the within-Parkinson group second level T-maps were saved as
images and raw Beta scores were then extracted from these ROIs using
the MarsBar toolbox (Brett et al., 2002) in SPM12, the values of which
were averaged for reporting purposes only.
Task-based functional connectivity
In this analysis, we examined the effect of dopaminergic medication
on large-scale network interactions within and between motor auto-
maticity, attentional motor control and striatal networks. Task based
functional connectivity in these networks was calculated using pre-
defined regions of interest (ROI) as further described below. The
Response Exploration for Neuroimaging datasets toolbox (Duff et al.,
2007) was used to extract time series data of each predefined ROI for
each patient. Task-based functional connectivity was then calculated
using the Multiplication of Temporal Derivatives statistical method
(Shine et al., 2015). This method allows greater temporal resolution of
time-resolved connectivity in BOLD time series data when compared to
the conventional sliding-window Pearson's correlation coefficient
(Shine et al., 2015, 2016). The code is freely available at http://
github.com/macshine/coupling/ (Shine et al., 2015, 2016). First, mean
functional connectivity was calculated within and between each
network of interest and entered into condition (watch, walk) by
medication (on, off) repeated measures ANOVAs (alpha=0.05, False
Discovery Rate (FDR) correction 0.05). For significant interactions
post-hoc correlations were performed to further examine whether the
task-based functional connectivity was associated with worse step time
variability. Furthermore, to examine whether striatal dopamine
modulated the communication across large-scale networks, we
further examined the effects of dopamine on internal network
connectivity. A correlation analysis was performed on the amount of
functional connectivity during walk in the on state compared to the off
state (on-off) for the connectivity across each network.
Regions of interest
Regions of interest were defined using a combination of data-driven
regions identified using the age-matched healthy control group during
performance of the virtual gait task and pre-defined a priori regions
shown to be involved in attentional motor control in Parkinson's
disease and the striatum (see Supplementary Materials: Regions of
interest for full description). Defined regions of interest were then
utilized for subsequent functional connectivity analyses (see
Supplementary Table 2 for MNI coordinates). These regions composed
three different networks: motor automaticity, attention motor and
striatal networks.
Motor automaticity network
As it is currently unclear how lower limb motor automaticity is
achieved, data from the twelve matched healthy control subjects was
used to explore which brain regions would be involved with the
performance of the virtual reality task (walk >watch), and specifically
to identify which brain regions would be associated with maintaining
low step time variability. Based on this data-driven approach we
included the bilateral primary motor cortex area of the legs, thalamus,
putamen, superior orbitofrontal gyrus, lateral cerebellum and anterior
cingulate into the motor automaticity network. In addition, the
cerebellar locomotor and bilateral mesencephalic locomotor regions
were included as predefined a-priori regions of interest (See
Supplementary Materials: Regions of interest and Supplementary
Tables 1 and 2 for MNI coordinates).
Attention motor network
The low variability in step times seen in the healthy control
participants did not allow for the investigation of the attention
demanding cortical regions that are hypothesized to be associated with
high step time variability in the Parkinson's disease group following
dopamine depletion (Wu and Hallett, 2005; Yogev et al., 2005; Bohnen
and Jahn, 2013; Lewis and Shine, 2014; Clark, 2015; Wu et al., 2015;
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Peterson and Horak, 2016). As such, predefined ROIs were created for
regions that have been shown to be involved with the attentional
control of movements in Parkinson's disease, including the dorsal
lateral prefrontal cortex (DLPFC), pre-supplementary motor area (pre-
SMA), dorsal premotor cortex (PMd) and posterior parietal cortex
(PPC) (Cole and Schneider, 2007; Kurz et al., 2012; Shine, et al.,
2013b; Wu et al., 2011; 2015).
Striatal network
The striatal network consisted of seven predefined regions of
interest in the striatum of each hemisphere in the Parkinson's disease
group, as described by Bell et al. (2014). These striatal regions
correspond to dissociable functional systems (Di Martino et al., 2008;
Kelly et al., 2009) and enable broad coverage of the striatum (Bell et al.,
2014). The ROIs included the bilateral: inferior ventral striatum (VSi),
superior ventral striatum (VSs), dorsal caudate (DC), dorsal caudal
putamen (DCP), dorsal rostral putamen (DRP), ventral rostral puta-
men (VRP) and postcommissural putamen (PCP) (Di Martino et al.,
2008; Kelly et al., 2009; Bell et al., 2014). Based on the study by Di
Martino and colleagues (2008) we further defined the caudal putamen
seeds (DCP and PCP) as being most involved with sensorimotor tasks,
the dorsal caudate (DC) with cognitive control and the inferior ventral
striatum (VSi) seeds, which approximate the nucleus accumbens, with
limbic processing (Di Martino et al., 2008). These seeds were used to
define striatal cognitive-motor, limbic-motor and limbic-cognitive
connections during a post-hoc analysis, as further described below.
Results
Participant demographics and behavioural outcomes
Patients with Parkinson disease and healthy control subjects were
matched across multiple demographics (see Supplementary Table 4).
The Parkinson's disease patients had a mean levodopa equivalent daily
dose of 861 (±525) and disease duration (in years) of 6 (±2.9). Patients
demonstrated clinical improvement following dopaminergic treatment,
as indicated by a significantly lower UPDRS-III score and HY stages in
the on state (Table 1). The current cohort consisted of patients with a
range of freezing of gait severity, with eight subjects scoring a 0
(‘Never’), six subjects scoring a 1 (‘Very rarely’) and nine subjects
scoring > 1 (‘Rarely-Often-Always’) on the FOG-Q3. Importantly,
Parkinson's disease patients off medication had similar modal footstep
latencies as compared to when medicated, which together with similar
scores on UPDRS-III items 3.7 (toe tapping) indicate that any group
differences found were unlikely to be driven by an overall difference in
lower limb motor performance (e.g. rigidity) (Table 1). However as
predicted, step time variability was significantly higher in Parkinson
patients off their medication as compared to when on medication
(Table 1), suggesting between group differences in motor automaticity.
Indeed, no significant interaction effect was found between medication
(off, on) and symptom side severity (most affected, least affected) on
the coefficient of variation of footstep latencies (F=0.992, p=0.330).
This analysis also revealed no main effect of medication (F=2.698,
p=0.115) or main effect of symptom side severity (F=0.598, p=0.448).
Furthermore, a difference score in toe tapping ability between the
most- and least affected side did not significantly correlate with the
coefficient of variation in footstep latencies in either medication state
(Spearman correlation OFF: ρ=0.318, p=0.139; ON: ρ=−0.311,
p=0.149). Together, these results indicate that the change in step time
variability seen between medication states did not reflect asymmetry in
symptom severity.
Neuroimaging results
Whole brain activation (walk >watch)
The dopamine-depleted state of Parkinson's disease was associated
with a significantly positive BOLD response in the bilateral orbito-
frontal cortex during walk compared to negative BOLD during watch
(TFCE corrected, see Fig. 2B and Supplementary Table 3 for peak voxel
coordinates). In addition, within-group analysis revealed that in both
medication states patients demonstrated activation of the primary
motor cortex. However, when on medication patients also utilized the
pre-supplementary motor area, visual cortex and cerebellum, whereas
patients offmedication utilized the right mid frontal gyrus and bilateral
orbitofrontal cortex (see Supplementary Fig. 2). For exploration (i.e.
non-statistical) purposes only, post-hoc one-sampled and paired-
sampled t-tests were performed on the mean beta values in the
orbitofrontal clusters that were found to be significantly different
between medication states on the condition of interest (walk > watch)
(See Fig. 2C). These results confirmed that in the off state, the beta
values in the orbitofrontal clusters were significantly different from
zero during both walk and watch blocks (all p < 0.01, Bonferonni
corrected) and significantly different between walk and watch blocks
(Left orbitofrontal: t=4.36, p < 0.001; Right orbitofrontal: t=5.42, p <
0.001, Bonferonni corrected). No differences in beta values were found
for both orbitofrontal clusters in the dopaminergic on state between
walk and watch blocks (Left orbitofrontal: t=0.560, p=0.592; Right
orbitofrontal: t=0.881, p=0.151), which were also not significantly
different from zero (all p > 0.1).
Whole brain activation (parametric modulator)
The goal of this analysis was to identify regions that were
consistently associated with greater step time variability. The BOLD
responses associated with the parametric modulator in the Parkinson's
disease group are presented in Fig. 3. In the off state Parkinson's
disease patients had significant negatively signed beta values across the
right dorsal premotor cortex and left posterior parietal cortex in
contrast to the slight positively signed beta values in these regions in
the on state (Fig. 3C and E). This suggests that a negative association
exists between BOLD response in these regions and step time
variability in the off state. Furthermore, patients on medication had
significant positively signed beta values in the right lateral cerebellum
compared to the off state (Fig. 3C and E), indicating that the cerebellar
regions were recruited during periods of increasing step time variability
when medicated, although these findings did not survive TFCE correc-
tion for multiple comparisons. As tremor amplitude in Parkinson's
disease has previously been associated with increased beta values in the
cerebellum (Helmich et al., 2012), a post-hoc Spearman correlation
analysis was performed between the sum score of UPDRS-III tremor
items 3.15–3.18 and the beta weights of the right cerebellum cluster
found to be significantly associated with the parametric modulator. The
results showed no significant correlations between tremor scores and
cerebellar Beta weights for both medication states (OFF: ρ=0.199,
Table 1
Demographic and Behavioural Statistics within the Parkinson's disease group (n=23)
during different medication states (off/on).
Task OFF ON Test-value P-value
UPDRS-III 27.8 (14) 22.9 (14) 2.62 0.015a
HY 2 (1–3) 2 (1–3) −2.12 0.034b
Toe-Tap Right 1 (0–3) 1 (0–4) −0.428 0.669b
Toe-Tap Left 1 (0–3) 1 (0–3) −0.775 0.439b
Modal FSL 0.48 (0.15) 0.48 (0.12) −0.011 0.991a
CV 29.6 (20) 16.4 (8.3) 3.50 0.002a
NOTE: UPDRS-III=Movement Disorder Society Unified Parkinson's Disease Rating
Scale motor section III, Toe-Tap=Scores on item 3.7 of the Movement Disorder Society
Unified Parkinson's Disease Rating Scale, Modal FSL=Modal Footstep Latency during
performance of walk in the virtual reality task, CV=Coefficient of Variation in footstep
latencies during the performance of walk in the virtual reality task.
a Paired-samples t-test used and Mean (SD) and t-value reported.
b Non-parametric Wilcoxon Signed Ranks Test used and Median (Range) and Z-value
reported for ordinal variables.
M. Gilat et al. NeuroImage 152 (2017) 207–220
212
p=0.362; ON: ρ=0.142, p=0.517), indicating that tremor was unlikely
to explain the results found.
To explore whether Parkinson patients utilized a cortico-cerebellar
network in order to operate movements as a compensation for cortico-
striatal impairments (Rascol et al., 1997; Doyon et al., 2002), a post-
hoc correlation analysis was performed between the loading of the
parametric modulator regressor onto the right lateral cerebellum that
was found to be significant during the parametric modulator analysis
contrast (OFF >ON, see Fig. 3C) and the functional connectivity within
the attention motor control network. A positive correlation was found
between the loading of the variability regressor onto the right lateral
cerebellum and the total functional connectivity within the regions of
the cognitive network for the Parkinson's disease group when off
medication (r=0.452, p=0.030, uncorrected), whereas the negative
correlation found when patients were medicated did not reach statis-
tical significance (r=−0.246, p=0.259) (Fig. 3F).
Task-based functional connectivity
As predicted a significant main effect of condition was found for all
network connections showing an increased functional connectivity
during walk as compared to watch (see Supplementary Fig. 3, FDR
corrected). Furthermore, a significant main effect of medication was
found within the attention motor network (FDR corrected, see Fig. 4).
A significant condition (watch, walk) by medication (off, on) interac-
tion effect was found within the striatum (F(1,22)=5.022, p=0.035,
uncorrected, see Fig. 4). Post hoc simple effect analysis showed that
patients on medication were able to increase internal functional
connectivity within the striatal network during walk compared to
Fig. 3. BOLD responses (p < 0.005, k > 20, uncorrected) associated with step time variability as per the parametric modulator analysis within the Parkinson's disease group (n=23),
between medication states (off/on). A=Whole brain BOLD responses within the Parkinson's disease group off medication (PD OFF); B=Whole brain BOLD responses within the
Parkinson's disease group on medication (PD ON); C=Whole brain BOLD responses within the Parkinson's disease group between medication states (PD OFF > PD ON); D=Parametric
modulator data from one subjects in each group over the time course of the virtual reality task; E=Mean Beta values for the regions associated with the parametric modulator contrast
OFF >ON, as per figure C; F=Scatterplot and linear correlation between the loading of the parametric modulator (Beta values) onto the right lateral cerebellum cluster that was found to
be significantly different on the contrast (OFF >ON) as per figure C and the total functional connectivity within regions of the attention motor control network for Parkinson patients off
medication (OFF) and on medication (ON). NOTE: ΔFSL=Absolute normalized and demeaned footstep latency per Repetition Time (3 s) over the course of the virtual reality task walk
condition; HC=Healthy Controls; CBM=Cerebellum, PMd=dorsal premotor cortex, PPC=Posterior Parietal Cortex; *indicates significant correlation.
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watch (Mean difference=0.367, p=0.003, FDR corrected), whereas
patients off medication were not (Mean difference=0.106, p=0.285).
To examine how striatal dopamine modulates the interactions
across large-scale networks, we further examined the effects of
dopamine on internal network connectivity. Results showed that
dopaminergic modulation of the striatal network significantly corre-
lated with the degree of dopaminergic modulation of internal motor
automaticity network (r=0.536, p=0.008, Bonferonni corrected) and
internal attention-motor network connectivity (r=0.464, p=0.026,
uncorrected). As expected, there was no relationship between dopami-
nergic modulation of the attention-motor network and motor auto-
maticity networks (r=0.219, p=0.315), indicating that the dopaminer-
gic innervation of the striatum may be a key driving factor in
modulating dopamine mediated change in functional connectivity in
other large-scale networks.
Imaging-behaviour associations
We further examined the relationship between the major imaging
findings in this study and behaviour, in order to explain how break-
down in network communication perturbs locomotor automaticity in
the dopamine depleted state. Following the significant condition by
medication interaction effect within the striatum, a post-hoc correla-
tion analysis was performed between the amount of functional
connectivity within the striatum during walk and step time variability
(Bonferonni corrected for multiple comparisons). Internal striatal
functional connectivity during walk correlated strongly with increasing
step time variability in the off state (r=0.616, p=0.002), whereas no
such correlation was found in the on state (r=−0.233, p=0.284). To
further explore these findings, a separate post-hoc analysis was
performed to see which striatal circuit (e.g. cognitive-motor, limbic-
motor or limbic-cognitive) was driving this correlation with step time
variability during walk (Fig. 5A-B). Interestingly, a significant correla-
tion was found between step time variability and the functional
connectivity in the striatal limbic-motor (r=0.688, p < 0.001) and
limbic-cognitive (r=0.597, p=0.003) circuits, whereas the cognitive-
motor (r=0.380, p=0.068) functional connectivity did not reach
statistical significance (Fig. 5A-B). No significant correlations were
found in the on state (limbic-motor: r=−0.153, p=0.487; limbic-
cognitive: r=−0.227, p=0.297; cognitive-motor: r=−0.142, p=0.519).
As aforementioned, the whole brain analysis comparing walk >
watch between medication states revealed increased bilateral BOLD
responses in the orbitofrontal cortex in the off state (see Fig. 2). The
orbitofrontal cortex is known to have connections with multiple areas
of the striatum allowing it to adapt behaviour (Haber et al., 1995;
Fig. 4. Results for the Condition (watch, walk) by Medication (off, on) Repeated Measures ANOVA on functional connectivity values within and between the three networks in
Parkinson's disease patients (n=23). Top left - Main effect of Medication (off, on); Bottom left - Condition×Medication Interaction effect; Each matrix provides summary statistics from
the Repeated measures ANOVA analysis for within- and between network functional connectivity. P-values are embedded within each cell of the matrix. The colour scale represents F-
values. Top right - Mean MTD values within the attention motor control network showing the main effect of medication; Bottom right - Mean MTD values within the striatum network
showing the significant condition×medication interaction effect. NOTE: Auto=Motor Automaticity Network; Attn=Attention Motor Network; Stri=Striatum Network; PD off=Parkinson's
disease patients off dopaminergic replacement medication; PD on=Parkinson's disease patients on dopaminergic replacement medication; *p < 0.05, **p < 0.05 FDR corrected.
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Schoenbaum et al., 2009; Rolls, 2015). As such, to explore its
influences in the current study a second post-hoc analysis was
performed to investigate whether the functional connectivity between
the orbitofrontal cortex (see supplementary table 3 for MNI coordi-
nates) and intra-striatal circuits was correlated with step time varia-
bility (Fig. 5C). The results showed that the functional connectivity
between the bilateral orbitofrontal cortex and inferior ventral striatum
(limbic, r=0.653, p < 0.001) and dorsal putamen seeds (motor,
r=0.643, p < 0.001) were significantly correlated to step time variability
in the off state (Bonferonni corrected for multiple comparisons),
whereas no correlation was found between step time variability and
the functional connectivity between the orbitofrontal cortex and dorsal
caudate nucleus (cognitive, r=0.293, p=0.174) (Fig. 5C). Again no
significant correlations were found in the on state (motor: r=−0.323,
p=0.132; cognitive: r=−0.167, p=0.447; limbic: r=−0.304, p=0.159).
Finally, it has been proposed that local depletion of dopamine levels
within the striatum in Parkinson's disease can lead to a reduced ability
to consecutively process information through complementary yet
competing cortico-striatal neural pathways (e.g. motor, cognitive and
limbic pathways), which may eventually result in the inhibition of
brainstem locomotor centres (Lewis and Barker, 2009; Lewis and
Shine, 2014). We therefore wanted to explore whether the increased
striatal limbic functional connectivity in Parkinson's disease patients
off medication could have been influenced by a reduced ability to
integrate this information into the consecutive motor or cognitive
cortico-striatal pathways. As such, a post-hoc analysis was performed
by correlating the degree of functional connectivity within the striatal
limbic circuits (e.g. limbic-motor and limbic-cognitive) with the
amount of functional connectivity between the primary motor cortex
and dorsal putamen (motor cortico-striatal loop) and between the
dorsolateral prefrontal cortex and dorsal caudate (cognitive cortico-
striatal loop) (Fig. 6A). Results showed that during the on state, the
functional connectivity in intra-striatal limbic circuits correlated
strongly with the functional connectivity between regions of the
cognitive cortico-striatal loop (striatal limbic-motor: r=0.615,
p=0.002; striatal limbic-cognitive: r=0.711, p < 0.001), but not the
motor cortico-striatal loop (striatal limbic-motor: r=−0.125, p=0.569,
limbic-cognitive: r=0.204, p=0.351) (Fig. 6B-C). Interestingly, no
significant correlations were found in the off medication state for
either the cognitive cortico-striatal loop (striatal limbic-motor:
r=−0.189, p=0.387; limbic-cognitive: r=0.077, p=0.728) or the motor
cortico-striatal loop (striatal limbic-motor: r=0.080, p=0.718; limbic-
cognitive: r=0.074, p=0.738).
Discussion
To our knowledge, this is the first study to investigate the role of
dopamine on the neural mechanisms underlying lower limb motor
automaticity impairments in Parkinson's disease. Twenty-three pa-
tients with Parkinson's disease performed an interactive virtual reality
paradigm consisting of two conditions (walk, watch) in conjunction
with functional MRI both on and off dopaminergic medication. The
main results were: (i) Parkinson's disease patients had greater step
time variability off dopaminergic medication and recruited the bilateral
orbitofrontal cortex when performing lower limb movements in the
virtual reality task, as compared to when appropriately medicated; (ii)
in the dopamine-depleted “off” state, patients with Parkinson's disease
demonstrated an over-reliance on regions associated with cognitive
Fig. 5. Post-hoc correlation analysis between functional connectivity in limbic circuits and step time variability during the walk condition of the virtual reality task in Parkinson's
disease patients off their dopaminergic medication. A=Representation of the limbic intra-striatal and orbitofrontal-striatal functional connections; B=Scatter plots for the correlation
analyses between functional connectivity in the intra-striatal limbic circuits and step time variability; C=Scatter plots for the correlation analyses between functional connectivity in the
orbitofrontal-striatal limbic circuits and step time variability. NOTE: PD OFF=Parkinson's disease patients off their dopaminergic replacement medication (n=23); Step time variability
measured as the coefficient of variation in footstep latencies; DC=Dorsal Caudate; DCP=Dorsal Caudal Putamen; VSi=Inferior Ventral Striatum; OFC=Orbitofrontal Cortex;
CV=Coefficient of Variation; *Indicates a significant p-value (p < 0.05) that survived Bonferonni correction for multiple comparisons.
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control, which is in contrast to the recruitment of the cerebellum to
maintain low variability in the “on” state; (iii) dopamine had a
demonstrable influence on intra-striatal functional connectivity during
lower limb movements; (iv) in the dopamine depleted-state, functional
connectivity in orbitofrontal-striatal limbic circuits was correlated with
step time variability; (v) with the administration of dopamine, the
aforementioned striatal limbic circuits became coupled with cognitive
cortico-striatal pathways that are putatively used to integrate the limbic
information in order to maintain effective motor performance.
As predicted, patients with Parkinson's disease demonstrated an
increased step time variability during the virtual reality gait task in the
dopamine depleted state compared to when medicated, indicative of a
loss of motor automaticity (Hausdorff 2003b; Yogev et al., 2005;
Plotnik et al., 2011; Kelly et al., 2012; Gilat et al., 2013). This finding
is in accordance with a broad literature showing that dopaminergic
medication improves step time variability during over ground walking
in Parkinson's disease (Hausdorff et al., 2003b; Schaafsma et al., 2003;
Bryant et al., 2016) and is thought to indicate a shift from an
automated towards a more attention demanding cognitive strategy of
motor control (Bohnen and Jahn, 2013; Clark, 2015; Peterson and
Horak, 2016).
During the walk condition, patients with Parkinson's disease in the
dopamine depleted state demonstrated significantly greater BOLD
activation across the bilateral orbitofrontal cortex compared to the on
state (TFCE corrected). The orbitofrontal cortex is involved in many
functions including modulation of attention and goal-directed beha-
viour (Rolls and Grabenhorst, 2008; Lewis and Barker, 2009;
Takahashi et al., 2011; Hartikainen et al., 2012; Marinelli et al.,
2015). These findings are in accordance with Ouchi et al. (2001) who
used dopamine transporter PET imaging (DAT and [11C]CFT) to show
that Parkinson's disease patients off their medication have significantly
increased activation in dopaminergic neurons of the bilateral orbito-
frontal cortices during continuous straight walking, whereas gait in
healthy controls activated the dopaminergic neurons in the putamen
(Ouchi et al., 2001). Importantly, orbitofrontal [11C]CFT uptake in
Parkinson's disease was inversely correlated with cadence during gait
(Ouchi et al., 2001).
The novel parametric modulator analysis used in the current study
showed that during periods of increasing variability Parkinson's disease
patients on medication engaged the bilateral cerebellum, a key hub
known to be important for automated feed-forward control of motor
timing and adaptation (Rand et al., 1998; Lang and Bastian, 1999;
Doya, 2000; Morton and Bastian, 2006; Wu and Hallett, 2013).
Recruiting this region may have allowed patients on medication to
appropriately adapt to sudden changes in step timing variability
without the need for attentional control (Horak and Diener, 1994;
Rand et al., 1998; Doya, 2000; Morton and Bastian, 2006)Without
dopaminergic medication however, the same patients became unable to
recruit the cerebellum and instead relied on cortical regions associated
with cognitive control. The slow and serial processing of these cognitive
resources (Schneider and Chein, 2003) could have required a longer
time for peripheral information to be integrated with the stepping
pattern resulting in a higher step time variability (Lucas et al., 2013;
Shine, et al., 2013a; Clark, 2015; Hamacher et al., 2015). These results
however did not survive TFCE correction for multiple comparisons,
warranting cautious interpretation.
A post-hoc analysis further showed that the loading of the
variability regressor onto the cerebellum correlated significantly with
the amount of functional connectivity within the attentional motor
network in the off state. This novel finding could reflect a compensatory
increase in network level organization where the attentional motor
network might be attempting to engage the cerebellum following a loss
of motor automaticity in the striatum (Wu et al., 2009; 2011), although
seemingly failing to do so. As the cerebellum receives relatively minor
dopaminergic innervation (localized mostly in the vermis) (Melchitzky
and Lewis, 2000) but shares strong reciprocal connections to the basal
ganglia (Morton and Bastian, 2004; Bostan et al., 2013), it could be
through functional coupling with the basal ganglia, that dopamine
modulates cerebellar circuits. The failure to recruit the cerebellum in
the off state of Parkinson's disease could therefore be the result of
impaired basal ganglia – cerebellar coupling (Morton and Bastian,
2004; Bostan et al., 2013). This is in accordance with previous resting
state functional MRI studies showing reduced functional coupling
between the striatum and the cerebellum in the dopamine depleted
Fig. 6. Post-hoc correlation analysis between the amount of functional connectivity in the cognitive and motor cortico-striatal loops and intra-striatal limbic pathways in Parkinson's
disease patients on dopaminergic replacement medication (n=23). A=Representation of the cortico-striatal and intra-striatal limbic pathways used for the analysis; B=Scatter plots for
the correlations between the amount of functional connectivity between the cognitive cortico-striatal loop and intra-striatal limbic pathways; C=Scatter plots for the correlations between
the amount of functional connectivity between the motor cortico-striatal loop and intra-striatal limbic pathways. NOTE: PD ON=Parkinson's disease patients on dopaminergic
replacement medication; DC=Dorsal Caudate; DCP=Dorsal Caudal Putamen; VSi=Inferior Ventral Striatum; DLPFC=Dorsolateral Prefrontal Cortex; M1=Primary motor cortex of the
leg area; *Indicates a significant p-value (p < 0.05) that survived Bonferonni correction for multiple comparisons.
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state of Parkinson's disease (Hacker et al., 2012; Jech et al., 2013; Bell
et al., 2014).
Striatal dysfunction can lead to an over-activation of the output
nuclei of the basal ganglia (e.g. subthalamic nucleus and globus
pallidus internus) that send inhibitory GABAergic projections to the
cerebellum (via the pontine nuclei), thus hampering cerebellar com-
pensation abilities in Parkinson patients off medication (Lewis and
Barker, 2009; Bostan et al., 2013; Lewis and Shine, 2014). This is
further evidenced by an increase in neuronal activation of deep
cerebellar nuclei following high-frequency stimulation of the subtha-
lamic nucleus in rats (Moers-Hornikx et al., 2011) and normalized
cerebellar activation in patients with Parkinson's disease that received
subthalamic deep brain stimulation (Asanuma et al., 2006; Grafton
et al., 2006; Hill et al., 2013; Wu and Hallett, 2013). Future studies are
encouraged to further investigate these important dopamine related
compensatory and pathological alterations in striatal-cerebellar and
cortico-cerebellar networks during gait in Parkinson's disease (Wu and
Hallett, 2013). In addition, these results lend weight to investigating
the potential therapeutic implications of non-invasive cerebellar sti-
mulation techniques (e.g. transcranial magnetic stimulation) to im-
prove gait in patients with Parkinson's disease (Koch et al., 2008). The
cerebellum also shares connections with the frontal and parietal
cortices via the thalamus, which is also intimately involved in corti-
co-basal ganglia circuitry (Lewis and Barker, 2009; Bohnen and Jahn,
2013; Verlinden et al., 2016). It is therefore somewhat surprising that
the current study did not find any significant thalamic influence on step
time variability. For instance, higher white matter microstructure
radiations between the thalamus and cortical and cerebellar regions
have recently been shown to be associated with improved gait
measures, including step width variability in healthy elderly
(Verlinden et al., 2016). Future studies specifically examining thala-
mic-cortical connectivity as a function of motor automaticity may be
more sensitive to the effects of dopamine on thalamic circuitry. In
addition, it remains to be determined whether white matter changes
are associated with increased gait variability in Parkinson's disease.
The negative association found in the off state between step time
variability and BOLD responses of the right dorsal premotor cortex and
left posterior parietal cortex indicate that Parkinson's disease patients
are unable to bring these brain regions online, leading to increasing
step time variability. Alternatively, patients may have utilized these
cortical regions as a compensatory strategy to improve their stepping
performance in the off state. Future studies are now needed to test
these hypotheses, as causality could not be inferred from these results.
The functional connectivity analysis revealed a significant main effect
of condition where each within and between network connection
significantly increased its functional connectivity during walk compared
to watch, highlighting the involvement of these predefined networks in
lower limbmotor performance in Parkinson's disease (Lewis and Barker,
2009; Bohnen and Jahn, 2013; Hamacher et al., 2015; Wu et al., 2015;
Peterson and Horak, 2016). Furthermore, a significant main effect of
medication was found within the attentional motor network, showing
overall increased functional connectivity in the off state. This dopami-
nergic effect likely reflects the attentional compensatory strategy em-
ployed by Parkinson patients off medication as a result of impaired
striatal functioning (Bohnen and Jahn, 2013; Clark, 2015; Wu et al.,
2015). Indeed, the dopaminergic innervation of the striatum signifi-
cantly correlated with the effects of dopamine within the other networks,
reflecting the importance of striatal dopamine in large-scale network
function during lower limb movements (Kelly et al., 2009; Jech et al.,
2013; Bell et al., 2014). Furthermore, a significant condition by
medication interaction effect was found within the striatum. This finding
advances previous resting state functional MRI studies by showing that
impaired integration across striatal subdivisions in the dopamine
depleted state of Parkinson's disease found during rest also affects lower
limb motor performance (Helmich et al., 2010; Surmeier et al., 2010;
Hacker et al., 2012; Sharman et al., 2013; Bell et al., 2014).
To our knowledge, this study is the first to show that impaired
crosstalk across the dopaminergically-depleted striatum of Parkinson's
disease correlates with increased step time variability. Furthermore, our
post-hoc analyses revealed that intra-striatal limbic circuits were driving
this correlation with worse step time variability. In fact, the functional
connectivity within the orbitofrontal-ventral striatum limbic circuit was
strongly correlated with increased step time variability in the dopamine
depleted state. The current study therefore provides novel pathophysio-
logical evidence to suggest that activation in the orbitofrontal cortex
during gait in Parkinson's disease is related to activity within a limbic
cortico-striatal circuit that, in the context of reduced dopamine, inter-
feres with the striatal control of lower limb motor function.
Our findings are supported by primate work showing that the
terminals of the orbitofrontal cortex are extensive throughout the
dopaminergic neurons, which influence a wide area of the striatum,
particularly the ventral striatum and core of the nucleus accumbens
(Haber et al., 1995). Furthermore, a resting state functional MRI study
by Di Martino et al. (2008) showed that in healthy adults the
spontaneous fluctuations in BOLD response in the inferior ventral
striatum primarily correlated with the orbitofrontal cortex, indicating
that strong functional connections exist between these regions in
humans (Di Martino et al., 2008). Yang et al. (2016) also recently
showed that functional connectivity during rest was increased between
the ventral striatum and orbitofrontal cortex in Parkinson's disease
patients off dopaminergic medication as compared to when medica-
tion, indicating that dopamine has a profound influence on this
orbitofrontal-striatal limbic circuitry (Yang et al., 2016).
The striatal projections allow the orbitofrontal cortex to regulate
motor actions under the influence of dopamine, for instance to adapt
behaviour in the face of unexpected outcomes (Schoenbaum et al.,
2009; Takahashi et al., 2009; Rolls, 2015). It has previously been
proposed that error signals processed by the midbrain dopaminergic
neurons that project to the striatum originate within regions of the
orbitofrontal cortex that encode expected value and performance
outcome, and which later connect to the ventral striatum (Takahashi
et al., 2011; Rolls, 2015). The orbitofrontal cortex indeed receives
negative prediction error feedback (i.e. sensory evidence that did not
match the predicted performance outcome) from every sensory system,
making it an important hub for multisensory integration that enables
planning and learning performance outcomes (Kringelbach, 2005;
Schoenbaum et al., 2009; Takahashi et al., 2009; Goble et al., 2011;
Rolls, 2015; Chanes and Barrett, 2016). As Parkinson's disease patients
have known sensorimotor impairments (Nolano et al., 2008; Conte
et al., 2013; Ehgoetz Martens et al., 2013; Lucas et al., 2013), the
increased BOLD responses found in the orbitofrontal cortex in the
Parkinson group off medication could reflect an attempt to adapt
behaviour following increased negative prediction error feedback
(Kringelbach, 2005; Schoenbaum et al., 2009; Takahashi et al.,
2009). Indeed, our results further showed that increased intra-striatal
limbic functional connectivity was correlated with increased functional
connectivity within regions of the cognitive cortico-striatal pathway
selectively in the “on” state. This might indicate that with sufficient
dopaminergic resources, the striatum is able to functionally integrate
limbic information into the parallel cortico-striatal pathways, which
can then provide top-down control over motor performance to resolve
the prediction error and prevent motor deterioration (i.e. compensa-
tion) (Postuma and Dagher, 2006; Lewis and Barker, 2009; Rolls,
2015). However, dopamine depletion likely impairs such parallel
cortico-striatal integration within the striatum, as evidenced by the
lack of such correlations in “off” state (Lewis and Barker, 2009; Bell
et al., 2014; Wu et al., 2015). The prediction error would therefore
remain unresolved and hence, continue to induce an increased limbic
drive within the striatal network. This could impair motor performance
directly by innervating the inhibitory basal ganglia output structures
that project to the brainstem locomotor centres (Lewis and Barker,
2009; Lewis and Shine, 2014). In addition, the increased limbic drive
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likely demands a proportion of the depleted dopaminergic resources
within the striatum, further depriving the dorsal striatum from its
ability to process automated motor sequences (Wu et al., 2015).
Therefore, based on the results of the current study, it can be
postulated that although the ventral striatal-orbitofrontal circuit may
usually be employed as a compensatory strategy to overcome negative
error feedback, without sufficient dopaminergic resources utilizing this
network can actually deteriorate motor performance in Parkinson's
disease patients.
This study now forms the basis for future work. The orbitofrontal
cortex has previously been associated with the integration of emotional
information into decision processes (Bechara et al., 2000). In addition,
anxiety and depression are associated with impaired gait performance
in Parkinson's disease patients (Rochester et al., 2004, 2005; Lord
et al., 2011, 2013; Ehgoetz Martens et al., 2015), and these deficits are
amenable to dopaminergic medication (Ehgoetz Martens et al., 2015).
Previous authors have postulated that depression and anxiety impair
goal-directed attentional processing (Rochester et al., 2004, 2005),
possibly by increasing computational load of the ventral striatum-
orbitofrontal pathway resulting in response conflict in the dopamine
depleted cortico-basal ganglia motor circuitry (Lewis and Barker, 2009;
Ehgoetz Martens et al., 2013, 2015). Future studies should therefore
investigate the complex interaction between dopamine, mood distur-
bance and gait impairments in Parkinson's disease.
In addition, the current patient cohort consisted mostly of patients
with moderate bilateral disease (1 subject scored HY=1; 18 subjects
scored HY=2–3; 3 subjects scored HY=3 and no subjects scored HY >
3). As such, future work is needed to investigate whether the neural
basis underlying gait variability changes with disease severity.
Furthermore, it is recommended that future studies account for
laterality in brain pathology when analysing neuroimaging data in a
cohort of Parkinson's disease patients with obvious unilateral symptom
severities. It is also important to note that although dopamine evidently
plays a key role, gait disturbances in Parkinson's disease likely reflect a
multisystem neurodegenerative disorder beyond the loss of dopami-
nergic neurons, especially as the disease progresses (Bohnen and Albin,
2011; Bohnen and Jahn, 2013; Bohnen et al., 2013). For instance,
prefrontal cholinergic neurons are key players in attentional control
functions that may be put under increasing pressure following striatal
and prefrontal deterioration in Parkinson's disease (Bohnen et al.,
2013; Gonzales and Smith, 2015). Gait speed has indeed been shown to
be most affected in patients with both nigrostriatal dopaminergic and
cortical cholinergic denervation (Bohnen et al., 2013). Future studies
using larger cohorts are now needed to investigate the role of
dopaminergic, cholinergic and other neurotransmitter systems on gait
automaticity impairments in Parkinson's disease and Parkinson's
disease subgroups, for example Parkinson's disease patients with and
without freezing of gait (Bohnen and Albin, 2011; Bohnen et al., 2014).
Furthermore, dual task interference provides an alternative avenue
to study motor automaticity impairments (Yogev et al., 2005; Kelly
et al., 2012; Wu et al., 2015). Future studies are therefore encouraged
to further evaluate dual task interference to confirm that the increased
step time variability seen in the Parkinson's disease patients off
medication reflects reduced motor automaticity (Poldrack et al.,
2005; Wu et al., 2015). However, similar to walking and most daily
behaviours, simple motor tasks such as foot tapping are usually
performed automatically in healthy subjects (Wu et al., 2015).
Furthermore, once a motor task is automatic it becomes difficult to
revert back to controlled behaviour (Schneider and Chein, 2003; Wu
et al., 2015). It can therefore be assumed that the performance in
healthy control participants and low variability seen in Parkinson’s
disease patients on medication indicated a more automatic motor
performance. In addition, a supplementary correlation analysis was
performed between the functional connectivity values and another
behavioural motor outcome of the virtual reality paradigm, namely
modal footstep latency, showing no significant correlations (See
Supplementary Table 4). This further indicates that the findings of
the current study are indeed specific to step time variability and thus
motor automaticity. In accordance with the findings in this study,
previous behavioural research has shown that the administration of
dopaminergic replacement therapy often improves step time variability
in Parkinson's disease patients (Hausdorff et al., 2003a; Lord et al.,
2011; Rochester et al., 2011; Bryant et al., 2016). Furthermore,
impairments in dual-task walking are also often improved by optimal
dopaminergic replacement therapy (Camicioli et al., 1998; Lord et al.,
2011; Elshehabi et al., 2016). Together, this evidence suggests that
dopaminergic therapy may influence gait-related neural computations
through modulation of motor automaticity.
While multiple motor skills rely upon motor automaticity, in this
study, step time variability was employed as a surrogate for motor
automaticity in an attempt to model simple gait. Equally, however, dual
task paradigms can also provide insights into the breakdown of
automaticity in Parkinson's disease by loading additional attentional
resources with overt task demands. Future studies are now needed to
further investigate the interaction between dopamine and dual tasking
ability during gait in patients with Parkinson's disease. Finally, a
limitation inherent in the study of motor automaticity is that indirect
surrogate measures are required. Therefore, the component processes by
which dopaminergic replacement therapy improves motor skills cannot
be precisely isolated. While it is hypothesized that dopamine replace-
ment therapy exerts its major mechanism of action by improving motor
automaticity in subcortical structures leading to reduced step time
variability, dopamine may also modulate other sub-processes including,
coordination, balance, proprioception, affective processing and cognition
that may affect step time variability and motor automaticity.
In conclusion, this study showed that dopamine depletion in
Parkinson's disease impairs motor automaticity by reducing striatal
functioning and cerebellar compensation strategies, which lead to
increased attentional motor control and excessive orbitofrontal-striatal
limbic interference.
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ABSTRACT: Background: Freezing of gait is a dis-
abling symptom of Parkinson’s disease that ultimately
affects approximately 80% of patients, yet very little
research has focused on predicting the onset of freezing
of gait and tracking the longitudinal progression of symp-
toms prior to its onset. The objective of the current study
was to examine longitudinal data spanning the transition
period when patients with PD developed freezing of gait
to identify symptoms that may precede freezing and cre-
ate a prediction model that identifies those “at risk” for
developing freezing of gait in the year to follow.
Methods: Two hundred and twenty-one patients with
PD were divided into 3 groups (88 nonfreezers, 41 tran-
sitional freezers, and 92 continuing freezers) based on
their responses to the validated Freezing of Gait-
Questionnaire item 3 at baseline and follow-up. Critical
measures across motor, cognitive, mood, and sleep
domains were assessed at 2 times approximately 1
year apart.
Results: A logistic regression model that included age,
disease duration, gait symptoms, motor phenotype,
attentional set-shifting, andmoodmeasures could predict
with 70% and 90% accuracy those patients who would
and would not develop, respectively, freezing of gait over
the next year. Notably, the Freezing of Gait-Questionnaire
total and the anxiety section of the Hospital Anxiety and
Depression Scale were the strongest predictors and alone
could significantly predict if one might develop freezing of
gait in the next 15months with 82% accuracy.
Conclusions: Our results suggest that it is possible to
identify the majority of patients who will develop freez-
ing of gait in the following year, potentially allowing tar-
geted interventions to delay or possibly even prevent
the onset of freezing. VC 2017 International Parkinson
and Movement Disorder Society
Key Words: Parkinson’s disease; freezing of gait;
cognition; anxiety; motor; sleep
Freezing of gait (FOG) is a common and complex symp-
tom of Parkinson’s disease (PD) with a poorly understood
onset1 and limited options for successful treatment.2
Although approximately 80% of patients ultimately
develop FOG,3 predicting who and when is currently not
possible, thus thwarting targeted interventions.
To date, only 2 studies have followed early-stage PD
patients over time to examine the risk factors associ-
ated with the development of FOG.4,5 Findings from
the DATATOP cohort suggested that the risk of devel-
oping FOG was significantly higher in more advanced
PD patients with predominant gait, balance, speech,
and bradykinetic motor symptoms rather than tremor-
dominant symptoms.5 A more recent study also identi-
fied an akinetic-rigid phenotype as a primary risk
factor for FOG along with lower education, not using
a dopamine agonist, and higher scores on the mood,
cognitive disturbance, and sleep disorder domains of
the Hamilton Depression Rating Scale in a Chinese
population when followed over 3 years.4
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Previous work has also reported that freezing is
associated with cognitive dysfunction such as atten-
tional set-shifting, conflict resolution, and visuospatial
processing.6-9 Furthermore, research has shown that
cognition declines at a faster rate in freezers compared
with nonfreezers over a 2-year period.10 However, lit-
tle research has disentangled whether these cognitive
deficits precede the onset of FOG or whether cognitive
decline accelerates after FOG develops. Affective dis-
orders have also been linked to FOG,11 with both
anxiety and depression more common in freezers than
in nonfreezers.12 It is still debated whether these affec-
tive disturbances precede the onset and possibly con-
tribute to the development of FOG or whether anxiety
and depression arise as a result of developing FOG.13
Finally, heterogeneity studies have highlighted an over-
lap between the nontremor phenotype and rapid eye
movement (REM) sleep behavior disorder (RBD), in
which patients experience dream enactment.14 It has
been postulated that the neuropathology underlying
RBD may lie within the brain stem,15-17 an anatomical
region that contains the pedunculopontine nucleus, a
structure that is believed to play a critical role in gait
function.18,19 Work investigating patients with FOG
has demonstrated that although RBD is associated
with freezing in the early stages of disease, this rela-
tionship is not observed in advanced PD.15 Thus, it
remains unclear whether RBD might be useful to con-
sider when predicting who might develop FOG in the
future. Together, this body of evidence suggests that
specific clinical symptoms may represent useful bio-
markers for predicting the onset of FOG.
The objective of the current study was to create a
more substantive predictive profile for transitional
freezers by combining potential indicators of FOG
from previously highlighted motor, cognitive, affec-
tive, and sleep domains. The current study assessed 3
groups of PD participants: (1) those who remained
nonfreezers over time, (2) those who developed FOG,
and (3) those who continued to freeze. First, we
sought to identify symptoms that preceded FOG, then
created a logistic regression model to predict those
who would or would not develop FOG in the next
year. Based on previous research, we hypothesized
that in addition to obvious risk factors such as age
and disease duration, a non-tremor-dominant pheno-
type with executive dysfunction, greater affective dis-
turbance, and RBD might significantly predict the
onset of FOG.
Methods
Participants
Longitudinal data were analyzed from 221 Parkin-
son’s disease patients who attended the Parkinson’s
Disease Research Clinic at the Brain and Mind Centre,
University of Sydney, between 2008 and 2016. Ethical
approval was obtained from the University of Sydney
Human Research and Ethics Committee and written
informed consent obtained from each patient. Partici-
pant inclusion criteria included: a confirmed diagnosis
of PD based on the UK Brain Bank clinical criteria20
by a trained neurologist (S.J.G.L.) and longitudinal
data from at least 2 points approximately 6-24
months apart. Patients were identified as freezers if
they had responded positively on a validated screening
instrument for identifying freezers, namely, item 3 of
the Freezing of Gait-Questionnaire (FOG-Q3): “Do
you feel that your feet get glued to the floor while
walking, making a turn or when trying to initiate
walking (freezing)?”1,21 Based on their response to
FOG-Q3 at baseline and follow-up, participants were
classified into 3 groups: nonfreezers (n588) — those
who reported 0 at both baseline and follow-up; transi-
tional freezers (n541) — those who reported 0 at
baseline and 1 or more at follow-up; and continuing
freezers (n592) — those who reported 1 or more at
both baseline and follow-up. All participants were
assessed on their regular dose of medication.
Motor, Cognitive, Limbic, and Sleep Domains
The Unified Parkinson’s Disease Rating Scale motor
subsection (UPDRS-III) assessed motor symptoms22
with the exclusion of question 3.11 (“Freezing of
gait”).23 A tremor-dominant (TD)/non-TD phenotype
ratio was also calculated.24,25 The FOG-Questionnaire
total (FOG-Q total) was used to assess global gait dis-
turbance; however, item 3 was removed from the
total, given that it was used to classify participants.
Finally, dopamine dose equivalence (DDE) was also
recorded when available.
Cognition was evaluated using the following mea-
sures: Digit Span (DS) Forwards and Backwards to
examine attention and working memory, the Mini-
Mental State Examination (MMSE) to measure global
cognitive functioning, age-scaled Logical Memory
(LM-I and LM-II) retention scores to assess verbal
memory, and the Trail-Making Test parts A (TMT-A)
and B (TMT-B) to assess psychomotor speed and
attentional set-shifting ability, respectively.26,27 Anxi-
ety and depression were evaluated using the Hospital
Anxiety and Depression Scale subscores (HADS-A and
HADS-D).28 Finally, RBD was evaluated using a sub-
score of 4 questions (RBDSQ4) pertaining specifically
to movements during REM sleep on the RBD Screen-
ing Questionnaire.29
Statistical Analyses
Linear mixed-effects models were employed to
examine all variables longitudinally across all 3
groups. Age and disease duration were entered as
covariates. Bonferroni post hoc analyses were carried
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out to examine significant group effects and interac-
tions (see Table 1). To further unpack the relationship
between freezing of gait (frequency and severity) and
cognitive and affective factors, correlational analyses
were also carried out on baseline data (see Table 2).
A backward stepwise (likelihood ratio) binary logis-
tic regression was used to identify potential baseline
predictors of FOG approximately 1 year before freez-
ing onset (continuing freezers were excluded from this
analysis). The dependent variable for the regression
analysis was the presence or absence of FOG at
follow-up. The independent variables included: the
TD/non-TD ratio, FOG-Q total, UPDRS-III, TMT-A
and TMT-B, DS-Forwards, DS-Backwards, LM-II,
HADS-A and HADS-D, RBDSQ4, MMSE, and age
and disease duration at baseline. The stepwise method
was chosen based on the exploratory nature of the
study, and a backward model was employed to reduce
the type II error rate. The significance level at which
variables were entered and removed from the model
was P50.05 and P50.1 respectively. The Homer
and Lemeshow test was used to examine the goodness
of fit for the model. In addition, in an effort to maxi-
mize clinical relevance, a post hoc reduced-factor
model was constructed on the basis of the most signifi-
cant predictive factors from the backward logistic
regression described above. The aim of this secondary
analysis was to understand which tools could be
implemented in clinical settings to detect those at risk
for developing FOG and the success rate of these
predictors.
Results
Longitudinal Analyses
Table 1 reports mean6 SD scores between groups
and P values for main effects and interactions from
the linear mixed-effects models. Table 2 illustrates the
relationship between freezing severity and cognitive
and affective symptoms across all participants.
Motor
Overall group effects were found for DDE
(F2,05.185 7.23, P50.001), UPDRS-III (F2,213.97
544.30, P<0.001), and TD/non-TD ratio (F2,216.84
510.02, P<0.001). Post hoc analyses revealed that
nonfreezers were receiving a lower dose of dopaminer-
gic medication and had lower symptom severity com-
pared with the transitional and continuing freezers.
Continuing freezers also had significantly worse motor
symptom severity compared with transitional freezers.
In addition, nonfreezers had a significantly higher TD/
non-TD ratio compared with both freezer groups
(indicating that freezers had a greater non-TD score).
A main effect of time was also found for UPDRS-III
(F1,175.265 4.11, P5 0.044), such that all PD patients
had significantly worse symptom severity at follow-up
compared with baseline.
A significant interaction between group and time was
found for FOG-Q total (F2,2185 24.76, P<0.001).
Post hoc analyses revealed that at baseline, continuing
freezers had significantly worse gait severity than transi-
tional freezers and nonfreezers, but there was no differ-
ence between transitional freezers and nonfreezers.
However, at follow-up, transitional freezers had signifi-
cantly more impaired gait than nonfreezers. Continuing
freezers continued to have the most severe gait impair-
ment, which was significantly greater than transitional
freezers and nonfreezers.
Cognition
Overall group effects were found for MMSE
(F2,160.75516.72, P< 0.001), DS-Backwards (F2,136.59
5 6.63, P50.002), and TMT-B-A (F2,128.135 6.17,
P50.003). Post hoc analyses showed that there were no
significant differences in performance on the MMSE, DS-
Backwards, or TMT-B-A between transitional freezers and
nonfreezers. Transitional freezers performed significantly
better on the MMSE compared with continuing freezers
but were not different from continuing freezers on the DS-
Backwards or TMT-B-A. Continuing freezers performed
significantly worse on the MMSE, DS-Backwards, and
TMT-B-A compared with nonfreezers. A main effect of
time was found for MMSE (F1,123.175 4.88, P<0.001),
LM-I and LMT-II (F1,120.365 4.39, P50.038; F1,118.69
5 14.54, P<0.001), and TMT-B-A (F1,116.755 4.05,
P50.046), which showed that although MMSE and
TMT-B-A scores got worse over time, scores for LM-I and
LMT-II improved.
A significant interaction between group and time
was found for TMT-B (F2,119.215 3.08, P50.050).
Post hoc analysis revealed that at baseline transitional
freezers were not different from nonfreezers or con-
tinuing freezers. However, by follow-up, transitional
freezers performed significantly worse on the TMT-B
compared with nonfreezers, and continuing freezers
were significantly worse compared with transitional
freezers and nonfreezers. Thus, both freezing groups
showed a significant increase in TMT-B scores at
follow-up compared with baseline, whereas the non-
freezers did not change (Figure 1).
Mood
A group effect was found for HADS-A
(F2.209.995 8.78, P< 0.001; Figure 2). Post hoc analyses
revealed that both transitional freezers and continuing
freezers had significantly greater anxiety compared with
nonfreezers. A main effect of time was found for
HADS-A (F1,198.425 56.27, P<0.001), which revealed
that anxiety worsened over time across all groups.
There was a significant interaction between group
and time for HADS-D (F2,200.3053.61, P50.029).
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Post hoc analyses showed that continuing freezers had
significantly greater depression than transitional freez-
ers and nonfreezers at baseline, but were not different
from transitional freezers at follow-up. Continuing
freezers also reported significantly lower depression
scores at follow-up compared with baseline.
Sleep
Overall group effects were found for RBDSQ4
(F2,215.505 5.21, P5 0.006). Post hoc analyses
revealed that transitional freezers were not different
from nonfreezers or continuing freezers; however, con-
tinuing freezers had significantly higher RBDSQ4
scores than nonfreezers.
Predictors of Freezing
A model (see Table 3) was found to be a good fit
for the data (v2ð7Þ55.91, P5 0.55), which included 75
participants (52 nonfreezers and 23 transitional freez-
ers). The following predictors were included in the
final model: age (B5 0.11, P5 0.054), disease dura-
tion (B50.15, P50.091), FOG-Q total (B5 0.85,
P5 0.01), TD/non-TD ratio (B5 -1.60, P50.085),
TMT-B (B5 -0.02, P50.055), HADS-A (B5 0.92,
P5 0.001), and HADS-D (B5 -0.32, P50.067). The
overall predictive success of the model was 84%, and
it correctly classified 69.6% of transitional freezers
and 90.4% of nonfreezers.
Given that FOG-Q total and HADS-A were the
strongest predictors in the above model, we examined
the predictive power of using only these factors in an
effort to maximize clinical relevance. A model was
found to be a good fit for the data (v2ð8Þ5 6.23,
P5 0.62), which included 117 participants (80 non-
freezers and 37 transitional freezers). The model had
an overall predictive success of 82.1%, which cor-
rectly classified 64.9% of patients who developed
FOG and 90% of patients who remained nonfreezers.
The following equation represents the probability (p)
of developing FOG in the following year based on this
restricted model:
Logðp=1 2 pÞ 5 22:383 1 0:457 ðFOG2Q totalÞ 1 0:305 ðHADS2AÞ
Discussion
The overall aim of this study was to identify symp-
toms that preceded FOG and to create a predictive
model that could be used to identify those at risk for
developing freezing in the following year. Although
there were many expected differences at baseline
between freezers and nonfreezers,15,24 there were a
few measures that differentiated between transitional
freezers and nonfreezers at baseline (ie, 1 year prior to
the onset of FOG).
FIG. 1. Transitional freezers showed greater deficits in set-shifting
compared with nonfreezers at follow-up but not baseline.
FIG. 2. Transitional freezers and continuing freezers had greater anxi-
ety compared with nonfreezers at baseline and follow-up.
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Symptoms That Precede FOG
Motor aspects such as the DDE, UPDRS-III, and a
non-TD phenotype were found to be greater in transi-
tional freezers (and continuing freezers) than in non-
freezers at baseline and follow-up. These findings are
consistent with previous research showing that freezers
have worse motor symptoms, especially nontremor
symptoms.4,5,15,24,30 Such patients require greater
dopaminergic therapy to manage these more severe
symptoms.31,32 Anxiety was also greater in transi-
tional freezers (and continuing freezers) compared
with nonfreezers regardless of time, which provides
strong evidence that anxiety precedes the onset of
FOG. These results are in support of previous work
suggesting that anxiety is greater in freezers than in
nonfreezers12 and might be an important contributor
to the underlying mechanism of FOG.33 However,
depression was not significantly different in transi-
tional freezers than nonfreezers at baseline or follow-
up and therefore may not predict FOG onset. Never-
theless, continuing freezers had worse depression than
transitional and nonfreezers at baseline, which is simi-
lar to previous accounts.5,12 Interestingly, depression
in continuing freezers was reduced at follow-up com-
pared with baseline and no longer differed from tran-
sitional freezers, suggesting that this symptom was
better managed by follow-up.
Surprisingly, there were no differences at baseline
between transitional freezers and nonfreezers across
the array of cognitive or sleep outcomes. Rather, once
transitional freezers had developed FOG by follow-up,
attentional set-shifting impairments (TMT-B) were
found compared with nonfreezers. Furthermore, only
transitional freezers and continuing freezers (but not
the nonfreezer group) showed a significant decline in
set-shifting capabilities over time. Furthermore, the
severity of FOG measured by the total score on the
FOG-Q (including item 3) was associated with wors-
ened cognition (regardless of neuropsychological
assessment), greater affective symptom severity, and
greater RBD score. Taken together, these findings
might suggest that cognitive dysfunction and sleep dis-
turbances either become gradually more impaired as
FOG onset approaches as a function of disease pro-
gression or that FOG onset and impaired cognition
and sleep occur within a similar time frame because of
shared neurobiological underpinnings such as choliner-
gic denervation within the pedunculopontine nucleus,
for example.
Predicting Freezing of Gait
This study demonstrates that by examining specific
symptoms (ie, TD/non-TD ratio, FOG-Q total, TMT-
B, anxiety, depression) along with age and disease
duration, we could successfully predict with 84%
accuracy those PD patients who transitioned to
become freezers and those who did not in the follow-
ing year. The current findings are aligned with previ-
ous work,4,5 which also showed that more severe gait
disability, having a non-tremor-dominant phenotype,
and anxiety and depression were significant FOG risk
factors. Notably, the only domain that was not pre-
sent in this model was sleep. Because RBD is generally
considered a prodromal marker of PD, it may not be
a useful indicator of later-stage symptoms such as
freezing despite biological overlap between RBD and
FOG.
The ability to predict FOG has tremendous implica-
tions for patients, caregivers, and clinicians, because it
provides a unique opportunity to implement early
therapeutic interventions to delay or even prevent the
onset of FOG. This is likely to prolong patients’
mobility and quality of life. For this reason, we also
evaluated a more restricted model to predict FOG
including simply 2 questionnaires that could be
administered by a nonspecialist. Although the predic-
tive power was not as strong as the full model
described above, by using only the FOG-Q total and
the HADS-A score, we could predict whether one
TABLE 2. Relationships between freezing severity and
cognitive, affective, and sleep symptoms
FOGQ-Total (severity)
MMSE 20.409b
TMT-A 20.288b
TMT-B 20.218a
Digit Span Forward 20.232b
Digit Span Backwards 20.245b
LM-I -0.305b
LM-II 20.272b
HADS-A 0.206b
HADS-D 0.499b
RBDSQ4 0.185b
aP< 0.05.
bP< 0.01.
TABLE 3. Motor and nonmotor predictors of freezing
of gait
B (SE) Odds ratio 95% CI
Age 0.11 (0.06) 1.11 0.10-1.24
Disease duration 0.15 (0.09) 1.16 0.98-1.39
TD/non-TD ratio 21.60 (0.93) 0.20 0.03-1.24
FOG-Q total 0.85a (0.33) 2.34 1.23-4.45
TMT B raw score 20.02 (0.01) 0.99 0.97-1.00
HADS-A 0.92a (0.28) 2.50 1.46-4.30
HADS-D 20.32 (0.17) 0.73 0.52-1.02
Constant 27.94a (3.58)
R25 0.45 (Cox & Snell), R250.64 (Nagelkerke). Homer and Lemeshow
Goodness of fit v2ð7Þ5 5.83, P50.56.
aWald statistic P< 0.05.
TD, tremor dominant; FOG-Q, Freezing of Gait Questionnaire; TMT, Trail-
Making Test; HADS-A and -D, Hospital Anxiety and Depression Scale anxi-
ety and depression subscores.
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might develop FOG in the next year with 82.1% accu-
racy. It should be noted that this model is much better
at classifying those who will not develop FOG (90%
accuracy) than those who will (65% accuracy). None-
theless, it may be a useful screening tool to identify
individuals at risk who may need further assessment,
such as comprehensive testing to improve predictive
power, and could also identify candidates at risk or
eligible for early intervention studies. Because 80% of
patients will develop PD eventually, it is likely that a
1-year assessment is not enough, and additional fac-
tors that were not measured here may also contribute
to these prediction models. Thus, future research
should consider flagging and following at-risk individ-
uals for a longer period, beyond the time frame cap-
tured in this study, to determine whether the
predictive accuracy improves over time.
Limitations and Clinical Implications
A limitation of this study was the lack of DDE data
for numerous participants, which led us to exclude
DDE from the logistic regression. Because DDE is typ-
ically associated with disease duration and symptom
severity, it might be expected to contribute in a similar
way to these other variables that were included in the
model. Alternatively, given that dopaminergic dysfunc-
tion may impact the degree to which network loops
cross over, dopamine agonists may play a crucial role
in the development of FOG and may be a predictive
factor worth exploring in future research. A second
limitation that should be noted is that a subjective
questionnaire was used to classify freezers, rather than
an objective measure of freezing, which may be supe-
rior at detecting freezers and minimizing misclassifica-
tion. In the current study, a video of FOG was not
presented to participants prior to answering the FOG-
Q, although many of the participants had clinically
confirmed freezing and continued to report FOG in
subsequent visits. Nonetheless, future work should
aim to use a video of FOG to minimize classification
errors and if possible clinically confirm all participants
who report FOG.
Despite these limitations, the findings from this
study provide clinicians with means to better predict
the likelihood that a patient will develop FOG. Future
studies should focus on developing appropriate inter-
ventions, with the goal of delaying or even halting the
onset of FOG for those most at risk of transitioning.
Current treatment options for FOG are very limited
and hindered by inconsistent results2; thus, preventive
measures may prove more effective. Cognitive training
(CT) has been speculated to be a promising treatment
for FOG.34 Given that CT is targeted at improving
executive functions in PD,35 it aims to promote the
activation of compensatory networks and alleviate the
cognitive interference that precedes FOG.34
Alternatively, cholinesterase inhibitors might be used
to target cognitive dysfunction preceding FOG onset.
Research has linked FOG and neocortical cholinergic
denervation36 and has suggested cholinergic denerva-
tion as a potential mechanism underlying depression-
modulated cognitive impairment, which can exacer-
bate the cognitive symptoms found in PD.37 Impor-
tantly, a recent review concluded that cholinesterase
inhibitors can enhance cognitive function in PD
patients with cognitive impairment38 and have also
been shown to be promising for reducing falls in
PD.39 Thus, further trials examining cholinesterase
inhibitors are a much-needed undertaking.40 Finally,
given that anxiety is a strong predictor of FOG onset,
anxiety should be targeted as part of preventive efforts
for potential freezers, especially because to date, no
randomized, controlled trials have been undertaken to
explore how anxiety management could delay the
development or progression of FOG.
Conclusion
A careful assessment of selected symptoms can accu-
rately predict the onset of FOG over a 15-month inter-
val. These findings will hopefully allow future targeted
treatments for FOG in PD, which would greatly
enhance the quality of life for a substantial proportion
of PD patients.
Acknowledgments: We are grateful to the research participants
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The functional network signature of
heterogeneity in freezing of gait
Kaylena A. Ehgoetz Martens,1,2 Julie M. Hall,1,2,3 Matthew J. Georgiades,1,2 Moran Gilat,1,2
Courtney C. Walton,1,2 Elie Matar,1,2 Simon J. G. Lewis1,2 and James M. Shine1,2
Freezing of gait is a complex, heterogeneous, and highly variable phenomenon whose pathophysiology and neural signature
remains enigmatic. Evidence suggests that freezing is associated with impairments across cognitive, motor and affective domains;
however, most research to date has focused on investigating one axis of freezing of gait in isolation. This has led to inconsistent
findings and a range of different pathophysiological models of freezing of gait, due in large part to the tendency for studies to
investigate freezing of gait as a homogeneous entity. To investigate the neural mechanisms of this heterogeneity, we used an
established virtual reality paradigm to elicit freezing behaviour in 41 Parkinson’s disease patients with freezing of gait and
examined individual differences in the component processes (i.e. cognitive, motor and affective function) that underlie freezing
of gait in conjunction with task-based functional MRI. First, we combined three unique components of the freezing phenotype:
impaired set-shifting ability, step time variability, and self-reported anxiety and depression in a principal components analysis to
estimate the severity of freezing behaviour with a multivariate approach. By combining these measures, we were then able to
interrogate the pattern of task-based functional connectivity associated with freezing (compared to normal foot tapping) in a sub-
cohort of 20 participants who experienced sufficient amounts of freezing during task functional MRI. Specifically, we used the first
principal component from our behavioural analysis to classify patterns of functional connectivity into those that were associated
with: (i) increased severity; (ii) increased compensation; or (iii) those that were independent of freezing severity. Coupling between
the cognitive and limbic networks was associated with ‘worse freezing severity’, whereas anti-coupling between the putamen and
the cognitive and limbic networks was related to ‘increased compensation’. Additionally, anti-coupling between cognitive cortical
regions and the caudate nucleus were ‘independent of freezing severity’ and thus may represent common neural underpinnings of
freezing that are unaffected by heterogenous factors. Finally, we related these connectivity patterns to each of the individual
components (cognitive, motor, affective) in turn, thus exposing latent heterogeneity in the freezing phenotype, while also identifying
critical functional network signatures that may represent potential targets for novel therapeutic intervention. In conclusion, our
findings provide confirmatory evidence for systems-level impairments in the pathophysiology of freezing of gait and further
advance our understanding of the whole-brain deficits that mediate symptom expression in Parkinson’s disease.
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Introduction
Freezing of gait is a complex and poorly understood symp-
tom of Parkinson’s disease that typically presents as a par-
oxysmal and transient episode in which patients report
feeling as though their feet are ‘glued’ to the floor
(Schaafsma et al., 2003). Management of the condition re-
mains difficult, partly because of the heterogeneous nature
of the disorder. For instance, freezing of gait can be pro-
voked in a wide variety of situations (e.g. when distracted,
turning or when feeling anxious) (Nutt et al., 2011). These
common ‘triggers’ can be broadly classified into impair-
ments within three behavioural categories: cognitive,
motor and limbic.
Impairments in cognitive flexibility, namely attentional set-
shifting deficits are a widely recognized ‘cognitive signature’
associated with freezing of gait (Amboni et al., 2008; Hallett,
2008; Shine et al., 2013d; Szeto et al., 2015). For instance,
patients with freezing of gait typically perform significantly
worse on part B of the Trail Making Test (TMT)
(Hall et al., 2014, 2015; Beck et al., 2015), and intra-extra
dimensional set shifting test (Stefanova et al., 2014).
Additionally, patients with freezing of gait show greater
dual-task interference (Peterson et al., 2015) and commit
more errors (Pieruccini-Faria et al., 2014) when asked to
perform a secondary cognitive task while walking. These
behavioural deficits align with the observation that dividing
attention, or switching motor programmes often provokes
freezing of gait (Schaafsma et al., 2003; Nutt et al., 2011;
Beck et al., 2015), whereas dual motor-cognitive interventions
can improve clinical freezing (Killane et al., 2015).
The motor signature of freezing is generally characterized
by impairments in gait automaticity, which is normally
operationalized by an increase in step-to-step variability
(Hausdorff et al., 2003), step length variability (Thevathasan
et al., 2012; Barbe et al., 2014) and/or step time
variability (Pieruccini-Faria et al., 2015; Weiss et al., 2015)
during regular walking, even in the absence of freezing.
Additionally, step time variability in patients with freezing of
gait is also exacerbated during split belt treadmill walking
(Nanhoe-Mahabier et al., 2013), while approaching narrow
doorways (Almeida and Lebold, 2010; Ehgoetz Martens
et al., 2013b; Silveira et al., 2015), walking in threatening
situations (Ehgoetz Martens et al., 2013a, 2014b), during
sharp turns (Bhatt et al., 2013), and while dual-tasking
(Pieruccini-Faria et al., 2014; Beck et al., 2015). In fact, vari-
ability in stepping has even been shown to be worse in pa-
tients with freezing of gait while performing a stationary
virtual reality tapping task (Gilat et al., 2013) and repetitive
stepping in place task (Nantel et al., 2011).
Finally, emotional disturbances, such as anxiety, have
been suggested to represent a key limbic signature of freez-
ing (Giladi and Hausdorff, 2006). Panic attacks (Vazquez
et al., 1993; Lieberman, 2006) and physiological heart rate
changes (Maidan et al., 2011) have been temporally linked
to the onset of freezing of gait episodes, and threatening or
stressful situations (e.g. walking over an elevated virtual
plank) can also reliably trigger freezing of gait (Bloem
et al., 2004; Ehgoetz Martens et al., 2014b). Recent re-
search has also shown that patients with freezing of gait
have worse symptoms of anxiety and depression compared
to those without freezing of gait (Burn et al., 2012; Ehgoetz
Martens et al., 2016c), and greater anxiety is also asso-
ciated with worse freezing severity (Ehgoetz Martens
et al., 2016b).
Several models have been proposed to explain the patho-
physiology of freezing (Nieuwboer and Giladi, 2013).
However, most mechanistic explanations have focused on
impairments in one component domain (e.g. cognitive or
motor), and thus essentially underestimate the role of
system-level impairments in freezing. In contrast, the
‘cross-talk’ model (Lewis and Barker, 2009) explicitly em-
braces the interactions between the component dimensions
of freezing. Specifically, the model suggests that freezing of
gait is triggered by episodic discordant ‘cross-talk’ between
competing yet complimentary frontostriatal circuits that
span motor, cognitive and limbic cortical areas. This
‘cross-talk’ is proposed to overload the information process-
ing capacity within the dopamine-depleted striatum, thus
producing momentary synchronous firing in the output
nuclei of the basal ganglia, which in turn would lead to
increased inhibition in brainstem locomotor areas, and con-
sequently freezing of gait (Lewis and Shine, 2016). In this
model, the corticostriatal architecture is critical for balan-
cing integration and segregation across disparate motor,
cognitive, and limbic circuits, which is required for optimal
information processing and hence guided the regions of
interest selected for this study. It can be proposed that the
corticostriatal dysfunction seen in Parkinson’s disease may
lead to interference and over-integration between these
normally segregated networks.
Functional imaging studies have provided broad empirical
support for the cross-talk model. Specifically, patients with
Parkinson’s disease and freezing have been shown to demon-
strate reduced frontal and parietal cortical activation but
increased subcortical activation (mesencephalic locomotor
region) during imagined walking (Snijders et al., 2011),
while the opposite pattern (i.e. increased frontal and parietal
activation but reduced subcortical activation) is observed
during freezing episodes (Shine et al., 2013b). Others have
looked beyond the role of individual regions, and examined
the interplay between regions, as well as large-scale networks.
For example, reduced functional coupling in fronto-parietal
networks at rest was identified in patients with freezing of
gait compared to those patients without (Tessitore et al.,
2012b), and reduced coupling between the cognitive control
network and the basal ganglia network was shown to be
specifically associated with episodes of freezing behaviour
elicited during functional MRI scanning (Shine et al.,
2013c). These studies suggest that freezing of gait can
be thought of as occurring due to dynamic dysfunctional
interactions across normally coordinated neural networks
(Fasano et al., 2015). However, recent reviews have
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promoted the need to characterize the heterogeneity and
complexity of freezing of gait, rather than to study contribu-
tors to freezing in isolation (Fasano et al., 2015; Snijders
et al., 2016). Therefore, a crucial next step towards under-
standing the freezing phenomenon is to examine the neural
signature of freezing across multiple levels of neural network
organization.
Here, we used a task-based functional MRI approach
in combination with a validated virtual reality task
(Gilat et al., 2013) to investigate the neural signature of
the heterogeneity of freezing of gait in Parkinson’s disease.
We aimed to clarify: (i) how specific regions are coordi-
nated during freezing compared to normal foot tapping
(i.e. a proxy for normal walking); (ii) how the freezing
signature varies as a function of the first principal compo-
nent (which relates to ‘freezing severity’); and (iii) whether
different behavioural signatures of freezing (i.e. cognitive,
motor, limbic) are associated with unique neural underpin-
nings. Based on previous research (Shine et al., 2013c), we
hypothesized that freezing epsiodes would be characterized
by abnormal patterns of functional connectivity within and
between anatomical cortico-striatal circuitry. This was
thought to reflect a loss of specificity between the cortex
and the striatum, and hence to increase the vulnerability of
the system to ‘overload’. Given the heterogeneity in freez-
ing, we further hypothesized that the freezing network
signature would be uniquely associated with individual
differences in the cognitive, motor, limbic component
processes of freezing.
Materials and methods
Participants
Forty-one patients with Parkinson’s disease and freezing of gait
were studied at the Brain and Mind Centre at the University of
Sydney. Inclusion criteria included: (i) a diagnosis of Parkinson’s
disease in accordance with the United Kingdom Parkinson
Disease Society Brain Bank Diagnostic Criteria; (ii) a self-re-
ported score of 51 on question 3 of the Freezing of Gait
Questionnaire (FOGQ3): ‘do you feel that your feet get glued
to the floor while walking, making a turn or when trying to
initiate walking (freezing)?’; (iii) clinically-evident freezing of
gait, confirmed visually by a neurologist (S.J.G.L.); and (iv) the
completion of the virtual gait paradigm in the MRI scanner in
the ‘OFF’ state (i.e. after a minimum of 12h withdrawal from
their regular dopaminergic medication). Exclusion criteria
included: (i) any additional neurological comorbidities (e.g. his-
tory or stroke or head injury); and (ii) any pathological lesions
or abnormalities that were identified by an experienced radiolo-
gist from the participants’ structural high-resolution T1-weighted
image. Because of the nature of our study (i.e. to investigate a
clinical phenomenon that only occurs in a particular group of
individuals), we did not include a traditional ‘control’ group. The
current study received ethical approval from the University of
Sydney Human Research Ethics Committee and was conducted
in accordance with the Declaration of Helsinki. All participants
provided written informed consent.
Data collection and analysis
Clinical and neuropsychological assessment
Participants’ motor symptom severity was assessed with Part
III of the Movement Disorders Society Unified Parkinson’s
Disease Rating Scale. Global cognition was assessed with the
Mini-Mental State Examination, and attentional set-shifting
was assessed with the TMT, parts A and B. Finally, affective
disturbance was assessed using the Hospital Anxiety and
Depression Scale (HADS).
Virtual gait task
Participants lay supine inside the MRI scanner with a mirror
that was mounted to the head coil, which enabled participants
to have a clear view of the screen where the virtual environ-
ment was projected. As detailed in previous work (Shine et al.,
2013a), foot pedals were positioned under the participants’
feet (Fig. 1A), and participants were instructed to flex and
extend their ankle in order to ‘tap’ the pedals, which in turn
allowed the participants to navigate forward through the vir-
tual environment (Shine et al., 2013a). Forward progression
was only achieved when participants alternately depressed
the pedals (i.e. left-right-left).
The virtual environment consisted of a straight corridor
(presented in first-person view) that contained environmentally
salient triggers, such as wide and narrow gaps and doorways.
As in previous experiments, cognitive cues were also included
to exacerbate set-shifting deficits. Both narrow doorways and
cognitive cues have previously been shown to elicit freezing
behaviour in susceptible individuals (Shine et al., 2013a).
Walking and stopping in the virtual environment was initiated
by simple (e.g. WALK and STOP) and complex cue words
(e.g. ‘WALK’ if the colour-word pair match and ‘STOP’ if
the colour-word pair do not match) that were displayed
on the screen (for further details see Shine et al., 2013b).
Performance on the task was titrated to acceptable levels
prior to scanning. Patients were familiarized with the task
prior to scanning to ensure acceptable performance. Sixteen
participants completed the full 10-min protocol, and 25
participants completed a shorter 5-min protocol.
The timing of each participants’ footsteps during the task
was collected by recording the onset of each sequential pedal
depression. From this output, the modal footstep latency
(i.e. step time) for the duration of the protocol was calculated
as the weighted average after removing all cognitive cues and
freezing of gait episodes (Shine et al., 2013b). Freezing of gait
was defined by any footstep latency that was longer than twice
the modal footstep latency. This definition is in line with past
work and has been previously shown to correlate with the
severity freezing of gait episodes experienced in the ‘real’
world (Gilat et al., 2013; Matar et al., 2013; Shine et al.,
2013a). The coefficient of variation of step time (i.e. step
time variability) was calculated for the duration of the proto-
col for which freezing of gait episodes were also removed.
Functional MRI acquisition and preprocessing
A General Electric 3T MRI was used to obtain T2*-weighted
echo planar functional images were acquired in sequential
order with repetition time = 3000ms, echo time = 40ms,
flip angle = 90!, 40 axial slices covering the whole
brain, field of view = 220mm, interslice gap = 0.4mm and
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raw voxel size = 3.9mm " 3.9mm " 4mm thick. High-reso-
lution 3D T1-weighted anatomical images with voxel
size = 0.4 " 0.4 " 0.9mm were obtained for co-registration
with functional scans.
Statistical Parametric Mapping Software (SPM12, Wellcome
Trust Centre for Neuroimaging, London, UK, http://www.fil.
ion.ucl.ac.ak/spm/software) was used for image preprocessing.
Functional scans were: (i) manually realigned along the
anterior-posterior commissure; (ii) slice time corrected to the
median (21st) slice in each repetition time; (iii) realigned to
create a mean realigned image and measures of 6! of rigid
head movements were calculated for later use in the correction
of minor head movements; (iv) unwarped to deal with residual
movement-related variance induced by the susceptibility-by-
movement interaction effects; (v) spatially normalized using
the T1-weighted image to improve segmentation accuracy;
(vi) co-registered; and (vii) smoothed using an 8-mm full-
width at half-maximum isotropic Gaussian kernel.
Figure 1 Experimental design and protocol. (A) The left panel illustrates a participant lying in the MRI scanner with the foot pedals at their
feet. The right panel shows an example of the virtual environment that the participant views while lying in the MRI scanner. As the participant
performs the task, depressing the pedals (e.g. left-right-left-right), step time is recorded and periods of normal foot tapping and freezing are
calculated. The relationship between the percentage of time spent frozen and the FCI (B: r = 0.40, P = 0.01); inverse of TMT- B (C: r = 0.35,
P = 0.02); step time variability (D: r = 0.56, P5 0.001); and HADS (E: r = 0.14, P = 0.37) are also illustrated. PCA = principle component analysis.
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Multiple precautions were taken to ensure strict control of
the effects of head motion: (i) all participants were instructed
to minimize head motion by keeping the legs and hips station-
ary and only moving the ankles to depress the foot pedals;
(ii) cushions were placed inside the head coil to limit the phys-
ical possibility of head motion; (iii) ArtRepair was used to
analyse each trail and applied the interpolation method to
correct for large amounts of global drift or scan-to-scan
head movement 41.5mm; and (iv) six motion and nuisance
regressors were regressed out of each participants’ extracted
time series during statistical modeling.
The freezing component index
To estimate a low-dimensional signature of the factors that
relate to freezing across subjects, we ran a principal compo-
nents analysis on a set of three behavioural variables that were
hypothesized a priori to be associated with the freezing pheno-
type: cognitive, TMT-B Z-score (inverted so that worse scores
were positive); motor, step time variability; and limbic, HADS
total. We labelled the first principal component (which ex-
plained 79.24% of the variance) the ‘Freezing Component
Index’ (FCI). To confirm that the FCI related to freezing of
gait severity, we correlated the principal component to
the percentage of time spent frozen during the virtual
reality task (any footstep latency that was longer than twice
the modal footstep latency) using a Spearman’s correlation
(Fig. 1B).
Region of interest selection
To improve the specificity of our imaging analysis, we prede-
fined a set of regions of interest. Based on previous work
(Lewis and Barker, 2009), we chose cortical and subcortical
regions that covered the motor, cognitive and limbic networks,
along with striatal regions that are functionally related to
each network. The cortical regions were chosen using the
term-based meta-analyses tool NeuroSynth (http://www.neuro-
synth.org/). Specifically, we identified the top regions asso-
ciated with the terms: ‘cognitive control network’, ‘motor
network’ and ‘anxiety’. It should be noted that anxiety and
depression identified similar regions during the NeuroSynth
search; however, we selected anxiety as the search term since
it has been more robustly linked to freezing. The peak
MNI coordinates for each region (Table 1) were then used
to construct 8mm region of interest spheres (Fig. 2). Based
on previous research (Di Martino et al., 2008; Bell et al.,
2015), we also defined a set of 2mm region of interest spheres
to parcellate the striatum into seven distinct regions.
Functional connectivity analysis
To conduct a task-based functional connectivity analysis, time
series data were extracted from the first level general linear
model for each of the 31 regions of interest (17 cortical, 14
striatal) using the MarsBaR toolbox (http://marsbar.source-
forge.net/). Further preprocessing steps included the normaliza-
tion of each region to its own mean and standard deviation
(SD), low pass filtering (f40.125Hz), and removal of the
mean signal across all regions at each time point. SPM12
software was then used to model freezing and normal foot
tapping (plus their temporal and spatial derivatives) using an
epoch design, after which the regressors were convolved with a
canonical haemodynamic response function. Normal foot
tapping epochs were defined as five consecutive footsteps
that were not interrupted by an environmentally salient cue
(such as a doorway) or by a cognitive cue. The criterion of
a minimum of five freezing events was selected to permit ef-
fective modelling of freezing events (Poldrack et al., 2011).
Thus, participants who experienced less than five freezing
events during functional MRI scanning were removed from
all of the subsequent imaging analyses. Our cohort of freezers
was made up of participants from two separate studies, which
varied the task length during functional MRI. Thus, our final
sample included 20 participants: 13 participants who com-
pleted a 10-min protocol and seven who completed a 5-min
protocol.
To estimate the time-resolved functional connectivity be-
tween each of the 31 regions of interest over the course of
the task, we used the multiplication of temporal derivatives
approach (Shine et al., 2015) with a window size of 10 repe-
tition times (i.e. 30 s). Briefly, this technique affords a win-
dowed estimate of functional connectivity as it evolves over
time (code is freely available at http://github.com/macshine/
coupling/). To determine whether functional connectivity
between regions changed with respect to freezing behaviour,
the pairwise connectivity estimates were fitted to a general
linear model comparing epochs of freezing with those of
normal foot tapping. To control for multiple comparisons,
we performed a non-linear permutation testing by creating a
null distribution of 5000 randomly permuted connectivity
matrices (Nichols and Holmes, 2002). Edges were deemed sig-
nificant if the connectivity strength was either stronger or
weaker than the 97.5th (or 2.5th) percentile of the null distri-
bution, respectively. To further minimize type I errors, we also
thresholded results using a large effect size (Cohen’s d5 0.8;
Supplementary Table 1).
To determine the relationship between abnormal functional
connectivity and freezing severity and heterogeneity, we sepe-
rately correlated the freezing4 normal foot tapping functional
connectivity matrix with the FCI and each individual component,
respectively (Supplementary Table 2). A similar non-parametric
permutation approach as detailed above was used to correct for
multiple comparisons. Specifically, we randomly re-sorted the
FCI vector across participants and then estimated the strength
of correlation between the reordered FCI and each pairwise func-
tional connection 5000 times per edge—edges 52.5th percentile
(P5 0.05) were retained for further interpretation. Only the sig-
nificant edges that both survived permutation testing and were
also significantly correlated with the FCI were reported.
To aid in the interpretation of our results, edges were
qualitatively sorted according to their relationship with the
FCI. We reasoned that edges that were similarly correlated
with the FCI (e.g. an edge with increased coupling during
freezing was positively correlated the FCI or an edge with
decreased coupling during freezing was inversely correlated
with the FCI) may represent an index of freezing ‘severity’
(i.e. greater coupling/anti-coupling was associated with a
greater ‘freezing severity’) (Fig. 3). In contrast, if the FCI
was correlated in the opposite direction to the mean pattern
observed in an edge (e.g. an edge with increased coupling was
associated with a lower ‘severity’ score on the FCI), then the
edge may be ‘compensatory’. Finally, if an edge was found to
be independent of the severity of freezing of gait correlates, it
was labelled as ‘independent’, suggesting that there was a sig-
nificant pattern of abnormal connectivity that was consistently
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Table 1 Cortical regions of interest identified using NeuroSynth
Region of
interest
x y z Z-score
Motor
PMC R 38 #2 58 10.06
L #24 #28 58 10.09
SMA R 4 #2 60 8.05
L #8 #4 56 8.62
CBM R 32 #64 #58 7.71
L #16 #66 #58 7.76
Cognitive
ACC M 0 #26 32 5.81
DLPFC R 44 18 32 6.43
L #46 18 36 6.8
PPC R 48 #46 40 5.61
L #42 #62 40 4.23
Limbic
MPFC R 18 36 32 4.36
L #14 46 26 5.51
AI R 44 6 #10 6.02
L #38 #2 #10 5.62
Amygdala R 22 #4 #18 7.38
L #24 #2 #24 9.21
ACC = anterior cingulate cortex; AI = anterior insula; CBM = cerebellum; DLPFC = dorsolateral prefrontal cortex; L = left; M = middle; MPFC = medial prefrontal cortex;
PMC = primary motor cortex; PPC = posterior parietal cortex; R = right; SMA = supplementary motor area.
Figure 2 Investigating the freezing network signature. (A) The regions of interest selected for this study. (B) A functional
connectivity schematic, which illustrates and defines the relationships between the time series of two regions. (C) A circular representation
that summarizes the freezing network connectivity depicting (i) limited connectivity between the cortex and the striatum; and (ii) a loss of
segregation and specificity between the cortico-striatal pathways. ACC = anterior cingulate cortex; AI = anterior insula; AMYG = amygdala;
CBM = cerebellum; DC = dorsal caudate; DCP = dorsal caudal putamen; DLPFC = dorsolateral prefrontal cortex; DRP = dorsal rostral putamen;
L = left; MPFC = medial prefrontal cortex; PCP = posterior caudal putamen; PMC = primary motor cortex; PPC = posterior parietal cortex;
R = right; SMA = supplementary motor area; VRP = ventral rostral putamen; VSi = ventral striatum inferior; VSs = ventral striatum superior.
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present in the cohort of patients with freezing of gait irrespect-
ive of freezing severity. A similar analysis was then conducted
using the individual component scores (i.e. cognitive, motor,
limbic); however, ‘independent’ edges were ignored due to
overlap across the three component domains.
Results
Executive summary
In this study, we made an explicit choice to expose the
detailed heterogeneity of the freezing of gait phenotype.
To clarify our results, we would like to first emphasize
the overarching framework that we applied to investigate
the multivariate nature of freezing. First, by contrasting
connectivity during freezing episodes to normal foot
tapping we constructed a ‘Freezing Network Signature’
(Figs 2C and 3). Second, we related the network signature
of freezing to the FCI (which is significantly correlated with
per cent time spent frozen during the task) in order to
assess which aspects might be associated with ‘severity’,
‘compensation’, or ‘independent’ altogether (Fig. 4).
Third, by decomposing the FCI into its cognitive, motor
and limbic components, we examined the relationship be-
tween individual behavioural components and the freezing
network signature further (Fig. 5). Characteristics of par-
ticipants both included and excluded from the functional
MRI analysis are presented in Table 2. Notably the two
groups (MRI + and MRI#) were matched in age, symptom
severity, cognitive status, FOGQ3, anxiety, total HADS,
processing speed, set-shifting ability and step time variabil-
ity. There were a few group differences such that the cohort
included in the functional MRI analysis (MRI + ) had a
significantly higher dopamine dose equivalence (P = 0.04),
greater depression score (although not clinical significant)
(P = 0.03), faster foot step latency (P5 0.01), and greater
amount of freezing (P5 0.01).
Freezing network signature
Figure 3 illustrates a summary of the overall network as a
function of freezing of gait (i.e. freezing4normal foot tap-
ping). During freezing episodes, the functional connectivity
was disrupted between the striatum and the cognitive
control network and the motor network compared to
normal foot tapping. However, increased functional con-
nectivity between the limbic network and striatum was
evident when freezing episodes were contrasted to
bouts of normal foot tapping. Further details are provided
below.
Cognitive network
During episodes of freezing, anti-coupling was observed
between the cognitive control network and striatum,
whilst increased coupling was observed within the cognitive
control network when compared to normal foot tapping.
The cerebellum was also significantly more coupled to the
caudate and cognitive control network.
Motor network
There was substantial disruption to the motor network
during freezing compared to normal foot tapping. Greater
anti-coupling was found both within the cortical motor
network, and within the putamen. Furthermore, the
motor network was also decoupled from the putamen
and and limbic structures and instead coupled to the
dorsal caudate nucleus.
Limbic network
Increased coupling between the limbic network (cortical
and subcortical) and the ventral striatum was found
Figure 3 Decomposing the freezing signature. During freezing episodes, functional connectivity was disrupted between the striatum and
the cognitive control network and the motor network compared to normal foot tapping. However, increased functional connectivity between the
limbic network and striatum was evident when freezing episodes were contrasted to bouts of normal foot tapping. C = caudate;
CBM = cerebellum; P = putamen; scLimbic = subcortical limbic; V = ventral striatum.
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during freezing compared to normal foot tapping.
Furthermore, increased coupling between the limbic net-
work (cortical and subcortical) and the cognitive control
network was found. In contrast, anti-coupling between
the cortical and subcortical limbic network and within
the subcortical network was marked during freezing com-
pared to normal foot tapping. Notably, the subcortical
limbic regions were tightly coupled to the dorsal caudate,
despite that the cognitive control network was anti-coupled
from the dorsal caudate nucleus.
Figure 4 Associations between the freezing network signature and the FCI. Functional connections identified in the Freezing
Network Signature, which were associated with a worse FCI are depicted in (A), whereas the connections that were associated with a better FCI
are depicted in (B). The remaining functional connections that were not significantly correlated to the FCI are depicted in C, and (D) dem-
onstrates a summary key that describes how the classification was determined. C = caudate; CBM = cerebellum; P = putamen; PC = principal
component; scLimbic = subcortical limbic; V = ventral striatum.
Figure 5 Unique network signatures for individual components of freezing. Functional connections identified in the freezing network
signature that were associated with more severe components are illustrated in the top panel (A, cognitive; B, motor; C, limbic). Functional connections
identified in the freezing network signature that were associated with reduced component scores (i.e. compensatory) are illustrated in the bottom panel.
C = caudate; CBM = cerebellum; COG = cognitive; P = putamen; scLimbic = subcortical limbic; STV = step time variability; V = ventral striatum.
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Relating the freezing network signa-
ture to the freezing component index
To assess which aspects of the freezing network signature
were associated with severity, compensation, or were inde-
pendent of severity, we first verified there was a significant
relationship between the percentage of time spent frozen
during the task and the FCI (r = 0.40, P = 0.01; Fig. 1B).
Furthermore, the FCI was also positively correlated with
FOGQ3 (r = 0.32, P = 0.045). Figure 4 summarizes the
relationship between functional connectivity and the FCI,
wherein the FCI was correlated with each significant
connection from the freezing signature (freezing4 normal
foot tapping; Fig. 3).
Severity versus compensation
Overall, a worse FCI (a proxy for freezing severity) was
associated with: (i) greater coupling within the cognitive
control network and also between the cognitive control
network and the limbic cortex; (ii) anti-coupling within
the putamen, and between the putamen and caudate nu-
cleus, as well as a loss of anti-coupling between the puta-
men and ventral striatum; and (iii) anti-coupling between
the motor cortex and the limbic subcortex, and cognitive
control network.
In contrast, reduced freezing severity (i.e. ‘Compensation’)
was associated with: (i) anti-coupling between the putamen
and cortical networks (cognitive control, limbic and motor
network); (ii) anti-coupling between the ventral striatum
and motor network; and (iii) increased coupling between
the cognitive control network and the cerebellum and
subcortical limbic network.
Freezing component signatures
To understand the heterogeneous network signature asso-
ciated with freezing, we decomposed the FCI into its cog-
nitive, motor and limbic parts, and further examined the
relationship between individual behavioural components
and the freezing network signature. Figure 5 depicts the
edges associated with better (green) or worse (purple)
scores for each of the three component domains (cognitive,
motor and limbic).
Cognitive signature (TMT-B)
Worse set-shifting ability was associated with decoupling be-
tween cognitive control network and the motor network, as
well as decoupling between the putamen and the ventral stri-
atum. Increased coupling within the ventral striatum was
observed, as well as between the ventral striatum and the
cortical limbic network, and between the cerebellum and
caudate nucleus was also associated with worse set-shifting
ability. Anti-coupling between the motor network and the
subcortical limbic network was related to worse set-shifting
ability. In contrast, better set-shifting ability was associated
with coupling between the cognitive control network and the
limbic network (cortex and subcortex), and anti-coupling
between the cortical and subcortical limbic network.
Decoupling between the cortex and striatum was also
associated with greater cognitive flexibility.
Motor signature (step time variability)
Worse step time variability was primarily associated with
limbic edges. Greater coupling between cortical limbic and
cognitive control networks, and greater anti-coupling be-
tween cortical and subcortical limbic networks as well as
Table 2 Demographic, clinical and neuropsychological and virtual reality characteristics
Total participants (n = 41) MRI + (n = 20) MRI# (n = 21)
Mean SD Mean SD Mean SD
Gender, n 9 F (22%) 3 F (15%) 6 F (29%)
Age 67.54 6.40 66.45 5.34 68.57 7.26
DDE 877.9 579.9 1069.5* 687.6 686.3* 374.4
MDS UPDRS-III 33.89 14.0 34.15 12.19 33.62 15.84
MMSE 27.90 2.07 27.65 2.16 28.14 2.01
FOGQ3 2.5 1.01 2.53 1.02 2.48 1.03
HADS-Anxiety 5.78 3.63 6.3 3.25 5.29 3.98
HADS-Depression 5.37 2.77 6.35* 2.83 4.43* 2.42
HADS Total 11.15 5.9 12.65 5.79 9.71 5.77
TMT-A (Z-score) #0.34 1.14 #0.26 0.97 #0.42 1.31
TMT-B (Z-score) #0.84 1.68 #0.80 1.40 #0.88 1.95
Step time variability 23.08 7.86 24.99 7.04 21.27 8.32
Modal foot step latency, s 0.52 0.27 0.38* 0.17 0.64* 0.29
Time spent frozen, % 0.10 0.09 0.14* 0.08 0.07* 0.14
Protocol completed (5-min:10-min) 25:16 7:13 18:3
*Significant group difference, P5 0.05.
DDE = dopamine dose equivalence; FOGQ3 = question 3 of the Freezing of Gait Questionnaire; MDS UPDRS-III = Movement Disorders Society Unified Parkinson’s Disease Rating Scale
motor subsection; MMSE = Mini-Mental State Examination; MRI + = participants included in the functional MRI analysis; MRI# = participants removed from the functional MRI analysis.
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within the putamen. Decoupling between the putamen and
subcortical limbic regions was also associated with greater
step time variability.
In contrast, reduced step time variability was primarily
associated with reduced coupling between the cortex and
striatum and across the striatum. More specifically, anti-
coupling between the putamen and the cognitive control
network and cortical limbic network, as well as anti-cou-
pling between the dorsal caudate and the putamen were
related to less variable step timing. Additionally, decoupling
between ventral striatum and both the motor network and
putamen, as well as decoupling between the motor network
and cognitive control network was also associated with
reduced step time variability.
Limbic signature (HADS)
Worse anxiety and depression was associated with
increased coupling between the cortical limbic and cogni-
tive control network, as well as between the motor network
and the dorsal caudate nucleus. Furthermore, anti-coupling
between the subcortical limbic network and the motor net-
work, within the putamen, and between the putamen and
the dorsal caudate was also related to worse affective
disturbance.
Similar to the step time variability, less affective disturb-
ance was associated primarily with anti-coupling between
the cortex and the striatum. Specifically, anti-coupling was
found between the putamen and the cognitive control net-
work and cortical limbic network, as well as between the
dorsal caudate and the cognitive control network.
Additionally, anti-coupling between the cortical and sub-
cortical limbic network was found. Decoupling between
the putamen and the subcortical limbic network and
motor network as well as decoupling between the motor
network and the various other cortical and striatal regions
(i.e. the cognitive control network, subcortical limbic net-
work, putamen, and the ventral striatum) was also related
to less severe anxiety and depression symptoms.
Discussion
In this study, we used a task-based connectivity analysis to
identify latent heterogeneity within the neural signature
underlying freezing of gait in Parkinson’s disease. When
compared to periods of normal foot tapping (i.e. a proxy
for normal walking), freezing episodes were characterized
by an overall loss of synchrony between the cortex and the
striatum, as well as a loss of segregation and specificity
between the cortico-striatal pathways (Figs 2B and 3).
Subsequent group-level behavioural interrogation allowed
us to dissociate the freezing signature into three distinct
categories (Fig. 4): a set of intracortical and intrastriatal
connections that were related to freezing severity; a group
of cortico-striatal connections that were putatively related
to compensation; and a network of cortico-striatal and
striato-cerebellar connections that were independent of
freezing severity. Finally, we related these deficits to indi-
vidual differences in the behavioural factors (cognitive,
motor, limbic) that predispose individuals towards freezing
episodes (Fig. 5). Together, these results provide confirma-
tory evidence for systems-level impairments in the patho-
physiology of freezing of gait in Parkinson’s disease.
Severity versus compensation
In contrast to previous studies, the approach used in this
study was able to decipher the patterns within the freezing
of gait phenotype that were related to individual differences
in freezing severity. Specifically, worsened scores on the
first principal component (i.e. inferring worse behavioural
freezing) was associated with increased connectivity within
the cognitive control network and between the cognitive
control network and other cortical networks (i.e. motor
and limbic; Fig. 4). That is, greater cortical ‘cross-talk’
was associated with worse freezing, and less cross-talk be-
tween the cortex and striatum was associated with less
freezing of gait. It is plausible that cortical areas may
become too integrated due to striatal dysfunction or peri-
ods of increased limbic drive. Alternatively, actively redu-
cing the ‘cross-talk’ between the striatum and cortex (e.g.
via maximizing temporal separation of regional activity)
may reduce the severity of freezing of gait and reflect a
compensatory strategy to overcome freezing episodes.
There is growing evidence that dopaminergic replacement
therapy may restore the appropriate corticostriatal connect-
ivity (Esposito et al., 2013; Tahmasian et al., 2015; Gilat
et al., 2017), and normalize the disrupted network
topology (Berman et al., 2016; Kim et al., 2017), thus po-
tentially minimizing ‘crosstalk’. Further research is needed
to determine whether dopaminergic replacement therapy
restores network segregation (Nieuwhof and Helmich,
2017), and whether network segregation versus integration
might be protective against freezing of gait. The current
findings also converge with previous suggestions that freez-
ing represents dysfunction within a distributed network of
widespread frontal and parietal cortical regions (Shine
et al., 2013c), and supplements studies that have shown a
reduction in frontoparietal blood oxygen level-dependent
activation (Snijders et al., 2011; Shine et al., 2013b), grey
matter atrophy in frontal and parietal cortices (Kostic et al.,
2012; Tessitore et al., 2012a; Herman et al., 2014), and
reduced perfusion rate in frontal networks (Imamura et al.,
2012) in association with freezing severity. Interestingly,
freezing severity has been associated with reduced func-
tional connectivity within the ‘executive-attention’ neural
network in the ‘resting’ state (Tessitore et al., 2012b),
whereas here we demonstrate the opposite pattern and re-
lationship during a task-based protocol. These differing re-
sults could emphasize that freezing is likely related to
altered cortical control of gait, or perhaps via failed com-
pensatory strategies that facilitate too much cortical inte-
gration. These findings also indirectly support predictions
of the cross-talk model, which hypothesizes that an
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overflow of communication between the cortex and the
striatum, paired with a loss of segregation (demonstrated
here by pathological cortical coupling) among competing
yet complimentary brain networks may overwhelm the
striatum, thus generating excessive inhibitory output from
the globus pallidus to the brainstem structures controlling
gait, ultimately manifesting freezing behaviour (Lewis and
Barker, 2009).
Similar to recent work, the current study also identified
patterns of abnormal cerebellar connectivity that were asso-
ciated with freezing of gait. In previous work, Fasano et al.
(2017) used a novel lesion network mapping technique to
show that lesions in the dorsal midline cerebellum were
implicated in generating freezing symptoms; however, it
was inconclusive whether the cerebellum’s role in lesion-
induced freezing was relevant for parkinsonian freezing of
gait. Several studies have shown abnormalities in cerebellar
locomotor regions’ structural and functional connectivity in
Parkinson’s disease patients with freezing (Schweder et al.,
2010; Fling et al., 2014; Vercruysse et al., 2015; Myers
et al., 2017), yet a recent study investigating cerebellar
theta burst stimulation found that it did not improve
freezing of gait in patients with Parkinson’s disease
(Janssen et al., 2017). In the current study, the connectivity
between the cerebellum and the striatum was a marked
feature of the network signature of freezing independent
of severity, whereas coupling between the cerebellum and
cognitive control network was found to be compensatory
(i.e. associated with less freezing). Therefore, we provide
further evidence that the cerebellum plays an important
role in the underlying pathophysiology of freezing of gait;
however, future research is needed to understand its
compensatory relationship in order to help guide the
development of effective new therapies.
Recent work by Nieuwhof et al. (2017) has also shown a
loss of segregation within cortico-striatal loops during dual-
task performance while foot-tapping in Parkinson’s disease
(Nieuwhof et al., 2017). Here, we advanced these findings
by mapping patterns of abnormal connectivity during freez-
ing, which were further related to individual differences in
predispositional components (Fig. 3). More specifically, we
used a low dimensional behavioural signature to infer pat-
terns of functional connectivity associated with increased
severity; with increased compensation; or those that were
independent of severity. Based on Nieuwhof’s predispos-
ition hypothesis, it may have been expected that a loss of
cortico-striatal segregation (i.e. greater striatal overlap)
might be independent of freezing severity, and thus repre-
sent trait-like factors common in all patients with freezing
of gait. Indeed, rather than the typical cortico-striatal
circuitries being functionally coupled (e.g. cognitive control
network – dorsal caudate; motor network – dorsal puta-
men; limbic network – ventral striatum), we observed in the
current study little specificity (i.e. greater overlap) in the
functional connectivity between the cortical networks and
the striatum during freezing compared to normal foot
tapping. Moreover, all positive edges between the cortex
and striatum (e.g. motor network – caudate, subcortical
limbic – caudate) were independent of freezing severity.
Furthermore, increased limbic connectivity with the
striatum, as well as disrupted communication within the
motor network and between the cognitive control network
and the striatum were also independent of freezing severity.
Therefore, one interpretation could be that these abnorm-
alities in communication were consistently present across
all patients with freezing of gait during episodes of freezing,
and thus may represent the true neural underpinnings of
freezing of gait that are unchanged by heterogeneous
trait-like factors.
In contrast, the first principal component (a proxy for
freezing severity) was associated with altered connectivity
across the striatal nuclei (Fig. 4). More specifically, worse
freezing behaviour was associated with a loss of coupling
within the putamen and between the dorsal caudate and pu-
tamen, and accompanied by greater coupling between the
ventral striatum and putamen. These findings are in keeping
with previous work which has demonstrated decreased blood
oxygen level-dependent signal in subcortical areas (such as
the caudate, globus pallidus internus, thalamus and mesen-
cephalic locomotor region) during freezing (Shine et al.,
2013b). Furthermore, these results may reflect the dopamin-
ergic aetiology of freezing of gait, since dopamine degener-
ation progresses posterior-dorsal to anterior-ventral within
the striatum (Poldrack, 2005; Wu and Hallett, 2005), thus
affecting the putamen and dorsal caudate more so than the
ventral striatum. This degenerative process could lead to
recruitment of the dopamine-preserved ventral striatum as a
compensatory strategy to aid with cortico-striatal processing,
which may also contribute to greater overlap and loss of
segregation within cortico-striatal pathways. This notion is
consistent with research suggesting that a bottleneck of pro-
cessing might occur when motor and cognitive inputs are
funnelled into the relatively spared ventro-anterior putamen
due to the gradient dopamine depletion in the dorsoposterior
putamen (Lewis and Barker, 2009). Hypothetically, in in-
stances where the ventral striatum may be needed for infor-
mation processing within its own segregated cortico-striatal
limbic loop, this over-recruitment may lead to vulnerability
across other systems that rely on compensatory ventral
striatum processing. In this way, limbic input may have a
greater capacity to interfere with motor output such as walk-
ing, which might offer a further explanation for the emerging
relationship between anxiety and freezing of gait.
Component signatures of freezing
Several of the regions that have been associated with freez-
ing of gait are also known to be intimately involved with
motor, cognitive and limbic functions, which in turn may
explain the well-known clinical relationship between freez-
ing and impairment across multiple behavioural domains
(Schaafsma et al., 2003; Giladi and Hausdorff, 2006;
Naismith et al., 2010; Nutt et al., 2011; Ehgoetz Martens
et al., 2014b; Hall et al., 2015). Indeed, this very feature of
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freezing forms an important basis of the ‘cross-talk’ model,
which describes freezing as a transient overload of infor-
mation processing capacity of within the broader network
of the brain (i.e. independent of the domain that catalyses
overload), ultimately leading to a breakdown in motor
function and freezing (Lewis and Barker, 2009; Lewis
and Shine, 2016). Given that the precise circuitry that
provokes freezing likely differs depending on the specific
trigger that will cause an episode (cognitive, motor,
limbic), this study aimed to explore how functional
connectivity correlated to particular cognitive, motor, and
limbic components of freezing (i.e. set-shifting ability, step
time variability, anxiety and depression severity), in an
effort to better understand their unique contributions and
neural underpinnings.
Cognitive signature
Set-shifting impairments are well known in Parkinson’s dis-
ease, and have been linked with dopaminergic depletion in
the caudate nucleus as well as reduced structural and func-
tional connectivity to frontal areas (Bartels et al., 2006;
Shine et al., 2013d). In the current study, worse set-shifting
ability was associated with greater coupling between the
cerebellum and the caudate as well as between the ventral
striatum and cortical limbic regions. In contrast, greater
cognitive flexibility was associated with coupling between
the cognitive control network and the limbic network and
less connectivity between the cortex and the striatum. In
patients with Parkinson’s disease, including patients with
freezing of gait, a relationship between affective disturbance
and performance on the TMT has been established, such
that anxiety and depression can interfere with set-shifting
abilities (Ehgoetz Martens et al., 2016d). Our findings may
fit with this notion, since greater synchronization within the
limbic cortico-striatal pathway relates to worsened TMT-B
performance, whereas greater ‘top-down’ control of the
limbic network is associated with more cognitive flexibility,
which confirms the dependent nature of cognitive and
affective disturbance in patients with freezing of gait.
Motor signature
Increased step time variability has also been robustly linked
with freezing of gait (Pieruccini-Faria et al., 2015; Weiss
et al., 2015) and is thought to reflect a loss in motor auto-
maticity due to dopaminergic denervation predominately in
the posterior dorsal putamen (Wu and Hallett, 2005). This
area of the putamen is thought be responsible for chunking
motor sequences to improve efficiency and free attentional
resources (Graybiel, 1998). Given that dopaminergic
depletion affects the posterior-dorsal putamen early on,
compensatory attentional and cognitive control networks
have been postulated to compensate by being brought
online to control and coordinate movements. Recent neu-
roimaging work has indeed shown that greater activation
in frontal areas (Wu and Hallett, 2005) and increased
intrastriatal functional connectivity was associated with
greater movement variability in patients with Parkinson’s
disease (Gilat et al., 2017). In patients with freezing of
gait, it might be expected that this loss of automaticity
(represented by increased step time variability) places an
even greater demand on limited attentional resources and
will be similarly related to dysfunctional striatal connectiv-
ity. Here, we found that worsened step time variability was
indeed related to disrupted connectivity within the striatum,
predominately between the putaminal nuclei. Furthermore,
less variability was associated with anti-coupling between
the putamen and the cortex, as well as reduced connectivity
between intra-striatal nuclei and between the cognitive con-
trol network and motor network. Overall these findings are
in support of previous work suggesting a loss of dopamine
in the dorsal striatum is related to greater step time
variability. Likewise, the pattern of results in this study
could also reflect a compensatory shift in processing, such
that the ventral-anterior striatum may be recruited more to
aid with cortico-striatal processing to control movement
since it may have more preserved dopaminergic neurons.
Furthermore, individuals with less step time variability also
had reduced connectivity between the cognitive control net-
work and motor network to employ top-down control of
movement, which is sensible given that cognitive control of
gait typically enhances variability and reduces rhythmicity.
Limbic signature
Although affective disturbance and freezing of gait are clo-
sely related, little research has examined the neural correl-
ates of anxiety or depression in Parkinson’s disease, let
alone the integrity and functional connectivity of the
limbic cortico-striatal pathway in patients with freezing of
gait. Here, we demonstrate for the first time that limbic-
striatal connectivity is a key component of the freezing
neural signature. Moreover, increased input from the
limbic network may contribute to interference in processing
at the level of the basal ganglia via ‘limbic load’, which has
been previously suggested based on behavioural results as a
potential mechanism underpinning freezing of gait (Ehgoetz
Martens et al., 2014b). Considering the loss of segregation
across the striatum, the ventral striatum may become in-
creasingly utilized for motor-related processing and move-
ment control, which could be especially problematic in
anxious patients, who have an ‘overactive’ limbic network
(and threat detection system) to begin with. Surprisingly,
however, we found that greater affective disturbance in
patients with freezing of gait was associated with
predominately motor network connectivity rather than
limbic per se.
Similar to variability and set-shifting, less affective dis-
turbance was associated with less functional connectivity
between the cortex and the striatum. This might suggest
that anxiety in Parkinson’s disease, or perhaps that which
is associated with freezing of gait is intimately related to
movement control deficits. A common discussion point is
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whether anxiety is a response to movement impairments or
a driving cause. It is well known that uncertainty in sensory
information provides the basis for anxious processes. Thus,
perhaps sensory impairments that underlie movement
symptoms could also provoke anxiety over time in
Parkinson’s disease. Previous work has demonstrated that
sensory deficits are linked to freezing as well (Ehgoetz
Martens et al., 2013b, 2014a, 2016a), such that freezing
was exacerbated when asked to walk toward a doorway in
the dark compared to a lit frame, and also suggest that the
threat in an environment compounds freezing behaviours
since freezing was also greater when walking toward a
doorway in the dark compared to a dark open space
(Ehgoetz Martens et al., 2013a). Further research is
needed to test whether anxiety is related to sensory impair-
ments in Parkinson’s disease early on in the disease course
(Ehgoetz Martens et al., 2016b), and also to further disen-
tangle whether anxiety is the chicken or egg to freezing.
Clinical implications
Overall, these findings suggest that unique neural signatures
exist and relate to different behavioural correlates of freez-
ing. The suggestion that freezing of gait subtypes may exist
has been previously put forward (Fasano et al., 2015);
however, to date, limited evidence has been presented.
This is the first study to examine multiple components of
freezing, and demonstrate that unique neural signatures are
present during freezing of gait episodes. Based on our re-
sults, one could speculate that different subtypes of freezing
of gait arise due to individual vulnerabilities within the di-
verse systems required for dynamic control of adaptive be-
haviour and locomotion. For instance, if one is highly
anxious, input from the limbic system to the striatum
could ‘tip the scale’, causing freezing episodes to occur
when the processing capacity of the system exceeds its
limit. Similarly, if someone has significant impairments to
motor automaticity and hence, relies more heavily on cog-
nitive control resources for normally automatic gait, then
instances that perturb or divide these necessary resources
may in turn provoke freezing of gait. However, these rela-
tionships are not always straightforward and remain
opaque, for example in situations where kinesia paradoxa
enable freezers to execute movement in highly stressful situ-
ations, cross-talk between circuitries might channel ad-
equate compensation rather than overload the system
(Nieuwhof and Helmich, 2017). Thus, further research is
certainly needed to illuminate whether segregation versus
integration is detrimental or compensatory across various
situations specific to freezing.
It should be noted that these findings do not necessarily
dispute the involvement of a common downstream path-
way of freezing (Lewis and Shine, 2016), but rather ex-
poses the fact that there are potentially distinct upstream
causes that may represent dissociable targets for treatment.
For example, treating anxiety may have beneficial effects
for specific individuals with freezing of gait (Ehgoetz
Martens et al., 2016c), whereas cognitive training might
be more effective for others (Walton et al., 2014; Leung
et al., 2015). Alternatively, an individual with either a
motor or anxious phenotype may benefit from sensory-
based training programmes that work on improving the
use of sensory information and restoring gait automaticity
(Sage and Almeida, 2009; Lefaivre and Almeida, 2015).
However, much research is still needed to clarify this
point and further research is also needed to characterize
these subtypes, and determine whether in a data-driven
approach there is any evidence of these different types,
and whether they lend support to different cortical mech-
anisms and thus different ‘cortically’ geared therapies.
Limitations and considerations
It is important to point out the shortcomings and limita-
tions of this work. First, we did not include any ‘ON’ state
patients with freezing of gait in this cohort. Although this is
a rare subtype of freezing of gait, it is currently unclear
whether the findings presented here would generalize to
this subgroup. Second, although the virtual gait task is
able to capture much of the coordination involved in
gait, it also has many limitations. For example, the con-
straints imposed by the functional MRI scanner are incom-
patible with analyses that interrogate the delicate control of
upright stance and dynamic balance required while
walking. Additionally, the freezing events detected could
be confounded by fatigue or a loss in concentration.
Another caveat in this study was that the participants
included in the imaging cohort had a faster modal footstep
latency on average than the cohort who were excluded.
Although a slower foot tapping speed may set the threshold
to detect freezing higher than those with a faster foot step
latency, we did not observe an association between modal
foot step latency and percentage of time spent frozen
(P4 0.1). Thus, it is unlikely that foot step latency
confounds the neuroimaging results reported in this study.
Finally, given that our focus was on investigating the
particular episodic characteristics of freezing, we did not
include a control group in this study. However, future
research should consider examining differences in continu-
ous gait patterns between Parkinson’s disease patients with
and without freezing to further understand the role of the
motor, cognitive and limbic networks and their contribu-
tion to gait variability and gait disturbances.
Conclusion
Overall, these findings provide confirmatory evidence for
systems-level impairments in the pathophysiology of freez-
ing of gait. Importantly, the findings of this study show
how functional connectivity during freezing is correlated
to particular cognitive, motor and limbic features in effort
to better understand their unique contributions and
neural underpinnings. Thereby we further advance our
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understanding of the whole-brain deficits that mediate
symptom expression in Parkinson’s disease.
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Cognitive training for freezing of gait in Parkinson’s disease: a
randomized controlled trial
Courtney C. Walton 1, Loren Mowszowski1,2, Moran Gilat1, Julie M. Hall1,3, Claire O’Callaghan1,4, Alana J. Muller1,
Matthew Georgiades1, Jennifer Y. Y. Szeto1, Kaylena A. Ehgoetz Martens1, James M. Shine1,5, Sharon L. Naismith1,2 and
Simon J. G. Lewis 1
The pathophysiological mechanism of freezing of gait (FoG) has been linked to executive dysfunction. Cognitive training (CT) is a
non-pharmacological intervention which has been shown to improve executive functioning in Parkinson’s disease (PD). This study
aimed to explore whether targeted CT can reduce the severity of FoG in PD. Patients with PD who self-reported FoG and were free
from dementia were randomly allocated to receive either a CT intervention or an active control. Both groups were clinician-
facilitated and conducted twice-weekly for seven weeks. The primary outcome was percentage of time spent frozen during a Timed
Up and Go task, assessed both on and off dopaminergic medications. Secondary outcomes included multiple neuropsychological
and psychosocial measures. A full analysis was first conducted on all participants randomized, followed by a sample of interest
including only those who had objective FoG at baseline, and completed the intervention. Sixty-five patients were randomized into
the study. The sample of interest included 20 in the CT group and 18 in the active control group. The primary outcome of
percentage time spent frozen during a gait task was significantly improved in the CT group compared to active controls in the on-
state. There were no differences in the off-state. Patients who received CT also demonstrated improved processing speed and
reduced daytime sleepiness compared to those in the active control. The findings suggest that CT can reduce the severity of FoG in
the on-state, however replication in a larger sample is required.
npj Parkinson's Disease  (2018) 4:15  ; doi:10.1038/s41531-018-0052-6
INTRODUCTION
Freezing of gait (FoG) is a disabling symptom of Parkinson’s
Disease (PD), which presents as a “brief, episodic absence or
marked reduction of forward progression of the feet, despite the
intention to walk”.1 FoG is well-known to lead to falls2 and lower
quality of life, making it an important target for treatment.3 The
pathophysiological mechanism of FoG has been linked to
executive dysfunction, particularly in aspects of cognitive
control,4 which aligns with neuroimaging evidence showing
fronto-parietal and fronto-striatal impairments.5 Recent meta-
analytic data suggests that cognitive training (CT) is an
effective6 and important7 behavioral intervention for improving
cognition, and in particular executive functions, in patients
with PD.
Given that these executive deficits have been hypothesized to
underlie the pathophysiological mechanisms of FoG, it is plausible
that reducing executive dysfunction via CT may lessen the severity
of FoG, by mediating more effective fronto-striatal function.8 A
number of studies have now shown that CT in PD can lead to
neuroplastic changes by way of increased activity and functional
connectivity in frontal-striatal regions.9–11 Given that FoG relates
to dysfunction in these areas, it is reasonable to hypothesize that
CT may facilitate more efficient processing between frontal and
striatal regions, leading to a reduction of FoG severity. Interested
readers are directed to a previous review from our group, which
has provided more extensive evidence and rationale for this
proposal.12
In this study, a double-blind randomized controlled trial was
conducted to explore the efficacy of CT targeting executive
functions in PD patients with FoG. We hypothesized that
participants receiving CT would show improvements as illustrated
by the reduced severity of FoG after completion of the
intervention. Additionally, we anticipated that secondary out-
comes including cognitive and psychosocial measures would
show improvement following the CT program.
RESULTS
Participants
Figure 1 illustrates the flow of participants moving through the
study. The first participant was randomized in April 2013 and the
last in June 2015. There were nine dropouts in the active
control condition (AC) (five prior to beginning the program) and
one participant was lost to follow up. There were no dropouts in
the CT group. In addition, in the AC group one participant was
removed entirely from the analysis as their diagnosis was
changed from PD to Progressive Supranuclear Palsy, and a
second was removed as they could not complete the TUG
assessments due to severe motor disability. Two participants
were removed from the CT group due to inadvertent
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incorrect randomization. These participants were retrospec-
tively identified as not meeting the original inclusion criteria and
thus it was determined their data would not be analysed at
any point.
Upon intervention completion, TUG scoring indicated that
despite self-reporting FoG, nine participants from the CT and four
from the AC group did not objectively exhibit FoG on baseline
assessment. Therefore, we designed two analysis populations
Fig. 1 CONSORT Flow diagram
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post-hoc. The full analysis set (FAS) included all participants
randomized into the study, whether or not they dropped out, or
showed objective FoG at BL. The sample of interest set (SIS) was
decided upon as a post-hoc analysis, to account for the fact that a
number of participants did not display FoG at baseline. The SIS
therefore included only those participants who showed objective
FoG on BL testing, as identified in the baseline TUG, and
completed the study in full. The SIS population is considered
the analysis of interest and is therefore what is reported in the
results, however all analyses were initially run on the FAS sample
to confirm no sampling bias. Demographic data for both the FAS
and SIS samples are provided in Table 1.
Primary outcome
Results of the SIS analysis for the primary outcome are displayed
in Table 2. This analysis showed that patients in the CT group
showed a large and statistically significant reduction in FoG
severity in the on-state compared to participants in the AC. There
was no difference in the off-state. The FAS analysis was consistent
with these results, suggesting that the SIS sample was not biased.
We did not compare performance across each of the four
conditions separately, on and off as this was not part of the
predetermined outcome plan, and secondly, we felt it was an
inappropriate exploratory analysis given the smaller than antici-
pated sample.
Secondary outcomes
Results of the SIS analysis for the secondary outcomes are
displayed in Table 3. In the SIS analysis, there were no statistically
significant differences for any of the secondary outcomes over
time between groups.
Covariate analysis
The covariate analysis showed that the results for the primary
outcome remained unchanged by the introduction of covariates
(i.e., still statistically significant). However, in terms of secondary
outcomes, the inclusion of DDE as a covariate led to TMT-A and
daytime sleep disturbance scores becoming significant, with those
in the CT group improving compared to the AC.
DISCUSSION
This pilot study represents one of the largest RCTs of CT to date in
PD. Though interpretation of the results must remain cautious
owing to the limitations outlined below, the results allude to the
potential for CT to reduce the severity of FoG in people with PD.
We showed that CT led to a large and significant reduction of FoG
severity compared to AC while in the on-state, but this was not
replicated in the off-state. These results were consistent, whether
we included participants who did not display FoG at baseline or
not, and when accounting for covariates. We suggest these results
warrant larger scale replication, employing the suggested
methodological adjustments we provide below.
The result of FoG only improving during the on-state is
noteworthy. Firstly, we preface this discussion by stating this is
the clinically relevant behavioral state, as patients in their day-to-
day life would take dopaminergic medications as prescribed to
minimize time in the off-state. Our provisional supposition to
explain this result is that participants in the off-state were too
impaired to benefit from any of the potential changes initiated
through CT. Training was expected to impact frontal processing
Table 1. Demographic data of participants in both analysis samples
FAS population SIS population
AC group (N
= 32)
CT group
(N= 29)
AC group
(N= 18)
CT group
(N= 20)
Gender (M/F) 22/10 21/8 11/7 14/6
Age, years 68.50 (7.5) 68.48 (8.0) 69.61 (7.8) 69.70 (7.6)
Years since
diagnosis
11.06 (6.6) 8.82 (4.9) 11.89 (6.6) 9.95 (4.4)
LEDD 934.71 (555.1) 769.37
(340.7)
975.43
(570.8)
828.8
(315.3)
Education, years 13.97 (3.2) 13.59 (3.2) 14.44 (3.5) 13.55 (3.4)
MMSE 28.16 (1.8) 27.72 (2.0) 28.56 (1.6) 27.35 (2.0)
Sessions
attended
11.58 (3.7) 13.31 (0.9) 13.06 (1.2) 13.4 (0.9)
Days until follow
up
8.91 (6.9) 6.48 (5.6) 9.11 (7.4) 7.20 (5.7)
Has DBS 6 4 3 4
MDS-UPDRS
Motor on
36.16 (13.7) 36.83 (13.3) 33.44 (12.6) 38.70 (13.7)
MDS-UPDRS
Motor off
43.76(11.7) 42.12 (12.4) 43.27 (11.8) 46.13 (10.9)
Hoehn and Yahr stage
1 1 0 1 0
2 12 11 5 5
2.5 6 5 5 5
3 11 9 6 7
4 2 4 1 3
LEDD levadopa equivalence daily dose, MMSE mini-mental state examina-
tion, DBS deep brain stimulation, MDS-UPDRS Movement Disorder Society
Unified Parkinson’s Disease Rating Scale
Table 2. Primary outcome data between groups before and after intervention
AC group CT group Comparison of change
%TF ona
BL 6.61 (3.92, 11.15) 9.16 (5.52, 15.19) 0.3 (0.14, 0.62); T=−3.36; p= 0.002; d= 1.02
FU 11.99 (7.11, 20.23) 4.95 (2.99, 8.21)
Change from BL 1.81 (1.08, 3.05) 0.54 (0.32, 0.90)
%TF offa
BL 16.61 (9.22, 29.93) 8.02 (4.59, 13.98) 1.07 (0.64, 1.76); T= 0.26; p= 0.800; d= 0.08
FU 15.44 (8.57, 27.81) 7.94 (4.55, 13.85)
Change from BL 0.93 (0.64, 1.34) 0.99 (0.70, 1.40)
aAnalysis conducted on Log10 transformed data and represented by geometric means. The change from baseline is a ratio of the geometric means at follow-
up compared with baseline. The comparison of the changes from baseline is the ratio of the change from baseline for the CT group compared the AC group.
95% CIs are presented in brackets. Direction of change and statistical significance was matched in the FAS analysis
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Table 3. Secondary outcome data between groups before and after intervention
AC group CT group Comparison of change
MOCA
BL 25.33 (23.57, 27.09) 24.15 (22.48, 25.82) 0.84 (−1.38, 3.06); T= 0.77;
FU 25.39 (23.63, 27.15) 25.05 (23.38, 26.72) p= 0.45;
Change from BL 0.06 (−1.55, 1.67) 0.9 (−0.63, 2.43) d= 0.24
HVLT-R total
BL 19.39 (16.83, 21.95) 18.50 (16.07, 20.93) −1.93 (−4.75, 0.88);
FU 21.72 (19.16, 24.28) 18.90 (16.47, 21.33) T=−1.39; p= 0.17;
Change from BL 2.33 (0.29, 4.38) 0.40 (−1.54, 2.34) d= 0.44
HVLT-R delayed
BL 5.67 (4.23, 7.10) 5.00 (3.64, 6.36) −0.53 (−2.21, 1.15);
FU 6.35 (4.89, 7.80) 5.15 (4.49, 6.751) T=−0.64; p= 0.53;
Change from BL 0.68 (−0.55, 1.92) 0.15 (−0.99, 1.29) d= 0.19
Digit span total
BL 16.00 (14.41, 17.59) 14.85 (13.34, 16.36) −0.93 (−2.18, 0.32);
FU 16.78 (15.19, 18.37) 14.70 (13.19, 16.21) T=−1.50; p= 0.14;
Change from BL 0.78 (−0.13, 1.69) −0.15 (−1.01, 0.71) d= 0.47
TMT-A timea,b
BL 44.74 (35.40, 56.48) 50.31 (40.10, 63.05) 0.78 (0.64, 0.95);
FU 45.67 (36.14, 57.64) 39.77 (31.65, 49.90) T=−2.57; p= 0.01;
Change from BL 1.02 (0.89, 1.18) 0.79 (0.69, 0.91) d= 0.62
TMT-B timea
BL 119.11 (95.63, 148.31) 136.08 (110.52, 167.51) 0.88 (0.75, 1.04);
FU 120.96 (97.11, 150.61) 122 (99.12, 150.29) T=−1.50; p= 0.14;
Change from BL 1.02 (0.90, 1.15) 0.90 (0.80, 1.01) d= 0.48
VF-phonemic
BL 37.22 (32.26, 42.19) 31.55 (26.84, 36.26) −0.47 (−3.96, 3.03);
FU 37.89 (32.93, 42.85) 31.75 (27.04, 36.46) T=−0.27; p= 0.79;
Change from BL 0.67 (−1.87, 3.2) 0.20 (−2.21, 2.61) d= 0.09
VF-semantic
BL 33.22 (28.46, 37.99) 30.45 (25.93, 34.72) −1.03 (−5.28, 3.23);
FU 34.00 (29.23, 38.77) 30.20 (25.68, 34.72) T=−0.49; p= 0.63;
Change from BL 0.78 (−2.31, 3.87) −0.25 (−3.18, 2.68) d= 0.15
VF-switching total
BL 12.11 (10.54, 13.68) 9.70 (8.21, 11.19) 1.18 (−0.51, 2.87);
FU 11.78 (10.20, 13.35) 10.55 (9.06, 12.04) T= 1.42; p= 0.16;
Change from BL −0.33 (−1.56, 0.89) 0.85 (−0.31, 2.01) d= 0.45
VF-switching accuracy
BL 10.83 (9.04, 12.63) 8.90 (7.20, 10.60) −0.09 (−2.54, 2.35);
FU 10.28 (8.48, 12.07) 8.25 (6.55, 9.95) T= 0.08; p= 0.94;
Change from BL −0.56 (−2.33, 1.22) −0.65 (−2.33, 1.03) d= 0.02
SDMT total
BL 35.44 (30.00, 40.89) 33.95 (28.78, 39.12) 0.47 (−3.74, 4.68);
FU 37.22 (31.77, 42.67) 36.20 (31.03, 41.37) T= 0.23; p= 0.82;
Change from BL 1.78 (−1.28, 4.83) 2.25 (−0.65, 5.15) d= 0.07
AGN latency
BL 595.75 (547.92, 643.58) 657.65 (608.42, 706.89) −29.89 (−66.37, 6.58);
FU 586.42 (538.89, 633.95) 618.43 (569.19, 667.67) T=−1.67; p= 0.10;
Change from BL −9.33 (−34.34, 15.68) −39.22 (−65.78, −12.67) d= 0.62
AGN omissionsa
BL 2.85 (1.49, 4.94) 4.35 (2.42, 7.37) 0.70 (0.46, 1.06);
FU 4.26 (2.42, 7.08) 4.15 (2.29, 7.05) T=−1.73; p= 0.09;
Change from BL 1.37 (1.03, 1.82) 0.96 (0.71, 1.3) d= 0.61
AGN commissionsa
Cognitive training for freezing of gait
CC Walton et al.
4
npj Parkinson’s Disease (2018)  15  Published in partnership with the Parkinson’s Foundation
and also occurred in the on-state. In the dopamine depleted state,
it is conceivable that the striatal dysfunction overshadowed any
benefit of CT,8,13 and FoG could not be improved. Our future
analysis of functional neuroimaging outcomes in this study may
be able to unravel this further.
A number of trials in older adults have now shown that CT can
have a beneficial impact on multiple gait parameters.14–16 In PD
specifically, a pilot study by Milman and colleagues17 showed that
12 weeks of CT could improve TUG performance. Unfortunately,
this pilot study did not employ a control group. Therefore, the
current results are an important extension showing improvements
on TUG performance via the reduction of FoG, compared to an
active control group.
Given that FoG was reduced in the CT group, we expected there
to be additional improvements in tests of EF, which were
presumed to underlie any improvement of FoG. However, changes
on these outcomes did not reach statistical significance. We were
therefore unable to confirm the hypothesis that improving EF
would be the driver of reduced severity of FoG. It is possible that
our smaller sample size was a factor however (though it was
deemed inappropriate to conduct post-hoc power analysis18).
Indeed, there were near medium-sized effect sizes (d ≥ 0.45) for
many of the executive tests we anticipated improvements on
including TMT-B, and shift-measures of the affective go-no-go test
(AGN) and verbal fluency (VF) (see Table 2). We do note however
that when adjusting for the effect of dopaminergic medication,
the CT group did show medium-sized significant improvements
compared to AC in processing speed and daytime sleepiness.
Limitations
This study has limitations which warrant consideration. The first is
that we did not meet the projected sample size target due to
feasibility issues with recruitment. In addition, there were a
number of dropouts in the AC group, although we note that over
half of these dropouts occurred prior to commencement of the
intervention and only one was due a lack of interest. The third
issue was that participants were randomized prior to TUG scoring.
This was necessary to avoid delay to participants being enrolled as
TUG scoring is time consuming, requiring skilled and trained
raters. Nonetheless, we attempted to address these limitations by
running the FAS analysis, which confirmed our primary result.
Additionally, despite random allocation, the groups were
unbalanced in their baseline FoG severity. The CT group had
more FoG than the AC in the on and less in the off-state. We
stratified the randomization by cognitive functioning (MOCA
scores), however it may be more appropriate in future to stratify
by objective FoG scores at baseline. We highlight however that
the results remained when accounting for the impact of LEDD,
and that the on-state is the clinically meaningful state. Related to
this unbalanced severity, it is important to highlight that the AC
group actually had worse FoG at follow-up compared to the CT
group in the on-state and this pattern of results was replicated in
the FAS analysis. Replication with a larger sample is needed to
demonstrate if this is a reliable finding, or represents the variability
found in small samples such as this one.
Table 3 continued
AC group CT group Comparison of change
BL 5.05 (3.35, 7.41) 4.28 (2.76, 6.42) 0.83 (0.54, 1.3);
FU 5.15 (3.45, 7.51) 3.48 (2.19, 5.30) T=−0.83; p= 0.41;
Change from BL 1.02 (0.75, 1.38) 0.85 (0.62, 1.17) d= 0.26
HADS total
BL 10.78 (7.85, 13.71) 12.70 (9.92, 15.48) −1.98 (−5.38, 1.42);
FU 11.56 (8.63, 14.48) 11.50 (8.72, 14.28) T=−1.18; p= 0.25;
Change from BL 0.78 (−1.69, 3.24) −1.2 (−3.54, 1.14) d= 0.37
PDQ-39 total
BL 26.69 (20.81, 32.58) 28.21 (22.63, 33.79) −3.33 (−8.07, 1.41);
FU 27.32 (21.43, 33.20) 25.50 (19.92, 31.09) T=−1.42; p= 0.16;
Change from BL 0.62 (−2.82, 4.06) −2.71 (−5.97, 0.55) d= 0.45
CBI total
BL 18.74 (10.62, 26.86) 33.51 (26.21, 40.81) −4.51 (−10.66, 1.64);
FU 20.85 (12.66, 29.04) 31.11 (23.86, 38.36) T=−1.49; p= 0.15;
Change from BL 2.11 (−2.52, 6.73) −2.4 (−6.45, 1.65) d= 0.53
SCOPA-S dayb
BL 4.77 (3.16, 6.38) 6.31 (4.72, 7.89) −1.66 (−3.27, −0.05);
FU 5.00 (3.39, 6.62) 4.88 (3.32, 6.44) T=−2.10; p= 0.04;
Change from BL 0.24 (−0.91, 1.38) −1.43 (−2.56, −0.29) d= 0.56
SCOPA-S night
BL 5.33 (3.18, 7.48) 6.00 (3.94, 8.06) −0.24 (−2.17, 1.68);
FU 5.61 (3.46, 7.76) 6.03 (3.97, 8.09) T=−0.26; p= 0.80;
Change from BL 0.28 (−1.09, 1.64) 0.03 (−1.32, 1.39) d= 0.06
MOCA Montreal cognitive assessment, HVLT-R Hopkins verbal learning test-revised, WMS-III Wechsler Memory Scale, VF verbal fluency, DKEFS Delis–Kaplan
executive function system, SDMT symbol digit modalities test, TMT trail making test, AGN affective go-no-go test, HADS Hospital Anxiety & Depression Scale,
SCOPA Scales for Outcomes in Parkinson’s disease, PDQ-39 the Parkinson’s disease questionnaire, CBI-R Cambridge behavioral inventory-revised
aAnalysis conducted on Log10 transformed data and represented by geometric means. The change from
baseline is a ratio of the geometric means at follow-up compared with baseline. The comparison of the changes from baseline is the ratio of the change from
baseline for the CT group compared the AC group
bResults are adjusted for DDE as a covariate. 95% CIs are presented in brackets
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Future directions
We believe there is reason to be hopeful for the use of these trials
in the future. Feedback from participants and family members
involved in the groups was overwhelmingly positive, our pilot
results highlight positive trends, and the importance of non-
pharmacological trials including CT has become increasingly
clear.7,19,20 We suggest that replication of this trial is warranted.
However, with the hope of improving any future work learning
from some of the issues that were raised during this study, we
suggest authors consider some of the following suggestions.
Future studies where possible should aim to score FoG severity
prior to enrollment. A certain threshold for severity (e.g., >5%)
should be specified for eligibility, and stratification across groups
could also be based on this. Where possible, additional methods
of FoG measurement could increase the reliability of %FoG scores.
This could be done through measures such as gait mats and
accelerometry data, and also repeat TuG assessments to address
measurement variability. Multisite recruitment would increase the
potential for sample size without relying on home-based CT,
which we do not believe would be a viable option,21 particularly in
this sample. The inclusion of additional data to aid analysis such as
measurement of expectancy effects and CT training data can be
useful. Finally, we did not include a long-term follow up
assessment. This has often been used as a criticism against CT,
though we rebut that very few interventions elicit sustained
improvements after the cessation of treatment. Thus, it is likely
that clinically, CT needs to be continuously delivered in order to
continue any found benefits, just like most other interventions
(e.g., exercise, medications etc). Nevertheless, obtaining a better
understanding of how long such results are maintained22 is useful
for future trial design and clinical applications, and thus future
studies could try to obtain this information if feasible.
CONCLUSIONS
The current study provides preliminary evidence that CT can
reduce the severity of FoG in PD during the on-state. This
improvement was seen without concurrent, significant changes to
executive functioning (despite near-medium sized effects on these
measures), but in the context of improved processing speed and
daytime sleep disturbance. Despite the limitations of this study,
these results add to the growing body of evidence showing that
CT is a useful therapeutic technique worthy of continued
exploration in PD.
METHODS
Study registration
This study was registered in 2013 on the 5 April through the Australian and
New Zealand Clinical Trials Registry (ACTRN12613000359730) and was
approved by the Human Research Ethics Committee of the University of
Sydney. Written informed consent was obtained from all participants.
Eligibility
Eligible participants were those diagnosed with idiopathic Parkinson’s
disease based on the UK Brain Bank clinical criteria,23 with self-reported
FoG at the time of assessment, and who were free from dementia as
determined by a score of ≥24 on the mini-mental state examination
(MMSE).24
Recruitment
The study was advertised in a local PD community magazine as well as
local PD community support groups. Potential participants were also
recruited from the Parkinson’s Disease Research Clinic at the Brain and
Mind Centre, University of Sydney. Interested participants were invited to
participate if they had previously reported a positive score on Question 3
of the Freezing of Gait Questionnaire (FOG-Q): “do you feel that your feet
get glued to the floor while walking, making a turn, or trying to initiate
walking (freezing)?”.25
Prior to recruitment, we used baseline data from a previously published
trial26 to conduct a power analysis using a conservative effect size estimate
of at least 0.2 in the study’s primary outcome. This suggested the minimum
sample size required for each group was 39 (based on power= 0.80 and α
= 0.05).
Study design
The study was a double-blind randomized active controlled trial. Interested
patients were enrolled by CCW and LM after they met eligibility criteria
during a baseline assessment and were then randomized into either the CT
or an AC group. Conditions were masked as either “morning” or
“afternoon” sessions, and the order of these was randomized between
recruitment waves prior to trial commencement. In order to facilitate
blinding, participants were told that each session involved different
computerized activities, but were not explicitly told of a treatment or
control group. Randomization of participants and morning/afternoon
sessions was carried out using a randomly generated number sequence
allocated by a blinded researcher not involved in trial recruitment, data
gathering, assessments or training. Randomization was undertaken using
permuted blocks and stratified by cognitive functioning, with strata
defined by Montreal cognitive assessment (MOCA) scores of <26 or ≥26.
Participants were advised of their allocation into the morning or afternoon
session by way of sealed opaque envelopes delivered by CCW upon
completion of the baseline assessments. Post-intervention assessments
were conducted by clinicians who were blinded to treatment allocation. All
participants allocated to the AC group were offered the opportunity to
complete CT after their involvement in the trial was complete. Ten
participants elected to complete this, with those who declined citing time
commitments as the primary reason.
Assessments
Baseline and post-intervention assessments were each completed in two
parts: on and off-medications. The on-state assessment included a
neuropsychological test battery, psychosocial measures, part III of the
Movement Disorders Society’s revision of the Unified Parkinson’s Disease
Research Scale (MDS-UPDRS),27 and a modified timed up-and-go (TUG)
task. These assessments were completed in a random counterbalanced
order and took approximately 2.5 h to complete. Baseline assessments
were conducted within 3 weeks prior to training commencement, and
follow-up assessment was within 3 weeks of the intervention finishing.
The practically defined off-state assessment was completed in the
morning on a different day when participants were asked not to take
their usual Parkinson’s medication until after the assessment, and
comprised a repeated MDS-UPDRS part III and TUG, taking approximately
1 h. Those with deep brain stimulation did not complete the off-state
assessment. A random subset of participants also underwent neuroima-
ging, however the investigation of any training-induced changes are a
tertiary outcome and are therefore not included in the current
manuscript.
Primary outcome
The primary outcome was percentage of time spent frozen (%TF) across all
four trials of a TUG assessment. Percentage was chosen as the primary
outcome as it was anticipated to be more sensitive than a reduction on the
FOG-Q, whilst accounting for inter-individual variability in gait speed and
the variable duration of freezing episodes across TUG tasks.26 In each task,
the participant was requested to get up from a chair, walk to a square box
shape taped to the floor five meters ahead and complete both a left and a
right turn (see Fig. 2). TUGs were video recorded and then scored
independently post-assessment. Six scorers (MG, JMH, AJM, MG, JYYS, and
KAEM) were randomly distributed videos of the TUGs. Scorers were given
baseline and follow-up TUG videos in a random order for the same
participant, to minimize pre-post scoring variability. FoG was tagged in the
video at any point when a participant made a paroxysmal and involuntary
cessation of normal progression of the feet through the task. This included
a typical trembling of the feet, short shuffling steps of a few centimetres in
length or a complete motor block.28
The %TF outcome was calculated by summing all FoG episodes across
the four conditions, and dividing by the total time to complete across all
conditions. Inter-rater variability amongst blinded scorers was strong, and
calculated by all scorers being given a random selection of the same six
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videos to independently score. The intraclass correlation coefficient was
.902 across all FoG episodes (average %TF: 9.56%). We note that two of the
six videos by chance did not contain FoG, however they were included to
confirm no false-positive scoring had occurred. As this inflated reliability
across scorers however, we re-calculated the coefficient with the two
videos removed to be sure. Scoring was still accurate across raters (.865)
(average %TF: 14.31%).
Secondary outcomes
Cognitive assessment. To assess global functioning for descriptive
purposes, the MMSE24 and MOCA29 were used. Total and delayed Hopkins
verbal learning test-revised scores were used to assess verbal memory.30
To assess attention and working memory, the total score from the Digit
Span subtest of the Wechsler Memory Scale was used.31 To assess verbal
fluency, the total words generated on each condition of the VF subtest of
the Delis–Kaplan executive function system was used.32 In this test, part 1
measures phonemic fluency across three letters, part 2 measures semantic
fluency across two categories while parts 3 and 4 assess switching
between two differing categories. Part 3 represents the total number of
correct items, while part 4 represents the total number of correct switches.
Processing speed was assessed by the number of correct responses on the
oral symbol digit modalities test.33 For these measures, higher scores are
indicative of better performance.
To assess processing speed and cognitive flexibility, times for parts A
and B respectively of the trail making test (TMT) were used.34 Finally, the
AGN of the Cambridge neuropsychological test automated battery35 was
used as a computerized measure of inhibitory control/switching. Mean
latency post-switch was used to determine performance in addition to the
number of commissions or omissions. For these tests, lower scores were
indicative of better performance. Alternate versions of each test with the
exception of Digit Span (not available) were used at baseline and follow-up
to minimise potential practice effects.
Psychosocial measures. Participants completed several questionnaires
targeting mood and wellbeing. The Hospital Anxiety & Depression Scale
was used to assess anxious and depressive symptoms.36 The Scales of
Outcomes in PD (SCOPA)-Sleep was used to assess sleep quality in terms of
both daytime sleepiness and night time sleep disturbance.37 The
Parkinson’s Disease Questionnaire (PDQ-39)38 was used as a measure of
quality of life. Finally, if a participant lived with a carer, the Cambridge
behavioral inventory-revised39 was used as an informant report of
cognitive and behavioral changes. For all of these scores, a higher score
was indicative of more substantial impairment.
Intervention. Both the CT and AC groups attended sessions at the Brain
and Mind Centre at the University of Sydney in our designated CT
laboratory, and both conditions were matched in terms of time, clinician
contact, computer use and social interaction. In accordance with our
previous CT programs for older adults (see,40,41) the intervention was
completed in a group format (n ≤ 10), and comprised of 2-h sessions, twice
weekly over 7 weeks (14 sessions in total). Both groups were supervised
and facilitated by CCW & LM. The first hour of the session was identical
across CT and AC groups: (i) 30–45min was designated to psycho-
education on a number of topics relevant to PD including cognition, sleep
and mood, and was delivered by multidisciplinary specialists and
researchers from the Brain and Mind Centre; (ii) participants then took
an enforced break of 10–15min. This first hour, whilst not CT per-se, was
included for both conditions as a means of increasing participant
engagement and has previously been shown to support our excellent
program adherence rates.40,41 The second hour of the session differed
across CT and AC groups:
(A) CT: Participants in this group completed a program of computerized
CT tasks, selected for their focus on executive functions and on the basis of
our previous experience employing the “Neuropsychological Educational
Approach to Remediation” approach41,42 in providing computerized CT to
>400 older adults,41,43,44 including those with PD.40 Tasks included
designated “brain training” programs (e.g., Attention Process Training-
III45) as well as commercially-available software (e.g., computerised
Sudoku), which were determined by clinical neuropsychologists (LM,
SLN) to target the cognitive processes of most interest to FoG (inhibitory
control, attentional set-shifting, working memory, processing speed and
visuospatial skills).4,12 Performance was monitored by the facilitators, with
the focus of progressively making the tasks more difficult where possible
for the participant. These changes were done in an individualized manner
based on performance and in consultation with the participant. Therefore
while the tasks delegated for each session where standardized across all
participants, there were differences in how far each progressed in terms of
difficulty. The majority of exercises provided the participant with feedback
in the form of scores, and this was further discussed between facilitators
and participants to help them better understand their performance.
(B) AC: Participants in this group completed a series of non-specific
computer-based tasks including predominantly watching informative
nature videos and answering content-related questions as previously
Fig. 2 Each condition involved two trials with a left and right turn version. In the 180° condition, the participant walked to the box, turned
around and returned to their chair; In the 540° condition, they completed a 540° turn in the box before returning to the chair; In the box
condition, participants shuffled around the box, keeping their inside foot to the outside of the box; in the dual task condition, participants did
the same as in the 180°, however completed a cognitive task as they walked. This was either naming the months backwards or multiples of 9
or 7 aloud. The %TF outcome was calculated by summing all FoG episodes across the four conditions, and dividing by the total time to
complete across all conditions
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used,46 as well as online “treasure hunts” devised by our team. These tasks
were designed to provide broader, generalized cognitive engagement
compared to the targeted focus on specific cognitive functions in the CT
condition. Therefore, those in this group were not expected to have
reduced FoG severity but were rather intended to match for clinician and
peer contact, along with computer use.
Statistical analysis. To minimize any potential bias, statistical analyses
were conducted by a consultant statistician experienced in RCTs who was
based at the University of Sydney (see acknowledgements) and who was
not involved in any other aspect of the trial. Data was analysed using SAS
software version 9.4.
The analysis took the form of a mixed effects model using fixed effects
fitted to all endpoints, to test the null hypothesis of no difference in
change over time across groups against the alternative hypothesis of a
difference between the two arms. An additional term in the model was
fitted to account for the repeated measures pre- and post-intervention.
“Participant” was declared a random effect. An unstructured covariance
pattern between baseline and post-intervention was used. The Kenward
and Roger’s method for correcting for the fixed effects, standard error bias
by inflation of the variance and Satterthwaite’s adjustment to the degrees
of freedom has also been applied to cater for the small sample size.
Analyses of endpoints with non-normal variance for analysis have been
transformed to the log10 scale for analysis. Results were back transformed
for interpretation and represent geometric means. Cohens d was
calculated as a measure of effect size with 0.2, 0.5, and 0.8 considered
small, medium and large effects in the CT compared to the AC group.47
Covariate analysis. An additional analysis was undertaken to investigate
the effects of the following covariates on all outcome measures: age,
education, levodopa equivalency daily dose LEDD;48 years since diagnosis,
and the amount of days between CT completion and FU assessment (days
until FU) on each outcome. Only significant results are reported.
Data availability statement
The data that support the findings of this study are available from the
corresponding author upon reasonable request.
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Visual Hallucinations Are Characterized by
Impaired Sensory Evidence Accumulation:
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Modeling in Parkinson’s Disease
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ABSTRACT
BACKGROUND: Models of hallucinations emphasize imbalance between sensory input and top-down influences
over perception, as false perceptual inference can arise when top-down predictions are afforded too much
precision (certainty) relative to sensory evidence. Visual hallucinations in Parkinson’s disease (PD) are associated
with lower-level visual and attentional impairments, accompanied by overactivity in higher-order association brain
networks. PD therefore provides an attractive framework to explore contributions of bottom-up versus top-down
disturbances in hallucinations.
METHODS:We characterized sensory processing during perceptual decision making in patients with PD with (n = 20)
and without (n = 25) visual hallucinations and control subjects (n = 12), by fitting a hierarchical drift diffusion model to
an attentional task. The hierarchical drift diffusion model uses Bayesian estimates to decompose task performance
into parameters reflecting drift rates of evidence accumulation, decision thresholds, and nondecision time.
RESULTS:We observed slower drift rates in patients with hallucinations, which were less sensitive to changes in task
demand. In contrast, wider decision boundaries and shorter nondecision times relative to control subjects were found
in patients with PD regardless of hallucinator status. Inefficient and less flexible sensory evidence accumulation
emerges as a unique feature of PD hallucinators.
CONCLUSIONS: We integrate these results with evidence accumulation and predictive coding models of halluci-
nations, suggesting that in PD sensory evidence is less informative and may therefore be down-weighted, resulting in
overreliance on top-down influences. Considering impaired drift rates as an approximation of reduced sensory
precision, our findings provide a novel computational framework to specify impairments in sensory processing that
contribute to development of visual hallucinations.
Keywords: Bayesian, Bottom up, Hierarchical drift diffusion model, Parkinson’s disease, Perception, Precision, Top
down, Visual hallucinations
http://dx.doi.org/10.1016/j.bpsc.2017.04.007
Visual hallucinations (VHs) are common in Parkinson’s disease
(PD), occurring in over 30% of newly diagnosed and early-
stage patients and increasing to upwards of 70% by the late
stages of the disease (1–3). However, despite their prevalence,
VHs remain poorly understood, and treatment options are
limited (4). Continued characterization of the psychological and
mechanistic correlates of VHs in PD will be crucial to inform
therapeutic advances.
Proposed explanatory models for VHs in PD emphasize a
state of reduced sensory input, where the ongoing perceptual
process is vulnerable to influence from internally generated
imagery (5–8). This is in keeping with a transdiagnostic
framework, where hallucinations arise when the balance
between sensory input and top-town influence over perception
is disrupted, such that sensory information is reduced or not
properly integrated, and there is a predominance of top-down
influence (9–13). In this context, there is both impairment in
sensory evidence accumulation and a failure of Bayesian
inference processes regulating top-down versus bottom-up
influences on perception.
In formal computational terms, VHs can be considered false
perceptual inference (13). Perceptual inference can be
computationally implemented by predictive coding or Kalman
filtering, in which incoming sensory input is predicted based
on past information, and a prediction error specifies the
difference between the expected and incoming evidence.
Precision is a measure of certainty determining the weight
those errors will have (termed their Kalman gain) in influencing
the updating of subsequent estimates (14). This is important
in theories of hallucinations, where the top-down versus
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bottom-up imbalance is driven by a possibly compensatory
imbalance of precision, in which top-down predictions are
afforded too much precision in relation to sensory evidence. A
prediction that follows is that patients with VHs should show
reduced sensory precision.
In PD, sensory input is affected by dopaminergic retinal
changes and impairments in lower-level visual processes and
attention—all of which can be more pronounced in patients
with hallucinations (15). However, hallucinations can also
occur in patients in whom ophthalmologic measures and
performances on lower-level perceptual tasks are equivalent to
those in nonhallucinating patients (16). A possibility is that
lower-level sensory impairment and reduced attention confer
risk factors for VHs in PD, but failures in the dynamic inte-
gration of visual input and attention trigger their occurrence
(6,8). We aimed to investigate the dynamic processes under-
lying visual perception in PD hallucinators by applying a drift
diffusion model (DDM) to an attentional task. Crucially, atten-
tional deficits (and the use of an attentional task) follow from
the above aberrant precision account. In predictive coding,
attention serves as a gain control mechanism to enhance the
precision of sensory prediction errors (17–21). Increased pre-
cision implies more in-depth processing of a stimulus (22).
Aberrant precision control is therefore consistent with an
attentional deficit, where sensory evidence is not efficiently
selected and enhanced, leading to failures in belief updating
and perceptual inference.
DDMs are based on the premise that reaction time and
response output can be decomposed into parameters
reflecting the latent cognitive processes driving task perfor-
mance (23). The DDM quantifies information extracted from a
stimulus (drift rate), the evidence needed to make a decision
(boundary separation), and components related to stimulus
encoding and response output (nondecision time) (24,25). In
the context of predictive coding, the drift rate can be used to
approximate precision or Kalman gain, as the rate of sensory
evidence accumulation would correspond to the precision (i.e.,
confidence or certainty) ascribed to the evidence being accu-
mulated. In this study, we applied a Bayesian hierarchical
version of the DDM, which is robust in the context of low trial
numbers (26,27). This makes the task suitable for clinical
contexts where task duration is necessarily limited, and it has
been successfully fitted to data from patients with PD in pre-
vious studies (28–30). We assessed participants on the
attention network task (ANT) (31), which allowed us to measure
perceptual decision making under conditions with different
levels of difficulty as determined by perceptual conflict in the
stimuli.
Under the DDM, we predicted that patients with VHs
would show reduced sensory precision relative to patients
without hallucinations, as evidenced by impairments in pa-
rameters reflecting the integration or accumulation of sensory
evidence in the decision-making process, i.e., the drift rate or
boundary separation. However, their nondecision compo-
nents should be similar. We also predicted that control sub-
jects and patients without hallucinations would modulate their
drift rate and boundary separation in response to the different
levels of perpetual conflict, but that patients with VHs would
not show the same level of flexibility in response to task
demands.
METHODS AND MATERIALS
Case Selection
We recruited 50 patients from the Parkinson’s Disease
Research Clinic at the Brain and Mind Centre, University of
Sydney. Patients were identified as hallucinators if they self-
reported visual hallucinatory phenomena and scored $1 on
question 2 of the Movement Disorder Society–sponsored
revision of the Unified Parkinson’s Disease Rating Scale (i.e.,
over the past week have you seen, heard, smelled or felt things
that were not really there? If yes, the examiner asks the patient
or caregiver to elaborate and probes for information) (32). This
resulted in 24 patients in the VH group and 26 patients in the
nonVH group. Four patients from the VH group and 1 from the
nonVH group were excluded from analysis owing to excessive
missed responses on the experimental task, leaving a final
cohort of 20 patients in the VH group and 25 patients in the
nonVH group. A proportion of these patients were included in a
previous behavioral study of the ANT (33). We recruited 12
age-matched control subjects from a volunteer panel.
All patients satisfied the United Kingdom Parkinson’s Dis-
ease Society Brain Bank criteria and were not demented,
scoring above the recommended Mini-Mental State Examina-
tion cutoff of $26 (34). Patients were assessed on the Hoehn
and Yahr Scale and the Motor Examination section of the
Unified Parkinson’s Disease Rating Scale. The Mini-Mental
State Examination and Montreal Cognitive Assessment were
administered as measures of general cognition. Clinical
assessments and the experimental task were performed with
patients in the “on” state, having taken their regular dopami-
nergic medication, and dopaminergic dose equivalence scores
were calculated. No patients in the cohort were taking anti-
psychotic medication or cholinesterase inhibitors. Control
subjects were screened for a history of neurological or psy-
chiatric disorders. The study was approved by the local ethics
committees, and participants provided informed consent.
Attention Network Task
We administered a shortened version of the ANT (31), which
requires participants to determine if a central arrow points left
or right. Central arrows are flanked by flat lines (neutral con-
dition), arrows facing the same direction (congruent condition),
or arrows facing a mixture of directions (incongruent condition)
(Figure 1A). The perceptual conflict in the incongruent condi-
tion is designed to place a greater demand on attentional
processes relative to the congruent and neutral conditions.
See Supplement for task details.
Hierarchical DDM of the ANT
DDMs are widely applied to rapid, two-choice decision-making
tasks such as the ANT (25,35,36). DDMs are typically
described by four main parameters: drift rate (v), boundary (a),
decision bias (z), and nondecision time (T). The decision pro-
cess is modeled as the gradual accumulation of information,
reflected by the drift rate, which continues until a decision
boundary is reached (37). The decision bias parameter cap-
tures a priori bias toward one of the two responses. Nonde-
cision time incorporates components that are not part of the
evidence accumulation process, including stimulus encoding,
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extracting stimulus dimensions, and executing a response (36).
Figure 1B is a schematic diagram of the drift diffusion process.
We applied a hierarchical DDM (hDDM) using the hDDM
toolbox (http://ski.clps.brown.edu/hddm_docs/) (26). The
hDDM uses Bayesian estimation to generate posterior distri-
butions of parameters. This approach optimizes the tradeoff
between within-subject and between-subject random effects,
accounting for both within-subject variability and group-level
similarities, as individual parameters are constrained by a
group-level distribution.
We tested three models that all assumed an unbiased
starting point (z), given that left/right responses were coun-
terbalanced, and assumed that nondecision time (T) would not
be expected to vary as a function of condition, as the stimulus
encoding and motor responses required across conditions
were comparable. Model specifications were as follows: in the
first model, only drift rate (v) was permitted to vary by condi-
tion, and decision boundary (a) was held constant; in a second
model, decision boundary (a) could vary across conditions, but
drift rate (v) was held constant; in a third model, both v and a
were free to vary across conditions. For all models, Markov
chain Monte Carlo simulations were used to generate 120,000
samples from the joint posterior parameter distribution. The
first 20,000 samples were discarded as burn-in, and we used a
thinning factor of 10, with outliers specified at 5%. Conver-
gence was assessed by visually inspecting the Markov chains
and computing the R-hat Gelman-Rubin statistic where suc-
cessful coverage is indicated by values ,1.1 (37). The best
model was determined by comparing the deviance information
criterion (DIC) of each model, which evaluates a model’s
goodness-of-fit while accounting for model complexity (i.e.,
number of free parameters), with lower DIC values indicating
better model fit (38). To further evaluate the best fitting model,
we ran posterior predictive checks by averaging 500 simula-
tions generated from the model’s posterior to confirm it could
reliably reproduce patterns in the observed data (26). The fitted
ANT data and hDDM source code can be found at https://
github.com/claireocallaghan/hDDM_ANT_PD.
Statistical Analysis
Independent samples t tests and analyses of variance with
Tukey post hoc tests compared demographics and behavioral
results from the ANT. Parameters from the hDDM were
analyzed using Bayesian hypothesis testing to determine the
extent of overlap between the percentage of samples drawn
from two posterior density distributions. Posterior probabilities
are considered significantly different if ,5% of the distribu-
tions overlap (26–28). The proportion of overlap in the posterior
probabilities is denoted by P to distinguish it from the classical
frequentist p values.
RESULTS
Participant Characteristics
The groups were matched for age (F2,54 = 1.31, p = .28).
Performance on the Mini-Mental State Examination was similar
across groups (F2,54 = 1.07, p = .35), but the Montreal
Cognitive Assessment revealed significant differences, with
the nonVH group performing below the control group ([F2,54 =
5.91, p , .01]; nonVH group vs. control group, p , .01; VH
group vs. control and nonVH groups, p = .17 and p = .19). The
patient groups did not differ in disease duration (t = 21.42,
p = .16), Hoehn and Yahr stage (t = 21.33, p = .19), Unified
Parkinson’s Disease Rating Scale Motor Examination
(t = 21.80, p = .08), or dopamine dose equivalence (t = 21.63,
p = .11) (Table 1).
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Figure 1. Attention network task conditions and drift diffusion model. (A)
The three conditions in the attention network task. Examples of left and right
stimulus cues for each condition are shown here; however, in the task, only
one cue was presented per trial for a maximum of 1700 ms. (B) Schematic
example of drift diffusion trajectories. Evidence is noisily accumulated to-
ward a left or right response (blue and red panels), which are separated by
the boundary threshold (a). The average evidence accumulation is denoted
by drift rate (v). The evidence accumulation begins after a period of
nondecision time (T). Density plots show the distribution of observable re-
action times (RT). [Adapted from Wiecki et al. (26) and Zhang and Rowe (73).]
Table 1. Demographics and Clinical Characteristics of
Patients With Parkinson’s Disease and Healthy Control
Subjects
Control Group
PD nonVH
Group
PD VH
Group
Number 12 25 20
Gender (M:F) 4:8 19:6 15:5
Age, Years 64.75 (5.97) 67.08 (8.22) 68.89 (6.05)
MMSE 29.08 (0.79) 28.39 (1.47) 28.79 (1.72)
MoCA 28.50 (1.45) 26.56 (2.11) 27.41 (1.50)
Disease Duration, Years — 5.52 (2.86) 7.11 (4.99)
Hoehn and Yahr Stage — 2.16 (0.47) 2.37 (0.60)
UPDRS III — 27.67 (11.54) 34.28 (13.97)
Values are mean (SD) or n.
F, female; M, male; MMSE, Mini-Mental State Examination; MoCA,
Montreal Cognitive Assessment; nonVH, non–visual hallucination; PD,
Parkinson’s disease; UPDRS III, Unified Parkinson’s Disease Rating
Scale Motor Examination; VH, visual hallucination.
Visual Hallucinations in PD
682 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging November 2017; 2:680–688 www.sobp.org/BPCNNI
Biological
Psychiatry:
CNNI
ANT Behavioral Results
Participants who made no response on more than one-third of
trials were excluded from the study. Trials where no response
was made were omitted from the behavioral and modeling
analyses, rather than using the upper limit reaction time, which
would bias the model. More trials were removed for the VH
group compared with the nonVH group, although patients and
control subjects did not differ significantly ([F2,54 = 4.06,
p , .05]; control group vs. nonVH and VH groups, p = .10 and
p = .09; VH group vs. nonVH group, p , .05).
After removal of no response trials, accuracy was 100%
across the three groups. Reaction times are plotted in Figure 2.
Global reaction times, regardless of condition, were fastest for
the control group followed by the nonVH group and then the
VH group, with significant differences evidenced by a main
effect for group in the analysis of variance ([F2,162 = 8.15,
p , .001]; VH group vs. control and nonVH groups, both
p , .01; nonVH group vs. control group, p = .59). A main effect
of condition revealed that reaction times were significantly
slower for the incongruent condition compared with both the
congruent and the neutral conditions, whereas the congruent
and neutral conductions were equivalent ([F2,162 = 17.02,
p , .000001]; incongruent vs. congruent and neutral, both
p , .00001; congruent vs. neutral, p = .98). There was no sig-
nificant interaction between group and condition, suggesting
that the relatively slowed reaction times for the incongruent
condition were consistent across groups (F4,162 = 0.04, p = .99).
hDDM Fit
All three models showed good convergence (see Supplement
for R-hat values). The best-fitting model was model three,
which allowed v and a to vary across conditions (DIC model
3 = 2636.496, compared with DIC model 1 = 2436.160, and
DIC model 2 = 2626.593). Posterior predictive checks showed
good agreement between the simulated and observed data as
shown in Supplemental Figure S1 plotting the observed data
against the model prediction. Comparisons showed that the
difference between the summary statistics of the simulated
and the observed data fell within the 95% credible interval.
Analysis of Model Parameters
Comparisons Between Groups. Figure 3 shows the
posterior probability density plots for the drift rate (top panel)
and decision boundaries (bottom panel) for the three groups
across each condition. The VH group had uniformly lower
drift rates compared with the nonVH group; these differed
significantly in all conditions (neutral, P = 0.05%; incongruent,
P = 0.04%; congruent, P = 3.41%). Drift rates of patients in
the VH group were also significantly lower than for control
subjects for the incongruent and neutral conditions (P =
0.04% and P = 3.43%), although not for the congruent
condition (P = 12.72%). Posterior probabilities did not differ
significantly between nonVH and control groups for any
condition (neutral, P = 84.21%; congruent, P = 66.45%;
incongruent, P = 41.19%).
For the decision boundary, there were no significant differ-
ences between the VH and nonVH groups for any of the
conditions (neutral, P = 31.19%; congruent, P = 50.96%;
incongruent, P = 9.45%). Both the VH and nonVH groups had
significantly larger decision boundaries than the control group
in the neutral and congruent conditions (VH group, P = 0.12%
and P = 0.03%; nonVH group, P = 0.03% and P = 0.03%), and
the nonVH group was also significantly larger in the incon-
gruent condition (nonVH group, P = 0.68%; VH group, P =
14.19%). As shown in Figure 4, the VH and nonVH groups had
similar nondecision times (P = 34.04%), which were
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Figure 2. Attention network task reaction times.
Reaction time distributions for the attention network
task across the three levels of task difficulty. Milli-
seconds are shown on the y axis. Bold black lines
designate the mean reaction times for each condi-
tion, and the dotted line shows the overall mean
across conditions. The filled colored plots show the
density distributions of the reaction times; these are
density plots of the data rotated and mirrored
symmetrically to show the shape of the data distri-
bution. nonVH, non–visual hallucination; VH, visual
hallucination.
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significantly shorter than the control group (VH group, P =
0.05%; nonVH group, P = 0.00%).
Comparisons Across Conditions. Figure 5 shows pos-
terior probabilities within each group for the three conditions
(control group, left panel; nonVH group, middle panel; VH
group, right panel). For drift rates, the control group showed an
expected pattern with significantly longer drift rates in the
incongruent condition compared with the neutral and
congruent conditions (P = 0.28% and P = 0.32%) and similar
rates in the neutral and congruent conditions (P = 50.92%).
The nonVH group showed a similar pattern with significantly
longer drift rates in the incongruent relative to the neutral and
congruent conditions (P = 1.55% and P = 0.15%), with similar
rates in the neutral and congruent conditions (P = 18.31%). In
contrast, compared with the control and nonVH groups, the VH
group showed less of a difference between the incongruent
and neutral conditions (P = 3.28%) and no significant differ-
ence between the incongruent and congruent conditions (P =
17.47%), with similar rates also between neutral and congruent
conditions (P = 17.80%). All groups showed a similar pattern
for decision boundaries across the conditions, with signifi-
cantly larger decision boundaries in the incongruent condition
relative to the neutral and congruent conditions (control group,
P = 0.00% and P = 0.00%; nonVH group, P = 0.00% and
P = 0.00%; VH group, P = 0.00% and P = 0.00%), with similar
thresholds in the neutral and congruent conditions (control
group, P = 38.80%; nonVH group, P = 37.32%; VH group,
P = 20.00%).
DISCUSSION
Our results demonstrate two features that characterize the
perceptual decision-making process of hallucinating patients
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relative to nonhallucinating patients: lower drift rates and
reduced ability to adjust drift rates to accommodate changes
in perceptual conflict. Behaviorally, all groups had 100% ac-
curacy on the ANT. Employing a task that patients with PD
could easily understand and execute was particularly impor-
tant, given the possibility of cognitive impairment in this patient
cohort. This ensured that we could accurately access
perceptual decision making without higher-order cognitive
deficits confounding performance. Hallucinating patients had
the slowest reaction times on the ANT, although each group
showed the expected pattern of shorter reaction times for the
easier (neutral and congruent) conditions and longer reaction
times for the more difficult (incongruent) condition. Our find-
ings from the hDDM reveal the added benefits of modeling
these data to uncover the cognitive processes underlying the
behavioral results.
The drift rate reflects how quickly information is accumu-
lated and reflects the quality or precision of evidence that
enters the decision-making process (25). In all three condi-
tions, the control and nonVH groups displayed similar drift
rates. The VH group had consistently lower drift rates. In
between-condition comparisons, drift rates are modulated by
task difficulty (24). This effect was apparent in our results for
both the control and the nonVH groups. These groups had
longer drift rates in the incongruent relative to the congruent
conditions, suggesting that their integration of information into
the decision-making process was flexibly modulated in
response to imprecise or ambiguous sensory evidence. In
contrast, the VH group had similar drift rates across the
congruent and incongruent conditions, indicating less flexible
context-dependent modulation of sensory accumulation.
Previous work has identified neural correlates of evidence
accumulation during perceptual decision making. In monkeys,
neuronal populations in sensory areas (e.g., middle temporal
visual area) fire in response to properties of a stimulus, and
downstream regions (e.g., lateral intraparietal, frontal eye
fields, dorsal lateral prefrontal cortex) integrate this information
over time until sufficient evidence is accumulated for a deci-
sion (39–42). In humans, evidence accumulation has been
related to frontoparietal regions [i.e., dorsal and ventrolateral
prefrontal cortex and frontal eye fields (43–46)] and the anterior
insula (47) as well as integration across large-scale networks
(48). In PD, abnormal local and network-level engagement of
frontoparietal and insula regions has been found in patients
with hallucinations (49–52) and is typically equated with
attentional dysfunction. In perceptual decision making, accu-
mulation of sensory evidence and attention are highly
collinear—and possibly inseparable—processes (23), consis-
tent with the relationship between attention and sensory pre-
cision specified by predictive coding accounts. It follows that
0.0
0.5
1.0
1.5
2.0
2.5
2.5 3.0 3.5 4.0
Control drift rate
Po
st
er
io
r p
ro
ba
bi
lit
y 
de
ns
ity
0
1
2
3
3.0 3.5 4.0
nonVH drift rate
0
1
2
3
2.25 2.50 2.75 3.00 3.25
VH drift rate
0.0
0.5
1.0
1.5
2.0
2.5
2 3 4 5
Control decision boundary
Po
st
er
io
r p
ro
ba
bi
lit
y 
de
ns
ity
0.0
0.5
1.0
1.5
2.0
3 4 5
nonVH decision boundary
0.0
0.5
1.0
1.5
3 4 5
VH decision boundary
Congruent Incongruent Neutral
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our finding of impaired drift rates may offer a more tangible,
computational framework to better specify attentional impair-
ments in patients with PD with VHs.
All groups modulated their decision boundaries in response
to the more difficult condition, displaying larger boundaries for
the incongruent relative to congruent and neutral conditions.
Flexible adaptation of decision thresholds in response to task
demands has been shown previously in patients with PD
(28,29). Despite the flexible adaptation of thresholds, regard-
less of hallucination status, patients with PD had larger deci-
sion boundaries than control subjects. The lack of difference
between the VH and nonVH groups suggests that a widening
of decision boundaries during perceptual decision making is a
feature of PD more generally. This corresponds to findings in
healthy aging, where older adults display wider decision
boundaries relative to younger adults (53–55). In older adults,
adopting conservative decision criteria is presumed to be a
compensatory strategy to prevent errors in speed and/or ac-
curacy tradeoff tasks, and this effect may be amplified in PD.
Hallucinating and nonhallucinating patients also had com-
parable nondecision times, and these were shorter than times
for control subjects. This might have seemed counterintuitive
in light of the longer nondecision times shown in aging (56,57),
but reduced nondecision times in PD have also been found
with the application of an hDDM to a saccadic go/no-go task
(30). Nondecision time encompasses diverse processes:
encoding evidence from a stimulus and extracting its di-
mensions to guide the decision-making process and execution
of a motor response (36). Decreased latencies in stimulus
encoding and extraction of details may drive this finding, or
shorter nondecision times may reflect motor impulsivity, which
has previously been documented in PD despite general motor
slowing (58,59). Future work may make this distinction in PD,
although currently nondecision time is a relatively under-
specified term compared with the other parameters in the
DDM, and few studies have successfully separated its sub-
components (23).
Inefficient and less flexible evidence accumulation during
perceptual decision making emerges as a unique feature of
hallucinating patients with PD, whereas changes in cautious-
ness and visuomotor processes are apparent regardless of
hallucinator status. Longer drift rate latencies lead to slower
decisions, and because perceptual decision making is a noisy
process, this increases the chance of errors (37,60). In hallu-
cinating patients with PD, low drift rates that are invariant to
changing environmental demands would be a source of low-
quality or imprecise information entering the perceptual
process.
In terms of aberrant precision control in hallucinating pa-
tients with PD, our results are consistent with the simulations
reported by Adams et al. (12), namely, an imbalance between
sensory precision and the precision of top-down prior beliefs.
In PD, there is degeneration of ascending gain-setting neuro-
modulatory systems (i.e., dopaminergic, cholinergic, and
noradrenergic) (61,62) that are associated with implementing
precision. Aberrant precision control may be an important
unifying principal across PD symptoms. For example, motor
symptoms (in particular bradykinesia) may speak to failures in
the estimation and attenuation of proprioceptive and somato-
sensory uncertainty. In active inference accounts, estimating
sensory uncertainty is crucial for initiating movement, as the
goal of movement is to reduce the discrepancy between pre-
dicted and actual sensory inputs (63,64). Failures of sensory
attenuation and compensatory increases in the precision and/
or gain at higher levels of processing may underlie both the
false inference in VHs and the failure to realize predicted
movements in the proprioceptive domain.
Aberrant precision control is ultimately reflected as a failure
of Bayesian inference (11,13,65). In a Bayesian framework for
perception, sensory input (likelihood) is integrated with known
statistics about the environment (priors), forming an estimate
of the external stimulus (the posterior). Contributions of the
likelihood and prior in generating the posterior estimate are
weighted in accordance with their certainty. Noisy or imprecise
sensory input is uncertain and carries less weight, shifting the
balance in favor of priors. In this context, perception is
vulnerable to excessive influence from internally generated
beliefs and expectations. In PD, if visual information is accu-
mulated slowly and inefficiently and is therefore less informa-
tive, this may contribute to the down weighting of bottom-up
information in favor of top-down information.
While the Bayesian framework is a compelling description of
hallucinations, it does not necessarily favor a singlemechanistic
explanation (66). For example, both aberrant predictive coding
across hierarchal brain circuitry (67) and large-scale disruptions
in the excitatory-to-inhibitory tone of the brain (68) accommo-
date a Bayesian formulation of hallucinations. Reconciling
computational descriptions of hallucinations with amechanistic
framework will open important therapeutic avenues, as pre-
dictive coding and excitatory-to-inhibitory accounts rely on
distinct neuromodulatory and neurotransmitter profiles. In PD,
we are beginning to uncover the psychological and neural sig-
natures associated with a bottom-up versus top-down imbal-
ance in perception. Along with the results of the current study
and evidence of lower-level deficits in attention and visual
processing, previous work has identified overactivity in the
default network of patients with PD with hallucinations (69) and
increased coupling between the default network and visual
cortex (50). Given the role of the default network in construction
of mental imagery (70) and its positioning as a transmodal
system distinct from unimodal sensory regions (71), over-
engagement of the default network during visual perception
may be a source of excessive top-down influence.
Hallucinations develop progressively in PD, beginning with
minor illusions before complex hallucinations emerge (4). Pa-
tients initially retain full insight into these symptoms, appreci-
ating their occurrence as part of the disease process. With
disease progression and cognitive decline, patients can lose
insight and develop delusional ideas around the hallucinations.
Delusions themselves can be viewed as the instantiation of
new priors, to accommodate increasingly noisy or imprecise
sensory input (11,72). We employed a limited assessment of
hallucinations. Future studies may want to stratify patients in
more detail based on the severity and phenomenology of their
hallucinations to determine how the imbalance between top-
down versus bottom-up influence evolves over the disease
course. Additionally, we chose a task manageable for patients
with PD; nevertheless, lower-level visual deficits could render
such a task more challenging. Future work should employ
more detailed visual testing to determine the influence of
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low-level vision on sensory evidence accumulation, and repli-
cating the current findings in other perceptual decision-making
tasks will be important.
In conclusion, our results suggest that impaired drift rate
can be used to approximate precision, providing a novel
computational framework encompassing the sensory pro-
cessing and lower-level attentional deficits previously
described in individuals with VHs. Alterations in the dynamic
process of sensory evidence accumulation may therefore be a
valuable marker to exploit in future explanatory and therapeutic
studies of PD VHs.
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Abstract: Parkinson’s disease (PD) is characterized by a 
range of motor symptoms. Besides the cardinal symptoms 
(tremor, bradykinesia/akinesia, and rigidity), PD patients 
also show other motor deficits, including gait disturbance, 
speech deficits, and impaired handwriting. However, 
along with these key motor symptoms, PD patients also 
experience cognitive deficits in attention, executive func-
tion, working memory, and learning. Recent evidence sug-
gests that these motor and cognitive deficits of PD are not 
completely dissociable, as aspects of cognitive dysfunc-
tion can impact motor performance in PD. In this article, 
we provide a review of behavioral and neural studies on 
the associations between motor symptoms and cognitive 
deficits in PD, specifically akinesia/bradykinesia, tremor, 
gait, handwriting, precision grip, and speech production. 
This review paves the way for providing a framework for 
understanding how treatment of cognitive dysfunction, 
for example cognitive rehabilitation programs, may in 
turn influence the motor symptoms of PD.
Keywords: akinesia; bradykinesia; cognitive dysfunction; 
cognitive training; freezing of gait; grip force; Parkinson’s 
disease; postural instability; tremor.
Introduction
Parkinson’s disease (PD) is a degenerative neurological 
condition that affects 1–2% of the population (Kish et al., 
1988). PD manifests when 60–80% of the dopaminergic 
neurons within the substantia nigra pars compacta (SNc) 
are degenerated, initially disrupting midbrain regions 
such as the thalamus and subthalamic nucleus, basal 
ganglia, globus pallidus, nucleus basalis of Meynert, and 
substantia nigra. This disruption is then echoed through-
out various cortical areas, such as the prefrontal cortex, 
supplementary and primary motor cortices, as well as 
the cerebellum. These cortical regions are viewed as 
being responsible for the cardinal motor symptoms of PD, 
including bradykinesia, resting tremor, rigidity, gait dis-
turbance, and postural instability (Jankovic and Tolosa, 
2007; Lees et al., 2009). While these symptoms are salient 
characteristics of PD, there are many underlying cognitive 
deficits that are not so visible. These include disturbances 
to memory, executive function, visuospatial perception, 
and language (Weintraub and Burn, 2011). Each of these 
functions is influenced by the basal ganglia (Monchi 
et  al., 2000; Cameron et  al., 2010; Macoir et  al., 2013; 
Caproni et  al., 2014). The basal ganglia are connected 
with cortical regions via a complex network of parallel 
circuits. Five basal ganglia-thalamocortical loops have 
been recognized, comprising a motor, oculomotor, dorso-
lateral prefrontal, lateral orbitofrontal, and anterior cin-
gulate circuit. Each basal ganglia-thalamocorticol circuit 
receives inputs from these cortical regions and traverses 
specific regions of the basal ganglia and thalamus nuclei 
and projecting back to the cortex (Alexander et al., 1986). 
The operation of these circuits as fully segregated parallel 
loops has been challenged (Joel and Weiner, 1997), with 
more recent evidence supporting a degree of integration 
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of information across the basal ganglia-thalamocortical 
circuits (Haynes and Haber, 2013), allowing for interaction 
between the motor and cognitive circuits. The integration 
of these two circuits suggests that damage to one would 
manifest in both cognitive and motor deficits. It also sug-
gests that treatment of cognitive deficits alongside physi-
cal therapy would be highly beneficial for the patient. 
Additionally, anatomical studies show that there are 
additional open loops (i.e. loops in which the afferent and 
efferent cortical areas of the basal ganglia are different) 
(Joel and Weiner, 1997; Graybiel, 1998). Computational 
models have been incorporating such open loops (Amos, 
2000; Djurfeldt et al., 2001). Further, besides the frontal 
cortex, the occipital cortex (Seger, 2013) and medial tem-
poral cortex (Middleton and Strick, 1996) also receive pro-
jections from the basal ganglia. It has been suggested that 
basal ganglia projections to these areas support visual 
and memory processes (Middleton and Strick, 1996; Seger, 
2013). Basal ganglia projections to the prefrontal cortex 
has been suggested to play a role in working memory 
(Moustafa and Maida, 2007; Moustafa et al., 2008).
Indeed, a strong relationship between motor and cog-
nitive processes is evident. For example, different corti-
cal areas play a role in the cognitive processes that guide 
movement, including motor planning and goal-based 
motor processes (Matsumoto et al., 2003; Mushiake et al., 
2006; Riggeal et al., 2007; Colman et al., 2009; Smulders 
et al., 2012; Wylie et al., 2012). Various studies in healthy 
individuals suggest a strong relationship between motor 
and cognitive processes (Matsumoto et al., 2003;  Mushiake 
et  al., 2006; Riggeal et  al., 2007; Colman et  al., 2009; 
Smulders et al., 2012; Wylie et al., 2012). However, while 
some studies have found clear links between motor and 
cognitive measures (Shine et al., 2013d; Schneider et al., 
2015), these data suggest that the primary motor symp-
toms and cognitive deficits of PD are associated with the 
different clinical course of the illness. However, the inter-
relationships among motor and cognitive processes in PD 
are not well characterized. As an example, the prefrontal 
cortex is important for the maintenance of information 
(e.g. goals) in working memory, which aids production 
of motor responses, including hand and eye movements 
(Ohbayashi et  al., 2003; Moustafa et  al., 2013a). Indeed, 
locomotive dysfunction in the elderly is associated with 
brain volume changes (Kostic et al., 2012; Tessitore et al., 
2012) and aberrant neural activity (Matsui et  al., 2005) 
within the prefrontal cortex, suggesting a potential rela-
tionship between working memory and locomotion in PD. 
The dorsolateral prefrontal loop also plays a key role in 
motivation (Lawrence et al., 1998). So it is not surprising 
that some PD patients experience motivational disorders 
(Aarsland et al., 2009). Motivation places a value on per-
ceived goals, so low motivation levels would affect goal-
directed behaviors, which may exacerbate several PD 
symptoms, such as bradykinesia and gait impairments, 
which are discussed in the following sections. To our 
knowledge, the effect of motivation on these motor pro-
cesses has not been studied in PD.
Currently, while the presence of the core motor symp-
toms remains essential for diagnosis, many PD patients 
demonstrate marked cognitive impairment even at the 
time of first presentation (Foltynie et  al., 2004). Deficits 
across various cognitive domains including attention, 
working memory, and executive function have been 
described and tend to worsen with disease progression in 
tremor-dominant and akinesia-dominant (also known as 
akineto-rigid or non-tremor dominant) phenotypes and 
young-onset and rapid disease progression subgroups 
(Zetusky and Jankovic, 1985; Jankovic et al., 1990; Rajput, 
1993; Schiess et al., 2000; Lewis et al., 2005; Zaidel et al., 
2009; Mure et al., 2011; Poletti et al., 2011b; Schillaci et al., 
2011; Lee et al., 2012; Moustafa and Poletti, 2013). Patients 
in the akinesia-dominant subgroup experience a more 
rapid disease progression compared to tremor-dominant 
patients (Louis et  al., 1999; Eggers et  al., 2012). Impor-
tantly, compared to tremor-dominant patients, patients 
with severe akinesia are more likely to experience severe 
cognitive impairments or even dementia (Aarsland et al., 
2003; Williams-Gray et  al., 2007b; Poletti et  al., 2011a, 
2012).
The anatomy of the neural circuitry gone awry in PD 
is summarized here, to serve as a reference point to be 
consulted throughout the following review. To begin with, 
the cortex, including primary motor cortex; ventral and 
dorsal premotor cortex; supplementary motor areas; and 
rostral, dorsal, and ventral cingulate areas, have one-way 
excitatory glutamatergic effects with the putamen, brain-
stem, and spinal cord, as well as a bidirectional excitatory 
relationship with the thalamus. The direct pathway of the 
putamen, which has an inhibitory GABAergic connection 
with the internal segment of the globus pallidus and sub-
stantia nigra pars reticulata, receives glutamatergic exci-
tation from the SNc and thalamus. The indirect pathway 
of the putamen has an inhibitory GABAergic effect on 
the external segment of the globus pallidus, which itself 
goes on to inhibit the internal segment of the globus pal-
lidus and substantia nigra pars reticulata. The subtha-
lamic nucleus is inhibited by this indirect pathway of the 
putamen but in turn sends excitatory signals back to the 
external segment of the globus pallidus, as well as to the 
cortex, internal segment of the globus pallidus, substan-
tia nigra pars reticulata, and pedunculopontine nucleus 
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(PPN), which itself finally excites the brainstem and 
spinal cord and bidirectionally inhibits the thalamus and 
its subcomponents (DeLong and Wichmann, 2007).
This review addresses cognitive-motor relationships 
in PD, describing how specific changes in cognitive func-
tion are associated with changes in motor performance. 
We aim to achieve this by highlighting the specific aspects 
of the motor symptoms in PD that are associated with cog-
nitive deficits and suggest that they may have a common 
pathophysiology.
Akinesia/bradykinesia
Akinesia and bradykinesia are considered among the 
primary motor features in PD. These symptoms are char-
acterized by difficulty initiating movements, poverty of 
action, slowness of movements, a lack of spontaneous 
movement (such as swinging of the arms during walking, 
automatic blinking, changes of facial expression, or ges-
turing during speech) as well as sequential movements, 
which are affected due to difficulties in transitions 
between subcomponents of movement (Berardelli et  al., 
2001). Studies have found that PD patients with akinesia 
have more dopamine loss in the basal ganglia than do 
PD patients with predominant tremor symptoms (Schil-
laci et  al., 2011), with basal ganglia dysfunction consid-
ered to be the neural mechanism underlying bradykinesia 
symptoms (Berardelli et al., 2001). Dopamine is excitatory 
on the direct (“Go”) pathway, which facilitates respond-
ing, whereas it is inhibitory on the indirect (“No Go”) 
pathway, suppressing a response (Frank and O’Reilly, 
2006). A reduction in dopamine levels in PD therefore 
results in difficulty initiating movements and slowness 
of movements. Notably, computational and mechanistic 
models suggest that the source of akinesia involves hyper-
excitability of striatal neurons originating in the indirect 
pathway leading to suppression of movement (Wiecki and 
Frank, 2010; Collins and Frank, 2014). In addition, cholin-
ergic neurotransmission plays a critical role in controlling 
voluntary movement. As dopamine levels in the striatum 
decrease, cholinergic levels increase, suggesting that an 
imbalance of these neurotransmitters may underlie the 
motor symptoms of PD (Zhao-Shea et al., 2010).
Associations with cognitive dysfunction
Dopamine plays not only a crucial role in motor function; 
it also substantially influences a diversity of cognitive 
processes. Therefore, it is not surprising that akinesia-
dominant PD patients often show a more severe pattern 
of cognitive or executive dysfunction (Jankovic et  al., 
1990; Vakil and Herishanu-Naaman, 1998; Lewis et  al., 
2005; Burn et al., 2006; Lyros et al., 2008; Oh et al., 2009; 
Domellof et  al., 2011). For example, studies have shown 
an association between akinesia and poor performance 
on tests of executive function that are dopamine depend-
ent, such as probabilistic learning tasks (Moustafa et al., 
2013b). This pattern was also present in other studies in 
which PD patients with predominant tremor were less 
impaired than akinesia-dominant PD s at performing 
procedural learning tasks, including the Tower of Hanoi 
task (Vakil and Herishanu-Naaman, 1998), as well as on 
working memory (Domellof et al., 2011; Poletti et al., 2012) 
and set shifting (Domellof et al., 2011, 2013; Poletti et al., 
2012; Moustafa et al., 2013a). Akinesia-dominant patients 
were also more likely to experience bradyphrenia (slow-
ness of thinking and information processing) (Rafal et al., 
1984; Berardelli et al., 2001), suggesting more widespread 
cognitive disturbance than in the tremor-dominant type of 
PD.
Specifically, in non-medicated PD patients, reduced 
levels of dopamine impair learning from positive feed-
back, while facilitating learning from negative feed-
back (Wiecki and Frank, 2010; Collins and Frank, 2014). 
In patients on dopaminergic medication, the opposite 
occurs: dopamine replacement therapy facilitates learn-
ing from positive feedback, but patients are impaired at 
learning from negative feedback because the medication 
blocks the effect of normal dopamine dips (Wiecki and 
Frank, 2010; Collins and Frank, 2014). In addition, D2 
receptor blockade results in progressively worse motor 
performance due to a learning process dissociable from 
the direct performance effects of DA blockade (Wiecki 
et al., 2009; Beeler et al., 2012).
Working memory and executive functions required 
for set shifting, for example those involved in the Wis-
consin Card Sorting and the Trail Making Test, are often 
impaired in PD patients with the akinesia dominant 
subtype (Domellof et al., 2011, 2013; Poletti et al., 2012; 
Moustafa et  al., 2013a). Working memory impairment 
in PD may be due to a lack of appropriate regulation 
of the gating mechanism of the basal ganglia, impair-
ing information processing in the frontostriatal system 
(Frank et al., 2001). Similar to reinforcement learning, 
“Go” and “No Go” signals can facilitate and suppress 
the updating of information into prefrontal working 
memory representations (O’Reilly and Frank, 2006). 
Thus, the basal ganglia is assumed to operate as a 
gating mechanism to modulate information updates to 
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the prefrontal cortex (Frank et  al., 2001; O’Reilly and 
Frank, 2006).
Furthermore, set-shifting deficits in non-medicated 
PD patients are also consistent with an inability to update a 
new attentional set, while medicated patients show atten-
tional shifting deficits when having to ignore distractors 
that had previously been task relevant (Moustafa et  al., 
2008). It has been suggested that set-shifting abnormali-
ties may result from a paroxysmal over-excitation within 
the output nuclei of the basal ganglia circuitry (Lewis and 
Barker, 2009). Thus, akinesia/bradykinesia, as well as 
certain cognitive deficits in PD, is likely due to dopamine 
depletion within the basal ganglia, possibly impairing an 
optimal basal ganglia output selection.
Moreover, tests of working memory and attention 
have robust correlations with cortical cholinergic activ-
ity. Cholinergic system degeneration and dysfunction are 
significant contributors to cognitive impairment in PD 
(Pagano et  al., 2015). Cognitive deficits caused by pre-
frontal dopaminergic changes in PD are likely to be aug-
mented by a cholinergic component (Bohnen and Albin, 
2011). Furthermore, the akinesia phenotype is also associ-
ated with the development of dementia. Again, basal fore-
brain cholinergic system degeneration appears early in PD 
and worsens coincident with the appearance of dementia 
(Bohnen and Albin, 2011; Gratwicke et al., 2015a).
Non-tremor-dominant PD patients display more severe 
cognitive and executive dysfunction than do patients with 
tremor-dominant PD. This is likely due to the more severe 
degradation of dopamine and choline systems in these 
patients as cognitive and executive function has a strong 
reliance on these two systems (Bohnen and Albin, 2011; 
Moustafa et al., 2013b; Pagano et al., 2015).
Tremor
The neural substrates underlying the development of 
tremor in PD are still unclear. However, tremor has been 
associated with cerebellar, thalamic, and subthalamic 
nucleus abnormalities (Kassubek et  al., 2002; Probst-
Cousin et al., 2003; Weinberger et al., 2009; Zaidel et al., 
2009; Mure et al., 2011; Helmich et al., 2012). It has also 
been suggested that cerebellar activation in PD patients 
during movement is a compensation mechanism for 
corticostriatal motor circuit under-activation (Yu et  al., 
2007; Wu and Hallett, 2013). In addition, Rosenberg-Katz 
et  al. (2013) found that PD patients with tremor show a 
lower mean loss of grey matter in the pre-supplementary 
and primary motor areas than in non-tremor patients. A 
few studies argue that tremor is dopamine independent 
(Benamer et  al., 2000, 2003; Pirker et  al., 2002; Spiegel 
et al., 2007).
Associations with cognitive dysfunction
Patients with the tremor-dominant subtype of PD are less 
often cognitively affected in comparison to akinesia-dom-
inant patients. Several studies have shown that tremor is 
not associated with impaired cognitive function (Lewis 
et  al., 2005; Elgh et  al., 2009; Hall et  al., 2014). Indeed, 
the frontostriatal pathways, which play a key role in 
cognitive deficits in PD, are relatively spared in patients 
with predominantly tremor symptoms (Lewis et al., 2005; 
 Williams-Gray et al., 2007a,b).
Gait impairment
Gait impairment and postural instability are hallmarks 
of PD. Patients with PD have reduced stride length and 
walking speed while double support duration and cadence 
rate are increased (Morris et al., 1998). During later stages 
of the disease, patients may also experience freezing 
of gait (FOG) (Lewis and Barker, 2009), wherein their 
walking motion ceases, often leading to falls (Rudzinska 
et  al., 2013). Postural instability is also known to cause 
falls in many patients (Koller et  al., 1989). PD patients 
may display clinical features of postural instability that 
are evident during quiet, undisturbed stance, such as 
poor anticipatory postural responses, abnormal postural 
sway, and inadequately organized automatic postural 
reactions. Performing voluntary actions, such as leaning, 
may reveal reduced limits of stability. Additional deficits 
may be evident upon disequilibrium, including slower 
compensatory stepping reactions, direction-specific 
instability, and incorrectly directed protective arm move-
ments (Horak et al., 2005; Mancini et al., 2008; Grimber-
gen et al., 2009; Rocchi et al., 2012). Gait impairment and 
postural instability are more common among PD patients 
with rapid disease progression (Jankovic et al., 1990), as 
well as in advanced-stage rather than early-stage PD (Kim 
et al., 2013).
Gait disorders and postural instability respond poorly 
to dopaminergic drugs, which suggest that they are caused 
by non-dopaminergic lesions (Karachi et al., 2010). It has 
been shown that gait and posture are under the control of 
cholinergic neurons of the PPN (Lee et al., 2000), which is 
part of a pathway involved in the initiation, acceleration, 
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deceleration, and termination of locomotion. This 
pathway is under the control of the deep cerebellar and 
basal ganglia nuclei, particularly via inputs from the 
medial globus pallidus, substantia nigra pars reticulata, 
and subthalamic nucleus (Lee et al., 2000). In addition, 
there is accumulating evidence that implicates the basal 
ganglia nuclei in the performance of “automatic” behav-
iors, which walking normally is, and the dysfunction of 
the basal ganglia in PD is proposed to interfere with auto-
matic execution of walking, which is then performed in a 
goal-directed fashion (Redgrave et al., 2010).
Thus, tasks such as walking, which are automated 
in healthy individuals, require focused attention in PD 
patients. Aberrant neural activity (Matsui et  al., 2005) 
and brain volume changes (Kostic et al., 2012; Tessitore 
et  al., 2012) within the prefrontal cortex, an area that 
is also important for the maintenance of information 
(e.g. goals) in working memory (Ohbayashi et al., 2003; 
Moustafa et  al., 2013a), also play a key role in locomo-
tor dysfunction. Further, functional decoupling of goal-
directed frontostriatal systems might be responsible for 
triggering episodes of FOG. This impaired coupling would 
lead to the loss of inhibitory influence over the output 
structures of the basal ganglia (Pahapill and Lozano, 
2000; Lewis and Barker, 2009; Shine et al., 2013b), poten-
tially leading to decreased activity within in areas of the 
mesencephalic locomotor region that coordinate gait 
(Pahapill and Lozano, 2000). This phenomenon might 
be triggered through dopaminergic depletion in the stri-
atum and over-activity within the subthalamic nucleus. 
In addition, the inconsistent effects of dopaminergic 
therapy on stability in PD have led some researchers to 
suggest that the postural and balance deficits in PD may 
result from lesions to both dopaminergic and non-dopa-
minergic nuclei (Bloem et al., 1996; Rocchi et al., 2002; 
Grimbergen et al., 2009).
Associations with cognitive dysfunction
For both the pervasive and paroxysmal gait impairments 
in PD, there are robust and consistent links with impair-
ments in cognition. Since gait dysfunction, postural 
instability, and akinesia are characteristics of PD often 
associated with the non-tremor-dominant phenotype 
(Lewis et al., 2005), associations with the aforementioned 
cholinergic cognitive dysfunction and development of 
dementia also apply to gait dysfunction in PD. In addition, 
a clear example of shared mechanisms is the difficulty 
that PD patients experience with walking while perform-
ing a concurrent cognitive task. For example, in healthy 
participants, studies found that texting while walking can 
impact gait (Schabrun et  al., 2014) and overall walking 
performance (Demura and Uchiyama, 2009), possibly 
due to affecting attentional performance (Woollacott and 
Shumway-Cook, 2002). This effect is more prominent 
in patients with moderate PD, as their walking becomes 
impaired during simultaneous performance of a simple 
goal-directed secondary motor task (e.g. “walk and talk”) 
(Bond and Morris, 2000). With the addition of a more cog-
nitively demanding secondary task, larger variations in 
the gait parameters of PD patients are observed ( Hausdorff 
et  al., 2003), perhaps uncovering an underlying impair-
ment in the allocation of or limitation of attentional 
resources or in neuronal efficiency. In healthy adults, dual 
tasking is attention demanding too, but healthy individ-
uals tend to give priority to postural tasks. PD patients, 
however, adopt a “posture second” approach, increasing 
the risk of falls (Bloem et al., 2001).
There is also growing evidence of a striking association 
between FOG and executive dysfunction (Amboni et  al., 
2008; Naismith et al., 2010; Shine et al., 2013e; Hall et al., 
2014; Walton et al., 2014). During clinical assessment, the 
addition of a cognitive task, such as counting out loud in 
multiples of seven while walking along a standardized 
track, can severely exacerbate the frequency and sever-
ity of freezing (Yogev et al., 2005; Ricciardi et al., 2014). 
Other studies have found that walking dysfunction in PD 
is related to difficulty in resolving response interference 
produced by distractors (Plotnik et al., 2011; Vandenbos-
sche et al., 2011). Interestingly, individuals with freezing 
also suffer from similar deficits in cognitive tasks that 
require multiple shifts between cognitive sets (Naismith 
et al., 2010; Shine et al., 2012; Hall et al., 2014), suggesting 
that the pathophysiological mechanisms underlying FOG 
may reflect impairments in cognitive processing under 
temporal pressure (Shine et  al., 2013c). An explanation 
for the concurrence of cognitive and ambulatory deficits 
in PD may lie in impaired compensatory processes within 
the brain. The loss of automatic function would necessar-
ily force an individual to use more cognitive architecture 
to accomplish what would otherwise be routine tasks 
(such as walking), thereby decreasing the individuals’ 
capacity to flexibly deal with changes in their surround-
ing environment.
Locomotive dysfunction is due to aberrant neural 
activity (Matsui et  al., 2005) and brain volume changes 
(Kostic et al., 2012; Tessitore et al., 2012) within the pre-
frontal cortex, an area that is also important for the main-
tenance of information (e.g. goals) in working memory 
(Ohbayashi et  al., 2003; Moustafa et  al., 2013a). Addi-
tionally, the nucleus basalis of Meynert is located in the 
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forebrain, and its cholinergic neurons are known loci 
of degeneration in PD (for reviews, see Gratwicke et  al., 
2015a,b), with more severe cholinergic loss being associ-
ated with cognitive impairment. In PD, neuropathology 
in the nucleus basalis of Meynert leads to impairment of 
both arousal and selective attention, thus mediating some 
components of cognitive dysfunction and dementia.
In sum, there are at least two main cognitive deficits 
involved in gait impairments. The first is damage to the 
basal ganglia, which results in impairment to “automatic 
process,” such as movement. This results in PD patients 
requiring more attentional resources to initiate and 
maintain the walking motion and postural stability. Gait 
impairment is much more common in akinesia/bradykin-
esia-dominant PD patients, implying that they also suffer 
the same severe cognitive and executive dysfunction. This 
limitation on their attentional resources, combined with 
the increased load required for walking, results in the gait 
impairments and freezing observed in this group of PD 
patients.
Handwriting
Handwriting involves the coordination of finger move-
ments as well as integration of sensory input to guide suc-
cessful motor output. Evidence suggests that handwriting 
can be used as an early detection tool for PD (Rosenblum 
et al., 2013), as PD patients typically exhibit a diminutive 
form of handwriting known as micrographia. In an early 
study on PD micrographia, McLennan et al. (1972) found 
that it is present in a large proportion of PD patients and 
is dissociable from other PD motor symptoms includ-
ing tremor and rigidity. In PD, micrographia may be an 
example of a motor decrement where amplitude is lost 
with repetitive movements. In addition to micrographia, 
handwriting in PD is characterized by a jagged contour 
and sharp fluctuations in velocity and acceleration pro-
files (Van Gemmert et  al., 1999; Teulings et  al., 2002). 
Aspects of handwriting including stroke size, peak accel-
eration, stroke duration, ratio between mean and stand-
ard deviation of stroke length, or duration have been used 
for PD diagnostics (Teulings and Stelmach, 1991; Phillips 
et  al., 1993). Compared to healthy controls, PD patients 
were found to exhibit increased movement time, reduced 
maximum and minimum values of magnitude of pen 
velocity, and more velocity inversions.
Studies found that inhibition of the supplementary 
cortex has been shown to improve handwriting in PD 
(Randhawa et  al., 2013). Dopaminergic treatment in PD 
patients resulted in marked improvements of the kin-
ematics of handwriting movements (Tucha et  al., 2006). 
Indeed, through computational modeling, reducing DA 
levels to the basal ganglia, substantia nigra, and globus 
pallidus external pathways also leads to a reduction in 
letter size, as seen in PD (Gangadhar et  al., 2008; for a 
review, see Helie et al., 2013).
Associations with cognitive dysfunction
In daily life, during handwriting, mental load is often 
present, such as simultaneous calculations or memory 
recall. Similar to walking, it was found that handwriting 
relies on cognitive processing (Thomassen and  Teulings, 
1985) and is sensitive to the availability of cognitive 
resources. For example, it was found that PD patients 
took significantly longer to write while dual tasking 
(Van Gemmert et al., 1998). However, with the provision 
of external cues (e.g. lines for writing), the symptoms of 
micrographia in PD were lessened (Oliveira et al., 1997). It 
is suggested that in PD patients who experience difficul-
ties with performing automatic movements such as hand-
writing, adding a secondary task may increase mental 
load, causing a reduction in writing size, because the 
writing task must then be performed in a more automated 
manner to free resources to fulfill the requirements of the 
concurrently performed secondary task (Van Gemmert 
et al., 1998).
In PD, small handwriting was found to correlate with 
disease severity, motor abnormalities, as well as cognitive 
impairment as measured by the Mini-Mental State Exami-
nation (Wagle Shukla et al., 2012). While writing relies on 
sequential motor processing, that is the coordination of 
different fingers (Catalan et al., 1999), to our knowledge, 
no study has tested the relationship between these two 
domains in PD. However, it is not known whether this 
deficit is an example of a more general deficit in dual 
tasking and task switching and how it is affected by dopa-
minergic medication.
A possible mechanism explaining this reduction in 
the size of handwriting in PD patients may be deficits in 
action-perception loops or changes in sensory feedback 
(e.g. visual or proprioceptive). Indeed, PD patients show 
a discrepancy between visual and kinesthetic feedback 
(Teulings et  al., 2002). This may be due to a degenera-
tion of DA neurons in the nigro-striatal pathway, which 
may lead to impairment in scaling the size (amplitude) 
of movements (Contreras-Vidal and Stelmach, 1995; 
 Contreras-Vidal et  al., 1995). Despite the linguistic com-
ponent of writing, the association between cognition and 
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motor performance is unclear for micrographia. However, 
importantly, the impact of optimal response selection 
of the basal ganglia that influences many cognitive and 
motor performances is also apparent in handwriting.
A number of studies have examined the role of feed-
back in handwriting. Since complex movement emerges 
out of perception-action interactions, changes in sensory 
feedback (e.g. visual or proprioceptive) are likely to intro-
duce corresponding changes in motor output, such as 
in handwriting. Teulings et  al. (2002) controlled visual 
feedback for healthy controls and early-stage PD patients 
such that only vertical gain of handwriting was altered, 
while leaving horizontal gain intact. Both healthy con-
trols and PD patients showed gradual adaptation that 
compensated for distorted visual feedback. Another study 
on the effect of delayed visual feedback on handwriting 
found that most PD patients learned to adjust to feedback 
delay analogous to healthy controls (Smith and Fucetola, 
1995). Of the five patients who participated in the study, 
only one who suffered from micrographia exhibited dif-
ficulty in adapting to delayed feedback, suggesting the 
further studies employing a large sample of PD patients 
with micrographia are needed to investigate the nature of 
sensory feedback and micrographia.
In sum, similar to posture and gait, impairments in 
handwriting in PD patients may be partly due to poor dual 
task control. However, there may also be an impairment 
of sequential motor processing that can contribute to 
handwriting deficits in PD patients, but more research is 
needed to confirm or refute this link.
Precision grip
Precision grip (PG) is defined as a grip formed by one 
finger (typically the index finger) and thumb to hold a 
small object (Napier, 1956). This form of grip enables us to 
make (Marzke, 1997; Susman, 1998) and dexterously use 
tools (Moyà-Solà et al., 1999; Ambrose, 2001; Young, 2003; 
Jones and Lederman, 2006).
Although sensorimotor control may seem to func-
tion independently of the cognitive system (Flanagan 
and Beltzner, 2000), various studies reveal an overlap 
between the motor areas for skilled movements, percep-
tual, and cognitive functions (Olivier et al., 2007; Grafton, 
2010). For example, significant influence of a word’s 
physical representation like apple or grape (Glover et al., 
2004) and numerical magnitude like numbers 1 or 9 
(Badets et al., 2007; Andres et al., 2008) affect grip motor 
control.
Associations with cognitive dysfunction
In concurrent motor and perceptual task performance, 
individuals show longer reaction times, delayed and less 
accurate grip size adjustment, and impaired perpetual 
task performance. This indicates that motor and percep-
tual systems share overlapping attentional resources 
(Hesse and Deubel, 2011; Hesse et al., 2012). The addition 
of a delay to an occluded target dual-task increases the 
grip aperture, showing that motor, visual processing, and 
memory utilize similar resources (Singhal et  al., 2007). 
While attention, visual processing, memory, and motor 
processing employ overlapping resources, only limited 
aspects of PG are affected in a PG-lift task with increased 
cognitive load. Using a task involving PG-lift task and a 
complex visual search combined with counting, it was 
found that a longer preload phase, a higher peak and 
static grip force, and a higher safety margin was employed 
in the combined motor-cognitive task compared to motor 
task alone (Guillery et  al., 2013). Therefore, the PG and 
cognitive tasks utilize similar resources for processing 
information.
Impairment in PG in PD has been attributed to two pos-
sible cognitive deficits, the first being poor sensory-motor 
coordination. There are multiple studies supporting a sen-
sorimotor impairment in PD patients (Shine et al., 2013a; 
Diaz-Hung et  al., 2014). Fellows et  al. (1998) have dem-
onstrated that this impairment is evident in PD patients 
due to excessive grip levels and delayed lifting actions. 
However, Gupta et al. (2013) suggest that the impairment 
may lie in risk-taking behaviors as part of impulse control 
disorders (Voon et al., 2011; Catalan et al., 2013) that are 
prevalent in approximately 36% of PD patients (Callesen 
et al., 2014). According to Gupta et al. (2013), an excessive 
grip is an indication of an increased “safety margin” to 
ensure the object does not fall. This effect is more salient 
in PD patients while off, than on, medication, indicat-
ing higher risk behavior, which is in line with research 
on the interrelationship between impulsivity and dopa-
mine medications (Catalan et al., 2013; Piray et al., 2014). 
Further research aimed at investigating sensory-motor 
coordination and impulsive behaviors would provide 
greater insight into the interaction of cognition and motor 
control and help identify which cognitive impairments 
affect PG.
Speech problems
Most PD patients develop speech and voice disorders at 
some point during their illness (Ho et al., 1998), including 
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stuttering and difficulty initiating speech. Speech in 
PD is often hypophonic (i.e. hypokinetic, soft speech), 
monotonic (i.e. speech quality tends to be soft, hoarse, 
and monotonous), and/or festinating (i.e. excessively 
rapid, soft, poorly intelligible speech) (Jankovic, 2008). 
Dysarthria, which refers to slurred, slow, and difficult-
to-understand speech, is also common in PD. There are 
few studies investigating neural substrates of speech 
dysfunction in PD. In one study in PD, it was found that 
the basal ganglia plays a role in speech production and 
syntactic ability (Lieberman et al., 1992) as well as phone-
mic and semantic fluency test performance (Ellfolk et al., 
2014). One recent study found that bradykinesia affects 
the prosody of the patients’ speech (Azevedo et al., 2013), 
perhaps suggesting a link between speech production 
and dopamine in PD.
Associations with cognitive dysfunction
Studies have found that speech and cognitive processes 
are not necessarily dissociable (Altmann et  al., 2001; 
Wiseheart et  al., 2009). For example, prior studies have 
found a correlation between verbal and cognitive meas-
ures (Lieberman et  al., 1992). A recent review has also 
highlighted the relationship between speech production 
and cognitive measures in PD (Altmann and Troche, 2011). 
In PD, evidence suggests that both working memory and 
executive function processes affect speech production 
(Troche and Lori, 2012). Verb production also correlates 
with cognitive measures, such as working memory in PD 
(Colman et al., 2009).
Discussion
This review investigated the relationship between cog-
nitive processes and motor symptoms in PD, including 
akinesia/bradykinesia, tremor, rigidity, handwriting, 
and speech problems. Not surprisingly, cognitive impair-
ments in PD are strongly related to some motor symptoms 
more than others are. This might be due to some cognitive 
processes that rely on the integrity of the basal ganglia-
thalamocortical loops along with some motor operations, 
while others do not. In addition, as discussed above, 
there is evidence of an interaction between the cogni-
tive and motor loops in the basal ganglia, as opposed to 
each being fully segregated. For example, PD patients 
with the akinesia-dominant phenotype are more likely to 
suffer executive dysfunction, bradyphrenia (i.e. slowness 
of thinking and information processing), and dementia 
than those with the tremor-dominant phenotype. Tremors 
have been suggested to not be associated with cognitive 
dysfunction, with the frontostriatal pathways important 
for healthy cognition appearing relatively spared in those 
patients suffering predominantly from tremors. Gait dys-
function, which is often associated with akinesia in non-
tremor-dominant patients, also appears to be linked with 
cognitive dysfunction. Not only are attentional deficits 
during locomotion evident, but there is also mounting 
evidence of a strong association between the episodic 
symptom of FOG and executive dysfunction. The relation-
ship between cognitive and motor processes in PD is less 
clear for handwriting and speech. Given that both hand-
writing and speech have a linguistic component, the lack 
of a clear association with cognitive dysfunction in PD is 
somewhat surprising.
Focusing future studies on these weaker relationships 
may shed some light on the interaction of cognition and 
motor symptoms in PD. Such research might additionally 
attempt to investigate these cognitive-motor symptom 
relationships beginning at early, preclinical stages, at 
which symptoms are just evident, and follow the trajec-
tory of these unfolding impairments and the temporal 
and pathophysiological relationships to other symptoms. 
Another direction for research might be to attempt to break 
down motor processes into small component parts, to elu-
cidate what types of cognitive processes are involved at 
each part and how cognitive dysfunction might contribute 
to motor impairment. The unraveling of such cognitive-
motor associations is of importance as it may lead to the 
possibility of active interventions such as cognitive train-
ing programs for the treatment of motor impairments, 
including akinesia/bradykinesia, gait dysfunction, and 
FOG in PD patients and also older adults.
While the focus of this paper has been on the interac-
tion of cognition and motor function in PD, there is also 
evidence for motivational modulation of movement speed 
in PD from behavioral (Ballanger et al., 2006; Shiner et al., 
2012; Kojovic et al., 2014; MacDonald and Byblow, 2015) 
and imaging studies (Ballanger et  al., 2008). Regions of 
the cerebral cortex that are engaged in motivation, cogni-
tion, and sensorimotor control, as well as brainstem struc-
tures, feed into the striatum and the subthalamic nucleus, 
the principal input nuclei of the basal ganglia. This input 
is important for action selection in different motor and 
nonmotor domains by inhibiting irrelevant internal and 
external stimuli. Given the structural and functional simi-
larity in information processing across the partially seg-
regated motor, cognitive, and limbic circuits (Alexander 
et  al., 1986), some degree of interaction and integration 
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of information across circuits may occur (Joel and Weiner, 
1994; Haynes and Haber, 2013). Thus, at least for some of 
the motor symptoms of PD, an imbalance between neu-
rotransmitters such as dopamine and acetylcholine may 
underlie deficits with inhibiting irrelevant and selecting 
optimal responses by the basal ganglia (Aosaki et  al., 
2010), causing both motor and cognitive impairments.
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